cl_id,name,EC_No,CAS_No,cl_classification,sourse,num_of_notifiers,ghs_and_notifiers
50357,Sodium methanesulphinate,243-669-6,20277-69-4,Acute Tox. 4,Notified C&L,49,H302:48;H332:4;H312:3;H315:3;H319:3;H351:1;H335:2
50358,"Formaldehyde, telomer with 1,3-benzenedimethanamine, 1,3-benzenediol and ethenylbenzene",615-240-7,710292-85-6,Skin Sens. 1B;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,74,H411:3;H401:3;H317:3;Not classified:71
50361,"Hexamethylene diisocyanate, oligomers, reaction products with 3-methoxypropylamine and ethylenediamine",925-601-3,,Not Classified,Notified C&L,83,Not classified:83
50363,Terbutaline sulphate,245-386-3,23031-32-5,Repr. 2,Notified C&L,44,H361:41;H373:3;H302:4;H332:3;H317:2;H334:2
50372,Bromopentafluorobenzene,206-449-0,344-04-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H315:51;H319:51;H335:49;H332:1;H302:1;H312:1
50377,"(2S-cis)-3-acetoxy-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one monohydrochloride",251-443-3,33286-22-5,Acute Tox. 4,Notified C&L,118,H302:117;H315:7;H319:7;H412:6;H361:11;H311:7;H301:1;H411:1;H335:1;H362:4;H351:1;H318:1;H317:1;H360:2
50378,[(chloromethyl)sulphonyl]benzene,230-581-8,7205-98-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:40;H319:40;H335:39
50382,2-nitrobenzonitrile,210-301-0,612-24-8,Acute Tox. 4;Acute Tox. 4,Notified C&L,43,H302:38;H332:38;H300:4;H311:5;H315:1;H319:1;H331:1;H301:1
50385,2-(p-bromophenoxy)ethanol,252-181-2,34743-88-9,Acute Tox. 4,Notified C&L,40,H302:40
50386,Promethazine,200-489-2,60-87-7,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,53,H411:6;H302:53;H317:5;H318:6;H319:9;H410:9;H332:2;H312:2
50387,Bromopropylate,242-070-7,18181-80-1,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,134,H400:89;H410:89;H315:45;H319:4
50388,Diethyl(2-hydroxyethyl)ammonium acetate,237-216-1,13695-28-8,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1;H317:1
50391,"Solvent naphtha (petroleum), light arom.;Low boiling point naphtha - unspecified;[A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C",265-199-0,64742-95-6,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
50397,Indometacin,200-186-5,53-86-1,Acute Tox. 2;Skin Sens. 1;Repr. 1B,REACH registration C&L,222,H300:186;H360:83;H317:82;H373:35;H413:35;H318:35;H335:35;H336:35;H301:36;H341:5;H310:5;H334:7;H361:5;H412:2;H362:4;H372:2;H311:2;H411:1
50400,"Fatty acids, C16-22, compds. with triethanolamine",271-956-6,68647-51-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,61,H315:59;H319:59;Not classified:2
50402,"Benzenepropanoic acid, β-amino-3-fluoro-, (βS)-",615-753-6,723284-79-5,,Notified C&L,5,H315:5;H319:5;H335:5;H332:1;H302:1;H312:1
50403,2-diisopropylaminoethanol,202-536-2,96-80-0,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,158,H412:111;H314:158;H302:158;H311:158;H331:75;H335:6;H332:83;H318:83
50405,"N,N-bis(2-ethylhexyl)-1H-benzotriazole-1-methylamine",279-446-5,80301-64-0,Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,129,H315:129;H410:124;H400:129;H317:129;H411:5
50407,Germanium tetrabutanolate,246-595-2,25063-27-8,Acute Tox. 4;Acute Tox. 4,Notified C&L,42,H302:38;H312:38;H315:4;H319:4
50408,Oestr-4-en-17-one,222-878-6,3646-28-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 1B,Notified C&L,16,H332:16;H360:16;H350:16;H302:16;H312:16
50412,3-methylpentyl acetate,252-785-6,35897-13-3,Flam. Liq. 3,Notified C&L,1,H226:1
50413,"3,4,5-Trifluor-4'-(4-trans-pentylcyclohexyl)-[1,1'-biphenyl]",603-995-5,137019-95-5,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
50414,"4,4'(4-(4-methoxyphenyl)-1,3,5-triazin-2,4-diyl)bisbenzene-1,3-diol",444-500-0,1440-00-2,Aquatic Chronic 3,Harmonised C&L,0,H412:0
50416,"Butanedioic acid, 2,3-bis(benzoyloxy)-, (2R,3R)-, compd. with (2S)-3-(dimethylamino)-1-(3-methoxyphenyl)-2-methyl-1-propanone (1:1)",617-656-4,850222-41-2,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,4,H315:4;H319:4;H411:4;H302:4;H317:4
50421,"(±)-2-[4-[3-[[4-benzamido-5-(dipropylamino)glutaryl]oxy]propyl]-1-piperazinyl]ethyl 1-(p-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetate, compound with maleic acid (1:2)",261-656-3,59209-40-4,Acute Tox. 3;Aquatic Acute 1,Notified C&L,1,H400:1;H301:1
50425,"2,4-di-tert-pentylphenol",204-439-0,120-95-6,Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 2,REACH registration C&L,87,H411:2;H302:87;H314:24;H319:63;H400:40;H318:22;H410:25;H315:21
50432,2-(4-aminophenyl)ethanol,203-174-8,104-10-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H315:42;H319:42;H335:41;H302:1
50433,"Residues, calcium sulfate-contg., flue gas wet desulfurization neutralization",302-652-4,94114-19-9,Not Classified,Notified C&L,2,Not classified:2
50436,"Fatty acids, C16-18, Et esters",292-945-2,91031-43-5,Not Classified,Notified C&L,7,Not classified:7
50437,"Benzenesulfonic acid, 3-[2-[2-(acetylamino)-4-aminophenyl]diazenyl]-, sodium salt (1:1)",616-504-4,77804-86-5,Not Classified,Notified C&L,83,Not classified:83
50438,"Ethyl 2,3,6-trimethylcyclohexyl carbonate",301-136-6,93981-50-1,Not Classified,Notified C&L,114,Not classified:114
50441,1-(methylamino)anthraquinone,201-417-2,82-38-2,Not Classified,REACH registration C&L,2217,Not classified:2162;H315:54;H319:54;H335:53;H413:1
50443,Hex-2-yn-1-ol,212-128-6,764-60-3,Acute Tox. 4,Notified C&L,39,H302:39;H318:1;H226:1
50447,"1,4-dibromotetrafluorobenzene",206-448-5,344-03-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H315:46;H319:46;H335:45
50450,"2-Propenoic acid, 1,1'-[2-ethyl-2-[[2-hydroxy-3-[(1-oxo-2-propen-1-yl)oxy]propoxy]methyl]-1,3-propanediyl]bis[oxy(2-hydroxy-3,1-propanediyl)] ester",616-302-6,76185-15-4,Not Classified,Notified C&L,1,Not classified:1
50451,"Hexa-1,5-diyne",211-029-5,628-16-0,,Notified C&L,6,H411:4;H304:5;H225:6;H336:4;H315:1;H319:1
50453,1-nitro-2-naphthylamine,210-121-2,606-57-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
50455,"Diethyl[2-[2-[(1-phenylcyclopentyl)formyloxy]ethoxy]ethyl]ammonium dihydrogen 2-hydroxypropane-1,2,3-tricarboxylate",245-449-5,23142-01-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,76,H315:39;H332:38;H319:39;H302:40;H312:38;H335:39;Not classified:36
50458,methyl isocyanate,210-866-3,624-83-9,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1;Acute Tox. 2;STOT SE 3;Resp. Sens. 1;Repr. 2,Harmonised C&L,0,H315:0;H225:0;H330:0;H361:0;H318:0;H317:0;H334:0;H311:0;H335:0;H301:0
50459,1-methylfluorene,217-048-5,1730-37-6,Not Classified,Notified C&L,4,Not classified:3;H315:1;H319:1;H302:1;H335:1
50461,2-propylvaleryl chloride,220-914-5,2936-08-5,,Notified C&L,5,H314:5;H290:1;H318:1
50463,"2,2'-dithiodipyridine",218-343-1,2127-03-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,65,H315:64;H319:64;H335:63;H302:3;Not classified:1
50469,"Amines, N-C8-22-alkyltrimethylenedi-, reaction products with sodium chloroacetate, sodium salts",307-456-2,97659-51-3,Skin Irrit. 2,Notified C&L,49,H315:47;H411:1;H319:2;H400:1
50470,"Protein hydrolyzates, animal",309-203-1,100085-61-8,Not Classified,REACH registration C&L,96,Not classified:96
50476,"Reaction Mass of 5-ethylbicyclo[2.2.1]hept-2-yl methyl ether and 6-ethylbicyclo[2.2.1]hept-2-yl methyl ether and 1-ethyl-3-methoxytricyclo[2.2.1.02,6]heptane",403-610-9,122795-41-9,Aquatic Chronic 2,Notified C&L,37,H411:37
50477,Difluoroacetic acid,206-839-0,381-73-7,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,49,H318:2;H314:49;H319:2;H335:2;H332:1;H290:1
50478,(diethoxyphosphoryl)acetic acid,608-560-3,3095-95-2,Eye Dam. 1,REACH registration C&L,44,H318:2;H302:41;H315:1;H332:1;H319:1;H335:1;H314:1
50483,carvone (ISO);2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-one,202-759-5,99-49-0,Skin Sens. 1,Harmonised C&L,0,H317:0
50489,"Disodium [5-chloro-3-[[4,5-dihydro-3-methyl-5-oxo-1-(3-sulphophenyl)-1H-pyrazol-4-yl]azo]-2-hydroxybenzene-1-sulphonato(4-)]hydroxychromate(2-)",229-054-5,6408-31-7,Not Classified,REACH registration C&L,2063,Not classified:2055;H411:4;H319:3;H315:2;H335:1
50490,"N-(9,10-dihydro-9,10-dioxoanthracen-1-yl)-7-oxo-7H-benzo[e]perimidine-4-carboxamide",224-151-9,4216-01-7,Not Classified,Notified C&L,5,Not classified:5
50492,"Keratins, hydrolyzates",274-001-1,69430-36-0,Not Classified,Notified C&L,60,Not classified:60
50494,"3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl methacrylate",217-877-2,1996-88-9,Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Resp. Sens. 1,Notified C&L,41,H318:39;H317:40;H314:40;H334:40;H315:1;H319:1
50498,Propionamidine hydrochloride,222-753-6,3599-89-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H315:3;H319:3;H335:2
50499,Caesium,231-155-4,7440-46-2,Water-react. 1;Skin Corr. 1B,Notified C&L,51,H260:50;H314:50;H228:4;H318:7;Not classified:1;H361:1
50505,"Peptones, horse",308-510-8,98072-56-1,Not Classified,Notified C&L,3,Not classified:3
50507,"Copper(2+), [N-(2-aminoethyl)-N'-[2-[(2-aminoethyl)amino]ethyl]-1,2-ethanediamine-N,N',N'',N''',N'''']-",610-291-1,46240-82-8,Not Classified,Notified C&L,1,Not classified:1
50515,"2,4,6-trimethylbenzoyl chloride",213-339-6,938-18-1,Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,134,H412:88;H318:89;H413:4;H314:134;H290:1
50517,"reaction mass of: 7,9,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecane-1,16-diyl-prop-2-enoate;7,7,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecan-1,16-diyl-prop-2-enoate",412-260-6,52658-19-2,Eye Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H319:0;H317:0
50518,"Manganese, 4-[(4-chloro-5-methyl-2-sulfophenyl)azo]-3-hydroxy-2-naphthalenecarboxylic acid complex",235-471-3,12238-31-2,Not Classified,REACH registration C&L,168,Not classified:168
50519,"Amides, from C16-22-fatty acids and tetraethylenepentamine",285-081-2,85029-56-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
50520,(+)-2-amino-1-butanol,227-475-9,5856-62-2,Skin Corr. 1B,REACH registration C&L,57,H314:57;H302:53;H400:1;H318:2;H335:1
50523,5-nitrothiophene-2-carbaldehyde,224-850-9,4521-33-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:39
50524,(3RS)-N-methyl-3-phenyl-3-[4-(trifluoromethyl)-phenoxy] propan-1-amine HCl,611-817-2,59333-67-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,101,H315:93;H302:99;H400:59;H318:97;H301:2;H331:1;H410:2
50529,Calcium tartrate,221-621-5,3164-34-9,Not Classified,REACH registration C&L,49,Not classified:49
50530,"2-[p-[(2,6-dichloro-4-nitrophenyl)azo]-N-ethylanilino]ethanol",229-694-5,6657-40-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,38,H315:38;H319:38;H413:38;H302:38;H335:38
50532,"N,N-bis(2-hydroxyethyl)oleamide",202-281-7,93-83-4,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,841,H315:317;H318:104;Not classified:520;H319:175;H411:202;H400:42;H410:4;H373:1;H302:1;H312:1;H335:1
50534,"Phenol, isobutylenated methylstyrenated",270-604-9,68457-74-9,Not Classified,Notified C&L,22,Not classified:22
50536,"2-(β-D-ribofuranosyl)-1,2,4-triazine-3,5-diol",200-199-6,54-25-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,38,H332:38;H302:38;H312:38;H351:38
50538,3'-methylbenzanilide,209-490-2,582-77-4,Acute Tox. 4,Notified C&L,38,H302:38
50539,1-(chloromethyl)-4-vinylbenzene,216-471-2,1592-20-7,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1,Notified C&L,53,H302:53;H317:53;H314:53;H311:39;H312:14;H318:3;H332:1;H290:1
50540,Tris(2-hydroxyethyl)methylammonium hydroxide,251-624-7,33667-48-0,Acute Tox. 4;Skin Corr. 1A,Notified C&L,32,H312:32;H314:32
50545,Tributylamine,203-058-7,102-82-9,Acute Tox. 4;Acute Tox. 2;Skin Irrit. 2;Acute Tox. 1,REACH registration C&L,3205,H315:2763;H302:3182;H310:2520;H330:2721;H319:446;H412:441;H311:602;H411:155;H331:39;H314:10;H317:1;H335:1;H301:1
50549,Montmorillonite,215-288-5,1318-93-0,,Notified C&L,103,Not classified:99;H315:4;H335:4;H318:4
50552,Lithium 2-hydroxyethoxide,245-520-0,23248-23-9,Repr. 1A,Notified C&L,58,H360:32;H314:26
50555,"Tricarbonyl[(1,2,3,4,5,6-η)-1,3,5-cycloheptatriene]chromium",235-196-9,12125-72-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H315:38;H332:38;H319:38;H302:38;H312:38;H335:38
50558,"D-Glutamic acid, 5-(phenylmethyl) ester",607-810-9,2578-33-8,Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38
50563,Clobetasol,246-633-8,25122-41-2,Repr. 1B;STOT RE 2;Aquatic Chronic 4,Notified C&L,41,H373:40;H360:38;H413:38;H302:1
50567,4-[(2-aminoethoxy)ethyl]morpholine,243-595-4,20207-13-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H332:1;H319:1;H302:1;H312:1;H335:1
50571,"1-Pentanol, 3-mercapto-2-methyl-",607-151-7,227456-27-1,Acute Tox. 4,Notified C&L,113,H302:113
50573,Methyl 3-[(trimethylsilyl)oxy]-2-butenoate,263-483-9,62269-44-7,Flam. Liq. 3,Notified C&L,38,H226:38
50574,"α,4-dichlorotoluene",203-242-7,104-83-6,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,94,H332:91;H411:91;H302:91;H312:91;H317:88;H319:34;H314:10;H318:3;H341:1;H311:1;H331:1;H301:1
50576,"Bis[[S-(R*,R*)]-(β-hydroxy-α-methylphenethyl)methylammonium] sulphate",231-243-2,7460-12-0,Acute Tox. 4;Skin Sens. 1,Notified C&L,158,H302:158;H317:84;H315:38;H319:38;H335:38;H332:36;H372:35;H312:1
50577,"Butane-1,2,3,4-tetracarboxylic acid",216-938-0,1703-58-8,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,55,H319:50;H302:54;H315:7;H335:7;H318:4;Not classified:3;H332:2;H312:2
50578,p-nitro-N-propylbenzylamine hydrochloride,268-721-5,68133-98-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H315:42;H319:42;H335:42
50581,Tetraamminopalladium sulfate,426-980-3,13601-06-4,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1;H302:1
50583,2-(p-tolyl)pyridine,224-734-8,4467-06-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:44;H319:44;H335:39
50592,"Disodium 5-[[4'-[(7-amino-1-hydroxy-3-sulphonato-2-naphthyl)azo][1,1'-biphenyl]-4-yl]azo]salicylate",219-391-6,2429-82-5,Acute Tox. 4;Carc. 1A;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H400:38;H410:38;H302:38;H350:38
50593,3-(diethylamino)-7-[[p-(dimethylamino)phenyl]azo]-5-phenylphenazinium chloride,220-695-6,2869-83-2,Not Classified,Notified C&L,1,Not classified:1
50596,Nikethamide,200-418-5,59-26-7,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,79,H315:75;H319:75;H335:74;H301:79;H332:1;H311:3;H331:2
50599,5-hexyldihydro-4-methylfuran-2(3H)-one,266-847-5,67663-01-8,Not Classified,Notified C&L,114,Not classified:79;H315:35
50601,Hexakis(methoxymethyl)melamine,221-422-3,3089-11-0,Eye Irrit. 2,Notified C&L,626,H319:445;Not classified:149;H317:18;H302:14;H315:2;H351:1
50602,(2-hydroxyethyl)(methyl)[2-(stearoyloxy)ethyl]ammonium methyl sulphate,264-499-9,63833-73-8,Not Classified,Notified C&L,31,Not classified:31
50603,"azamethiphos (ISO); S-[(6-chloro-2-oxooxazolo[4,5-b]pyridin-3(2H)-yl)methyl] O,O-dimethyl thiophosphate",252-626-0,35575-96-3,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,206,H332:156;H400:157;H302:206;H317:163;H410:162;H319:43
50609,1-methoxybutan-2-ol,258-763-2,53778-73-7,Flam. Liq. 3,Notified C&L,40,H226:40
50610,"Octahydro-4,7-methano-1H-indenemethyl formate",268-286-1,68039-78-1,Not Classified,Notified C&L,88,Not classified:88
50612,"Cantharellus cibarius, ext.",296-882-1,93164-99-9,Not Classified,Notified C&L,1,Not classified:1
50614,"2,6-diamino-1H-pyrimidin-4-one",200-254-4,56-06-4,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,102,H400:85;H410:85;Not classified:12;H315:5;H319:5;H335:3;H302:1
50616,4-biphenylacetic acid,227-233-2,5728-52-9,Acute Tox. 3;Acute Tox. 1;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 1;STOT SE 3,Notified C&L,97,H315:97;H330:52;H319:97;H310:52;H335:96;H301:97;H331:39
50617,"2,5-Diamino-1,4:3,6-dianhydro-2,5-deoxy-D-sorbitol",688-094-5,143396-56-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
50618,"Sulfuric acid, mono-C15-18-alkyl esters, sodium salts",272-273-6,68784-79-2,Not Classified,Notified C&L,1,Not classified:1
50622,"Tetrasodium 3-[[5-[[4-chloro-6-[[3-[[2-(sulphonatooxy)ethyl]sulphonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-2-sulphonatophenyl]azo]-4-hydroxy-6-[(3-sulphonatophenyl)amino]naphthalene-2-sulphonate",279-276-1,79809-26-0,Not Classified,Notified C&L,1,Not classified:1
50625,Pyrrole-2-carbaldehyde,213-705-5,1003-29-8,Not Classified,REACH registration C&L,140,Not classified:3;H315:137;H319:137;H335:136
50628,cis-epoxysuccinic acid,240-604-3,16533-72-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,2,H315:2;H319:2;H335:1
50631,"1-amino-1-cyanamino-2,2-dicyanoethylene, sodium salt",425-870-2,19450-38-5,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H317:0
50634,(RS)-2-methylbutyryl chloride,260-787-3,57526-28-0,Flam. Liq. 3;Skin Corr. 1A,REACH registration C&L,133,H314:44;H226:3;H317:88;H225:42;H315:1;H319:1;H335:1
50635,2-[4-(bromomethyl)phenyl]acetic acid,604-016-4,13737-36-5,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,47,H315:42;H319:42;H335:41;H334:39;H314:4;H332:1;H341:1
50636,"Quassia, ext.",272-809-9,68915-32-2,Flam. Liq. 2,Notified C&L,1423,H225:1286;H226:87;Not classified:25;H224:24;H302:1
50640,"16α,17,21-trihydroxypregna-1,4,9(11)-triene-3,20-dione 21-acetate",278-593-2,77017-20-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 2;Aquatic Chronic 2,REACH registration C&L,4,H315:4;H319:4;H411:4;H361:4;H335:4
50643,Bismuth chloride oxide,232-122-7,7787-59-9,Not Classified,REACH registration C&L,305,Not classified:256;H315:48;H319:48;H335:48;H413:1
50650,N-methylbenzanilide,217-704-0,1934-92-5,Acute Tox. 4;Skin Sens. 1,Notified C&L,38,H302:38;H317:38
50652,Benzyl 5-oxoprolinate,262-291-2,60555-57-9,Not Classified,Notified C&L,2,Not classified:2
50656,"1H-Pyrrole-3-carboxamide, 5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-",418-950-3,125995-03-1,Aquatic Chronic 4,Notified C&L,29,H413:29
50658,N-phenylpiperazine,202-165-6,92-54-6,Acute Tox. 3;Acute Tox. 1;Skin Corr. 1A,REACH registration C&L,64,H310:23;H314:63;H301:62;H311:40;H318:2;H319:1;H302:2
50659,1-iodododecane,224-293-1,4292-19-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H315:44;H319:45;H335:43;H332:1;H302:1;H312:1
50662,Platinum tetrachloride,236-645-1,13454-96-1,Acute Tox. 3;Skin Sens. 1;Eye Dam. 1;Resp. Sens. 1,Notified C&L,56,H318:41;H317:56;H334:50;H301:51;H290:7;H314:17;H302:5;H341:4;H315:1;H340:1
50663,"ethidium bromide;3,8-diamino-1-ethyl-6-phenylphenantridinium bromide",214-984-6,1239-45-8,Acute Tox. 4;Acute Tox. 2;Muta. 2,Harmonised C&L,0,H302:0;H341:0;H330:0
50667,2-hydroxy-1-methylethylacrylate,220-852-9,2918-23-2,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 3,Harmonised C&L,0,H314:0;H317:0;H311:0;H331:0;H301:0
50669,2-(dimethylamino)ethyl benzoate,218-630-1,2208-05-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:40;H319:39;H335:38;H317:1
50671,zinc ammoniate ethylenebis(dithiocarbamate)-poly[ethylenebis(thiuramdisulfide)]; metiram,618-430-8,9006-42-2,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,86,H400:83;H410:83;H317:83;Not classified:3
50673,"5-Chloro-2,3-difluoropyridine",618-273-5,89402-43-7,Flam. Liq. 3;Acute Tox. 4;Aquatic Chronic 3,Notified C&L,232,H412:231;H302:231;H226:232;H315:1;H319:1;H335:1
50674,(1-methylpiperidin-4-yl)methanol,681-545-7,20691-89-8,Eye Irrit. 2,Notified C&L,45,H319:45;H315:6;H335:6
50675,"1,2-dimethylcyclohexene",216-814-6,1674-10-8,Flam. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H225:38;H319:38;H302:38;H335:38
50679,Gadolinium triiodide,236-997-6,13572-98-0,Skin Sens. 1;Repr. 1B,Notified C&L,45,H360:38;H317:38;H315:7;H319:7;H335:7
50680,"Naphtha (petroleum), acid-treated;Low boiling point naphtha - unspecified;[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-115-2,64742-15-0,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
50691,Heptan-1-ol,203-897-9,111-70-6,Eye Irrit. 2,REACH registration C&L,1539,H319:1448;H332:52;H331:42;H302:10;H312:9;H311:1;H335:1;H301:1
50694,N-(2-phenylethyl)acetamide,212-897-8,877-95-2,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
50696,"Phosphorous acid, tripentyl ester",606-400-7,1990-22-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H315:1;H319:1;H302:1;H412:1
50697,"bromoxynil (ISO);3,5-dibromo-4-hydroxybenzonitrile;bromoxynil phenol",216-882-7,1689-84-5,Acute Tox. 3;Skin Sens. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H330:0;H400:0;H361:0;H317:0;H410:0;H301:0
50698,"Extracts (petroleum), heavy naphthenic distillate solvent",265-111-0,64742-11-6,Carc. 1B,Harmonised C&L,0,H350:0
50702,"Reaction mass of pyrimido[5,4-g]pteridine-2,4,6,8-tetramine and 2,6,8-triamino-pyrimido[5,4-g]pteridine-4(1H)-one",440-560-7,346709-25-9,Not Classified,REACH registration C&L,84,Not classified:84
50705,"2,6-di-tert-butyl-4-mercaptophenol",213-451-5,950-59-4,,Notified C&L,1,Not classified:1
50707,"2-Amino-4,5-dimethoxybenzonitrile",608-025-4,26961-27-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:39;H319:39;H335:39;H332:5;H302:5;H312:5;H311:1;H331:1;H301:1
50710,trans-vinylenebis[diphenylphosphine],213-570-2,983-81-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:43;H319:43;H335:42
50712,"5-(4-methylphenyl)-5-phenylimidazolidine-2,4-dione",257-028-3,51169-17-6,Acute Tox. 4;Carc. 2;Repr. 2,Notified C&L,39,H351:38;H361:39;H302:39
50714,"2,4-dimethylpent-2-ene",210-905-4,625-65-0,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,39,H304:39;H225:39
50719,Methothrin,608-982-8,34388-29-9,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
50726,Crystacal,607-950-0,26499-65-0,Not Classified,Notified C&L,71,Not classified:71
50727,Cobalt dichromium tetraoxide,234-613-1,12016-69-2,,Notified C&L,4,H350:4;H302:4;H317:4;H314:4
50729,Polystyrene-block-poly(ethylene-ran-butylene)-block-polystyrene-graft-maleic anhydride,601-265-0,113569-15-6,Flam. Sol. 2,Notified C&L,1,H228:1
50731,"2,3-dihydro-2-methyl-1H-indol-1-amine monomethanesulphonate",286-857-3,85392-00-3,Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1
50732,8-benzyl-7-(2-(N-ethyl-2-hydroxyethylamino)ethyl)theophylline,606-448-9,2016-63-9,Acute Tox. 4,Notified C&L,1,H302:1
50736,silicon dioxide; synthetic amorphous silicon dioxide (nano),231-545-4,7631-86-9,Not Classified,REACH registration C&L,7065,Not classified:6373;H315:277;H319:438;H335:526;H332:121;H372:75;H302:30;H371:22;H373:46;H370:4;H312:4;H314:3;H350:8;H340:7;H412:7;H260:3;H251:2;H304:2;H225:2;H411:1;H317:2;H334:2;H261:2
50738,Trimethylaluminium,200-853-0,75-24-1,Pyr. Liq. 1;Water-react. 1;Skin Corr. 1B,REACH registration C&L,221,H250:217;H260:216;H314:217;H318:16;H315:4;H332:4;H304:4;H224:4;H361:4;H411:4;H336:4;H225:2;H261:2;H252:2
50741,3-ethyl-5-(2-hydroxyethyl)-4-methylthiazolium bromide,258-925-2,54016-70-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H315:41;H319:41;H335:40
50743,Iron carbonate,209-259-6,563-71-3,Not Classified,Notified C&L,2,Not classified:2
50745,"2-[(2,4-diaminophenyl)thio]ethanol dihydrochloride",279-671-9,81029-01-8,Acute Tox. 4;Skin Sens. 1,Notified C&L,38,H302:38;H317:38
50746,5-Hexynoic Acid,610-982-8,53293-00-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H315:40;H319:40;H335:40;H314:11;H332:2;H302:3;H312:3;H318:4;H290:1
50748,(2-methoxyethoxy)acetic acid,240-161-6,16024-56-9,Skin Corr. 1B,Notified C&L,44,H314:43;H318:1
50752,C.I. Food Yellow 13,616-849-0,8004-92-0,Not Classified,Notified C&L,2172,Not classified:2097;H302:75;H315:2;H319:2
50753,Alpha-acetylphenylacetonitrile,224-737-4,4468-48-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,41,H315:41;H332:41;H319:41;H302:41;H312:41;H335:41
50754,"N,N''-(methylenedi-p-phenylene)bis[N'-tridecylurea]",275-275-5,71216-00-7,,Notified C&L,1,H413:1
50755,4-methyloxazole-5-carbonitrile,213-709-7,1003-52-7,Flam. Liq. 3;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,3,H332:2;H319:2;H412:2;H302:2;H226:1;H331:1;H311:1;H301:1;H315:1;H335:1;H312:1;H227:1
50756,1-(2-chlorophenyl)piperazinium chloride,255-262-0,41202-32-8,,Notified C&L,2,H302:2;H315:1;H332:1;H319:1;H335:1
50758,"Glycerides, C14-18 and C16-22-unsatd.",288-225-2,85681-87-4,Not Classified,Notified C&L,53,Not classified:53
50761,4-(4-nitrobenzyl)pyridine,214-108-2,1083-48-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:38
50763,"Siloxanes and Silicones, di-Me, polymers with Me silsesquioxanes and polyethylene-polypropylene glycol mono-Bu ether",614-606-3,68554-65-4,Not Classified,Notified C&L,98,Not classified:93;H315:5;H318:5
50765,Naftalofos,216-078-6,1491-41-4,Acute Tox. 3;Acute Tox. 2,Notified C&L,38,H310:38;H301:38
50766,dimexano (ISO);bis(methoxythiocarbonyl) disulphide,215-993-8,1468-37-7,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H302:0
50768,Xylidine,215-091-4,1300-73-8,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Chronic 2,Notified C&L,74,H373:73;H411:73;H311:72;H331:72;H301:73;H330:2;H351:2;H310:1;H371:1;H319:1;H302:1;H312:1
50769,Phenyl 4-hydroxybenzoate,241-698-9,17696-62-7,Skin Irrit. 2;Skin Sens. 1,REACH registration C&L,46,H315:41;H319:41;H317:2;Not classified:5
50771,"1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]anthraquinone dihydrochloride",274-619-1,70476-82-3,Muta. 1B;Repr. 1B,Notified C&L,42,H360:39;H340:39;H302:4;H332:1;H350:2;H361:1;H312:1;H362:2;H319:1;H413:1;H310:2;H370:1;H341:1;H351:1;H372:1
50777,p-tolylmercury chloride,208-716-7,539-43-5,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H330:38;H400:38;H373:38;H300:38;H310:38;H410:38
50778,"Pregna-1,4-diene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-, monosodium salt, (6α,11β)-",219-156-8,2375-03-3,Carc. 2;Repr. 1B,Notified C&L,60,H351:39;H360:39;H361:20;H302:16;H312:16;Not classified:1;H373:1;H372:1
50779,"Benzene, dodecyl-, branched and linear, sulfonated, sodium salts",296-539-6,92731-37-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H315:1;H302:1;H318:1
50780,"Hexanedioic acid, polymer with 2,2-dimethyl-1,3-propanediol",608-153-0,27925-07-1,Not Classified,Notified C&L,94,Not classified:94
50781,N-[3-(dimethylamino)propyl]myristamide,256-214-1,45267-19-4,Skin Irrit. 2;Eye Dam. 1,Notified C&L,128,H315:126;H318:127;Not classified:1;H400:1;H410:1;H411:1
50786,2-(dodecylsulphinyl)ethanol,243-800-7,20413-40-5,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1,Notified C&L,38,H302:38;H317:38;H318:38
50788,(E)-dec-4-ene,243-034-3,19398-89-1,Flam. Liq. 3,Notified C&L,38,H226:38
50791,Disuccinimido dithiobispropionate,260-931-5,57757-57-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H315:41;H319:41;H335:40
50792,"foramsulfuron (ISO); 2-{[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]sulfamoyl}-4-formamido-N,N-dimethylbenzamide; 1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-dimethylcarbamoyl-5-formamidophenylsulfonyl)urea",605-666-1,173159-57-4,Aquatic Chronic 3,Notified C&L,16,H412:12;Not classified:4
50802,"Alcohols, C11-13-branched, ethoxylated",614-485-7,68439-54-3,Acute Tox. 4;Eye Dam. 1,Notified C&L,71,H302:37;H318:66;Not classified:5
50803,SODIUM METHYL METHYLPHOSPHONATE,616-015-6,73750-69-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,58,H315:38;H319:38;H335:38;Not classified:20
50806,Sulfamerazine,204-866-2,127-79-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H315:46;H319:46;H335:46;H302:1;Not classified:1
50808,Barium p-toluate,267-479-8,67874-52-6,Not Classified,Notified C&L,3,Not classified:2;H302:1;H332:1
50811,"5,5-pentamethylene-7-oxo-2,3,4,5,6,7-hexahydrocyclopenta[a] pyrimidine",922-971-8,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H315:2;H319:2;H302:2;H335:2
50812,5-nitrofurfurylidene di(acetate),202-166-1,92-55-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Muta. 2,REACH registration C&L,55,H332:50;H302:50;H312:50;H341:12;H351:40
50814,"Tris(2-ethylhexanoic) acid, trianhydride with boric acid",257-004-2,51136-86-8,Repr. 1B,Notified C&L,1,H360:1
50816,Diammonium phthalate,208-341-9,523-24-0,Not Classified,REACH registration C&L,3,Not classified:3
50819,N-4-pyridylbenzamide,226-019-6,5221-44-3,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H319:38;H302:38;H331:1;H311:1;H301:1
50821,3-furoic acid,207-689-9,488-93-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:44;H319:44;H335:43
50824,"2-methyl-5-(1,1,3,3-tetramethylbutyl)hydroquinone",400-530-6,723-38-6,Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H318:0;H317:0
50825,sodium (4-methoxybiphenyl-3-yl)diazenesulfonate,928-403-5,,Not Classified,REACH registration C&L,1,Not classified:1
50827,"(3S,3aR,4S,6S,6AR,7S,8S,9bS)-6- (Acetyloxy)-2,3,3a,4,5,6,6a,7,8,9b-decahydro-3,3a-dihydroxy-3,6,9-trimethyl-8-[[(2Z)-2-methyl-1-oxo-2-butenyl]oxy]-2-oxo-4-(1-oxobutoxy)azuleno[4,5-b]furan-7-yl octanoate",614-076-3,67526-95-8,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,42,H315:42;H319:42;H335:42;H334:42;H311:1;H331:1;H301:1
50828,Magnesium carbonate hydroxide,235-192-7,12125-28-9,Not Classified,REACH registration C&L,73,Not classified:71;H315:1;H319:2
50832,1-benzyl-3-carbamoylpyridinium chloride,225-814-5,5096-13-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:1;H319:2;H302:2;H335:1
50833,"Fatty acids, tall-oil, reaction products with 2-amino-2-(hydroxymethyl)-1,3-propanediol and formaldehyde",279-511-8,80585-00-8,Not Classified,REACH registration C&L,1,Not classified:1
50835,Tobramycin,251-322-5,32986-56-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,9,H315:4;H319:4;H335:4;H361:2;H317:1;H360:2;H400:1;H411:1;H372:1
50837,2-chloro-2-methylpropane,208-066-4,507-20-0,Flam. Liq. 2,REACH registration C&L,90,H225:90;H319:10;H351:10;H302:10;H335:10;H315:1
50838,2-octyldodecyl 12-[(1-oxooctadecyl)oxy]octadecanoate,289-991-0,90052-75-8,Aquatic Chronic 1,REACH registration C&L,75,H410:16;Not classified:59
50839,Potassium dibenzyl phosphate,616-628-9,78543-37-0,Eye Dam. 1,REACH registration C&L,2,H318:2
50841,"Fatty acids, castor-oil, Me esters",269-908-4,68390-63-6,Not Classified,REACH registration C&L,13,Not classified:13
50842,Methyl 3-mercaptopropionate,220-912-4,2935-90-2,Acute Tox. 3;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 2;Aquatic Chronic 1,REACH registration C&L,90,H330:77;H319:10;H312:41;H410:37;H301:42;H302:39;H226:45;H400:33;Not classified:6;H315:5;H335:4;H331:2;H332:2;H311:1
50849,Phenylurea,200-576-5,64-10-8,Acute Tox. 4,Notified C&L,45,H302:45;H315:2;H319:2
50850,"α,α-diphenylpiperidine-1-butyramide monohydrochloride",237-816-3,14007-53-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,17,H315:17;H319:17;H302:17;H335:17
50859,"Tetrasodium 4,4'-bis[[4-morpholino-6-(p-sulphonatoanilino)-1,3,5-triazin-2-yl]amino]stilbene-2,2'-disulphonate",249-323-0,28950-61-0,Not Classified,REACH registration C&L,2,Not classified:2
50860,"strawberry fragaria annassa, extract",927-774-0,,Not Classified,Notified C&L,1,Not classified:1
50861,"prallethrin (ISO);ETOC;2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate",245-387-9,23031-36-9,Acute Tox. 4;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H331:0;H410:0;H302:0;H400:0
50862,"Alkenes, C6-8-branched, C7-rich",307-298-4,97592-99-9,Flam. Liq. 2;Asp. Tox. 1;Aquatic Chronic 1,REACH registration C&L,2,H400:2;H410:2;H304:2;H225:2
50864,naphthalene,202-049-5,91-20-3,Acute Tox. 4;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H351:0;H410:0;H302:0;H400:0
50865,"2,2'-dithiodi(benzoic acid)",204-352-8,119-80-2,Skin Sens. 1A,REACH registration C&L,2089,H317:2041;H315:2088;H319:2088;H335:2086
50866,2-tert-butyl-p-benzoquinone,222-757-8,3602-55-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:38
50867,1H-purin-2-amine,207-197-4,452-06-2,Acute Tox. 4,Notified C&L,39,H302:39;H315:1;H319:1
50870,"Methyl 1,2,3,4-tetrahydro-6-naphthyl ether",217-049-0,1730-48-9,Skin Sens. 1B;Eye Irrit. 2B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H400:1;H320:1;H401:1;H317:1;H410:1
50877,"4,5-dichloro-3H-1,2-dithiol-3-one",214-754-5,1192-52-5,Acute Tox. 3;Skin Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,38,H315:38;H335:38;H400:38;H301:38
50885,tert-butyl isocyanate,216-544-9,1609-86-5,Flam. Liq. 2;Acute Tox. 3;Skin Corr. 1C;Skin Sens. 1;Eye Dam. 1;Acute Tox. 2;STOT SE 3,REACH registration C&L,84,H225:81;H330:83;H314:76;H318:3;H317:76;H335:81;H301:35;H302:46;H334:45;H412:33;H315:8;H319:8;H310:3;H226:3;H304:1;H312:2;H331:1
50886,2-methoxyethyl chloroformate,211-026-9,628-12-6,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,44,H314:44;H226:44;H330:6;H300:2;H318:1;H310:2
50894,"1,2-bis(benzyloxycarbonyl)ethylammonium toluene-p-sulphonate",220-746-2,2886-33-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H332:1;H319:1;H302:1;H312:1;H335:1
50895,"1,8-dimethoxyoctane-1,8-diyldiammonium dichloride",252-060-4,34490-86-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:43;H319:43;H335:42
50902,2-bromooctane,209-171-8,557-35-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
50906,Tetrazinc trioxide phosphite,264-938-4,64539-51-1,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,11,H400:2;H410:2;Not classified:9
50908,Cholest-5-ene,209-332-2,570-74-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
50909,L-chloromethyl (2-phenyl-1-(p-toluenesulphonylamino)ethyl) ketone,206-954-6,402-71-1,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,40,H315:39;H335:38;H318:39;H319:1
50915,5-(trifluoromethyl)uracil,200-197-5,54-20-6,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:43;H319:43;H335:43;H301:40;H317:1
50918,"trisodium 5-{[4-chloro-6-(1-naphthylamino)-1,3,5-triazin-2-yl]amino}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalenedisulfonate",440-480-2,341026-59-3,Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H318:0;H317:0
50922,1-(p-methoxyphenyl)acetaldehyde oxime,411-510-1,3353-51-3,Skin Sens. 1,Harmonised C&L,0,H317:0
50923,"Distillates (petroleum), naphtha steam cracking-derived, solvent-refined light hydrotreated;Low boiling point modified naphtha;[A complex combination of hydrocarbons obtained as the raffinates from a solvent extraction process of hydrotreated light distillate from steam-cracked naphtha.]",295-315-5,91995-53-8,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
50931,Cinnamyltriphenylphosphonium chloride,216-225-4,1530-35-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
50933,(2-chlorophenyl) (1-hydroxycyclopentyl) ketone,292-676-0,90717-17-2,Not Classified,Notified C&L,1,Not classified:1
50934,Methyl benzoylformate,239-263-3,15206-55-0,Skin Sens. 1,REACH registration C&L,237,H317:114;H315:73;H319:73;H335:73;Not classified:49;H331:1;H312:1
50935,12-methoxyibogamine,201-498-4,83-74-9,Acute Tox. 4,Notified C&L,38,H302:38
50936,C.I. Acid Brown 270,612-617-8,61901-26-6,Not Classified,Notified C&L,1,Not classified:1
50943,Tetrakis(1-methylethyl) orthosilicate,217-875-1,1992-48-9,Eye Dam. 1,Notified C&L,39,H318:39;H314:1
50947,Titanium bis(sulphate),237-215-6,13693-11-3,Not Classified,Notified C&L,1,Not classified:1
50948,(1H)-pyrazin-2-one,228-455-2,6270-63-9,Acute Tox. 4;Eye Dam. 1,Notified C&L,41,H302:39;H318:39;H315:2;H319:2;H335:1
50954,Diethyl dibutylmalonate,209-890-7,596-75-8,Acute Tox. 4,Notified C&L,38,H302:38
50956,"3,5,5-trimethylhexanoic acid, compound with 2-aminoethanol (1:1)",299-706-1,93894-11-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,26,H315:26;H319:26;H302:26;H412:1
50961,"1,1,1,2,3,3-hexafluoropropane",207-076-6,431-63-0,Press. Gas (Liq.),Notified C&L,2,H280:2
50964,"5-(2-Bromoethyl)-2,3-dihydrobenzofuran",603-191-4,127264-14-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H315:2;H319:2;H335:2;Not classified:1;H302:1
50965,"Cellulose, 2-hydroxyethyl ether",618-387-5,9004-62-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1047,H315:630;H319:631;H335:589;Not classified:414;H332:1;H302:1;H312:1
50968,"Proteinase, microbial alkaline",256-863-0,50936-53-3,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1;H334:1
50973,"α-cyano-3-phenoxybenzyl [1R-[1α(S*),3α]]-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate",265-898-0,65731-84-2,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Aquatic Acute 1,Notified C&L,2,H315:2;H332:2;H400:2;H319:2;H312:2;H410:2;H301:2
50977,"Waxes and Waxy substances, shellac, bleached",308-755-0,98219-84-2,Not Classified,Notified C&L,1,Not classified:1
50978,"3,4-dimethoxy-N-[3-(4-Methoxyphenyl)-1-methylpropyl]-β-phenylethylamine Hydrobromide",918-206-2,,Acute Tox. 3;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H319:2;H335:2;H301:2
50980,(2-hydroxyethyl)triphenylphosphonium chloride,245-521-6,23250-03-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
50982,Chromium oxalate,238-718-3,14676-93-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,3,H315:2;H332:3;H319:2;H302:3;H312:3;H335:3;H314:1
50983,Chlorotri[2H3]methylsilane,243-785-7,20395-57-7,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1A;Acute Tox. 4;STOT SE 3,Notified C&L,38,H332:38;H225:38;H314:38;H312:38;H335:38
50984,Ambenonium chloride,204-107-5,115-79-7,Acute Tox. 2,Notified C&L,38,H300:38
50990,"3-dibenzo[b,e]thiepin-11(6H)-ylidene-8-methyl-8-azabicyclo[3.2.1]octane hydrochloride",248-535-0,27574-25-0,Acute Tox. 4,Notified C&L,1,H302:1
50992,2-chloro-4-fluorophenol,217-876-7,1996-41-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H315:41;H319:41;H335:40;H411:4;H302:5;H312:5;H314:4;H332:1
50995,4-butylaniline,203-177-4,104-13-2,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Aquatic Chronic 3,Notified C&L,45,H315:45;H319:45;H412:38;H311:39;H331:39;H335:44;H301:39;H302:6;H332:2;H312:2
50996,Isopropenyl chloroformate,261-018-4,57933-83-2,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3;STOT SE 3,Notified C&L,41,H225:41;H314:41;H311:39;H331:39;H335:38;H301:39;H330:2;H302:2;H312:1;H318:1
51001,"Fatty acids, C16-18, esters with triethanolamine",292-942-6,91031-40-2,Eye Irrit. 2,Notified C&L,52,H319:35;Not classified:17;H315:2
51002,C.I. Acid Brown 324,612-618-3,61901-27-7,,Notified C&L,33,Not classified:33
51006,"4,4-dimethylpentan-2-ol",228-147-8,6144-93-0,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:39;H226:39
51009,"1,3-benzoxazine-2,4-dione",606-541-4,2037-95-8,Acute Tox. 4,REACH registration C&L,41,H302:41
51015,2-chloro-5-nitropyrimidin-4-amine,217-648-7,1920-66-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,39,H315:39;H319:39;H302:39;H334:39;H335:39
51017,"Phosphoric acid, dodecyl ester, potassium salt",254-414-3,39322-78-6,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,150,H315:143;H318:142;H333:7;H303:7;H319:1
51018,[(2-bromoethyl)thio]benzene,225-422-4,4837-01-8,,Notified C&L,4,H315:4;H319:4
51023,Formylhydrazine,210-867-9,624-84-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,204,H315:204;H319:204;H335:202;H336:156;H351:1;H411:1;H302:2;H311:1;H331:1;H332:1;H312:1
51027,Sodium salicylate,200-198-0,54-21-7,Acute Tox. 4;Eye Irrit. 2;Repr. 2,REACH registration C&L,427,H361:103;H319:342;H302:411;H301:13;H315:9;H335:13;Not classified:4;H312:1
51028,"Amines, dicoco alkylmethyl",262-990-2,61788-62-3,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,549,H315:528;H318:528;H400:529;Not classified:20
51029,"1,3-dihydro-5-nitro-2H-benzimidazol-2-one",202-282-2,93-84-5,Not Classified,Notified C&L,34,Not classified:30;H302:4;H332:4
51034,2-[(2-aminobenzoyl)amino]benzoic acid,210-304-7,612-34-0,Not Classified,REACH registration C&L,6,Not classified:6
51035,Phenazone,200-486-6,60-80-0,Acute Tox. 4,REACH registration C&L,242,H302:241;H315:161;H319:161;H317:145;H335:160;Not classified:1;H370:1
51038,(4-aminophenyl)phosphonic acid,226-260-7,5337-17-7,Skin Irrit. 2;Eye Irrit. 2A,Notified C&L,3,H315:3;H319:3
51041,"Amines, C10-14-branched and linear alkyl, [2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)][2-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]benzoato(2-)]chromate(1-)",285-084-9,85029-59-0,Aquatic Chronic 3,Notified C&L,114,H412:83;H400:24;H410:25;Not classified:6;H317:2;H350:2
51043,"3-methyl-1H-1,2,4-triazole",615-326-4,7170-01-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,42,H315:42;H335:41;H302:39;H318:38;H319:4
51046,Platinum dichloride,233-034-1,10025-65-7,Skin Corr. 1B;Skin Sens. 1;Resp. Sens. 1,Notified C&L,52,H334:46;H317:46;H314:45;H315:7;H319:6;H335:4;H290:2;H318:1;H413:1
51048,Isooctene,234-294-9,11071-47-9,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;Aquatic Chronic 2,REACH registration C&L,87,H315:87;H304:87;H225:87;H411:87
51050,"2,3-dihydroxybenzoic acid",206-139-5,303-38-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H315:47;H319:47;H335:46;Not classified:1;H303:1
51052,2-Methyl-7-(4'-tert-butylphenyl)indene,456-850-1,245653-52-5,Skin Sens. 1;Aquatic Chronic 4,Notified C&L,33,H413:33;H317:33
51057,"3,4-dichloro-1,2,5-thiadiazole",227-232-7,5728-20-1,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,60,H411:4;H302:5;H317:4;H315:45;H319:45;H335:44;Not classified:7;H412:4;H301:6;H332:1;H312:1
51058,Pivalic acid,200-922-5,75-98-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,186,H315:140;H319:139;H302:185;H332:47;H312:46;H314:45;H290:1;H318:3;Not classified:1;H331:1
51059,"1,3-Dihydro-3-(3-iodopropyl)-7,8-dimethoxy-2H-3-benzazepin-2-one",604-658-5,148870-57-9,Not Classified,REACH registration C&L,1,Not classified:1
51061,cadmium (non-pyrophoric);cadmium (pyrophoric),231-152-8,7440-43-9,,,0,H250:0;H350:0;H330:0;H400:0;H341:0;H361:0;H372:0;H410:0
51064,"Isooctadecanoic acid, triester with oxybis[propanediol]",601-711-4,120486-24-0,Not Classified,Notified C&L,37,Not classified:37
51066,"Ethyl 2,4-dichloro-3-oxobutyrate",201-789-6,88-00-6,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,2,H412:2;H302:2;H314:2;H318:2
51069,5-aminonaphthalene-2-sulphonic acid,204-351-2,119-79-9,Not Classified,REACH registration C&L,10,Not classified:7;H319:3;H335:2;H315:2
51078,"2,6,10,14,18,22,26,30,34-Hexatriacontanonaen-1-ol, 3,7,11,15,19,23,27,31,35-nonamethyl-, (2E,6E,10E,14E,18E,22E,26E,30E)-",603-532-7,13190-97-1,Not Classified,Notified C&L,1,Not classified:1
51080,Wheat flour,603-421-3,130498-22-5,Not Classified,Notified C&L,69,Not classified:69
51082,Allylbenzene,206-095-7,300-57-2,Flam. Liq. 3;Asp. Tox. 1,Notified C&L,82,H304:80;H226:81;H315:1;H319:1;H335:1;H225:1
51084,Pentylcyclohexane,224-296-8,4292-92-6,Acute Tox. 4;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H400:39;H319:38;H302:38;H410:39
51087,p-tolyl phenylacetate,202-990-1,101-94-0,Not Classified,Notified C&L,1557,Not classified:1557
51089,"Fatty acids, lanolin, Me esters",284-974-4,85005-41-0,Not Classified,REACH registration C&L,443,Not classified:443
51092,"Amides, from diethylenetriamine and tall-oil fatty acids",271-204-7,68526-43-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,59,H315:59;H319:59
51097,Potassium cocoyl hydrolyzed oat protein,606-911-5,220425-14-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
51100,"3,4-dihydro-2,2,4-trimethyl-2H-quinoline-1-ethyl acetate",264-496-2,63817-40-3,Not Classified,REACH registration C&L,2,Not classified:2
51101,"2-[[4-[[4-[[6-anilino-1-hydroxy-3-sulpho-2-naphthyl]azo]-1-naphthyl]azo]-6-sulpho-1-naphthyl]azo]benzene-1,4-disulphonic acid, magnesium sodium salt",300-523-7,93941-74-3,Not Classified,REACH registration C&L,11,Not classified:11
51102,"4,4'-sulfonylbisphenol, polymer with ammonium chloride(NH",439-270-3,260408-02-4,Aquatic Chronic 4,Harmonised C&L,0,H413:0
51103,Cyclopent-3-en-1-one,238-264-6,14320-37-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H315:2;H319:2;H335:2;H226:2
51104,"Trihydrogen [[[[5-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-2-sulphophenyl]amino]sulphonyl]sulphamoyl-29H,31H-phthalocyaninedisulphonato(5-)-N29,N30,N31,N32]cuprate(3-)",235-470-8,12238-09-4,Not Classified,Notified C&L,1,Not classified:1
51105,"2,2-dimethylbutyryl chloride",227-478-5,5856-77-9,Flam. Liq. 3;Skin Corr. 1B,REACH registration C&L,8,H314:8;H226:8;H318:1;H290:1
51106,(3-oxo-1(3H)-isobenzofurylidene)di-p-phenylene dibutyrate,263-646-4,62625-15-4,Acute Tox. 4,Notified C&L,38,H302:38
51108,"Proteinase, Bacillus subtilis, sutilain",235-390-3,12211-28-8,Eye Irrit. 2A;Resp. Sens. 1,Notified C&L,51,H319:50;H334:50;H315:25;H335:25;H317:1
51110,"Liquid styrene polymer with 2-methyl-1,3-butadiene",607-504-5,25038-32-8,Not Classified,Notified C&L,92,Not classified:85;H412:7
51111,Isopentyl acetoacetate,218-991-5,2308-18-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,88,H315:88;H319:88
51114,4'-methylbenzanilide,209-491-8,582-78-5,Acute Tox. 4,Notified C&L,38,H302:38
51115,"11β,17,21-trihydroxypregn-4-ene-3,20-dione 17-valerate",260-786-8,57524-89-7,Carc. 2,Notified C&L,40,H351:38;H361:1;H373:2;H332:1;H302:1;H312:1
51117,(2S)-3-(Dimethylamino)-1-(3-methoxyphenyl)-2-methyl-1-propanone,617-655-9,850222-40-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,5,H315:4;H319:4;H302:4;Not classified:1;H225:1;H411:1;H317:1
51118,"3,5-dinitro-p-toluic acid",240-603-8,16533-71-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:40;H319:40;H335:39
51119,Dioctyl succinate,238-499-4,14491-66-8,,Notified C&L,33,Not classified:33
51122,"Cyclohexane, 1,3-bis(isocyanatomethyl)-",609-567-4,38661-72-2,Acute Tox. 4;Skin Corr. 1C;Skin Sens. 1A;Eye Dam. 1;Acute Tox. 2;Resp. Sens. 1;Aquatic Chronic 4,REACH registration C&L,57,H330:5;H413:4;H314:4;H302:56;H318:4;H317:4;H334:4;H315:53;H332:52;H319:53;H312:52;H335:53;H300:1
51124,"Diphenylmethyl [2S-(2α,5α,6β)]-3,3-dimethyl-7-oxo-6-(phenoxyacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4-oxide",233-509-3,10209-09-3,Skin Sens. 1;Resp. Sens. 1,Notified C&L,38,H317:38;H334:38
51127,Sodium dicyanoamide,217-703-5,1934-75-4,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,147,H302:147;H317:101;H318:101;H315:45;H319:45;H335:43;H332:6;H312:6
51132,"Sodium hydrogen [2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)][2-hydroxy-3-[(2-hydroxy-1-naphthyl)azo]-5-nitrobenzenesulphonato(3-)]chromate(2-)",274-908-2,70815-17-7,,Notified C&L,1,H412:1
51133,"Silicic acid (H4SiO4), zinc salt (1:2), manganese-doped",271-896-0,68611-47-2,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,134,H400:2;H410:2;Not classified:94;H319:38;H332:38;H335:38
51139,benzyl benzoate,204-402-9,120-51-4,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H302:0
51140,carbetamide (ISO);(R)-1-(ethylcarbamoyl)ethyl carbanilate; (2R)-1-(ethylamino)-1-oxopropan-2-yl phenylcarbamate,240-286-6,16118-49-3,Acute Tox. 4;Carc. 2;Aquatic Chronic 2;Repr. 1B,Harmonised C&L,0,H351:0;H302:0;H360:0;H411:0
51142,Tetramethylhydrazine,229-119-8,6415-12-9,Flam. Liq. 3,Notified C&L,38,H226:38
51145,Diphosphorous tetraiodide,236-646-7,13455-00-0,Skin Corr. 1B;Eye Dam. 1,Notified C&L,39,H318:39;H314:39;H335:1
51146,Aluminium bromide,231-779-7,7727-15-3,Acute Tox. 4;Skin Corr. 1B,Notified C&L,46,H302:46;H314:46;Not classified:3;H290:3;H318:1
51147,"Lithium 3[(8R,9S,10R,13S,14S,17S)-17-hydroxy-10-13-dimethyl-1,2,4,7,8,9,10,11,12,13,14,15,16,17-tetrahydrospiro[cylopenta[a]phenantrene-3,2´-[1,3]dioxolan]-17-yl]prop-2-ynoate",603-973-5,136673-12-6,Skin Sens. 1A;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,1,H412:1;H402:1;H317:1
51151,trifluoroborane dihydrate,603-716-7,13319-75-0,Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Acute Tox. 2;STOT SE 3;STOT RE 2,Notified C&L,159,H330:105;H373:84;H314:159;H302:136;H318:84;H335:84;H332:53;H372:52
51155,"2,2'-dithiobis(5-nitropyridine)",218-344-7,2127-10-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:38;H242:1
51156,"1,2,3,4-tetrahydro-2,3-dioxoquinoxaline-6-carboxylic acid",237-975-9,14121-55-2,Not Classified,Notified C&L,11,Not classified:10;H315:1;H319:1;H335:1
51161,"3-chloro-1,1-diethoxypropane",252-623-4,35573-93-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H315:48;H319:48;H335:46;H226:47;H225:1
51164,reaction mass of: branched icosane;branched docosane;branched tetracosane,417-050-8,151006-58-5,Acute Tox. 4;Aquatic Chronic 4,Harmonised C&L,0,H332:0;H413:0
51165,Dinitronaphthalene,248-484-4,27478-34-8,Skin Irrit. 2;Eye Irrit. 2;Muta. 2,Notified C&L,1,H315:1;H319:1;H341:1
51166,"Phenol, reaction products with isobutylene and 2,2,4-trimethylpentene",270-607-5,68457-76-1,Not Classified,Notified C&L,1,Not classified:1
51169,Haematoporphyrin dihydrochloride,241-699-4,17696-69-4,Not Classified,Notified C&L,2,Not classified:2
51171,Oxymetazoline,216-079-1,1491-59-4,Acute Tox. 1;Eye Dam. 1;Acute Tox. 1;Aquatic Chronic 3,Notified C&L,90,H300:90;H318:90;H412:90;H330:90
51176,"Polyphosphoric acids, sodium salts",272-808-3,68915-31-1,Not Classified,Notified C&L,718,Not classified:653;H319:45;H400:19;H410:19;H315:5;H335:5;H371:1;H373:1
51181,Butizide,218-048-8,2043-38-1,Not Classified,Notified C&L,1,Not classified:1
51182,"Cuprate(2-), [4-hydroxy-3-[[2-hydroxy-4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-1-naphthalenesulfonato(4-)]-, sodium",289-115-7,86014-68-8,Not Classified,Notified C&L,33,Not classified:32;H317:1;H334:1
51184,Calcium arsenate,231-904-5,7778-44-1,,Notified C&L,5,H350:5;H400:4;H331:5;H410:5;H301:5
51188,"21-chloro-9-fluoro-11β,17-dihydroxy-16β-methylpregna-1,4-diene-3,20-dione 17-propionate",246-634-3,25122-46-7,Repr. 1B;STOT RE 2;Aquatic Chronic 4,Notified C&L,89,H373:55;H360:56;H413:55;H315:30;H319:30;H335:29;H361:5;H362:1;H302:2;H341:1;H332:1;H312:1;H372:1
51189,"4,4'-sulphonyldiphenol",201-250-5,80-09-1,Repr. 2,REACH registration C&L,402,H361:94;Not classified:290;H319:17;H315:6;H335:6;H412:1
51190,"Estra-1,3,5(10),7-tetraen-17-one, 3-(sulfooxy)-, sodium salt",240-727-2,16680-47-0,Carc. 1B,Notified C&L,54,H350:38;H351:16;H360:16
51192,4-methylbenzylamine,203-243-2,104-84-7,Skin Corr. 1B,Notified C&L,44,H314:44;H318:2
51196,2-isopropyl-5-methylhex-2-enal,252-406-4,35158-25-9,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Carc. 2,REACH registration C&L,1448,H315:1437;H319:72;H351:1;H317:1;H335:68;Not classified:11;H226:6
51201,bromoform;tribromomethane,200-854-6,75-25-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;Aquatic Chronic 2,Harmonised C&L,0,H315:0;H319:0;H411:0;H302:0;H331:0
51203,"1,2-Benzenedicarboxylic acid, di-C16-18-alkyl esters",290-580-3,90193-76-3,Not Classified,REACH registration C&L,22,Not classified:22
51204,"1,1'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bisbenzene",228-846-8,6362-80-7,Acute Tox. 4;Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,73,H400:58;H373:56;H302:56;H317:46;H410:58;H315:25;H319:15;H335:12;Not classified:1;H411:1
51218,"5-Brom-2,3-difluor-alpha-[1-(4-propylcyclohexyl)ethenyl]-benzylalcohol",924-607-3,,Not Classified,Notified C&L,1,Not classified:1
51219,4-phenylcyclohexan-1-ol,226-613-5,5437-46-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
51220,4-formylphenyl acetate,212-898-3,878-00-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,56,H315:56;H319:56;H335:55
51223,Dimethyl vinylphosphonate,225-076-4,4645-32-3,Acute Tox. 4,REACH registration C&L,44,H302:6;H314:38;H351:4
51224,Terbium trihydroxide,235-010-6,12054-65-8,Not Classified,Notified C&L,2,Not classified:2
51226,[2-(2-methoxyethoxy)ethoxy]acetic acid,240-162-1,16024-58-1,Eye Dam. 1,REACH registration C&L,42,H318:41;H315:2;H319:1;H335:1;H302:1
51227,"Terpineol, sulfurized",272-274-1,68784-80-5,Skin Irrit. 2,Notified C&L,1,H315:1
51231,Adiponitrile,203-896-3,111-69-3,Acute Tox. 3;Acute Tox. 4,REACH registration C&L,174,H332:97;H301:174;H315:72;H330:73;H319:73;H335:72;H370:2;H373:1;H311:1;H372:1
51233,"Octahydro-4,7-methano-1H-indene-2,5-dimethanol",248-857-1,28132-01-6,Eye Irrit. 2,Notified C&L,112,H319:112
51234,"Gas oils (petroleum), acid-treated;Gasoil - unspecified;[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-112-6,64742-12-7,Carc. 1B,Harmonised C&L,0,H350:0
51237,"3,4-dihydro-2H-pyran",203-810-4,110-87-2,Flam. Liq. 2;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,148,H315:114;H225:147;H319:114;H412:6;H317:89;H335:9;Not classified:1
51245,"(R)-5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide (7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate",920-209-9,,Acute Tox. 4;Skin Irrit. 2,REACH registration C&L,2,H315:2;H302:2
51246,"2,4,6-trimethoxy-1,3,5-triazine",212-896-2,877-89-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
51247,Betahistine,227-086-4,5638-76-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,45,H315:45;H319:45;H335:45
51248,2-methoxy-p-toluidine,254-498-1,39538-68-6,Acute Tox. 4,Notified C&L,39,H302:39;H315:1;H332:1;H319:1;H312:1;H335:1
51251,"2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazole-4-carbaldehyde",213-452-0,950-81-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:39
51254,"1H-1,2,3-triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione",215-992-2,1468-26-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1;H312:1
51255,3-butylpyridine,208-715-1,539-32-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:38
51257,1-fluoro-3-nitrobenzene,206-953-0,402-67-5,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2,Notified C&L,44,H331:38;H373:43;H311:43;H301:43;H315:5;H330:6;H319:5;H335:1;H300:1;H310:1
51259,Nicergoline,248-694-6,27848-84-6,Acute Tox. 4,Notified C&L,233,H302:233;H332:4;H410:1;H312:1
51261,Cobalt hydroxide oxide,234-614-7,12016-80-7,Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1B;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,29,H332:6;H350:25;H400:6;H317:19;H334:29;H410:6;H360:19;H341:13;H411:17;H302:3;H372:6;H373:7;H412:6
51263,S-ethyl ethanethioate,210-904-9,625-60-5,Flam. Liq. 2,Notified C&L,163,H225:163;H315:46;H302:42;H318:42;H335:45;H319:4
51268,"Methanaminium, N-[4-[[4-(cyclohexylamino)-1-naphthalenyl][4-(dimethylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, chloride (1:1)",602-797-6,12262-18-9,Acute Tox. 3;Eye Dam. 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H318:1;H301:1
51274,(trimethylsilyl)acetic acid,219-067-4,2345-38-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:44;H319:44;H335:43
51275,"6-butyl-3,6-dihydro-2,4-dimethyl-2H-pyran",246-098-0,24237-00-1,Aquatic Chronic 2,Notified C&L,1554,H411:1297;Not classified:257
51276,"Tail gas (petroleum), gas oil catalytic cracking absorber;Petroleum gas;[A complex combination of hydrocarbons obtained from the distillation of products from the catalytic cracking of gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]",269-623-5,68308-03-2,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H350:0;Not classified:0;H220:0;H340:0
51283,"Tetramethyl 3,8,13,17-tetrakis(2-methoxy-2-oxoethyl)-21H,23H-porphine-2,7,12,18-tetrapropionate",239-447-3,15435-60-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,38,H315:38;H319:38
51292,Methyl 4-Iodosalicylate,605-947-9,18179-39-0,Acute Tox. 3,Notified C&L,45,H301:39;H315:6;H319:7;H335:4
51297,2-(2-thienyl)ethyl methanesulphonate,262-747-0,61380-07-2,Acute Tox. 4;Skin Sens. 1,Notified C&L,1,H302:1;H317:1
51300,"Yttrium oxide sulfide (Y2O2S), europium-doped",272-276-2,68784-83-8,,Notified C&L,9,Not classified:9
51304,"1,1,2-trichloro-3,3,3-trifluoropropene",207-075-0,431-52-7,,Notified C&L,5,H331:4;H302:5;H312:5;H332:1
51305,Octdecyl (R)12-[(1-oxooctadecyl)oxy]oleate,302-494-6,94109-52-1,Not Classified,Notified C&L,1,Not classified:1
51308,"Bis(D-gluconato-O1,O2)zinc",224-736-9,4468-02-4,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,222,H400:102;H410:105;H318:120;Not classified:91;H302:5
51309,2-amino-6-fluorobenzonitrile,616-451-7,77326-36-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,REACH registration C&L,50,H315:11;H332:8;H319:49;H302:8;H312:3;H335:4;H311:9;H331:4;H301:4
51310,"4-[{4-(anilino) phenyl]-(4-phenyliminocyclohexa-2,5-dien-1-ylidene)methyl]-2-Methylaniline.",616-848-5,8004-91-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,3,H332:2;H302:2;H312:2;H315:1;H319:1;H335:1;H412:1
51311,4-nitrophenyl-beta-D-galactopyranoside,221-584-5,3150-24-1,Not Classified,Notified C&L,2,Not classified:2
51312,N-pyridin-4-ylacetamide,226-018-0,5221-42-1,Acute Tox. 4,Notified C&L,1,H302:1
51313,Bucetin,214-109-8,1083-57-4,Acute Tox. 4;Acute Tox. 4;Carc. 1B,Notified C&L,38,H312:38;H332:38;H350:38
51314,rosin; colophony,232-484-6,8052-10-6,Skin Sens. 1,Harmonised C&L,0,H317:0
51315,"2,2'-thiobis[4-(1,1,3,3-tetramethylbutyl)phenol]",221-959-3,3294-03-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
51317,"Reaction products of acrylic acid with 4,4'-isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with fatty acids, C 18-unsatd., dimers",923-691-9,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
51318,"Fatty acids, C12-18, α-sulfo, 1-Me esters, sodium salts",288-224-7,85681-86-3,Skin Irrit. 2;Eye Dam. 1,Notified C&L,4,H315:2;H318:4;H319:1;H412:1
51319,2-methylpropyl 2-hydroxy-2-methylbut-3-enoate,406-235-9,72531-53-4,Skin Irrit. 2;Eye Irrit. 2,Harmonised C&L,0,H315:0;H319:0
51321,sec-butyl 4-hydroxybenzoate,241-697-3,17696-61-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
51322,"Siloxanes and Silicones, di-Me, polymers with Me silsesquioxanes and polypropylene glycol mono-Bu ether",614-605-8,68554-64-3,Not Classified,Notified C&L,41,Not classified:41
51324,Mentha pulegium,616-909-6,8007-44-1,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,88,H411:88;H302:88
51329,Broxuridine,200-415-9,59-14-3,Muta. 1B;Repr. 2,Notified C&L,51,H361:42;H340:42;H341:7;H351:3;H315:1;H319:1;H335:1;H360:1
51338,(4-Methoxyphenyl)boronsäure,611-482-2,5720-07-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,53,H315:52;H319:52;H335:50;H302:3;Not classified:3;H332:1;H312:1
51341,Cement copper,266-964-1,67711-88-0,Acute Tox. 2;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Acute Tox. 2;Resp. Sens. 1;Muta. 2;Carc. 1A;Repr. 1A;Lact.;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,53,H360:52;H350:52;H330:34;H362:34;H400:51;H341:51;H314:34;H300:34;H318:51;H317:35;H334:34;H372:51;H410:52;H315:17;H332:18;H302:18;H301:17;H373:1;Not classified:1
51343,KV545,457-750-0,,Aquatic Chronic 4,REACH registration C&L,1,H413:1
51349,"2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one, monohydrate",606-668-5,209216-23-9,Acute Tox. 4;Carc. 2;Repr. 2;STOT RE 1,Notified C&L,7,H351:4;H361:2;H302:5;H372:4;Not classified:2;H360:2;H362:2
51350,Pentane-3-thiol,210-476-3,616-31-9,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 3,Notified C&L,12,H331:10;H302:10;H225:12;H315:1;H319:1;H335:1
51356,"Glycine, N-acetyl-N-[3-(trifluoromethyl)phenyl]valyl-",609-497-4,379685-96-8,Not Classified,Notified C&L,1,Not classified:1
51359,Methyl 4-chloro-2-(chlorosulphonyl)benzoate,286-858-9,85392-01-4,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Carc. 2,REACH registration C&L,39,H315:39;H318:39;H351:6;H336:6
51361,Pentabromophenol,210-167-3,608-71-9,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Aquatic Acute 1,Notified C&L,42,H315:42;H400:38;H319:42;H311:38;H331:38;H335:42;H301:42
51364,"Amylase, gluco-",232-877-2,9032-08-0,Resp. Sens. 1,REACH registration C&L,90,H334:89;Not classified:1
51367,Phosphorus triiodide,236-647-2,13455-01-1,Skin Corr. 1B;STOT SE 3,Notified C&L,38,H335:38;H314:38
51368,"4,4-dimethyloxazolidine-2-thione",258-924-7,54013-55-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
51369,4-methylaminobenzoic acid,234-121-7,10541-83-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,REACH registration C&L,46,H315:7;H332:2;H319:7;H302:41;H312:2;H335:7;H317:39
51373,"9,10-dibromoanthracene",208-342-4,523-27-3,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,46,H400:39;H410:39;H315:6;H319:7;H335:6
51380,5-acetamido-2-aminobenzenesulphonic acid,202-534-1,96-78-6,Not Classified,REACH registration C&L,14,Not classified:14
51381,Perfluoro-tert-butyl alcohol,219-157-3,2378-02-1,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47,H315:47;H319:47;H332:40;H335:46;H331:7;H311:2;H301:2;H302:1;H312:1
51384,"2-Propenoic acid, polymer with 2-propenamide, sodium salt",607-842-3,25987-30-8,Not Classified,Notified C&L,66,Not classified:66
51386,"Fatty acids, tall-oil, reaction products with N-(3-aminopropyl)-1,3-propanediamine",284-976-5,85005-42-1,Not Classified,Notified C&L,8,Not classified:8
51391,(chloromethyl)dimethylphenylsilane,217-392-6,1833-51-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:38
51397,"2,3-xylyloxyacetic acid",220-911-9,2935-63-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,42,H315:42;H335:42;H302:38;H318:38;H319:4
51398,"2-(4-aminophenyl)-6-tert-butyl-1H-pyrazolo[1,5-b][1,2,4]triazole",415-910-7,152828-25-6,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H317:0
51399,O-benzyl-L-tyrosine,240-699-1,16652-64-5,Not Classified,Notified C&L,1,Not classified:1
51411,Ammonium octanoate,227-765-5,5972-76-9,Skin Sens. 1;Aquatic Acute 1,Notified C&L,1,H400:1;H317:1
51412,Sulfabenz,204-865-7,127-77-5,Acute Tox. 4,Notified C&L,39,H302:39;H315:1;H319:1;H335:1
51414,4'-methoxy-2'-nitroacetanilide,204-353-3,119-81-3,,Notified C&L,4,H302:4
51420,"2,6-di-tert-butyl-4-(methoxymethyl)phenol",201-787-5,87-97-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,38,H315:38;H319:38;H335:38;H413:38
51422,"Balsams, copaiba, acetates",304-451-7,94266-43-0,Skin Irrit. 2,Notified C&L,1338,H315:1338
51424,"Diisobutyl 3,9-perylenedicarboxylate",220-379-8,2744-50-5,Not Classified,Notified C&L,148,Not classified:148
51425,"1-methoxycyclohexa-1,4-diene",220-747-8,2886-59-1,Flam. Liq. 3,Notified C&L,39,H226:39
51426,4-chloro-2-nitrophenol,201-927-5,89-64-5,Not Classified,REACH registration C&L,121,Not classified:2;H315:119;H319:119;H335:118;H302:5
51427,cis-3-chloroacrylic acid,216-545-4,1609-93-4,Skin Corr. 1B;Eye Dam. 1;STOT SE 3,Notified C&L,42,H335:38;H318:38;H314:42
51432,"Naphthalenesulfonic acid, dinonyl-, calcium salt, basic, overbased",306-108-7,96152-37-3,,Notified C&L,1,Not classified:1
51435,"2,2,7,7-tetramethyl-3,6-dioxa-2,7-disilaoctane",230-950-3,7381-30-8,Flam. Liq. 3,Notified C&L,40,H226:40;H315:1;H319:1
51437,Pyridinium chloride,211-027-4,628-13-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,65,H315:65;H332:44;H319:63;H302:65;H335:49;H312:2
51439,"Oak, Quercus infectoria, ext.",296-944-8,93165-57-2,Not Classified,Notified C&L,1,Not classified:1
51440,Dinitrogen oxide,233-032-0,10024-97-2,Ox. Gas 1;Press. Gas (Liq.);STOT SE 3,REACH registration C&L,630,H280:401;H270:630;H336:39;H281:209;H330:4
51444,(hexyloxy)acetic acid,261-017-9,57931-25-6,Skin Corr. 1B,Notified C&L,2,H314:2
51450,Tridecyl acrylate,221-351-8,3076-04-8,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,157,H315:118;H319:118;H411:106;H317:86;H335:107;H300:38;H314:38
51451,"(1α,2β,4β,6α)-2,2,7-trimethyl-3-oxatricyclo[4.1.1.02,4]octane",250-938-1,32162-27-9,Flam. Liq. 3;Acute Tox. 3;STOT SE 3,REACH registration C&L,3,H331:3;H335:3;H226:3;H315:1
51459,Octanesulphonic acid,223-535-3,3944-72-7,Skin Corr. 1B;Skin Sens. 1,Notified C&L,38,H317:38;H314:38
51463,"Phosphatidic acids, hydrogenated rape-oil, ammonium salts",309-201-0,100085-59-4,Not Classified,Notified C&L,1,Not classified:1
51464,"21-hydroxypregn-4-ene-3,20-dione 21-(3-phenylpropionate)",237-815-8,14007-50-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 2,Notified C&L,17,H332:17;H361:17;H351:16;H302:17;H312:17
51465,Triphenylmethane,208-275-0,519-73-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H315:1;H319:1;H335:1;Not classified:1
51467,H109357,401-140-9,,Not Classified,Notified C&L,1,Not classified:1
51471,"1-{[2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole monomethanesulfonate",617-843-0,86386-77-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H332:1;H319:1;H302:1;H312:1;H335:1
51472,"p-mentha-1(6),8-dien-2-ol",202-757-4,99-48-9,Not Classified,Notified C&L,157,Not classified:113;H315:44;H319:44;H335:44
51474,"1,2-benzisothiazol-3-amine",245-388-4,23031-78-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,90,H315:90;H319:90;H302:90;H335:90
51476,"(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-6-methyl-3-trimethylsilyloxyoxan-2-yl]oxy-10-(2-ethoxypropan-2-yloxyimino)-14-ethyl-12,13-dihydroxy-7-methoxy-4-[(2R,4R,5S,6S)-4-methoxy-4,6-dimethyl-5-trimethylsilyloxyoxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one",805-486-5,119665-62-2,Not Classified,REACH registration C&L,2,Not classified:2
51482,Hydrogen (acetato-O)trifluoroborate(1-),231-477-5,7578-36-1,Acute Tox. 4;Skin Corr. 1A;Acute Tox. 4;STOT RE 1,Notified C&L,83,H302:83;H332:83;H372:83;H314:83
51486,"1,1,3,3-tetramethoxy-1,3-dimethyldisiloxane",242-072-8,18186-97-5,Flam. Liq. 3,Notified C&L,38,H226:38
51493,Dipropyl sulphone,209-913-0,598-03-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H332:1;H319:1;H302:1;H312:1;H335:1
51494,"Dimethyl naphthalene-2,6-dicarboxylate",212-661-4,840-65-3,Aquatic Chronic 4,REACH registration C&L,98,H413:1;Not classified:97
51496,4-cyclohexyloxybenzoic acid,205-369-3,139-61-7,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
51497,"Tetrabutylammonium, salt with trifluoromethylsulphonic acid (1:1)",252-783-5,35895-70-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:44;H319:44;H335:43
51499,"Benzene, tri-C6-12-alkyl derivs.",273-516-9,68988-14-7,Not Classified,Notified C&L,1,Not classified:1
51503,Nadide,200-184-4,53-84-9,Not Classified,REACH registration C&L,8,Not classified:7;H315:1;H319:1;H335:1
51504,"Phosphoric acid, dodecyl ester, sodium salt",256-865-1,50957-96-5,Skin Irrit. 2;Eye Dam. 1,Notified C&L,29,H315:29;H318:29
51505,Bromonitromethane,209-258-0,563-70-2,Ox. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:40;H272:39;H335:40;H319:40
51506,Nitrosodiphenylamine,201-663-0,86-30-6,Skin Sens. 1A;Carc. 2;Repr. 2;STOT RE 2;Aquatic Chronic 1,REACH registration C&L,97,H373:35;H351:35;H361:34;H317:34;H410:34;H411:52;H302:61;H315:19;H319:20;Not classified:2;H371:1;H341:1
51508,3-hydroxycinnamic acid,209-615-0,588-30-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H315:41;H319:41;H335:41
51509,"9,12-Octadecadienoic acid (9Z,12Z)-, dimer, compd. with (9Z,12Z)-N-[3-(dimethylamino)propyl]-9,12-octadecadienamide (1:1)",603-091-0,125804-10-6,Not Classified,Notified C&L,37,Not classified:37
51511,(3-methylbut-2-enyl)triphenylphosphonium bromide,216-224-9,1530-34-3,,Notified C&L,4,H315:4;H319:4;H335:4
51515,Triethyl orthopropionate,204-108-0,115-80-0,Flam. Liq. 3,REACH registration C&L,60,H315:54;H319:59;H302:42;H226:59;H335:4
51523,"Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, polymer with 1,1'-methylenebis[4-isocyanatocyclohexane], 1-decanol-blocked",615-185-9,70879-50-4,Not Classified,Notified C&L,55,Not classified:55
51524,"21-chloro-9-fluoro-17-hydroxy-16β-methylpregna-1,4-diene-3,11,20-trione 17-butyrate",246-635-9,25122-57-0,Carc. 2,Notified C&L,43,H351:38;H361:3;H373:3;H360:2;H413:3;H410:1;H400:1
51525,Barium bis[5-chloro-4-ethyl-2-[(2-hydroxy-1-naphthyl)azo]benzenesulphonate],267-122-6,67801-01-8,Not Classified,Notified C&L,92,Not classified:92
51526,Dichloro(diphenyl)silane,201-251-0,80-10-4,Skin Corr. 1A;Aquatic Chronic 2,REACH registration C&L,613,H411:114;H314:171;Not classified:443;H310:40;H318:16;H302:6;H311:5;H319:4;H335:7;H290:1
51533,"Rape oil, ethoxylated",605-414-0,165658-60-6,Not Classified,Notified C&L,23,Not classified:23
51536,"Fatty acids, C16-22, esters with triethanolamine",292-943-1,91031-41-3,Not Classified,Notified C&L,6,Not classified:6
51537,4-chlorophenylisocyanate,203-176-9,104-12-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 2;STOT SE 3;Resp. Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H315:0;H330:0;H400:0;H410:0;H302:0;H318:0;H334:0;H335:0
51540,"sodium (R)-2-(2,4-dichlorophenoxy)propionate",413-340-3,119299-10-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H315:0;H302:0;H317:0;H318:0
51542,Erythromycin,204-040-1,114-07-8,Not Classified,REACH registration C&L,164,Not classified:66;H319:63;H317:35;H334:34;H361:2;H332:1;H302:2;H312:2;H362:1
51543,2-(indol-3-yl)ethylamine hydrochloride,206-446-4,343-94-2,Acute Tox. 3;Eye Irrit. 2,Notified C&L,94,H319:94;H301:93;H315:1
51547,Amphetamine,206-096-2,300-62-9,Flam. Liq. 2;Acute Tox. 1,REACH registration C&L,40,H300:40;H225:2;H226:38
51548,4-propylphenyl trans-4-(4-propylcyclohexyl)benzoate,277-043-9,72928-02-0,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
51549,Tetradecyl chloroformate,260-330-8,56677-60-2,Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 1,REACH registration C&L,86,H315:86;H410:86;H317:86
51552,"Amides, from diethylenetriamine, oleic acid and tall-oil fatty acids",271-203-1,68526-42-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
51554,6-methyl-5-nitroquinoline,245-447-4,23141-61-9,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,42,H315:42;H335:42;H318:38;H301:38;H319:4;H302:4
51555,Ethyl methyl sulphide,210-868-4,624-89-5,Flam. Liq. 2;Eye Irrit. 2A;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,195,H319:1;H402:1;H412:9;H225:192;H315:22;H224:3
51560,Barium dihydride,236-763-3,13477-09-3,Acute Tox. 4;Acute Tox. 4,Notified C&L,171,H302:171;H332:171
51571,"1-chloro-2,3-dimethylbenzene",612-040-1,608-23-1,,Notified C&L,9,H315:9;H319:6;H335:5;H411:3;H317:3
51574,5-allyl-5-(2-cyclopenten-1-yl)barbituric acid,200-979-6,76-68-6,Acute Tox. 3,Notified C&L,1,H301:1
51575,Methylthiouracil,200-252-3,56-04-2,Acute Tox. 4;Carc. 2,Notified C&L,55,H351:47;H302:54;H312:2;Not classified:1;H332:1;H361:1;H350:1
51576,2-hydroxyphenethyl alcohol,231-863-3,7768-28-7,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,41,H302:41;H318:40;H315:1;H332:1;H319:1;H312:1;H335:1
51578,"Dipotassium bis[μ-[tartrato(4-)-O1,O2:O3,O4]]diantimonate(2-) , stereoisomer",234-293-3,11071-15-1,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,89,H411:82;H302:69;H332:79;H315:4;H319:4;H412:4;H317:4;H301:17;Not classified:4;H318:3
51580,2-methylcyclohexyl acetate,227-231-1,5726-19-2,Eye Irrit. 2,REACH registration C&L,10,H319:9;H315:1;Not classified:1
51583,Chrome alumina pink spinel,269-230-9,68201-65-0,Not Classified,Notified C&L,33,Not classified:33
51586,Tioxolone,225-653-0,4991-65-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H315:42;H319:42;H302:41;H335:40;H301:1
51587,4-bromophenylacetonitrile,240-602-2,16532-79-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,58,H315:58;H332:53;H319:58;H412:1;H302:12;H312:53;H335:58;H301:46;H311:5;H331:5
51590,"(2S)-2-(3,4-difluorophenyl)oxirane",600-116-7,1006376-63-1,Flam. Liq. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1;H227:1
51591,Thallium (I) ethanolate,243-786-2,20398-06-5,Acute Tox. 2;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,42,H411:42;H300:42;H373:42;H330:42
51593,3-methylisoxazol-5-amine,238-719-9,14678-02-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H315:45;H319:45;H335:44
51597,Xylitol,201-788-0,87-99-0,Not Classified,REACH registration C&L,123,Not classified:123
51600,Gum arabic,232-519-5,9000-01-5,Not Classified,Notified C&L,2208,Not classified:1588;H315:487;H319:586;H317:486;H334:486;H335:487
51601,2-bromo-2-methylpropane,208-065-9,507-19-7,Flam. Liq. 2,Notified C&L,47,H225:47;H315:1;H319:1
51602,"Zinc, isodecanoate isooctanoate complexes, basic",282-787-2,84418-74-6,Not Classified,Notified C&L,1,Not classified:1
51603,Zinc tetraisopropyl bis(dithiophosphate),251-024-5,32391-13-2,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,37,H411:33;H319:37;H315:4
51605,Carbon,231-153-3,7440-44-0,Eye Irrit. 2;STOT SE 3,Notified C&L,2619,H319:1408;H335:1327;Not classified:1055;H252:141;H228:17;H251:8;H373:5;H315:7;H300:3;H226:2;H412:2;H302:2
51609,"Bile, extract",232-369-0,8008-63-7,Not Classified,REACH registration C&L,13,Not classified:6;H315:7;H319:7;H302:2;H317:2;H335:4
51615,3-(phenothiazin-10-yl)propionic acid,421-260-5,362-03-8,Aquatic Chronic 2,Harmonised C&L,0,H411:0
51624,[(2-chloroethyl)sulphonyl]benzene,213-337-5,938-09-0,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,44,H331:39;H311:39;H301:39;H314:6;H332:1;H341:1;H302:1;H312:1;H318:1
51625,3-hydroxyquinoxaline-2-carboxylic acid,214-877-4,1204-75-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
51630,1-(4-Methylbenzoyl)-1-phenylpiperidinium 5-benzyl-4-hydroxy-2-methoxybenzenesulfonate,457-010-7,504387-13-7,Acute Tox. 4,Notified C&L,1,H302:1
51633,1-benzyl-N-(2-nitrophenyl)piperidin-4-amine,230-675-9,7255-89-2,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
51636,"Amines, bis(hydrogenated tallow alkyl)methyl",262-991-8,61788-63-4,Skin Irrit. 2;Aquatic Acute 1,Notified C&L,81,H315:70;H400:76;H319:21;Not classified:5;H318:4;H314:4;H410:2
51637,3-chlorobenzohydrazide,216-812-5,1673-47-8,,Notified C&L,6,H315:6;H319:6;H335:5
51639,"Amines, C16-18-alkyl",292-550-5,90640-32-7,Asp. Tox. 1;Skin Irrit. 2;Eye Dam. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,64,H315:64;H304:64;H400:64;H373:64;H318:64;H410:64
51640,N-methyl-2-nitroaniline,210-303-1,612-28-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2,REACH registration C&L,44,H331:44;H373:44;H311:44;H301:44;H411:4
51643,Trimethyl[(1-methylvinyl)oxy]silane,217-393-1,1833-53-0,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:38;H225:39
51644,N-ethylbenzylamine,238-265-1,14321-27-8,Skin Corr. 1B,REACH registration C&L,49,H314:49;H318:1;Not classified:1;H412:1;H301:1
51645,"2'-(β-D-glucopyranosyloxy)-4',6'-dihydroxy-3-(4-hydroxyphenyl)propiophenone",200-487-1,60-81-1,Not Classified,REACH registration C&L,69,Not classified:26;H315:43;H319:43;H335:43
51647,"Amines, C10-14-branched and linear alkyl, bis[2-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]benzoato(2-)]chromate(1-)",285-083-3,85029-58-9,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,205,H411:149;H317:149;H410:38;Not classified:16;H400:10;H315:2;H319:2
51648,Methyl N-[4-[(2-chloro-4-nitrophenyl)azo]phenyl]-N-(2-cyanoethyl)-β-alaninate,229-692-4,6657-37-0,Not Classified,Notified C&L,35,Not classified:35
51649,(3-nitrophenyl)phosphonic acid,226-261-2,5337-19-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,38,H315:38;H302:38;H318:38
51650,2-(4-fluorophenyl)-5-(5-iodo-2-methylbenzyl)thiophene,618-312-6,898566-17-1,Skin Sens. 1B;Aquatic Chronic 4,REACH registration C&L,42,H413:39;H317:3;H302:38;H318:38;Not classified:1
51651,"Chondroitin, 4-(hydrogen sulfate), sodium salt",609-686-1,39455-18-0,Not Classified,Notified C&L,1,Not classified:1
51652,"6-nitro-2,4-xylidine",216-662-0,1635-84-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H315:43;H332:43;H319:43;H302:43;H312:43;H335:43
51654,"1,3-Butanediol, polymer with α-butyl-ω-hydroxypoly[oxy(methyl-1,2-ethanediyl)] and 1,3-diisocyanatomethylbenzene",614-443-8,68400-67-9,Not Classified,Notified C&L,6,Not classified:6
51662,"3,3'-methylenebis[6-[[2,4-dihydroxy-5-[(4-sulphophenyl)azo]phenyl]azo]benzoic] acid, sodium salt",286-391-0,85223-35-4,Eye Dam. 1,Notified C&L,87,H318:83;Not classified:3;H315:1
51664,4'-fluorobutyrophenone,209-492-3,582-83-2,Acute Tox. 4,Notified C&L,132,H302:127;H315:5;H319:5;H335:5
51665,Acesulfame,251-622-6,33665-90-6,Not Classified,Notified C&L,1,Not classified:1
51667,"2,2-dibromomalonamide",277-205-9,73003-80-2,Acute Tox. 4;Skin Sens. 1B;Eye Dam. 1;Acute Tox. 2;Aquatic Chronic 3,Notified C&L,120,H330:55;H412:55;H302:55;H318:55;H317:55;H319:43;Not classified:20;H315:5;H335:4;H411:2
51669,Isobutyl benzoate,204-401-3,120-50-3,Not Classified,Notified C&L,1571,Not classified:1571
51670,"Pitch, coal tar, high-temp., secondary;Pitch Redistillate;[The residue obtained during the distillation of high boiling fractions from bituminous coal high temperature tar and/or pitch coke oil, with a softening point of 140 °C to 170 °C (284 °F to 392 °F) according to DIN 52025. Composed primarily of tri- and polynuclear aromatic compounds which also contain heteroatoms.]",302-650-3,94114-13-3,Carc. 1B,Harmonised C&L,0,H350:0
51672,"Reaction product of: copper, (29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32)-, chlorosulfuric acid and 3-(2-sulfooxyethylsulfonyl)aniline, sodium salts",420-980-7,,Eye Dam. 1,Harmonised C&L,0,H318:0
51673,"Dimethyl [R(R*,R*)]-tartrate",210-166-8,608-68-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
51674,"10-methoxy-1,6-dimethylergoline-8β-methanol",252-405-9,35155-28-3,Acute Tox. 4;Acute Tox. 4,REACH registration C&L,4,H302:4;H332:2;H371:1;H412:1;H318:1;H312:1
51678,Reaction mass of 2-O-α-L-Rhamnopyranosyl-α-L-rhamnopyranosyl-β-hydroxydecanoyl-β-hydroxydecanoic acid and α-L-Rhamnopyranosyl-β-hydroxydecanoyl-β-hydroxydecanoic acid,604-610-3,147858-26-2,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1,H315:1;H319:1
51679,"Sulfuric acid, mono-C10-16-alkyl esters",271-897-6,68611-55-2,Skin Corr. 1B,Notified C&L,1,H314:1
51681,"N,N'-[azinobis(methylidyne-4,1-phenylene)]bis(acetamide)",241-740-6,17745-84-5,Aquatic Acute 1,Notified C&L,38,H400:38
51682,p-toluonitrile,203-244-8,104-85-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,49,H315:47;H319:47;H335:41;H334:38;H317:1;Not classified:1
51694,ethyl 2-(3-nitrobenzylidene)acetoacetate,404-490-0,39562-16-8,Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H318:0;H317:0
51699,"poly(oxypropylenecarbonyl-co-oxy(ethylethylene)carbonyl), containing 27 % hydroxyvalerate",403-300-3,,Skin Sens. 1,Harmonised C&L,0,H317:0
51700,Melamine salt of Phosphoric ester with Formaldehyde,929-628-1,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:2
51702,"2,6-Dihydroxy-4-methylbenzoic Acid",610-406-5,480-67-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H315:3;H319:3;H335:2
51705,"1-ethyl-2-[1,2,3,4-tetrahydro-1-(2-hydroxyethyl)-2,2,4-trimethyl-6-quinolyl]benz[cd]indolium chloride",264-497-8,63817-45-8,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H400:1;H410:1;H302:1;H318:1
51706,4-phenylbenzophenone,218-345-2,2128-93-0,Not Classified,REACH registration C&L,2358,Not classified:2268;H400:90;H410:90;H360:90;H317:90
51709,Galactose,200-416-4,59-23-4,,Notified C&L,75,Not classified:75
51710,"3-[o-(α,α,α-trifluorotolyl)]propionic acid",301-594-7,94022-99-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H315:44;H319:44;H302:41;H335:44;H332:1;H312:1
51715,"Benzenesulfonic acid, 5-[[4-[bis(2-hydroxyethyl)amino]-6-methoxy-1,3,5-triazin-2-yl]amino]-2-[2-[4-[[4-methoxy-6-[(2-sulfoethyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]ethenyl]-, sodium salt, compd. with 2-aminoethanesulfonic acid monosodium salt and 2,2'-iminobis[ethanol]",286-669-1,85305-32-4,Not Classified,Notified C&L,4,Not classified:4
51718,"Tetrahydro-2,5-dimethylfuran",213-707-6,1003-38-9,Flam. Liq. 3,Notified C&L,42,H226:39;H225:3
51720,"Alkenes, C18-24, ethylene polymn. by-product",272-807-8,68914-55-6,Not Classified,Notified C&L,59,Not classified:55;H304:4
51721,Actinomycin C,232-485-1,8052-16-2,Acute Tox. 2;Acute Tox. 2;Acute Tox. 1;Repr. 1B,Notified C&L,38,H300:38;H360:38;H310:38;H330:38
51722,"Hexahydro-1,3,5-trinitroso-1,3,5-triazine",237-766-2,13980-04-6,Acute Tox. 3,Notified C&L,38,H301:38
51723,"Amines, N-C8-22-alkylpolytrimethylenepoly-, carboxymethyl derivs., sodium salts",307-458-3,97659-53-5,Aquatic Acute 1,Notified C&L,26,H400:24;Not classified:1;H315:1;H318:1
51724,α-methylthiophene-2-methanol,218-992-0,2309-47-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H332:1;H319:1;H302:1;H312:1;H335:1
51725,"Disodium hydrogen bis[4-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-3-hydroxynaphthalene-1-sulphonato(3-)]chromate(3-)",229-052-4,6408-29-3,Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,167,H319:61;H412:101;H317:8;Not classified:12;H315:5;H413:2;H335:1
51727,"Yttrium borate phosphate vanadate, europium-doped",272-275-7,68784-82-7,Not Classified,REACH registration C&L,12,Not classified:12
51729,2-bromopropane,200-855-1,75-26-3,Flam. Liq. 2;STOT RE 2;Repr. 1A,Harmonised C&L,0,H373:0;H360:0;H225:0
51731,"1,3,5-triisopropyl-2,4-diaminobenzene",613-175-9,6318-09-8,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,2,H412:2;H302:2;H312:1
51733,Desmopressin,240-726-7,16679-58-6,Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1,Notified C&L,19,H332:19;H317:18;H314:18;H334:18
51736,Dibutyl azelate,220-850-8,2917-73-9,Aquatic Chronic 4,Notified C&L,12,H413:12
51738,"Benzoic acid, 2-[2-[1-[[(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)amino]carbonyl]-2-oxopropyl]diazenyl]-",612-066-3,61036-28-0,Not Classified,Notified C&L,68,Not classified:68
51739,Tetrabutylplumbane,217-649-2,1920-90-7,,Notified C&L,4,H360:4;H330:4;H400:4;H373:4;H300:4;H310:4;H410:4
51740,"Addition reaction of triethylene glycol and neodecanoic acid, oxiranylmethyl ester",919-298-7,,Not Classified,Notified C&L,71,Not classified:71
51741,"sodium 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfinate",422-100-7,102061-82-5,Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H318:0;H317:0
51742,Phenol novolac type of epoxy acrylate,685-172-0,68585-21-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4,H315:4;H319:4
51752,"Propanoic acid, 2-hydroxy-, ammonium salt (1:1), (2S)-",604-012-2,137296-15-2,Not Classified,REACH registration C&L,2,Not classified:2
51762,N-butylpentylamine,254-497-6,39536-61-3,Acute Tox. 4;Eye Dam. 1,Notified C&L,38,H302:38;H318:38
51763,Heptylamine,203-895-8,111-68-2,Flam. Liq. 3;Acute Tox. 3;Skin Corr. 1C;Skin Sens. 1A;Eye Dam. 1,REACH registration C&L,47,H314:47;H318:4;H317:2;H226:47;H301:2
51770,nickel divanadium hexaoxide,257-970-5,52502-12-2,Skin Sens. 1;STOT RE 1;Carc. 1A,Harmonised C&L,0,H350:0;H317:0;H372:0
51773,2-aminobenzothiazole-6-carboxylic acid,202-283-8,93-85-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:44;H319:44;H335:44;H332:2;H302:2;H312:2
51776,"pyracarbolid (ISO);3,4-dihydro-6-methyl-2H-pyran-5-carboxanilide",246-419-4,24691-76-7,Aquatic Chronic 3,Harmonised C&L,0,H412:0
51777,"Distillates (petroleum), acid-treated middle;Gasoil - unspecified;[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-113-1,64742-13-8,Carc. 1B,Harmonised C&L,0,H350:0
51781,"2-(but-3-yn-1-yl)-2,3-dihydro-1H-isoindole-1,3-dione",604-387-2,14396-90-8,Skin Sens. 1;Eye Irrit. 2,Notified C&L,39,H319:39;H317:39;H315:1;H302:1;H335:1
51784,2-[2-(nonylphenoxy)ethoxy]ethyl stearate,301-211-3,93982-20-8,Not Classified,Notified C&L,1,Not classified:1
51785,Fluocortolone,205-811-5,152-97-6,Acute Tox. 3;Repr. 1A;STOT RE 1,REACH registration C&L,1,H360:1;H372:1;H301:1
51801,"Trans-2,6-dimethylindan-1-amine",700-575-4,,Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 3,Notified C&L,1,H412:1;H302:1;H314:1
51806,Dipropyl phthalate,205-015-8,131-16-8,Carc. 2;Repr. 2,Notified C&L,138,H351:90;H361:133;H411:44;Not classified:4;H315:1;H319:1
51810,4-methylsalicylaldehyde,211-813-7,698-27-1,Acute Tox. 4,Notified C&L,277,H302:233;H315:44;H319:44;H335:43
51814,2-(5-halo-2-hydroxy-aryl)-3H-heteropolycycle-4-one,434-050-3,,Not Classified,Notified C&L,1,Not classified:1
51816,4-phenyl-3-buten-2-ol,241-501-6,17488-65-2,Not Classified,Notified C&L,88,Not classified:88
51819,Thulium trichloride,236-904-9,13537-18-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H315:39;H319:39;H335:39;H314:1;Not classified:1
51825,Chlorovinylmagnesium,222-575-9,3536-96-7,Flam. Liq. 2;Water-react. 1;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,306,H260:195;H225:156;H314:223;H318:38
51830,"Phosphoric acid, 2-ethylhexyl ester, compd. with 2,2'-iminobis[ethanol]",277-274-5,73070-48-1,Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,10,H412:1;H318:5;H314:1;H315:8;H319:5
51831,"ethofumesate (ISO); (RS)-2-ethoxy-2,3-di­hydro-3,3-dimethyl­benzofuran-5-yl methanesulfonate;(±)-2-ethoxy-2,3-dihydro-3,3-dimethylbenzofuran-5-yl methanesulfonate",247-525-3,26225-79-6,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
51832,7-oxo-7-phenylheptanoic acid,616-130-1,7472-43-7,,Notified C&L,5,H315:5;H319:5;H335:5
51834,Hydroxyzine embonate,233-582-1,10246-75-0,Acute Tox. 4,Notified C&L,40,H302:40;H361:1
51835,trans-menthone,201-941-1,89-80-5,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,1798,H412:1572;H302:107;H226:1346;H315:258;H317:250;H351:25;Not classified:1;H319:2;H304:1
51837,"Amines,hydrogenated tallow alkyl,ethoxylated,acetates (salts)",614-375-9,68201-30-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,43,H315:23;H319:23;Not classified:20
51840,p-chlorophenyl phenyl sulphone,201-242-1,80-00-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,44,H332:39;H302:44;H312:43;H315:4;H319:4;H335:4
51843,"4,5-dihydro-5-oxo-4-[[4-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]azo]-1-(4-sulphophenyl)-1H-pyrazole-3-carboxylic acid",233-418-9,10149-98-1,Aquatic Chronic 3,REACH registration C&L,4,H412:4
51845,Undec-10-en-1-ol,203-971-0,112-43-6,Not Classified,Notified C&L,1567,Not classified:1562;H315:5;H319:5;H335:4
51849,"1H,3H,5H-oxazolo[3,4-c]oxazole-7a(7H)-methanol",229-457-6,6542-37-6,Not Classified,Notified C&L,60,Not classified:60
51852,mequinol;4-methoxyphenol;hydroquinone monomethyl ether,205-769-8,150-76-5,Acute Tox. 4;Eye Irrit. 2;Skin Sens. 1,Harmonised C&L,0,H319:0;H302:0;H317:0
51854,Tri(dimethylamino)benzotriazol-1-yloxyphosphonium hexafluorophosphate,260-279-1,56602-33-6,Flam. Sol. 1;Skin Irrit. 2;STOT SE 3,Notified C&L,54,H315:54;H228:44;H335:52;H319:14;H400:1;Not classified:2;H410:1
51858,4-phenylimidazole,211-580-1,670-95-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,214,H315:214;H319:200;H335:213
51859,"Menthane, didehydro derivative",249-579-3,29350-67-2,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1544,H411:1286;H304:1544;H317:1286;H226:1544
51861,"Sodium 2,4,6-trimethylbenzenesulphonate",228-157-2,6148-75-0,Not Classified,Notified C&L,8,Not classified:8
51864,"Ethyl N-(2,4-dinitrophenoxy)thioacetate",259-095-4,54322-32-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H315:42;H319:42;H335:42
51865,"2,6-dimethoxy-p-cresol",229-641-6,6638-05-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,208,H315:208;H319:208;H302:164;H335:207
51866,Cefadroxil,256-555-6,50370-12-2,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,63,H315:63;H319:63;H317:63;H334:63;H335:63
51867,C-Dion,439-740-8,,Not Classified,Notified C&L,34,Not classified:34
51870,(1-chloroethyl)benzene,211-594-8,672-65-1,Flam. Liq. 3;Skin Irrit. 2;Eye Dam. 1;Resp. Sens. 1;STOT SE 3,Notified C&L,40,H315:40;H318:39;H334:39;H226:40;H335:39;H319:1
51871,"(S)-2-[1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl] pyrrolidin-3-yl] -2,2-diphenyl-acetamid hydrobromide",603-705-7,133099-07-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H315:39;H319:41;H335:39;H400:3;H302:2;H410:2;H301:1
51873,"N,N'-dibenzylethylenediamine",205-408-4,140-28-3,Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,129,H411:83;H318:84;H314:89;H301:83;H315:40;H319:40;H302:46;H335:40
51877,Ellagic acid,207-508-3,476-66-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,84,H315:83;H319:83;H335:82;Not classified:1
51878,"Tetrasodium (c-(3-(1-(3-(e-6-dichloro-5-cyanopyrimidin-f-yl(methyl)amino)propyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)-4-sulfonatophenylsulfamoyl)phthalocyanine-a,b,d-trisulfonato(6-))nickelato II, where a is 1 or 2 or 3 or 4,b is 8 or 9 or 10 or 11,c is 15 or 16 or 17 or 18, d is 22 or 23 or 24 or 25 and where e and f together are 2 and 4 or 4 and 2 respectively",410-160-7,148732-74-5,Eye Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H319:0;H412:0;H317:0
51883,"9-methyl-2,3,4,9-tetrahydro-1H-carbazol-4-one",608-096-1,27387-31-1,Acute Tox. 3;Aquatic Chronic 3,Notified C&L,42,H412:40;H301:39;Not classified:1;H302:2
51885,Sodium 2-sulphonatoethyl laurate,230-949-8,7381-01-3,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,13,H319:13;H412:8;H315:5
51887,"6,6-dimethylcyclohex-2-en-1-one",613-816-2,6553-64-6,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B,REACH registration C&L,3,H302:3;H314:2;H226:2;H315:1;H318:1;H335:1
51891,Cyclopropanecarboxylic acid,217-162-5,1759-53-1,Acute Tox. 4;Skin Corr. 1B,REACH registration C&L,262,H302:189;H314:220;H373:157;H412:156;Not classified:33;H332:3;H312:3;H290:1;H318:2
51892,"Copper, diazotized 2-amino-1,4-benzenedisulfonic acid-diazotized 2-[(4-aminophenyl)amino]-5-nitrobenzenesulfonic acid-diazotized 4-nitrobenzeneamine-Dyer's mulberry extract coupling products complexes",276-687-8,72480-58-1,,Notified C&L,60,Not classified:60
51894,Methyltrioctylammonium chloride,225-896-2,5137-55-3,Acute Tox. 3;Skin Corr. 1;Eye Dam. 1;Repr. 1B;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,227,H360:3;H400:45;H373:3;H314:3;H318:45;H410:45;H301:217;H315:224;H319:182;H302:10
51895,Zinc fumarate (1:1),258-134-2,52723-61-2,Not Classified,Notified C&L,2,Not classified:2
51899,"2,4-dimethylhexanoic acid",274-702-2,70621-82-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,2,H315:2;H302:2;H318:2;H335:1
51900,"fenpropidin (ISO); (R,S)-1-[3-(4-tert-butylphenyl)-2-methylpropyl]piperidine",614-049-6,67306-00-7,Acute Tox. 4;Skin Sens. 1B;Eye Dam. 1;Acute Tox. 4;STOT SE 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,236,H332:198;H400:195;H373:156;H410:195;H302:236;H318:194;H317:195;H335:194;H319:39;H312:38;H315:37;H372:3;H208:1
51905,"(R,R)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminochromium(III) chloride",605-379-1,164931-83-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H332:38;H302:38;H312:38;Not classified:1
51906,"3,4-bis(4-methoxyphenyl)hex-3-ene",231-872-2,7773-34-4,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H400:38;H410:38
51909,"Naphtho[1,2-d]thiazol-2-amine",254-822-1,40172-65-4,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
51911,"Lignin, alcali, reaction products with formaldehyde and sodium bisulfite",614-548-9,68512-35-6,Eye Irrit. 2,Notified C&L,122,H319:109;H335:17;Not classified:13
51914,"1,8-dioxacycloheptadecan-9-one",217-033-3,1725-01-5,Not Classified,Notified C&L,260,Not classified:225;H412:35
51916,"Octanethioic acid, S-[3-(triethoxysilyl)propyl] ester, reaction products with 2-methyl-1,3-propanediol and 3-(triethoxysilyl)-1-propanethiol",485-270-1,,Skin Sens. 1A;Aquatic Acute 1,REACH registration C&L,4,H400:4;H317:4
51924,Trisodium 8-[(7-amino-1-hydroxy-3-sulphonato-2-naphthyl)azo]-5-[[4-(phenylazo)-6-sulphonatonaphthyl]azo]naphthalene-2-sulphonate,229-332-6,6476-10-4,Not Classified,Notified C&L,2,Not classified:2
51925,1-Methyl-3-propylimidazolium Iodide,601-586-6,119171-18-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,14,H315:13;H319:13;H335:8;Not classified:1
51926,"2-(1-phenylethyl)-1,3-dioxolane",224-449-9,4362-22-5,Not Classified,Notified C&L,88,Not classified:88
51930,"N-(trans-4-Hydroxycyclohexyl)-3,5-dibromo-2-hydroxybenzylidenamine",924-083-6,,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,1,H411:1;H302:1
51933,2-Chloro-5-fluoroaniline,610-238-2,452-83-5,,Notified C&L,8,H315:6;H332:6;H319:6;H373:5;H302:6;H311:7;H331:1;H301:2;H312:1
51939,Isopentyl acrylate,224-204-6,4245-35-6,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,35,H315:35;H319:35;H412:34;H226:35
51941,"chlorfenvinphos (ISO);2-chloro-1-(2,4 dichlorophenyl) vinyl diethyl phosphate",207-432-0,470-90-6,Acute Tox. 2;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H300:0;H410:0;H311:0
51943,"5,9-diaminobenzo[a]phenoxazin-7-ium perchlorate",255-561-6,41830-80-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:39
51947,"Carbamic acid, N-[(1R,3aR,4aR,6R,8aR,9S,9aS)-9-[(1E)-2-[5-(3-fluorophenyl)-2-pyridinyl]ethenyl]dodecahydro-1-methyl-3-oxonaphtho[2,3-c]furan-6-yl]-, ethyl ester",612-523-7,618385-01-6,STOT SE 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H371:1;H373:1;H400:1;H410:1
51948,"Diisononylnaphthalenedisulphonic acid, compound with 2,2',2''-nitrilotriethanol (1:2)",264-320-4,63568-36-5,,Notified C&L,1,Not classified:1
51949,"Anthra[9,1,2-cde]benzo[rst]pentaphene-5,10-dione, bromo derivatives",215-516-3,1328-18-3,Not Classified,REACH registration C&L,1,Not classified:1
51950,Nifurtimox,245-531-0,23256-30-6,STOT RE 2,Notified C&L,24,H373:24
51954,Fluorapatite (Ca5F(PO4)3),215-144-1,1306-05-4,,Notified C&L,5,H315:5;H319:5;H335:5
51958,"(3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methylpiperidine",924-787-3,110429-36-2,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,3,H302:3;H318:3
51961,Perfluorotoluene,207-104-7,434-64-0,Flam. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3,Notified C&L,51,H315:47;H225:51;H319:47;H302:46;H331:42;H335:7;H332:5;H311:1;H301:1
51966,1-methyl-2-(1-methylpropyl)cyclohexyl acetate,276-442-5,72183-75-6,Not Classified,Notified C&L,1374,Not classified:1374
51972,methyl vinyl ether,203-475-4,107-25-5,Press. Gas;Flam. Gas 1,Harmonised C&L,0,Not classified:0;H220:0
51975,Glycerol trioctanoate,208-686-5,538-23-8,Not Classified,REACH registration C&L,153,Not classified:153
51976,"Amines, N-coco alkyltrimethylenedi-",263-195-3,61791-63-7,Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Aquatic Acute 1,Notified C&L,143,H400:143;H302:105;H314:143;H318:87;H372:37;H301:38;H410:1
51979,Diethyl dibromomalonate,211-151-9,631-22-1,,Notified C&L,5,H314:5
51980,"2-butoxyethyl 2,4,5-trichlorophenoxyacetate",219-828-0,2545-59-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H315:38;H400:38;H319:38;H410:38;H302:38;H335:38
51983,"Butanoic acid, (trans,trans)-4'-propyl[1,1'-bicyclohexyl]-4-yl ester",600-397-6,103130-72-9,Not Classified,Notified C&L,1,Not classified:1
51984,Chloromethyl phenyl sulphide,230-579-7,7205-91-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
51985,"5-phenylpenta-2,4-dienophenone",210-385-9,614-57-3,Aquatic Chronic 4,Notified C&L,42,H413:38;H315:4;H319:4;H335:4
51989,Dexamethasone,200-003-9,50-02-2,Repr. 2;STOT RE 2,REACH registration C&L,164,H361:17;H373:45;H360:99;H315:44;H319:45;H317:47;H334:43;H335:43;H410:37;H362:1;Not classified:1;H351:1;H372:2;H302:1
51992,"Imidodicarbonic diamide, N-methyl-N'-[3-methyl-4-[4-[(trifluoromethyl)thio]phenoxy]phenyl]-",600-737-3,106310-17-2,Aquatic Chronic 2,Notified C&L,1,H411:1
51993,Furfuryl propionate,210-776-4,623-19-8,Not Classified,Notified C&L,88,Not classified:88
51997,Disodium azelate,241-298-4,17265-13-3,Not Classified,Notified C&L,2,Not classified:2
51998,"2-chloro-5-nitro-N-(2,4-xylyl)benzenesulphonamide",272-653-1,68901-10-0,Not Classified,REACH registration C&L,2,Not classified:2
51999,Tetraammonium (1-hydroxyethylidene)bisphosphonate,230-411-2,7101-46-4,Acute Tox. 4;Eye Irrit. 2,Notified C&L,83,H319:83;H302:83
52001,2-(phenylthio)quinoline,244-828-2,22190-12-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 4,Notified C&L,38,H315:38;H413:38;H302:38;H318:38;H335:38
52004,"Alkenes, C10-16 α-",272-492-7,68855-58-3,Not Classified,Notified C&L,1,Not classified:1
52006,C.I. Acid Blue 281,607-130-2,226923-51-9,Not Classified,Notified C&L,5,Not classified:5
52007,m-nitrophenyl isocyanate,222-025-8,3320-87-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,44,H315:44;H319:44;H302:44;H334:44;H335:44;H331:4
52013,Galbanum gum,232-532-6,9000-24-2,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1484,H304:1370;H400:1418;H317:1458;H226:1395;H410:1454;H302:61;H411:28;H228:26;H315:5;H316:1;H401:1
52015,"Fatty acids, C14-18 and C16-18-unsatd., esters with neopentyl glycol",285-533-9,85116-81-0,Not Classified,REACH registration C&L,16,Not classified:16
52019,"Pyridine-2,5-dicarboxylic acid",202-834-2,100-26-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H315:48;H319:48;H335:47
52020,"1,3-dimethylimidazolidin-2-one",201-304-8,80-73-9,Acute Tox. 4;Eye Dam. 1;Repr. 2,REACH registration C&L,337,H361:273;H302:335;H318:255;H373:175;H315:45;H319:59;H311:45;H314:22;H312:13;Not classified:1;H301:1;H335:1;H371:1;H336:1
52023,"Gases (petroleum), unifiner stripper off;Refinery gas;[A combination of hydrogen and methane obtained by fractionation of the products from the unifiner unit.]",272-885-3,68919-12-0,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H350:0;Not classified:0;H220:0;H340:0
52025,3-amino-1H-pyrazole-4-carboxamide,226-252-3,5334-31-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H315:2;H332:1;H319:2;H302:2;H312:1;H335:2
52027,"Oxacyclohexadecane-2,13-dione",405-830-0,,Not Classified,Notified C&L,38,Not classified:37;H411:1
52028,5-aminotoluene-2-sulphonamide,302-499-3,94109-57-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H302:1;H335:1
52030,"7-[(3,7-dimethylocta-2,6-dienyl)oxy]-4-methyl-2-benzopyrone",256-621-4,50542-90-0,Not Classified,Notified C&L,88,Not classified:88
52031,"Electrolytes, copper-manufg., spent",273-752-2,69012-54-0,Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1;Eye Dam. 1;Resp. Sens. 1;Muta. 2;Carc. 1A;Repr. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,18,H360:18;H350:18;H400:18;H341:18;H314:18;H302:18;H318:18;H334:18;H317:18;H372:18;H410:18
52032,"Spinels, cobalt manganese black",307-213-0,97553-53-2,Not Classified,Notified C&L,33,Not classified:33
52035,Piperidine-2-carboxylic acid,208-616-3,535-75-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H315:46;H319:46;H335:46
52036,3-chlorotoluene,203-580-5,108-41-8,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H332:0
52037,"C,C'-azodi(formamide)",204-650-8,123-77-3,Resp. Sens. 1,Harmonised C&L,0,H334:0
52038,3-(trifluoromethyl)anisole,207-229-7,454-90-0,,Notified C&L,7,H315:6;H319:6;H335:5;H226:7
52041,"Cyclopropane-1,1-dicarboxylic acid",209-917-2,598-10-7,Skin Corr. 1B,Notified C&L,48,H314:47;H290:1;H318:1;H315:1;H319:1;H335:1
52050,"3,4-(methylenedioxy)phenol",208-561-5,533-31-3,Acute Tox. 4,REACH registration C&L,61,H302:5;H315:52;H319:51;H335:51;H351:5;H373:3;H312:4;H332:4;Not classified:2;H318:2
52052,"2-(hydroxymethyl)-2-[[(1-oxodocosyl)oxy]methyl]propane-1,3-diyl didocosanoate",256-237-7,45326-01-0,Not Classified,Notified C&L,1,Not classified:1
52055,m-tolylhydrazinium(1+) chloride,211-276-9,637-04-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H315:44;H332:40;H319:44;H302:45;H312:40;H335:43
52056,"Silane, [2-(dimethylsilyl)ethyl]trimethyl-",613-006-9,6231-75-0,Flam. Liq. 2,Notified C&L,1,H225:1;H226:1
52058,2-hydroxy-3-methylcyclopent-2-enone,201-303-2,80-71-7,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,1731,H302:49;H317:35;H318:35;Not classified:1644;H315:38;H319:38;H335:38;H334:38;H224:1
52059,"Fatty acids, C14-18 and C16-18-unsatd., esters with pentaerythritol",285-534-4,85116-82-1,Not Classified,Notified C&L,16,Not classified:16
52061,1-(4-methoxyphenyl)pent-1-en-3-one,203-190-5,104-27-8,Not Classified,Notified C&L,151,Not classified:79;H317:72
52062,2-bromoethyl chloroformate,225-361-3,4801-27-8,Skin Corr. 1B,Notified C&L,38,H314:38
52063,4-[(4-Fluorophenylimino)methyl]phenol,438-950-7,,Not Classified,REACH registration C&L,2,Not classified:2
52064,Bis[2-[2-(2-butoxyethoxy)ethoxy]ethyl] succinate,265-806-9,65520-45-8,Not Classified,Notified C&L,56,Not classified:56
52065,"Trisodium [μ-[3-[[4'-[[6-benzamido-1-hydroxy-3-sulpho-2-naphthyl]azo]-3,3'-dihydroxy[1,1'-biphenyl]-4-yl]azo]-4,5-dihydroxynaphthalene-2,7-disulphonato(7-)]]dicuprate(3-)",278-174-4,75284-35-4,Not Classified,REACH registration C&L,3,Not classified:3
52067,Mebhydrolin,208-364-4,524-81-2,Not Classified,REACH registration C&L,2,Not classified:2
52075,Dimethyl diselenide,230-410-7,7101-31-7,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,44,H400:43;H373:42;H226:40;H331:43;H410:43;H301:43;H311:1;H330:1;H300:1;H310:1
52076,"Octahydro-4,7-methano-1H-indene-5-methanol",260-789-4,57526-50-8,Eye Irrit. 2,REACH registration C&L,2,H319:1;Not classified:1
52077,"8-benzyl-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione",220-725-8,2879-15-4,Acute Tox. 4,Notified C&L,3,H302:2;Not classified:1
52083,Methyl m-toluate,202-753-2,99-36-5,Not Classified,REACH registration C&L,46,Not classified:2;H315:44;H319:44;H302:39;H335:43
52084,"Methyl 4,6-dimethyl-2-oxo-2H-pyran-5-carboxylate",255-283-5,41264-06-6,Not Classified,REACH registration C&L,4,Not classified:2;H315:2;H319:2;H335:2
52089,"1,2-dichloro-4-isothiocyanatobenzene",229-526-0,6590-94-9,Skin Corr. 1B;Eye Dam. 1,Notified C&L,46,H318:39;H314:45;H332:6;H302:6;H312:5;H335:2;H315:1;H319:1
52095,Tris(4-methylphenyl)phosphine,213-863-5,1038-95-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H315:45;H319:45;H335:44;H413:1;H317:1;H372:1
52096,"1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furoyl)piperazine monohydrochloride",242-903-4,19237-84-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 2,Notified C&L,74,H315:39;H319:39;H361:70;H302:42;H335:38;H373:32
52097,Drofenine hydrochloride,208-954-1,548-66-3,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,4,H411:2;H302:2;H332:2;H410:1;Not classified:1
52098,"4-[(2,3-dichlorophenyl)azo]-3-hydroxy-2-naphthoic acid",276-351-0,72121-71-2,Not Classified,Notified C&L,33,Not classified:33
52099,"Milk, skim, hydrolyzed",271-045-3,68514-61-4,Not Classified,Notified C&L,88,Not classified:88
52101,"Raffinates (petroleum), catalytic reformer ethylene glycol-water countercurrent exts.;Low boiling point modified naphtha;[A complex combination of hydrocarbons obtained as the raffinate from the UDEX extraction process on the catalytic reformer stream. It consists of saturated hydrocarbons having carbon numbers predominantly in the range of C",270-088-5,68410-71-9,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
52103,"2-butoxyethyl [(3,5,6-trichloropyridin-2-yl)oxy]acetate",265-024-8,64700-56-7,Acute Tox. 4;Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,98,H400:95;H373:55;H302:98;H317:59;H410:59;H315:39
52104,trans-2-hydroxycinnamic acid,210-386-4,614-60-8,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,78,H315:78;H319:78;H335:77;H301:48
52109,Cholest-5-ene-3-β-yl chloroacetate,222-415-8,3464-50-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
52111,"(1Z)-3-[({2-[(DIAMINOMETHYLIDENE)AMINO]-1,3-THIAZOL-4-YL}METHYL)SULFANYL]-N'-SULFAMOYLPROPANIMIDAMIDE",616-396-9,76824-35-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,116,H315:87;H319:79;H302:25;H332:25;H335:24;H317:3;H334:2;H312:1
52113,"Disodium 3,6-dihydroxynaphthalene-2,7-disulphonate",230-499-2,7153-21-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:40;H319:40;H335:39
52114,Brass,603-111-8,12597-71-6,Not Classified,Notified C&L,77,Not classified:77
52115,Dibutylbis(nonanoyloxy)stannane,247-367-5,25955-19-5,Muta. 2;Repr. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,56,H360:56;H400:56;H341:56;H372:56;H410:56
52121,"(1R-endo)-3-bromo-1,7,7-trimethylbicyclo[2.2.1]heptan-2-one",233-652-1,10293-06-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:40;H319:40;H335:39;H290:1
52123,1-dimethylcarbamoyl-5-methylpyrazol-3-yl dimethylcarbamate;dimetilan (ISO),211-420-0,644-64-4,Acute Tox. 3;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H312:0;H301:0
52124,2-[methyl[(nonafluorobutyl)sulphonyl]amino]ethyl acrylate,266-733-5,67584-55-8,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,308,H411:19;H317:195;Not classified:113
52126,"Soaps, stocks, animal-fat, acidulated, hydrogenated",296-494-2,92704-60-4,Not Classified,Notified C&L,1,Not classified:1
52129,3-methylbut-1-ene,209-249-1,563-45-1,Flam. Liq. 1,Notified C&L,155,H224:155;H315:39;H304:39;H319:39;H335:38
52135,Ammonium phenolate,227-769-7,5973-17-1,Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H312:1;H311:1;H301:1
52136,Lithium iodate,237-365-2,13765-03-2,Ox. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 1B,Notified C&L,39,H315:39;H335:39;H360:39;H319:39;H272:39
52137,Hydroxylapatite (Ca5(OH)(PO4)3),215-145-7,1306-06-5,Not Classified,REACH registration C&L,199,Not classified:189;H315:10;H319:10;H335:7
52139,"4,4'-methylenedi-2,6-xylenol",226-378-9,5384-21-4,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,44,H400:43;H410:4;H315:39;H319:39;H335:38
52142,Dioxobis(stearato)dilead,260-043-8,56189-09-4,Acute Tox. 4;Acute Tox. 4;Repr. 2;STOT RE 2;Aquatic Chronic 1,Notified C&L,1,H332:1;H400:1;H373:1;H361:1;H302:1;H410:1
52145,3-methyl-2-pent-2-enylcyclopent-2-enone,207-668-4,488-10-8,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1906,H315:256;H319:255;H320:1;Not classified:1650;H335:201
52147,"Castor Oil, reaction product with Soybean Oil",919-697-6,,Skin Sens. 1B,REACH registration C&L,26,H317:26
52148,Diacetoxydi-tert-butoxysilane,236-112-3,13170-23-5,Skin Corr. 1B,REACH registration C&L,151,H314:151;H302:96;H318:60
52149,"2,4-dimethylbenzylamine",202-380-5,94-98-4,Skin Corr. 1B,Notified C&L,4,H314:4;H315:1;H332:1;H319:1;H302:1;H312:1;H335:1;H318:1
52152,"4-propylcyclohexyl [trans[trans(trans)]]-4'-propyl[1,1'-bicyclohexyl]-4-carboxylate",280-293-1,83242-83-5,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
52153,methyl 2-[[4-(2-cyanophenyl)phenyl]methylamino]-3-nitrobenzoate,604-135-1,139481-28-0,Not Classified,REACH registration C&L,2,Not classified:2
52155,2-chloro-5-(trifluoromethyl)pyridine,257-856-5,52334-81-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Muta. 2,Notified C&L,104,H315:103;H332:61;H319:103;H341:59;H302:62;H312:60;H335:101;H370:1;H372:1
52158,2-chloropyridine,203-646-3,109-09-1,Acute Tox. 4;Acute Tox. 2;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1,REACH registration C&L,100,H315:95;H330:45;H400:47;H373:29;H302:29;H318:33;H310:90;H410:42;H319:56;H331:54;H335:44;H301:71;H311:10;Not classified:2
52159,Ethyl β-alaninate hydrochloride,224-203-0,4244-84-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H315:3;H319:3;H335:3
52160,"9β,11β-epoxy-6α-fluoro-21-hydroxy-16α,17-(isopropylidene)dioxypregna-1,4-diene-3,20-dione",269-854-1,68352-03-4,Acute Tox. 1;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Repr. 1A,Notified C&L,1,H315:1;H332:1;H360:1;H319:1;H300:1;H312:1;H335:1
52165,Chromium orthophosphate,232-141-0,7789-04-0,,Notified C&L,84,Not classified:38;H315:32;H319:45;H302:14
52166,"Tricyclo(3.3.1.1'3,7)dec-1-yl isocyanate",224-564-4,4411-26-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,41,H315:41;H332:40;H319:41;H302:40;H312:39;H335:41
52173,"N,N-dimethylbutylamine",213-156-1,927-62-8,Flam. Liq. 2;Acute Tox. 3;Skin Corr. 1A;Eye Dam. 1;STOT SE 3,REACH registration C&L,60,H225:60;H314:60;H318:21;H335:20;H301:58;H330:38;H302:1;H332:1
52184,Potassium glycerophosphate,215-291-1,1319-69-3,Not Classified,Notified C&L,4,Not classified:3;H315:1;H318:1
52185,Etherified Light Cracked Naphtha,464-490-1,,Flam. Liq. 1;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Muta. 1B;Carc. 1B;Repr. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,1,H315:1;H304:1;H224:1;H340:1;H350:1;H373:1;H361:1;H411:1;H336:1
52186,tetrahydrofuran,203-726-8,109-99-9,Flam. Liq. 2;Eye Irrit. 2;STOT SE 3;Carc. 2,Harmonised C&L,0,H351:0;H319:0;H335:0;H225:0
52188,"Guanidine, cyano-, reaction products with glycidyl Ph ether",291-372-5,90387-94-3,Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H411:1;H317:1;H314:1
52191,"Poly(oxy-1,2-ethanediyl), a-decyl-[?]-hydroxy-, phosphate, sodium salt",614-353-9,68186-37-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
52195,Tris(2-hydroxyethyl)ammonium acetate,238-874-2,14806-72-5,Not Classified,REACH registration C&L,73,Not classified:73
52196,"3,4-dihydroxy-5-methoxybenzaldehyde",223-513-3,3934-87-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H315:41;H319:41;H335:41
52197,6-methyl-2-pyridylmethanol,214-358-2,1122-71-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H315:46;H319:46;H335:45;H302:1
52198,"1,10-decanediyl bismethacrylate",229-745-1,6701-13-9,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,44,H400:2;H410:2;H317:43;H315:42;H319:42;H412:38;H335:41
52199,"Slack wax (petroleum), carbon-treated;[A complex combination of hydrocarbons obtained by treatment of petroleum slack wax with activated charcoal for the removal of trace polar constituents and impurities.]",309-723-9,100684-49-9,Carc. 1B,Harmonised C&L,0,H350:0
52200,"4,6-dichloro-1,3,5-triazin-2(1H)-one, sodium salt",220-357-8,2736-18-7,Not Classified,REACH registration C&L,3,Not classified:1;H315:1;H319:1;H335:1;H317:1
52204,Butyl 2-methylvalerate,228-569-2,6297-41-2,Skin Irrit. 2;Skin Sens. 1B,Notified C&L,1417,H315:1396;H317:1396;Not classified:21
52208,2-[[2-chloro-4-[(4-nitrophenyl)azo]phenyl]amino]ethanol,256-061-0,43047-20-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
52209,Alverine dihydrogen citrate,226-929-3,5560-59-8,Not Classified,Notified C&L,5,Not classified:2;H332:3;H302:3;H312:3;H301:1
52213,Tellurium,236-813-4,13494-80-9,Skin Sens. 1B;Acute Tox. 4;Repr. 1B;Aquatic Chronic 4,REACH registration C&L,415,H413:144;H332:331;H360:144;H317:145;H319:185;H335:184;H301:81;H310:21;H315:12;H300:16;H361:12;Not classified:4;H412:1
52215,N-(2-hydroxyethyl)isonicotinamide,228-432-7,6265-74-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:39
52218,2-bromo-5-hydroxybenzaldehyde,608-410-7,2973-80-0,Acute Tox. 4;Aquatic Acute 1,Notified C&L,44,H400:43;H302:44;H332:1;H312:1;H315:2;H319:2;H317:2;H335:2
52223,"(2E,4E)-2,4-decadien-1-ol",242-291-9,18409-21-7,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,87,H315:87;H412:77;H317:77
52225,"2,6-dichlorotoluene",204-269-7,118-69-4,Skin Irrit. 2;Aquatic Chronic 2,REACH registration C&L,105,H315:66;H411:32;H335:62;H302:41;H318:38;H319:58;H412:33;H400:3;H373:3;H361:3;Not classified:1;H413:1
52228,"Disodium 4-amino-3-[[4-[[4-[(2,4-diaminophenyl)azo]phenyl]sulphonyl]phenyl]azo]-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulphonate",257-732-0,52204-07-6,,Notified C&L,10,H317:10
52239,4-methylaminophenol,205-768-2,150-75-4,Acute Tox. 4;Acute Tox. 4;Muta. 2;Aquatic Chronic 1,Notified C&L,1,H410:1;H302:1;H332:1;H341:1
52240,"3,7-dimethyloct-6-en-3-ol",242-359-8,18479-51-1,Skin Irrit. 2,REACH registration C&L,1535,H315:21;Not classified:1514;H319:1;H317:1
52247,"2,3-dichloro-6-nitroaniline",265-378-3,65078-77-5,Aquatic Chronic 2,Notified C&L,2,H411:2;H315:1;H332:1;H319:1;H302:1;H312:1;H335:1
52251,Ethyltriphenylphosphonium iodide,225-245-2,4736-60-1,Acute Tox. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,436,H400:26;H300:44;H318:142;H410:27;H315:218;H319:220;H312:261;H335:206;H301:387;H412:19;H411:14;Not classified:5;H336:1
52252,Octadecane-1-sulphonyl chloride,233-417-3,10147-41-8,,Notified C&L,4,H314:4
52253,"Pyrazolidine, hydrochloride (1:2)",618-324-1,89990-54-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 1B;Aquatic Chronic 3,REACH registration C&L,41,H315:41;H350:2;H319:41;H412:2;H302:2;H335:41
52256,4-(1-ethyl-1-methylhexyl)phenol,257-907-1,52427-13-1,Acute Tox. 4;Skin Corr. 1B;Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H400:38;H314:38;H361:38;H302:38;H410:38
52257,Bromoselenobenzene,252-238-1,34837-55-3,Met. Corr. 1;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,44,H290:38;H400:44;H373:43;H331:43;H410:44;H301:43;H315:1;H319:1;H335:1;H330:1;H314:1;H300:1;H318:1
52259,1-(4-chloro-phenyl)-2-methyl-but-3-en-1-ol,602-965-9,123989-31-1,Skin Sens. 1B;Aquatic Chronic 2,Notified C&L,190,H411:190;H317:190;H315:34
52260,"Disodium 9,10-dihydro-9,10-dioxoanthracene-1,5-disulphonate",212-716-2,853-35-0,Eye Irrit. 2,Notified C&L,1,H319:1
52261,"Tetrasodium [({fluoro-[(2-{[fluoro-({5-(hydroxy-kO)-6-[(E)-(2-{(E)-[2-(hydroxy-kO)-sulfophenyl]diazenyl}-4,5-dimethoxyphenyl)diazenyl]-sulfonaphthalen-2-yl}amino)-heteromonocyclyl]amino}alkyl)amino]- heteromonocyclyl}amino)benzene-disulfonato(2-)]copper",466-470-8,,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H318:1;H317:1
52262,"1,3-dibenzyl-2-thiourea",215-837-9,1424-14-2,Acute Tox. 3;Eye Dam. 1;Aquatic Acute 1,Notified C&L,42,H400:38;H318:38;H301:38;H302:4
52266,"Poly(thio-1,4-phenylene)",607-644-7,25212-74-2,,Notified C&L,1,Not classified:1
52269,2-[4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]piperazin-1-yl]ethyl heptanoate,241-529-9,17528-28-8,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Repr. 2,Notified C&L,11,H361:11;H319:11;H302:11;H317:11
52270,Poly(4-styrenesulfonic acid-co-maleic acid) sodium salt,614-218-4,68037-40-1,Not Classified,Notified C&L,118,Not classified:80;H319:38
52272,N-Methyl-gama-(1-naphthalenyloxy)-2-thiophenepropanamine,601-438-0,116539-59-4,Carc. 2;Repr. 2,Notified C&L,9,H351:9;H361:9
52279,Sodium [[4-[(4-amino-m-tolyl)(p-anilinophenyl)hydroxymethyl]phenyl]amino]benzenesulphonate,250-253-8,30586-13-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:40;H319:40;H335:40
52280,"5,6,7,8-tetrahydro-2-naphthoic acid",214-469-6,1131-63-1,Acute Tox. 4,Notified C&L,39,H302:39
52290,trans-oct-2-ene,236-463-2,13389-42-9,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,71,H304:71;H225:49;H315:23;H319:23;H226:22;H335:24
52291,m-nitrophenethyl alcohol,257-611-2,52022-77-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
52296,"amines, tallow alkyl",263-125-1,61790-33-8,Acute Tox. 4;Skin Corr. 1B;Asp. Tox. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H304:0;H400:0;H373:0;H314:0;H302:0;H410:0
52307,Germanium(II) chloride dioxane complex (1:1),608-226-7,28595-67-7,Skin Corr. 1B;Acute Tox. 4;Carc. 2,Notified C&L,39,H351:38;H332:38;H314:39
52312,3-nitropyridin-2-ylamine,224-144-0,4214-75-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:44;H319:44;H335:43;H302:4
52313,"3,4,5-trimethoxybenzamide",221-406-6,3086-62-2,Not Classified,Notified C&L,1,Not classified:1
52314,Dipraseodymium trioxide,234-845-3,12036-32-7,Not Classified,REACH registration C&L,14,Not classified:8;H319:5;H335:5;H315:1;H413:1
52315,"Formaldehyde, polymer with 2-methylphenol and phenol",607-920-7,26354-11-0,Not Classified,Notified C&L,6,Not classified:6
52319,"2-Propenoic acid, 2-methyl-, 2-methylpropyl ester, polymer with 1-ethenyl-4-methylbenzene and 2-ethylhexyl 2-propenoate",601-574-0,118922-88-6,Not Classified,Notified C&L,5,Not classified:5
52320,Potassium ethyl malonate,228-156-7,6148-64-7,Not Classified,REACH registration C&L,48,Not classified:7;H315:41;H319:41;H335:40
52324,Disodium 5-nitro-2-oxidobenzenesulphonate,238-550-0,14528-64-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:44;H319:44;H335:43
52325,2-phenylimidazole,211-581-7,670-96-2,Acute Tox. 4,REACH registration C&L,276,H302:210;H315:205;H319:227;H335:204;Not classified:5;H312:1;H411:1
52326,"1,5-pentanediyl diacrylate",253-235-8,36840-85-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,55,H315:55;H319:55;H335:54;H411:38;H341:16;H317:17
52330,"(4aR,4bS,6aS,7S,9aS,9bS,11aR)-4a,6a-dimethyl-2-oxohexadecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid",926-719-8,103335-55-3,Repr. 2,Notified C&L,1,H361:1
52331,"Carbonic dichloride, polymer with 4,4'-(1-methylethylidene)bis[2,6-dibromophenol], bis(2,4,6-tribromophenyl) ester",615-282-6,71342-77-3,,Notified C&L,50,Not classified:50
52332,D-glucitol monooleate,215-602-0,1333-68-2,Not Classified,Notified C&L,20,Not classified:20
52333,"Benzene, 2-fluoro-4-[4-(trans-4-pentylcyclohexyl)-1-cyclohexen-1-yl]-1-(trifluoromethoxy)-",616-024-5,738599-68-3,Not Classified,Notified C&L,1,Not classified:1
52334,diallyl phthalate,205-016-3,131-17-9,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H302:0
52336,Kebuzone,212-715-7,853-34-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H302:1;H335:1
52337,2-nitrophenyl isocyanate,222-024-2,3320-86-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H315:39;H332:39;H319:39;H302:39;H312:39;H335:39
52338,N-acetyl-L-histidine,219-678-6,2497-02-1,Skin Irrit. 2;Eye Irrit. 2B;STOT SE 3,Notified C&L,1,H315:1;H335:1;H320:1
52339,(2-hydroxyethyl)dimethylammonium lactate,260-322-4,56669-87-5,Not Classified,Notified C&L,83,Not classified:83
52341,"5-(1,5-dimethyl-4-hexenyl)dihydrofuran-2(3H)-one",262-608-4,61099-53-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,88,H315:88;H319:88
52348,Cinnamyl isovalerate,205-407-9,140-27-2,Not Classified,Notified C&L,283,Not classified:283
52349,Dimethyl 2-chloroterephthalate,242-475-9,18643-84-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
52350,1-bromo-4-phenylmethoxybenzene,614-179-3,6793-92-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,43,H315:9;H319:43;H335:43
52352,3-chloro-5-trifluoromethyl-2-pyridylamine,401-670-0,79456-26-1,Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H302:0
52353,"9-Octadecen-1-ol, (Z)-, reaction products with hydrogen sulfide, sulfur and 2,4,4-trimethylpentene",291-763-0,90480-30-1,Not Classified,Notified C&L,1,Not classified:1
52354,"2,2,3,3-tetrafluoropropionic acid",212-049-7,756-09-2,Skin Corr. 1B,Notified C&L,45,H314:45;H290:1;H318:1;H335:1
52355,"Anthracene-1,4,9,10-tetraol",207-507-8,476-60-8,Not Classified,Notified C&L,2040,Not classified:2040
52357,Silver(I)octanoate,607-453-9,24927-67-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
52358,4-(4-methyl-3-pentenyl)cyclohex-3-ene-1-carbaldehyde,253-617-4,37677-14-8,Skin Sens. 1B;Aquatic Chronic 2,Notified C&L,1356,H411:1288;H317:1013;H315:65;H400:65;H318:65;H410:65;Not classified:4;H226:2
52359,Dieuropium(3+) trisulphate,236-903-3,13537-15-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
52368,Deflazacort,238-483-7,14484-47-0,Repr. 1A;STOT RE 2,Notified C&L,29,H373:27;H360:24;H361:4;H362:2;H315:1;H332:1;H319:1;H312:1;H335:1
52370,diethylenetriamine,616-182-5,75037-24-0,Aquatic Chronic 2,Notified C&L,1,H411:1
52372,Isopulegol,201-940-6,89-79-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1795,H315:1527;H319:1511;H302:1794;H335:41;H317:24;Not classified:1
52376,Tetraheptylammonium chloride,233-583-7,10247-90-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
52379,4-(Difluoromethoxy)iodobenzene,603-260-9,128140-82-9,Skin Irrit. 2,Notified C&L,40,H315:39;H332:1;H302:1;H312:1;H319:1;H335:1
52384,Cyclopropyl isothiocyanate,260-278-6,56601-42-4,Flam. Liq. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Notified C&L,44,H301:44;H331:38;H314:44;H226:44;H330:6
52385,(2H3)methylammonium chloride,231-089-6,7436-22-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
52386,Sodium octadecylxylenesulphonate,301-210-8,93982-19-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,25,H315:25;H319:25
52388,"(8α)-5'α-benzyl-12'-hydroxy-2'-isopropylergotaman-3',6',18-trione",208-119-1,511-07-9,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H331:1;H311:1;H301:1
52389,"2,2-dimethyl-1,3-propanediyl dioleate",255-713-1,42222-50-4,Not Classified,REACH registration C&L,41,Not classified:41
52390,"2-Propenoic acid, 2-methyl-, decyl ester, polymer with dodecyl 2-methyl-2-propenoate, hexadecyl 2-methyl-2-propenoate, hexyl 2-methyl-2-propenoate, methyl 2-methyl-2-propenoate, octadecyl 2-methyl-2-propenoate, octyl 2-methyl-2-propenoate and tetradecyl 2-methyl-2-propenoate",600-531-3,104199-42-0,Not Classified,Notified C&L,6,Not classified:6
52391,"Agropyron repens, ext.",283-459-1,84649-79-6,Not Classified,Notified C&L,142,Not classified:140;H226:2;H319:1
52393,Diisobutyl carbonate,208-730-3,539-92-4,Not Classified,Notified C&L,17,Not classified:17
52394,4-Amino-1-methyl-3-N-propyl-pyrazole-5-carboxamide,604-160-8,139756-02-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H315:40;H319:40;H335:39;H302:1
52395,Zinc nitrate hydrate,604-035-8,13778-30-8,Ox. Sol. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H315:42;H335:42;H319:42;H302:42;H272:42
52397,"[4-[[4-(diethylamino)phenyl]phenylmethylene]-2,5-cyclohexadien-1-ylidene]diethylammonium acetate",278-585-9,76994-37-1,Flam. Liq. 3;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,144,H400:99;H314:91;H318:89;H317:89;H226:88;H410:99;H301:90;Not classified:43;H319:10;H302:9;H412:1;H312:1;H315:1
52398,"Resin acids and Rosin acids, reaction products with acrylic acid, sodium salts",295-848-3,92129-47-0,Not Classified,Notified C&L,1,Not classified:1
52402,2-(1-naphthylamino)ethanol,220-904-0,2933-59-7,Acute Tox. 4,Notified C&L,38,H302:38
52403,1-chloro-2-iodo-4-(trifluoromethyl)benzene,211-593-2,672-57-1,Acute Tox. 4;Skin Corr. 1B,Notified C&L,44,H302:39;H314:40;H315:4;H319:4;H332:1;H312:1
52404,Anisyl formate,204-582-9,122-91-8,Acute Tox. 4,REACH registration C&L,1665,H302:1665;H315:38;H332:38;H319:38;H312:38;H335:38;H304:24;H317:24;H318:24
52406,"Acetic acid ethenyl ester, polymer with 1,1-bis(ethenyloxy)butane and ethenol",608-089-3,27360-07-2,Not Classified,Notified C&L,46,Not classified:46
52407,2-[bis(2-ethylhexyl)amino]ethanol,202-912-6,101-07-5,Aquatic Chronic 1,REACH registration C&L,2,H410:2
52418,"Combustion product from Tank 105 (106), organic phase",921-493-7,,Flam. Liq. 1;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Repr. 2;STOT SE 1;STOT RE 2;Aquatic Acute 1,Notified C&L,1,H370:1;H304:1;H224:1;H400:1;H373:1;H410:1;H314:1;H361:1;H302:1;H318:1;H317:1;H335:1;H336:1
52421,"Reaction product of 2,2-Dimethylpropane-1,3-diol, Fatty acids, C18-unsatd., dimers and Fatty acids, C18-unsatd., trimers",921-408-3,,Not Classified,Notified C&L,6,Not classified:6
52426,"Copper, diazotized 5-amino-1-naphthalenesulfonic acid-diazotized 2-[(4-aminophenyl) amino]-5-nitrobenzenesulfonic acid-diazotized 4-nitrobenzeneamine-Dyer’s mulberry (Chlorophora tinctoria) extract coupling products complexes",276-688-3,72480-60-5,Not Classified,Notified C&L,12,Not classified:12
52428,Octyl dipropylene triamine,433-340-7,86423-37-2,Acute Tox. 3;Skin Corr. 1A;Skin Sens. 1;Aquatic Acute 1,Notified C&L,31,H400:31;H317:31;H314:31;H301:31
52429,Undecanal,203-972-6,112-44-7,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,1763,H315:1463;H400:17;H411:33;H412:297;H319:2;H335:2;H413:1
52432,"Tar oils, coal, low-temp.;Tar Oil, high boiling;[A distillate from low-temperature coal tar. Composed primarily of hydrocarbons, phenolic compounds and aromatic nitrogen bases boiling in the range of approximately 160°C to 340°C (320°F to 644°F).]",309-889-2,101316-87-4,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
52433,"Zinc, isooctanoate neodecanoate complexes, basic",282-797-7,84418-83-7,Not Classified,Notified C&L,1,Not classified:1
52435,"Hydrogen bis[3,5-di-tert-butylsalicylato(2-)-O1,O2]chromate(1-)",276-955-4,72869-85-3,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,21,H400:17;H410:17;H302:21
52444,(S)-(+)-3-Hydroxytetrahydrofuran,425-090-2,,Not Classified,REACH registration C&L,6,Not classified:6
52445,"Trisodium 2-[[6-[(4,6-dichloro-1,3,5-triazin-2-yl)methylamino]-1-hydroxy-3-sulphonato-2-naphthyl]azo]naphthalene-1,5-disulphonate",274-701-7,70616-90-9,Not Classified,Notified C&L,10,Not classified:5;H317:4;H334:4;H412:1
52448,Ammonium sulphamidate,231-871-7,7773-06-0,Acute Tox. 4,REACH registration C&L,199,H302:145;Not classified:55;H400:53;H332:16;H410:14;H315:4;H319:5;H335:4;H336:1
52449,guanidinium chloride;guanadine hydrochloride,200-002-3,50-01-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Harmonised C&L,0,H315:0;H319:0;H302:0
52450,1-(ethylamino)propan-2-ol,254-821-6,40171-86-6,Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H318:1;H314:1
52451,"Lemon, ext.",284-515-8,84929-31-7,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,2578,H315:2525;H304:2561;H411:714;H317:2525;H226:2562;H400:1435;H410:1626;Not classified:11;H319:2;H224:1;H401:1
52452,"Fatty acids, tall-oil, iron salts",263-009-0,61788-81-6,Not Classified,Notified C&L,13,Not classified:5;H361:6;H413:2;H317:1
52454,"(2,5-dimethylphenyl)acetonitrile",240-339-3,16213-85-7,,Notified C&L,7,H332:4;H302:4;H312:4;H315:3;H319:3;H335:2;H311:2;H331:2;H301:2
52457,"1,4-bis(2,2,2-trifluoroethoxy)benzene",266-304-2,66300-61-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,5,H315:5;H319:5;H302:5;H335:5
52459,"2,5-bis(p-toluidino)terephthalic acid",233-651-6,10291-28-8,Not Classified,Notified C&L,31,Not classified:31
52462,Nonan-3-ol,210-850-6,624-51-1,Not Classified,Notified C&L,89,Not classified:88;H319:1
52466,"Methyl (19α,20α)-16,17-didehydro-19-methyloxayohimban-16-carboxylate",229-331-0,6474-90-4,Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H302:38;H312:38
52468,4-[2-(1-methyl-2-(4-morpholinyl)ethoxy)ethyl]morpholine,407-940-4,111681-72-2,Eye Dam. 1,Harmonised C&L,0,H318:0
52471,"3,4,4a,5,8,8a-hexahydro-3',7'-dimethylspiro[1,4-methanonaphthalene-2(1H),2'-oxirane]",255-560-0,41816-03-9,Not Classified,Notified C&L,266,Not classified:256;H411:10
52472,"Quaternary ammonium compounds, di-C12-18-alkyldimethyl, Me sulfates",269-921-5,68391-02-6,Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 1,Notified C&L,4,H410:4;H302:4;H314:4
52475,"Oils, menhaden, oxidized",269-222-5,68201-51-4,Not Classified,Notified C&L,31,Not classified:30;H413:1
52476,"Alkenes, C14-18 α-",272-493-2,68855-59-4,Asp. Tox. 1,Notified C&L,59,H302:59;H304:59
52478,"reaction mass of: bis[(2-ethyl-1-oxohexyl)oxy]dioctyl stannane;bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxide;bis(1-phenyl-1,3-decanedionyl)dioctyl stannane;((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decanedionyl)dioctyl stannane",422-920-5,,STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H373:0;H410:0
52479,cisplatin,239-733-8,15663-27-1,Acute Tox. 2;Eye Dam. 1;Carc. 1B,Notified C&L,86,H300:77;H318:59;H350:77;H360:16;H340:24;H319:25;H351:9;H334:27;H317:26;H331:8;H335:18;H301:9;H315:9;H370:2;H314:2;H372:3;H362:3;H310:2;H290:2;H400:1;H361:1
52480,4-nitrophenethyl alcohol,202-835-8,100-27-6,Acute Tox. 4;Eye Irrit. 2,Notified C&L,41,H319:41;H302:41;H315:1;H332:1;H335:1
52482,2-chloro-6-fluorobenzoic acid,207-105-2,434-75-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,134,H315:134;H319:134;H335:133
52483,"(S)-2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole Tartrat Trihydrate",928-472-1,,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,1,H412:1;H302:1
52484,"1-[(2S,3S)-2-(benzyloxy)pentan-3-yl]-N-{4-[4-(4-hydroxyphenyl)piperazin-1-yl]phenyl}hydrazine-1-carboxamide",447-870-1,,STOT RE 2;Aquatic Chronic 4,Notified C&L,1,H373:1;H413:1
52487,"Fatty acids, soya, 2-ethylhexyl esters",297-443-7,93572-14-6,Not Classified,REACH registration C&L,86,Not classified:86
52489,"1-amino-4-[(3-amino-2-methyl-5-sulphophenyl)amino]-9,10-dihydro-9,10-dioxoanthracene-2-sulphonic acid",247-369-6,25956-35-8,Not Classified,Notified C&L,9,Not classified:9
52493,"Gases (petroleum), tar stripper off;Refinery gas;[A complex combination obtained by the fractionation of reduced crude oil. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]",272-884-8,68919-11-9,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H350:0;Not classified:0;H220:0;H340:0
52495,"Cyclopentane-1,2,3,4-tetracarboxylic acid",223-074-8,3724-52-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
52497,Bis-DPP Nickel(II)chloride,467-300-5,,Aquatic Acute 1,Notified C&L,1,H400:1;H410:1
52499,"N,N-dimethylpropanediamine",250-315-4,30734-81-7,Not Classified,Notified C&L,1,Not classified:1
52504,Pentyl phenylacetate,225-895-7,5137-52-0,Not Classified,REACH registration C&L,991,Not classified:991
52505,Hexacarbonylchromium,235-852-4,13007-92-6,Acute Tox. 3,Notified C&L,46,H301:43;H331:5;H332:1;H350:2;H400:3;H302:1;H312:1;H317:3;H410:3;Not classified:2
52506,glyoxal … %;ethandial … %,203-474-9,107-22-2,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 4;Muta. 2,Harmonised C&L,0,H315:0;H332:0;H319:0;H341:0;H317:0
52512,"[1,1-2H2]-2,2,2-trifluoroetane-1-[2H]ol",278-649-6,77253-67-9,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT RE 2,Notified C&L,44,H315:44;H332:44;H373:38;H302:44;H312:44;H318:43;H226:44;H335:5;H361:1;H319:1
52513,(2R)-2-(2-chlorophenyl)-2-hydroxyethanoic acid,444-040-0,52950-18-2,Skin Sens. 1;Eye Dam. 1,Notified C&L,87,H318:86;H317:87;H303:1;H334:1;H319:1
52515,3-nitrochalcone,210-384-3,614-48-2,,Notified C&L,5,H315:5;H319:5;H335:4
52516,Chloromethyl 4-chlorophenyl sulphide,230-578-1,7205-90-5,Skin Corr. 1B,Notified C&L,38,H314:38
52517,2-octyldodecyl myristate,245-205-8,22766-83-2,Not Classified,REACH registration C&L,22,Not classified:22
52519,Bis(acetato-O)hydroxychromium,239-427-4,15417-46-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
52521,"Fatty acids, vegetable-oil",262-994-4,61788-66-7,Not Classified,Notified C&L,32,Not classified:32
52526,"Fatty acids, coco, ethoxylated propoxylated",603-151-6,126645-98-5,Not Classified,Notified C&L,51,Not classified:31;H315:20
52528,Sodium 2-chlorobenzoate,241-297-9,17264-74-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
52530,Sodium hydroxytriphenylborate(1-),235-171-2,12113-07-4,Skin Corr. 1B,Notified C&L,38,H314:38
52532,Fuming sulfuric acid,616-954-1,8014-95-7,Skin Corr. 1A;STOT SE 3,Notified C&L,152,H335:151;H314:152;H330:40;H350:1;H290:1;H413:1;H318:1
52534,"Proteinase, Endothia aspartic",253-395-9,37205-60-0,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1;H334:1
52536,Isopropylphenyl diphenyl phosphate,248-848-2,28108-99-8,Not Classified,Notified C&L,1,Not classified:1
52541,Isopropyl isodecanoate,269-023-3,68171-33-5,Not Classified,REACH registration C&L,100,Not classified:100
52543,"6-sulfonamide-2-(3-methoxy-propyl)-1,1-dioxo-1,2,3,4-tetrahydro-1alpha 6-thieno[3,2-e][1,2]thiazin-4-ol",928-372-8,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,2,H332:2;H302:2;H312:2
52557,Cineole,207-431-5,470-82-6,Flam. Liq. 3;Skin Sens. 1B,REACH registration C&L,2235,H317:1870;H226:2205;H225:22;H319:12;Not classified:8;H315:7;H335:5;H318:5;H334:2;H411:1;H304:1;H412:1
52558,"2,4-dichloro-6-propoxy-1,3,5-triazine",247-875-7,26650-75-9,,Notified C&L,4,H314:4
52559,"Soybean oil, polymd., oxidized",614-321-4,68152-81-8,Not Classified,Notified C&L,6,Not classified:6
52560,1-amino-2-methylbutan-2-ol,257-184-2,51411-49-5,Skin Corr. 1B,Notified C&L,1,H314:1
52561,Tisopurine,226-251-8,5334-23-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H315:42;H319:42;H335:42
52562,"trans-(1R,2S)-2-(3,4-difluorophenyl)cyclopropylamine (R)-(-)-mandelate",619-507-9,376608-71-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,11,H315:9;H319:9;Not classified:2
52564,"17-hydroxypregna-4,9(11)-diene-3,20-dione",251-868-4,34184-82-2,Repr. 2;STOT RE 2,REACH registration C&L,1,H361:1;H373:1
52565,5-ethyl-5-phenylhydantoin,211-150-3,631-07-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,3,H315:3;H319:3;H302:3;H335:3
52567,Holmium,231-169-0,7440-60-0,Flam. Sol. 1,Notified C&L,49,H228:41;H250:4;H260:4;H252:4;Not classified:4
52568,Glycerol trilaurate,208-687-0,538-24-9,,Notified C&L,38,Not classified:38
52570,"Amines, N-coco alkyltrimethylenedi-, acetates",263-196-9,61791-64-8,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,90,H315:67;H400:89;H318:24;H317:1;H410:24;H319:63;H302:88;H314:23;H335:20;H290:1
52572,"(S)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-4-benzopyrone",209-016-4,552-58-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:40;H319:40;H335:40
52575,"2-aminooctadec-4-ene-1,3-diol",204-651-3,123-78-4,,Notified C&L,90,H315:90;H319:90;H335:90
52576,"2,2-bis(hydroxymethyl)propane-1,3-diyl dipalmitate",246-882-2,25354-61-4,Not Classified,Notified C&L,1,Not classified:1
52577,"2,5-dibutoxy-4-(morpholin-4-yl)benzenediazonium tetrafluoroborate",256-623-5,50543-78-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
52581,"N,N-dimethylmethanesulphonamide",213-039-5,918-05-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:40;H319:40;H302:39;H335:40
52582,Sodium N-(2-carboxyethyl)-N-(2-ethylhexyl)-β-alaninate,305-318-6,94441-92-6,Not Classified,REACH registration C&L,84,Not classified:45;H319:26;H412:25;H318:13;H315:5
52583,"(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-{[2'-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylate",604-437-3,144690-92-6,Not Classified,REACH registration C&L,1,Not classified:1
52584,"Gases (petroleum), butane splitter overheads;Petroleum gas;[A complex combination of hydrocarbons obtained from the distillation of the butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]",270-750-3,68477-69-0,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H350:0;Not classified:0;H220:0;H340:0
52590,"1-(3,4-dimethoxyphenyl)ethan-1-one",214-468-0,1131-62-0,Acute Tox. 4,Notified C&L,2,H302:2;H319:1
52591,3-butyl-1-methyl-1H-imidazol-3-ium chloride,460-120-8,79917-90-1,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1;H301:1
52592,tris(nonylphenyl) phosphite,247-759-6,26523-78-4,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H317:0
52594,"metalaxyl-M (ISO);mefenoxam;(R)-2-[(2,6-dimethylphenyl)-methoxyacetylamino]propionic acid methyl ester",615-135-6,70630-17-0,Acute Tox. 4;Eye Dam. 1,Harmonised C&L,0,H302:0;H318:0
52595,"1,3,5-trinitrobenzene",202-752-7,99-35-4,Expl. 1.1;Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H330:0;H201:0;H373:0;H400:0;H300:0;H310:0;H410:0
52596,"Formaldehyde, polymer with 4,4-(1-methylethylidene)bisphenol",607-535-4,25085-75-0,Not Classified,Notified C&L,69,Not classified:63;H413:3;H317:3
52597,Ketanserin,277-680-2,74050-98-9,Acute Tox. 4,Notified C&L,97,H302:97
52605,"di-μ-chlorobis[(1,2,5,6-η)cycloocta-1,5-diene]diiridium",235-170-7,12112-67-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,232,H315:232;H319:232;H302:191;H312:191;H335:230;H332:1
52606,4-chloro-5-methyl-1H-pyrazole,605-163-7,15878-08-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H302:1;H335:1
52607,"Fatty acids, C8-18 and C18-unsatd., reaction products with diethanolamine and propylene oxide",600-026-8,1000817-22-0,Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,87,H318:87;H317:87
52609,Trityl pentachlorostannate,239-426-9,15414-98-9,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,Notified C&L,38,H332:38;H314:38;H302:38;H312:38;H318:38
52610,Bis[methylguanidinium] sulphate,209-918-8,598-12-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H315:1;H332:1;H319:1;H302:1;H312:1
52611,"2-[7-(diethylamino)-2-oxo-2H-1-benzopyran-3-yl]-1,3-dimethyl-1H-benzimidazolium acetate",304-472-1,94275-84-0,Eye Irrit. 2,Notified C&L,2,H319:2
52612,"Tetrafluoroethylene, oxidized, oligomers, reduced, methyl esters, reduced, reaction products with ethylene oxide",500-749-8,162492-15-1,Not Classified,Notified C&L,22,Not classified:22
52613,"[1S-(1α,3β,5α)]-6,6-dimethyl-2-methylenebicyclo[3.1.1]heptan-3-ol",243-406-5,19889-99-7,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
52614,"Sodium [1α(Z),2β(1E,3R*),3α,5α]-(±)-7-[2-[4-(3-chlorophenoxy)-3-hydroxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoate",259-439-3,55028-72-3,Resp. Sens. 1;Repr. 1B;STOT SE 1;STOT RE 1,Notified C&L,45,H370:35;H360:42;H334:37;H372:35;H319:1;H302:3;H335:1;H317:1
52619,Lead tin trioxide,234-844-8,12036-31-6,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,44,H332:44;H360:44;H400:44;H373:44;H302:44;H410:44
52621,Disodium L-cystinate,265-025-3,64704-23-0,Not Classified,REACH registration C&L,1,Not classified:1
52628,"1H-Pyrrolo[3,4-b]pyridine, octahydro-6-(phenylmethyl)-, (4aS,7aS)-",604-777-2,151213-39-7,Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4;STOT RE 2;Aquatic Chronic 2,Notified C&L,34,H332:33;H373:33;H314:33;H411:33;H302:33;H315:1;H319:1;H335:1
52630,"Tetrasodium [μ-[[2,2'-(vinylene)bis[5-[[5-hydroxy-4-[(2-hydroxy-5-sulphophenyl)azo]-2-methoxyphenyl]azoxy]benzenesulphonato]](8-)]]dicuprate(4-)",274-552-8,70304-40-4,Not Classified,Notified C&L,14,Not classified:14
52632,Disodium 6-hydroxy-5-[(2-methoxy-4-sulphonato-m-tolyl)azo]naphthalene-2-sulphonate,247-368-0,25956-17-6,Not Classified,REACH registration C&L,318,Not classified:318
52639,1-nitro-4-propylbenzene,233-743-6,10342-59-3,,Notified C&L,4,H332:4;H302:4;H312:4
52649,4-Propylbenzoic Acid,607-366-6,2438-05-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H315:47;H319:47;H335:46;Not classified:1
52650,calcium chromate,237-366-8,13765-19-0,Acute Tox. 4;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H302:0;H350:0
52651,2-hexyldecyl oleate,304-693-3,94278-07-6,Not Classified,Notified C&L,3,Not classified:3
52655,Phenylarsine oxide,211-275-3,637-03-6,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,47,H331:47;H410:46;H400:42;H301:47;H373:4;H334:2;H350:1;H314:1
52656,cadmium oxide (non-pyrophoric),215-146-2,1306-19-0,Acute Tox. 2;Muta. 2;Carc. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H350:0;H330:0;H400:0;H341:0;H361:0;H372:0;H410:0
52658,"6-(1α,5aβ,8aβ,9-pentahydroxy-7β-isopropyl-2β,5β,8β-trimethylperhydro-8bα,9-epoxy-5,8-ethanocyclopenta[1,2-b]indenyl) pyrrole-2-carboxylate;ryania",239-732-2,15662-33-6,Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H302:0;H312:0
52664,Magnesium 2-propylvalerate,263-770-9,62959-43-7,,Notified C&L,2,H315:1;H319:1;H302:2;H360:1
52666,(±)-1-bromo-2-methylbutane,227-768-1,5973-11-5,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38;H225:38
52670,Copper phthalocyanine direct dye,,,Not Classified,Notified C&L,1,Not classified:1
52671,"3-[(4-Acetamido-2-Sulfophenyl)Diazenyl]-4,5-Dihydroxy-6-[(4-Nitro-2-Sulfophenyl)Diazenyl]Naphthalene-2,7-Disulfonic Acid",925-385-0,,Not Classified,Notified C&L,1,Not classified:1
52675,2-chloro-4'-fluorobenzophenone,217-300-4,1806-23-1,Muta. 2,Notified C&L,1,H341:1
52677,"Tris(pentane-2,4-dionato-O,O')neodymium",238-631-0,14589-38-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,39,H315:39;H332:39;H319:39;H302:39;H312:39
52685,Zirconium silicide,235-247-5,12138-26-0,Not Classified,Notified C&L,1,Not classified:1
52687,"2,4-dihydro-4-[4-[4-(4-methoxyphenyl)piperazin-1-yl]phenyl]-3H-1,2,4-triazol-3-one",278-009-6,74853-07-9,Not Classified,REACH registration C&L,2,Not classified:1;H302:1
52688,"3(or 5)-(4-(N-benzyl-N-ethylamino)-2-methylphenylazo)-1,4-dimethyl-1,2,4-triazolium methylsulphate",406-055-0,124584-00-5,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H302:0;H317:0;H318:0
52692,"1,2-dihydro-6-methyl-2-oxonicotinonitrile",224-202-5,4241-27-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H315:44;H332:39;H319:44;H302:44;H312:40;H335:43;H301:1
52693,"Cypress, Cupressus funebris, ext.",285-360-9,85085-29-6,Asp. Tox. 1;Skin Corr. 1C;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,1484,H411:17;H304:1484;H317:17;H314:17;H400:1428;H410:1391;H315:26
52696,Morpholin-3-one,203-647-9,109-11-5,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3,Notified C&L,50,H315:41;H302:49;H318:48;H317:40;H335:40;H332:9;H314:8;H311:8;H312:1;H319:1
52697,(allylsulphonyl)benzene,240-338-8,16212-05-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:43;H319:43;H335:38
52702,"(2β,3α,5α,16β,17β)-17-Acetoxy-3-hydroxy-2-(4-morpholinyl)-16-(1-pyrrolidinyl)androstane",601-596-0,119302-24-8,Not Classified,REACH registration C&L,3,Not classified:1;H332:1;H302:1;H312:1;H400:1;H319:1;H317:1;H410:1
52706,2-amino-4-methylbenzonitrile,248-020-0,26830-96-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H315:43;H332:42;H319:43;H302:42;H312:42;H335:42;H311:1;H331:1;H301:1
52707,Sodium 2-sulphonatoethyl oleate,205-522-4,142-15-4,,Notified C&L,1,H319:1
52708,"C.I. Basic Violet 3 with ≥ 0.1 % of Michler's ketone (EC no. 202-027-5);4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride",208-953-6,548-62-9,,,0,H350:0;H400:0;H302:0;H318:0;H410:0
52709,"Lavender, Lavandula angustifolia, ext.",289-995-2,90063-37-9,Asp. Tox. 1;Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,689,H319:328;H304:590;H412:390;H317:359;H315:339;Not classified:63;H411:22;H226:6;H401:1;H335:1;H371:1;H318:1
52713,N-sec-butylphthalimide,233-295-1,10108-61-9,Not Classified,Notified C&L,42,Not classified:37;H315:5;H319:5
52714,3-aminophenylboric acid hemisulphate,266-376-5,66472-86-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H315:45;H319:45;H335:44
52716,4-hydroxybutyramide,213-155-6,927-60-6,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
52718,"2,2-Dimethyl-1,3-dioxacyclohept-5-ene",600-086-5,1003-83-4,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,1,H319:1;H226:1
52719,"N,N-bis(3-(4,5-dihydro-1H-imidazol-2-yl)phenyl)urea) dipropionate",259-791-8,55750-06-6,Acute Tox. 4,Notified C&L,109,H302:108;Not classified:1
52723,4-methyl-5-vinylthiazole,217-160-4,1759-28-0,Acute Tox. 4,Notified C&L,1696,H302:1696;H315:96;H332:53;H319:96;H312:53;H335:95
52724,Bromomethylmercury,208-057-5,506-83-2,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H330:38;H400:38;H373:38;H300:38;H310:38;H410:38
52726,"POLY(OXY-1,2-ETHANEDIYL), .ALPHA.-TRIDECYL-.OMEGA.-HYDROXY-, PHOSPHATE, POTASSIUM SALT",614-352-3,68186-36-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,288,H315:268;H319:150;H318:116;H412:21;Not classified:18;H411:6;H314:1;H317:1
52727,"N-(2,5-dichloro-4-nitrophenyl)acetamide",253-917-5,38411-17-5,Eye Irrit. 2,Notified C&L,38,H319:38
52728,"Methylstyrene, mixed isomers",215-292-7,1319-73-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,8,H315:8;H332:8;H319:8;Not classified:8;H226:8
52730,"[(R*,R*)-6-fluoro-3,4-dihydro-2oxiranyl-2H-1-benzopyran",619-407-5,99199-90-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 3,Notified C&L,1,H315:1;H319:1;H335:1;H411:1
52737,4'-(pyrimidin-2-ylsulphamoyl)acetanilide,204-862-0,127-74-2,,Notified C&L,1,H302:1
52740,"2-amino-6-methyl-1,2,4-triazolo[1,5-a]pyrimidin-5(1H)-one",248-387-7,27287-73-6,Acute Tox. 4,Notified C&L,156,H302:156
52741,"2,4-dichloro-5-sulphamoylbenzoic acid",220-358-3,2736-23-4,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,REACH registration C&L,49,H315:49;H335:48;H318:10;H319:38
52743,4-butoxyphenol,204-583-4,122-94-1,Acute Tox. 4,Notified C&L,43,H302:39;H315:5;H319:5;H335:4
52748,Heptadecanenitrile,226-432-1,5399-02-0,Acute Tox. 4,Notified C&L,39,H302:39;H315:1;H332:1;H319:1;H312:1
52752,"2,4-dimethylbenzophenone",214-523-9,1140-14-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H302:1;H335:1
52753,"α,2,4-trichlorotoluene",202-381-0,94-99-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,104,H315:48;H400:17;H319:48;H410:16;H302:56;H335:49;H314:56;H332:34;H411:37;H290:8;H318:1;H312:1;H351:1
52755,"Spiro[17H-dicyclopropa[6,7:15,16]cyclopenta[a]phenanthrene-17,2'(5'H)-furan]-3,5'(2H)-dione, 1,3',4',6,7,8,9,10,11,12,13,14,15,16,20,21-hexadecahydro-10,13-dimethyl-, [6R-(6α,7α,8β,9α,10β,13β,14α,15α,16α,17β)]-",266-679-2,67392-87-4,Repr. 1B,Notified C&L,87,H360:82;H362:30;H351:47;H411:29;H302:46;H332:17;H312:16;H361:4;H373:1;H317:1
52764,"Boric acid (H3BO3), reaction products with glycerol",255-712-6,42220-19-9,Not Classified,Notified C&L,7,Not classified:7
52765,"1,1',1''-(benzene-1,3,5-triyltricarbonyl)tris[2-ethylaziridine]",231-762-4,7722-73-8,,Notified C&L,1,H304:1;H225:1;H340:1;H330:1;H350:1;H314:1;H411:1;H300:1;H310:1
52768,"2,4-dichlorobenzophenone",243-338-6,19811-05-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
52771,potassium chromate,232-140-5,7789-00-6,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;STOT SE 3;Muta. 1B;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1B,Harmonised C&L,0,H315:0;H340:0;H350:0;H400:0;H319:0;H410:0;H317:0;H335:0
52772,"p-dodecylbenzenesulphonic acid, compound with cyclohexylamine (1:1)",238-318-9,14356-38-8,,Notified C&L,60,H302:60;H312:60;H318:60
52775,Tris(4-nitrophenyl)amine,606-557-1,20440-93-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H315:39;H332:38;H319:39;H302:38;H312:38;H335:38
52776,[4-[cyano(p-tolyl)methyl]phenyl]ammonium chloride,277-564-1,73663-77-1,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1,Notified C&L,38,H315:38;H335:38;H318:38;H400:38
52779,"9-Octadecen-1-ol, (Z)-, reaction products with hydrogen sulfide, sulfur and 2,4,4-trimethylpentene, reaction products with phosphorus oxide (P2O5)",291-764-6,90480-31-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
52782,Iodo(trimethyl phosphite-P)copper,252-237-6,34836-53-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
52783,Diethyl (pyrrolidin-1-ylmethyl)phosphonate,257-488-5,51868-96-3,Skin Irrit. 2,Notified C&L,39,H315:39;H319:1
52786,4-chloro-1-naphthol,210-068-5,604-44-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,53,H315:53;H319:53;H335:52
52788,4-(3-methoxy-4-nitrophenyl)morpholine,230-122-1,6950-88-5,,Notified C&L,1,H315:1;H319:1;H335:1
52792,"L-Lysine, hydrate (1:1)",609-735-7,39665-12-8,Not Classified,Notified C&L,1,Not classified:1
52795,"cis-tetrahydro-1H-cyclopenta[c]furan-1,3(4H)-dione",252-773-0,35878-28-5,Skin Irrit. 2;Eye Dam. 1,Notified C&L,39,H315:39;H318:38;H319:1;H335:1
52796,"Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-[(3-sulfobenzoyl)oxy]-, monosodium salt, (11β,16α)-",223-514-9,3936-02-5,Repr. 2;STOT RE 2,Notified C&L,2,H361:1;H373:1;H315:1;H332:1;H319:1;H302:1;H312:1;H335:1
52797,Ajowan oil,616-791-6,8001-99-8,Aquatic Chronic 2,Notified C&L,54,H411:54;H304:1;H314:2;H302:2;H318:2;H317:1;H226:2
52800,"3-ethyl-2-[5-(3-ethyl-3H-benzoxazol-2-ylidene)penta-1,3-dienyl]benzoxazolium iodide",238-873-7,14806-50-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:38
52802,furan,203-727-3,110-00-9,Flam. Liq. 1;Acute Tox. 4;Skin Irrit. 2;Acute Tox. 4;Muta. 2;Carc. 1B;STOT RE 2;Aquatic Chronic 3,Harmonised C&L,0,H315:0;H332:0;H224:0;H350:0;H373:0;H412:0;H341:0;H302:0
52803,"7-chloro-5-(2-chlorophenyl)-2,3-dihydro-2-oxo-1H-1,4-benzodiazepin-3-yl pivalate",260-940-4,57773-81-6,STOT SE 3;Repr. 2,Notified C&L,1,H361:1;H336:1
52804,"1,2-Benzenedicarboxylic acid, mixed esters with 3,3'-oxybis[1,2-propanediol] and stearic acid",297-271-2,93384-59-9,Not Classified,Notified C&L,31,Not classified:31
52812,α-chloro-2-nitrotoluene,210-300-5,612-23-7,Skin Corr. 1B,Notified C&L,45,H314:45;H341:4;H318:2;H290:1;H332:1;H302:1;H312:1
52816,Yttrium zirconium oxide,264-885-7,64417-98-7,Not Classified,REACH registration C&L,56,Not classified:18;H315:38;H319:38
52820,methyl[2-(pyridin-4-yl)ethyl]amine,848-140-9,55496-55-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H315:1;H335:1;H302:1;H318:1
52822,"5-oxa-2-octyne-1,7-diol",216-522-9,1606-79-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:1;H302:1;H312:1;Not classified:1
52826,N-[2-[[(4-chlorophenyl)methylene]amino]phenyl]-1-Pyrrolidineacetamide,600-893-2,109037-60-7,Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H315:2;H319:2;H400:2;H410:2
52827,"Tricyclo[3.3.1.13,7]decan-1-amine, N,N-dimethyl-",609-335-2,3717-40-6,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Repr. 2;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,85,H412:85;H314:85;H361:85;H302:85;H318:85;H402:2
52828,"Sulfuric Acid, waste gas washing, copper smelting",922-670-1,,Met. Corr. 1;Skin Corr. 1A;Skin Sens. 1;Eye Dam. 1;Muta. 1B;Carc. 1A;STOT RE 2;Aquatic Chronic 1,REACH registration C&L,1,H340:1;H290:1;H350:1;H373:1;H314:1;H318:1;H317:1;H410:1
52830,AMARELO DRIMARENE X-RN; DRIMAREN GELB X-RN; DRIMARENE YELLOW X-RN; JAUNE DRIMARENE X-RN; JAUNE X-WK 1985; YELLOW X-WK 1985,400-080-0,,Not Classified,Notified C&L,39,Not classified:31;H317:8
52831,"Methyl (2S,4R)-4-hydroxypyrrolidine-2-carboxylate hydrochloride",609-795-4,40216-83-9,Not Classified,Notified C&L,7,Not classified:5;H315:2;H319:2;H335:2
52832,"Diethyl 2,4-diacetyl-3-(4-chlorophenyl)glutarate",284-201-0,84803-73-6,Not Classified,REACH registration C&L,1,Not classified:1
52833,Cupreine,208-363-9,524-63-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1;H302:1
52836,"Cymbopogon flexuosus, ext.",295-161-9,91844-92-7,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,305,H315:279;H318:236;H317:279;H411:61;H304:30;H400:30;H319:43;H410:30;Not classified:25;H412:3;H335:1
52837,Bis[2-[2-(2-butoxyethoxy)ethoxy]ethyl] adipate,265-807-4,65520-46-9,Not Classified,REACH registration C&L,122,Not classified:122
52838,"Fatty acids, tallow, potassium salts",263-124-6,61790-32-7,Not Classified,Notified C&L,3,Not classified:3
52839,"2-(4-(diethylaminopropylcarbamoyl)phenylazo)-3-oxo-N-(2,3-dihydro-2-oxobenzimidazol-5-yl)butyramide",404-910-2,164578-14-7,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H317:0
52840,(carboxylatomethyl)dodecyldimethylammonium,211-669-5,683-10-3,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,806,H315:705;H319:21;H317:101;H302:496;H312:537;H318:691;Not classified:47;H301:42;H400:6;H410:6;H412:8;H314:6;H371:1
52841,2-methylprop-2-en-1-ylamine,220-724-2,2878-14-0,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,5,H315:4;H319:4;H335:4;H225:5;H318:1;H314:1
52842,Thiocarbonohydrazide,218-769-8,2231-57-4,Acute Tox. 2;Acute Tox. 3;Acute Tox. 1,Notified C&L,46,H300:45;H330:41;H311:44;H319:3;H315:1;H312:1
52845,"O,S-dimethyl carbonodithioate",606-356-9,19708-81-7,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1;H312:1;H226:1
52849,5-ethylidene-3-hydroxy-4-methylfuran-2(5H)-one,253-236-3,36842-29-2,Flam. Liq. 3;Acute Tox. 4,Notified C&L,1,H302:1;H226:1
52851,"3,4-epoxybut-1-ene",213-210-4,930-22-3,Flam. Liq. 2;Acute Tox. 4;Eye Irrit. 2,Notified C&L,45,H319:41;H302:40;H225:45;H341:4;H315:1;H335:1
52852,"Disodium 4,4'-bis[(4-anilino-6-methoxy-1,3,5-triazin-2-yl)amino]stilbene-2,2'-disulphonate",222-326-4,3426-43-5,Not Classified,REACH registration C&L,140,Not classified:134;H319:6
52853,Dibutylchloroaluminium,222-576-4,3537-86-8,Pyr. Liq. 1;Water-react. 1;Skin Corr. 1B,Notified C&L,83,H250:83;H260:83;H314:83
52855,Azathioprine,207-175-4,446-86-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Muta. 1A;Carc. 1A;Repr. 1A,Notified C&L,107,H315:95;H360:63;H340:67;H350:107;H319:95;H302:107;H335:94;H361:4;H372:2;H317:1
52859,"Commiphora erythraea, ext.",309-134-7,100084-96-6,Acute Tox. 4,Notified C&L,133,H302:108;H315:25
52862,α-[(methylamino)methyl]benzyl alcohol,229-525-5,6589-55-5,Acute Tox. 4;Acute Tox. 4,Notified C&L,42,H302:38;H332:38;H315:4;H319:4;H335:4
52869,5-nitropyrimidin-2-ylamine,224-145-6,4214-76-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H315:46;H319:46;H335:45
52874,Methyl 4-(dimethoxymethyl)benzoate,255-714-7,42228-16-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H332:1;H319:1;H302:1;H312:1;H335:1
52881,4-methyl-2-pyrazolin-5-one,236-346-6,13315-23-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
52882,"2-amino-N-(2-chloro-6-methylphenyl)-1,3-thiazole-5-carboxamide",460-280-9,302964-24-5,Acute Tox. 3;Skin Sens. 1B;Repr. 2;STOT RE 1;Aquatic Chronic 2,Notified C&L,85,H361:85;H411:85;H317:85;H372:85;H301:85;H373:1;H410:1;H401:1
52886,"Hydrogen [4-[4-(dimethylamino)-α-(2-hydroxy-3,6-disulphonato-1-naphthyl)benzylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium, monosodium salt",221-409-2,3087-16-9,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,79,H319:42;H412:2;H315:40;H302:67;H335:39;Not classified:10
52887,Chlorophylls,215-800-7,1406-65-1,Flam. Liq. 3,Notified C&L,1287,H226:1287
52891,Dicyclohexylphenylphosphine,229-334-7,6476-37-5,Acute Tox. 4,Notified C&L,44,H302:44;H315:1;H319:1
52892,p-tert-butylphenyl dihydrogen phosphate,236-530-6,13421-39-1,Skin Corr. 1B,Notified C&L,76,H314:71;Not classified:5
52893,4-bromobutyryl chloride,213-154-0,927-58-2,Skin Corr. 1B;STOT SE 3,Notified C&L,44,H335:39;H314:44;H318:1
52894,4-CPA (ISO);4-chlorophenoxyacetic acid,204-581-3,122-88-3,Acute Tox. 4,Harmonised C&L,0,H302:0
52897,Heptadecafluoro-N-methyloctanesulphonamide,250-665-8,31506-32-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H332:1;H319:1;H302:1;H312:1;H335:1
52899,Copper(II) nitrate hydrate,604-036-3,13778-31-9,Ox. Sol. 2;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,42,H315:38;H272:42;H302:42;H318:38;H314:4
52900,2-Nitropropionic acid methy lester,612-095-1,6118-50-9,Acute Tox. 3,Notified C&L,38,H301:38
52902,"2,6-diaminoanthraquinone",205-013-7,131-14-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H315:41;H319:41;H335:40
52908,Primaquine bis(phosphate),200-560-8,63-45-6,Acute Tox. 3,Notified C&L,38,H301:38
52909,Tetrakis(tritolyl phosphite )nickel,252-777-2,35884-66-3,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1,REACH registration C&L,1,H315:1;H226:1;H302:1;H317:1;H311:1
52922,Quinine sulphate,212-359-2,804-63-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H315:41;H319:41;H335:41;H302:5;H332:4;H312:1;H317:2
52923,Bismuth oxide,235-736-3,12640-40-3,Not Classified,Notified C&L,9,Not classified:9
52925,3-(4-hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde,257-187-9,51414-25-6,Skin Sens. 1A,Harmonised C&L,0,H317:0
52926,2-(octylamino)ethanol,251-111-8,32582-63-1,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;STOT SE 3,Notified C&L,1,H335:1;H302:1;H312:1;H314:1
52928,"1-acetyl-4-(3-dodecyl-2,5-dioxo-1-pyrrolidinyl)-2,2,6,6-tetramethylpiperidine",411-930-5,106917-31-1,Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H315:0;H410:0;H400:0;H317:0
52930,(3-(Dimethylamino)propyl)triphenylphosphonium bromide,605-998-7,18355-96-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:39
52931,trypsin,232-650-8,9002-07-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Resp. Sens. 1,Harmonised C&L,0,H315:0;H319:0;H335:0;H334:0
52935,Undec-10-enal,203-973-1,112-45-8,Skin Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1667,H315:1641;H411:194;H319:1505;H412:1434;H317:1503;H304:20;Not classified:1
52936,"Aromatic hydrocarbons, C",295-551-9,92062-36-7,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
52937,"Trimethoxy(3,3,3-trifluoropropyl)silane",207-059-3,429-60-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,137,H315:97;H319:97;H335:94;H226:119;Not classified:18
52938,"4,4'-isopropylidenedi-o-cresol",201-240-0,79-97-0,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,50,H411:4;H319:49;H317:4;H315:44;H335:43;Not classified:1;H373:1;H341:1
52941,"2-Propenoic acid, telomer with sodium 2-methyl-2-[[](1-oxo-2-propen-1-yl)amino]-1-propanesulfonate (1:1) and sodium phosphinite (1:1)",600-950-1,110224-99-2,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,22,H319:22;H412:22;H290:1
52943,Busulfan,200-250-2,55-98-1,Acute Tox. 3;Acute Tox. 2;Acute Tox. 2;Carc. 1B,Notified C&L,50,H330:41;H310:40;H350:50;H301:41;H315:9;H360:7;H340:8;H319:9;H373:7;H300:9;H335:9;H361:2;H311:3;H331:2
52945,α-aminotoluene-4-sulphonamide monoacetate,235-855-0,13009-99-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H302:1;H335:1
52948,3-(m-hydroxyphenyl)-DL-alanine,212-270-9,775-06-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,53,H315:53;H319:53;H335:52
52949,"[iminobis(ethyleneiminomethylene)]diphosphonic acid, N,N-bis(phosphonomethyl) derivative",273-684-3,69009-91-2,Met. Corr. 1;Skin Corr. 1A;Eye Dam. 1,Notified C&L,20,H314:20;H290:20;H318:20
52950,"Addition products of m-phenylenebis(methylamine) with reaction mass of 2-(2-(2-butoxyethoxy)ethoxy)ethyl 5-isocyanato-2-methylphenylcarbamate, 2-(2-(2-butoxyethoxy)ethoxy)ethyl 3-isocyanato-4-methylphenylcarbamate and 2-(2-(2-butoxyethoxy)ethoxy)ethyl 3-isocyanato-2-methylphenylcarbamate",605-293-4,162568-25-4,Not Classified,REACH registration C&L,2,Not classified:2
52952,Allyl trimethylhexanoate,268-648-9,68132-80-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,112,H315:87;H319:87;H302:112
52954,"2-hydroxypropane-1,3-diyl dilaurate",208-731-9,539-93-5,Not Classified,Notified C&L,1,Not classified:1
52957,"3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl acrylate",241-527-8,17527-29-6,STOT RE 2,REACH registration C&L,171,H373:4;Not classified:109;H315:42;H319:42;H335:57
52959,"Phosphoric acid, C8-10-branched and linear alkyl esters, compds. with ethanolamine",306-951-0,97468-01-4,Not Classified,Notified C&L,3,Not classified:3
52960,potassium 4-iodo-2-sulfonato-benzoic acid,426-620-5,619297-89-1,Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H318:0
52967,Cloprop,202-915-2,101-10-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,109,H315:109;H319:109;H302:105;H335:108;H351:1
52969,Dimethyl 2-bromoterephthalate,242-476-4,18643-86-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
52970,"Potassium sodium 4,4'-bis[6-anilino-4-[bis(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl]amino]stilbene-2,2'-disulphonate",275-031-8,70942-01-7,Not Classified,REACH registration C&L,41,Not classified:41
52971,diethyl(ethyldimethylsilanolato)aluminium,401-160-8,55426-95-4,Pyr. Liq. 1;Water-react. 1;Skin Corr. 1A,Harmonised C&L,0,H250:0;H260:0;H314:0
52972,3β-hydroxyandrost-5-en-17-one acetate,212-714-1,853-23-6,Repr. 1B,REACH registration C&L,23,H360:4;H332:17;H361:18;H351:18;H302:17;H312:17;H315:1;H319:1;H335:1
52975,"3-Pyrrolidineacetonitrile, 1-[(4-methylphenyl)sulfonyl]-α,α-diphenyl-, (3S)-",603-706-2,133099-09-9,Not Classified,Notified C&L,1,Not classified:1
52976,"2,2'-[[4-[(4-nitrophenyl)azo]phenyl]imino]bisethanol",220-354-1,2734-52-3,Acute Tox. 4;Skin Sens. 1,Notified C&L,38,H302:38;H317:38
52978,Phenethyl isovalerate,205-406-3,140-26-1,Aquatic Chronic 2,REACH registration C&L,336,H411:24;Not classified:312
52983,"Tetrasodium isobenzofuran-3,3-diylbis(p-phenylene) bis(phosphate)",272-326-3,68807-90-9,Eye Irrit. 2,Notified C&L,1,H319:1
52984,(+)-O-Acetyl-D-malic Anhydride,616-740-8,79814-40-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,76,H315:43;H319:43;H335:42;H228:33;H314:33
52986,"oxydisulfoton (ISO);O, O-diethyl S-2-ethylsulphinylethyl phosphorodithioate",219-679-1,2497-07-6,Acute Tox. 2;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H300:0;H410:0;H311:0
52988,"Cyanourea, monosodium salt",278-584-3,76989-89-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H315:38;H332:39;H319:38;H302:39;H312:39;H335:38
52989,"4-(methylthio)-3,5-xylenol",230-947-7,7379-51-3,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1,H315:1;H319:1;H412:1;H311:1
52990,sodium 1-amino-4-[2-methyl-5-(4-methylphenylsulfonylamino)phenylamino]anthraquinone-2-sulfonate,400-100-8,84057-97-6,Aquatic Chronic 2,Harmonised C&L,0,H411:0
52992,"Extract residues (coal), tar oil alk., naphthalene distn. residues;Naphthalene Oil Extract Residue;[The residue obtained from chemical oil extracted after the removal of naphthalene by distillation composed primarily of two to four membered condensed ring aromatic hydrocarbons and aromatic nitrogen bases.]",277-567-8,73665-18-6,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
52994,Thiophene,203-729-4,110-02-1,Flam. Liq. 2;Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,256,H319:71;H302:249;H412:91;H225:250;H315:147;H332:114;H312:77;H318:141;H335:141;H331:52;H311:14;Not classified:6
52996,Hexakis(dimethylaminato)-µ-oxodiphosphorus(2+) bis[[]tetrafluoroborate(1-)],259-878-0,55881-03-3,Skin Corr. 1B,Notified C&L,39,H314:39;H302:1;H318:1
52997,ferbam (ISO);iron tris(dimethyldithiocarbamate),238-484-2,14484-64-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H315:0;H400:0;H319:0;H410:0;H335:0
53004,Bis(2-hydroxyethyl)dimethylammonium chloride,253-913-3,38402-02-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H315:42;H319:42;H302:38;H335:41
53005,Methyl 2-pyridyl ketone,214-355-6,1122-62-9,Not Classified,Notified C&L,433,Not classified:318;H315:115;H319:113;H335:102;H302:1
53009,Zinc ferrite brown spinel,269-103-8,68187-51-9,Not Classified,REACH registration C&L,176,Not classified:165;H315:11;H335:11;H318:11;H336:11
53011,"4-hydroxy-2,2,6,6-tetramethylpiperidine-1-ethanol",258-132-1,52722-86-8,Eye Irrit. 2A;Aquatic Chronic 3,REACH registration C&L,185,H412:98;H320:10;H319:171;H315:85;H318:69;H335:69;Not classified:2
53015,1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylpropan-1-one hydrochloride,251-867-9,34183-22-7,Acute Tox. 4,Notified C&L,151,H302:151;H332:52;H312:53;H340:2;H334:1;H315:1;H319:1;H335:1
53016,"Tar bases, quinoline derivs., benzyl chloride-quaternized",276-689-9,72480-70-7,Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,90,H302:89;H332:69;H314:90;H318:90;H330:20;H311:20;H411:1
53017,5-methylisophthalic acid,207-881-2,499-49-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H315:45;H319:45;H335:44
53022,Sulphosuccinic acid,225-898-3,5138-18-1,Skin Corr. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,93,H412:2;H318:43;H314:81;Not classified:6;H315:6;H319:6
53026,"1,3-dioxan-5-ol",225-248-9,4740-78-7,,Notified C&L,74,Not classified:39;H319:35
53027,"2,5-Furandione, dihydro-, mono-C20-24-2-alkenyl derivs., reaction products with diethylenetriamine",308-075-4,97862-31-2,,Notified C&L,1,Not classified:1
53028,1-phenylethan-1-one (1-phenylethylidene)hydrazone,211-979-0,729-43-1,Aquatic Acute 1,Notified C&L,38,H400:38
53032,"Fatty acids, vegetable-oil, potassium salts",262-993-9,61788-65-6,Skin Irrit. 2,Notified C&L,49,H315:33;Not classified:9;H319:7
53033,Potassium hydrogen sulphite,231-870-1,7773-03-7,Eye Irrit. 2,REACH registration C&L,7,H319:7;H335:7
53034,2-phenylcrotonaldehyde,224-567-0,4411-89-6,Not Classified,Notified C&L,158,Not classified:88;H315:70;H319:70;H335:44
53035,2-octyldodecyl stearate,245-204-2,22766-82-1,Not Classified,Notified C&L,48,Not classified:48
53038,"Trisodium 2-[[6-[(4-amino-6-chloro-1,3,5-triazin-2-yl)methylamino]-1-hydroxy-3-sulphonato-2-naphthyl]azo]naphthalene-1,5-disulphonate",274-700-1,70616-89-6,Not Classified,REACH registration C&L,59,Not classified:26;H318:32;H317:2
53050,5-ethyl-3-hydroxy-4-methylfuran-2(5H)-one,211-811-6,698-10-2,Acute Tox. 4,Notified C&L,1606,H302:1604;Not classified:2
53051,Cyclododecanol,217-031-2,1724-39-6,Aquatic Chronic 2,REACH registration C&L,57,H411:57
53053,Dichlorodipentylsilane,605-892-0,18037-39-3,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Acute Tox. 4,Notified C&L,1,H332:1;H314:1;H302:1;H312:1;H318:1
53054,calcium phosphide;tricalcium diphosphide,215-142-0,1305-99-3,Water-react. 1;Acute Tox. 2;Acute Tox. 3;Eye Dam. 1;Acute Tox. 1;Aquatic Acute 1,Harmonised C&L,0,H330:0;H400:0;H260:0;H300:0;H318:0;H311:0
53055,"O-(1H-6-Chlorbenzotriazol-1-yl)-1,1,3,3-tetramethyluroniumhe xafluorphosphat",608-825-3,330645-87-9,,Notified C&L,18,H228:7;H302:5;H315:9;H319:9;H335:7;Not classified:4
53059,Ammonium propionate,241-503-7,17496-08-1,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,101,H318:3;H314:3;H315:80;H319:80;H335:58;Not classified:18
53060,Jarytherm AX320,403-970-7,,Not Classified,Notified C&L,1,Not classified:1
53063,4-chloro-1-methylpiperidinium chloride,226-375-2,5382-23-0,Skin Corr. 1;Eye Dam. 1,REACH registration C&L,100,H318:4;H314:4;H315:95;H319:95;H335:94;Not classified:1
53069,"Alcohols, C12-16",272-490-6,68855-56-1,Aquatic Acute 1,Notified C&L,875,H400:632;Not classified:243;H410:13;H319:2;H411:1
53072,Diammonium diisononylnaphthalenedisulphonate,264-322-5,63568-37-6,,Notified C&L,1,Not classified:1
53073,"Cyclohexanol, 4-(1,1-dimethylpropyl)-, trans-",606-605-1,20698-30-0,,Notified C&L,4,H315:4;H319:4;H335:4
53074,2-bromooctanoic acid,220-079-7,2623-82-7,Skin Corr. 1B,Notified C&L,40,H314:40;H290:1;H318:1;H302:1
53077,"Poly[oxy(methyl-1,2-ethanediyl)], ω-hydroxy-ω'-methoxy-α,α'-(2,2-dimethyl-1,3-propanediyl)bis-",604-379-9,143775-91-1,Not Classified,Notified C&L,22,Not classified:22
53081,"4-[3-[3-carboxy-5-hydroxy-1-(4-sulphophenyl)-1H-pyrazol-4-yl]allylidene]-4,5-dihydro-5-oxo-1-(4-sulphophenyl)-1H-pyrazole-3-carboxylic acid, sodium salt, compound with triethylamine",290-098-3,90066-12-9,Skin Sens. 1,Notified C&L,2,H317:2;H228:1
53082,ethanediol;ethylene glycol,203-473-3,107-21-1,Acute Tox. 4,Harmonised C&L,0,H302:0
53084,"5-(methoxymethyl)pyridine-2,3-dicarboxylic acid",604-349-5,143382-03-0,Eye Dam. 1,Notified C&L,3,H318:1;H315:2;H319:2;H335:2
53085,"(S)-2,3-dihydro-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-benzopyrone",208-290-2,520-33-2,Not Classified,Notified C&L,92,Not classified:91;H315:1;H319:1
53088,"Benzenesulfonic acid, C10-60-alkyl derivs., calcium salts",290-636-7,90194-27-7,Aquatic Chronic 4,Notified C&L,556,H413:484;H317:61;H319:25
53090,Diammonium sodium hexakis(nitrito-N)rhodate,264-713-0,64164-17-6,Self-heat. 1;Ox. Sol. 3,Notified C&L,1,H272:1;H251:1
53095,"1,1,2,2-Tetrafluoroethyl 2,2,3,3-Tetrafluoropropyl Ether",605-433-4,16627-68-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,6,H315:4;H319:4;H335:4;H400:1;H373:1;H302:1;H330:1;H226:2;H225:1
53096,"Lawsonia inermis alba, ext.",284-514-2,84929-30-6,Not Classified,Notified C&L,1,Not classified:1
53107,Sodium p-tert-butylbenzoate,241-296-3,17264-53-8,Not Classified,Notified C&L,1,Not classified:1
53116,Cyclohexadecanone,607-739-3,2550-52-9,Aquatic Chronic 4,Notified C&L,144,H413:144
53124,Chloromethyl benzoate,226-254-4,5335-05-7,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 4,REACH registration C&L,1,H332:1;H314:1;H302:1;H312:1;H317:1
53126,2-nitrofluorene,210-138-5,607-57-8,Carc. 2;Aquatic Chronic 2,Notified C&L,39,H351:39;H411:39
53130,"Gases (petroleum), straight-run stabilizer off;Petroleum gas;[A complex combination of hydrocarbons obtained from the fractionation of the liquid from the first tower used in the distillation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]",272-883-2,68919-10-8,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H350:0;Not classified:0;H220:0;H340:0
53133,E-300,477-330-0,,Not Classified,Notified C&L,1,Not classified:1
53134,Diammonium carbonate,208-058-0,506-87-6,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,143,H412:94;H302:127;H319:50;Not classified:15;H315:5;H335:5
53136,"Glycine, N-(2-aminoethyl)-N-[2-[(carboxymethyl)amino]ethyl]-, N,N'-bis(C8-18-branched and linear alkyl) derivs.",309-297-4,100208-92-2,Not Classified,Notified C&L,7,Not classified:7
53145,3-methylheptan-2-one,219-142-1,2371-19-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1;H226:1
53148,Methyl 3-butenoate,223-076-9,3724-55-8,Flam. Liq. 2,Notified C&L,38,H225:38
53149,"Amines, N-tall-oil alkyltrimethylenedi-",263-192-7,61791-58-0,Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Aquatic Acute 1,Notified C&L,5,H400:5;H302:5;H314:5;H318:5
53154,Octabenzone,217-421-2,1843-05-6,Skin Sens. 1B,REACH registration C&L,969,H317:790;H413:338;H412:368;Not classified:85;H226:63;H410:15;H315:5;H319:4
53155,"1,1,1-trifluoro-N-phenyl-N-[(trifluoromethyl)sulfonyl]methanesulfonamide",609-445-0,37595-74-7,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,53,H315:53;H319:53;H301:4;H335:48
53160,"α,α'-dithiobisformamidine hydrochloride",238-876-3,14807-75-1,,Notified C&L,6,H315:5;H319:5;H335:4;Not classified:1
53165,"11.beta.,17.alpha.-Dihydroxy-6.alpha.-methylpregna-1,4-diene-3,20-dione",614-710-9,6870-94-6,STOT RE 2;Aquatic Chronic 4,REACH registration C&L,4,H373:4;H413:4
53168,"β,4-dimethyl-3-mercaptocyclohexaneethylthiol",225-363-4,4802-20-4,Not Classified,Notified C&L,179,Not classified:88;H400:38;H302:31;H315:22;H319:22;H335:22
53169,Tartronic acid,201-301-1,80-69-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H315:42;H319:42;H335:42
53172,"ethylenediammonium O,O-bis(octyl) phosphorodithioate, mixed isomers",400-520-1,,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H302:0;H314:0
53177,"Bile, hydrolyzates, depigmented, sodium salts",296-518-1,92731-18-5,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,4,H315:3;H319:3;H302:3;H317:3;Not classified:1
53179,Decafluorobiphenyl,207-107-3,434-90-2,Not Classified,Notified C&L,5,Not classified:3;H315:2;H332:1;H319:2;H302:1;H312:1;H335:2
53188,"2-Propenoic acid, 2-methyl-, tetracosyl ester, branched",292-146-9,90552-24-2,Not Classified,REACH registration C&L,2,Not classified:2
53191,"2,3,6,7-tetrahydro-9-methyl-1H,5H,11H-[1]benzopyrano[6,7,8-ij]quinolizin-11-one",255-285-6,41267-76-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H332:1;H319:1;H302:1;H312:1;H335:1
53192,"Asarum canadense, ext.",289-592-1,89957-73-3,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Muta. 2;Carc. 2;Aquatic Chronic 2,Notified C&L,1378,H315:1342;H319:1342;H341:1342;H351:1342;H411:1378;H302:1378;H317:1378
53194,"2,5-dimethyl-3-pyrroline",261-781-3,59480-92-1,Flam. Liq. 2,Notified C&L,38,H225:38
53195,"Disodium hydrogen 8-aminonaphthalene-1,3,6-trisulphonate",226-431-6,5398-34-5,Eye Dam. 1,Notified C&L,4,H318:3;H315:2;H319:1;H335:2
53196,N-carboxymethylpyridinium chloride,228-434-8,6266-23-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:39
53203,(2-aminoethoxy)(diphenyl)borane,208-366-5,524-95-8,,Notified C&L,95,H315:95;H319:95;H302:94;H335:94
53204,"reaction mass of: diester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:2);triester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:3)",427-140-9,,Carc. 2,Harmonised C&L,0,H351:0
53205,Hexyl methacrylate,205-521-9,142-09-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,250,H315:250;H319:250;H335:249;H411:48;H317:38;H410:1
53206,"[2,3'-bis[[(2-hydroxyphenyl)methylene]amino]but-2-enedinitrilato(2-)-N2,N3,O2,O3]nickel",265-022-7,64696-98-6,Not Classified,REACH registration C&L,2022,Not classified:2022
53210,"Trisodium bis[3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-2-hydroxy-5-nitrobenzenesulphonato(3-)]chromate(3-)",259-830-9,55809-98-8,Aquatic Chronic 2,REACH registration C&L,160,H411:64;H412:83;H318:83;H319:26;Not classified:10
53215,(2-chlorophenoxy)acetic acid,210-388-5,614-61-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:44;H319:44;H302:44;H335:43
53216,Calcium L-glutamate,242-905-5,19238-49-4,Not Classified,Notified C&L,4,Not classified:4
53218,"4,4',4''-methylidynetrianiline",208-952-0,548-61-8,Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,125,H412:125;H317:3
53221,Dicopper telluride,234-646-1,12019-52-2,,Notified C&L,6,H302:4;H332:4;Not classified:2
53222,1-(2-Ethylbutyl)cyclohexanecarbonitrile,619-573-9,855425-38-6,Skin Irrit. 2;Aquatic Chronic 4,REACH registration C&L,2,H315:2;H413:2
53225,(benzothiazol-2-ylthio)methyl thiocyanate;TCMTB,244-445-0,21564-17-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H315:0;H330:0;H400:0;H319:0;H302:0;H317:0;H410:0
53227,"Octafluoro-4,4'-biphenylenediamine",213-861-4,1038-66-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:40;H319:40;H335:39
53228,2-amino-5-nitrobenzyl alcohol,278-645-4,77242-30-9,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,1,H411:1;H302:1
53230,Diphenyl sulphide,205-371-4,139-66-2,Acute Tox. 4;Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,205,H315:205;H410:199;H302:205;H400:198;H319:4
53231,"Lavender, Lavandula stoechas, ext.",289-996-8,90063-38-0,Not Classified,Notified C&L,90,Not classified:36;H371:54;H412:54;H332:43;H317:54
53233,3-(2H-tetrazol-5-yl)pyridine,426-810-8,3250-74-6,Eye Dam. 1,Harmonised C&L,0,H318:0
53235,"reaction mass of: phenol, 6-(1,1-dimethylethyl)-4-tetrapropyl-2-[(2-hydroxy-5-tetra-propylphenyl)methyl (C",414-550-8,,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
53249,"4,6-Dimethoxy-2-(methylsulfonyl)pyrimidine",601-266-6,113583-35-0,,Notified C&L,5,H315:5;H319:5;H335:4
53251,"Benzene, 1-bromo-2-(methoxymethyl)-",610-887-1,52711-30-5,,Notified C&L,2,H315:2;H332:2;H319:2;H302:2;H312:2;H335:2
53252,Tramadol,248-319-6,27203-92-5,Acute Tox. 3;STOT SE 3,REACH registration C&L,7,H336:4;H301:5;H300:2;H312:2;H332:2;H315:1;H319:1;H331:1;H335:1
53255,Samarium trifluoride,237-367-3,13765-24-7,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,44,H331:38;H311:38;H301:38;H315:5;H332:4;H319:5;H302:4;H312:4;H335:5;Not classified:1
53263,"Soaps, stocks, coconut-oil, acidulated, hydrogenated",296-496-3,92704-62-6,Not Classified,Notified C&L,2,Not classified:2
53265,methyl 5-amino-4-cyano-3-(2-methoxy-2-oxoethyl)thiophene-2-carboxylate,614-070-0,674773-12-7,Not Classified,Notified C&L,2,Not classified:1;H319:1
53266,"2,4-dihydroxybenzonitrile",264-886-2,64419-24-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1;H302:1;H335:1
53268,[2H3]acetic anhydride,240-697-0,16649-49-3,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,39,H302:39;H332:39;H314:39;H226:39;H318:1
53271,"Dihydrogen [[N,N'-ethylenebis[N-(carboxymethyl)glycinato]](4-)-N,N',O,O',ON,ON']cuprate(2-)",259-169-6,54453-03-1,Not Classified,Notified C&L,2,Not classified:2
53274,"Alcohols, C7-21, ethoxylated",614-889-3,68991-48-0,Aquatic Acute 1;Aquatic Chronic 2,Notified C&L,2,H400:2;H411:2
53275,[(dibromomethylphenoxy)methyl]oxirane,250-080-8,30171-80-3,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,17,H315:17;H319:16;H411:16;H317:16;H410:1;H400:1
53276,Pyrimidin-2-ylamine,203-648-4,109-12-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,190,H315:190;H319:190;H335:189
53278,"4-(1,1,3,3-tetramethylbutyl)pyrocatechol",214-520-2,1139-46-4,Eye Dam. 1;Aquatic Chronic 4,Notified C&L,38,H318:38;H413:38
53281,Tetraphenyllead,209-871-3,595-89-1,,Notified C&L,5,H332:4;H360:4;H400:4;H373:4;H302:4;H410:4;H331:1;H311:1;H301:1
53286,"4-amino-1,3,5-triazine-2,6-dithiol",220-463-4,2770-75-4,,Notified C&L,4,H315:4;H319:4;H335:4
53288,5-(aminomethyl)-4-(carboxymethyl)-1H-pyrrole-3-propionic acid,207-666-3,487-90-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
53291,Metergoline,241-686-3,17692-51-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,197,H332:197;H302:197;H312:197
53292,"4-amino-6-((E)-(4-(4-(ethenylsulfonyl)butanoyl)amino)-diazenyl)-3-((E)-4- (ethenylsulfonyl)-diazenyl)-5-hydroxypolycarbocyclo, polysulfonate, polyphenyl, sodium salt",401-000-7,,Eye Irrit. 2,REACH registration C&L,1,H319:1
53296,"N,N-dimethyl-4-nitroaniline",202-832-1,100-23-2,,Notified C&L,5,H332:5;H302:5;H312:5
53297,hydrogen peroxide solution ...%,231-765-0,7722-84-1,Ox. Liq. 1;Acute Tox. 4;Skin Corr. 1A;Acute Tox. 4,Harmonised C&L,0,H271:0;H332:0;H302:0;H314:0
53299,Gum ghatti,232-534-7,9000-28-6,Not Classified,Notified C&L,52,Not classified:52
53300,Baddeleyite (ZrO2),234-843-2,12036-23-6,Not Classified,Notified C&L,21,Not classified:21
53303,ammonium dichromate,232-143-1,7789-09-5,Ox. Sol. 2;Acute Tox. 3;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 2;Resp. Sens. 1;Muta. 1B;Carc. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H360:0;H340:0;H330:0;H350:0;H400:0;H410:0;H314:0;H312:0;H317:0;H334:0;H372:0;H272:0;H301:0
53304,"6,6'-dimethyl-2,2'-bipyridine",224-566-5,4411-80-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H315:42;H319:42;H335:41
53305,"2,3,4,5,6,α-hexabromotoluene",253-985-6,38521-51-6,Skin Corr. 1B;Aquatic Chronic 4,Notified C&L,40,H413:38;H314:38;Not classified:2
53306,Dihydroxypyrimidine,454-380-1,,Repr. 1B;STOT RE 2,Notified C&L,1,H361:1;H373:1;H360:1
53307,3-chloropropanesulphonyl chloride,216-646-3,1633-82-5,Skin Corr. 1B;STOT SE 3,Notified C&L,55,H335:50;H314:55;H302:1;H318:1
53309,"Yarrow, Achillea nobilis, ext.",295-239-2,91845-64-6,Not Classified,Notified C&L,184,Not classified:184
53317,3-chlorophenol,203-582-6,108-43-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H332:0;H302:0;H312:0;H411:0
53323,CYCLOBUTANECARBOXAMIDINE HYDROCHLORIDE,615-325-9,71690-89-6,,Notified C&L,6,H315:6;H319:6;H335:6
53325,Anilinium iodide,256-239-8,45497-73-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
53327,2-ethyl-6-methylpyridine,214-356-1,1122-69-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H315:38;H335:38;H302:38;H318:38
53328,trichloromethylstannane,213-608-8,993-16-8,Repr. 2,Harmonised C&L,0,H361:0
53331,tetrahydrothiophene,203-728-9,110-01-0,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H315:0;H332:0;H225:0;H319:0;H412:0;H302:0;H312:0
53334,Gallium trinitrate,236-815-5,13494-90-1,Ox. Sol. 2;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,10,H315:9;H272:10;H319:9;H314:1;H335:1
53341,"2-Butenedioic acid (2Z)-, 1,4-bis[2-(2-methoxyethoxy)ethyl] ester, polymer with 1-hexadecene and 1-tetradecene",603-920-6,135397-33-0,Not Classified,Notified C&L,1,Not classified:1
53344,1-(pyridin-4-yl)propan-1-one,681-037-5,1701-69-5,,Notified C&L,6,H315:6;H319:4;H335:2;H302:2;H318:2
53345,Methyl 4-hydroxy-3-nitrobenzoate,202-755-3,99-42-3,,Notified C&L,5,H315:5;H319:5;H335:5
53347,α-N-ethylanilinotoluene-3-sulphonic acid,202-916-8,101-11-1,Not Classified,REACH registration C&L,2039,Not classified:2039
53350,3-Mercaptobenzoic Acid,610-432-7,4869-59-4,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,40,H315:40;H335:39;H318:39;H319:1
53351,Benzyl laurate,205-405-8,140-25-0,Not Classified,Notified C&L,1414,Not classified:1375;H315:39;H319:38;H335:38;H334:38
53353,"2,4-dimethoxyaniline",220-355-7,2735-04-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:40;H319:40;H302:44;H335:39;H373:5;H332:5;H311:4;H312:1
53359,6-pentyl-m-cresol,215-094-0,1300-94-3,Acute Tox. 4,Notified C&L,46,H302:46;H361:7;H410:6;H314:7;H318:1
53360,N-cyclohexyldocosanamide,241-454-1,17427-97-3,,Notified C&L,25,Not classified:25
53367,"isobutylidene-(2-(2-isopropyl-4,4-dimethyloxazolidine-3-yl)-1,1-dimethylethyl)amine",419-850-2,148348-13-4,Skin Corr. 1B;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H314:0
53369,1-naphthylurea,230-121-6,6950-84-1,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1;H301:1
53370,Diphenylsilane,212-271-4,775-12-2,Skin Irrit. 2,Notified C&L,47,H315:47;H319:8;H335:2
53372,"N-[ethyl(3-methylbutyl)amino]-3-methyl-1-phenyl-spiro[[1]benzo-pyrano[2,3-c]pyrazole-4(1H),1'(3'H)-isobenzofuran]-3'-one",417-460-7,,Aquatic Chronic 4,Harmonised C&L,0,H413:0
53377,"1,2-dihydro-1-(p-hydroxyphenyl)-5H-tetrazole-5-thione",257-909-2,52431-78-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H315:45;H319:45;H335:44;H228:1
53378,"5-heptyl-1,3,4-oxadiazole-2(3H)-thione",266-377-0,66473-10-7,Skin Sens. 1,Notified C&L,38,H317:38
53380,"Stearic acid, monoester with glycerol",250-705-4,31566-31-1,Not Classified,REACH registration C&L,668,Not classified:665;H315:2;H319:3
53381,2-naphthaldehyde,200-640-2,66-99-9,,Notified C&L,7,H315:7;H319:7;H302:7;H335:6;H332:1;H312:1
53382,Decanol,253-173-1,36729-58-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,24,H315:24;H319:24
53383,"5'α-benzyl-9,10α-dihydro-12'-hydroxy-2'-isopropylergotaman-3',6',18-trione monomethanesulphonate",246-434-6,24730-10-7,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,3,H400:1;H410:1;H302:2;H332:2
53384,Ciclopirox,249-577-2,29342-05-0,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,Notified C&L,148,H332:141;H319:145;H302:143;H312:141;H315:2;H317:3;H334:3;H335:1;H400:3;Not classified:2;H410:1
53387,4-(4-nitrophenoxy)aniline,228-159-3,6149-33-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H315:40;H319:40;H335:40;H332:1;H302:1;H312:1
53388,"(+-)-(R*,S*)-6-fluoro-3,4-dihydro-alpha-[[(phenylmethyl)amino]methyl]-2H-1-benzopyran-2-methanol",619-408-0,99199-91-4,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1;H317:1
53391,"Fatty acids, tall-oil, Et esters",295-390-4,92045-09-5,Not Classified,Notified C&L,3,Not classified:3
53398,Ethyl L-threoninate,433-730-7,,Skin Sens. 1,REACH registration C&L,1,H317:1
53400,"Disodium 1,1'-isopropylidenedi-p-phenylene bis[2-[[5-amino-3-methyl-1-(3-sulphonatophenyl)-1H-pyrazol-5-yl]azo]benzenesulphonate]",276-882-8,72828-69-4,Aquatic Chronic 3,REACH registration C&L,71,H412:46;Not classified:25
53401,"Amides, tallow, hydrogenated",263-123-0,61790-31-6,Not Classified,Notified C&L,58,Not classified:58
53402,N-[1-[2-(1H-indol-3-yl)ethyl]-4-piperidyl]benzamide monohydrochloride,254-136-2,38821-52-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:39;H319:39;H302:40;H335:39
53405,"demephion-O (ISO);O,O-dimethyl O-2-methylthioethyl phosphorothioate",211-666-9,682-80-4,Acute Tox. 2;Acute Tox. 3,Harmonised C&L,0,H300:0;H311:0
53408,"ETHYLIDENE BIS-4,1-PHENYLENE DICYANATE",610-326-0,47073-92-7,Acute Tox. 4;Eye Dam. 1;Acute Tox. 4;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,9,H332:9;H400:9;H373:9;H302:9;H318:9;H410:9
53409,"Heart, ext.",283-089-0,84540-00-1,Not Classified,Notified C&L,1,Not classified:1
53415,ethyl 3-amino-2-cyanoprop-2-enoate,609-521-3,38109-77-2,Acute Tox. 4;Skin Irrit. 2,Notified C&L,1,H315:1;H302:1
53416,"Lanolin, ethoxylated",612-384-2,61790-81-6,Not Classified,Notified C&L,587,Not classified:533;H413:54;H412:1
53419,2-amino-5-(aminosulphonyl)-4-chlorobenzoic acid,221-408-7,3086-91-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:38;H319:38;H335:38;H360:1
53426,1-(p-tolyl)cyclopropanecarboxylic acid,281-043-4,83846-66-6,Eye Irrit. 2,Notified C&L,38,H319:38
53427,5-(hydroxymethyl)furan-2-carbonitrile,289-476-0,89149-70-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H332:1;H319:1;H302:1;H312:1;H335:1
53431,"Sodium 1-(carboxymethyl)-4,5-dihydro-1(or 3)-(2-hydroxyethyl)-2-undecyl-1H-imidazolium hydroxide",271-949-8,68647-44-9,Eye Irrit. 2,Notified C&L,44,H319:36;Not classified:8
53432,hydroxy-(4-hydroxy-3-methoxy-phenyl)-acetonitrile,619-705-5,33630-46-5,Acute Tox. 3;Eye Dam. 1,Notified C&L,89,H318:89;H301:89
53435,"Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer, hydrogen sulfide-free;Petroleum gas;[A complex combination of hydrocarbons obtained from fractionation stabilization of catalytic reformed naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]",269-619-3,68308-00-9,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H350:0;Not classified:0;H220:0;H340:0
53438,(3R)-pyrrolidin-3-ol hydrochloride,600-598-9,104706-47-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H315:46;H319:46;H335:45
53440,Furfuryl butyrate,210-779-0,623-21-2,Not Classified,Notified C&L,89,Not classified:89
53441,C.I. Reactive Red 218,601-268-7,113653-03-5,Eye Irrit. 2,Notified C&L,1,H319:1
53444,Sodium p-octylbenzenesulphonate,228-158-8,6149-03-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:40;H319:40;H335:39
53446,"Boric acid, sodium salt",215-604-1,1333-73-9,Eye Irrit. 2;Repr. 1B;Aquatic Chronic 3,Notified C&L,16,H319:14;H360:14;H412:14;Not classified:2
53447,"3-[1-(3,5-dichlorophenyl)-1-methylethyl]-3,4-dihydro-6-methyl-5-phenyl-2H-1,3-oxazin-4-one",604-889-1,153197-14-9,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,197,H400:195;H410:195;H317:1;Not classified:1
53450,Bis(1-methylheptyl) phthalate,205-014-2,131-15-7,Not Classified,Notified C&L,3,Not classified:3
53459,"1-Propanesulfonic acid, 3-(cyclohexylamino)-2-hydroxy-",615-979-5,73463-39-5,Not Classified,Notified C&L,2,Not classified:2
53461,Triisopropylphosphine,229-333-1,6476-36-4,Pyr. Liq. 1;Skin Corr. 1B,Notified C&L,44,H250:43;H314:43;H252:4;H332:1;H302:1;H312:1
53464,N( 3( 3Dimethylamino1oxo2propenyl) phenyl)Nethylacetamide; NEtilN3(( 3dimetilamino1oxo2propenil),619-229-8,96605-66-2,Skin Corr. 1B;Eye Dam. 1,Notified C&L,2,H318:1;H314:1;H302:1
53466,Thonzylamine hydrochloride,200-561-3,63-56-9,Acute Tox. 3;Acute Tox. 4,Notified C&L,39,H312:38;H301:39
53469,Sintofen (aka Cintofen),603-426-0,130561-48-7,Carc. 2;Aquatic Chronic 2,Notified C&L,1,H351:1;H411:1
53471,"Lanolin, wax",269-220-4,68201-49-0,Not Classified,Notified C&L,353,Not classified:353
53472,"(1α,2α,3β,4α,5β,6β)-1,2,3,4,5,6-hexachlorocyclohexane",206-270-8,319-84-6,Acute Tox. 3;Acute Tox. 4;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,8,H400:5;H351:5;H312:5;H410:5;H301:7;Not classified:1
53476,"4,4-Dimethoxypiperidine",611-354-6,5608-82-2,Skin Corr. 1C;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,1,H411:1;H318:1;H314:1
53482,1-N-Boc-4-aminopiperidine,617-965-4,87120-72-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,49,H315:41;H335:39;H302:42;H318:39;H314:7;H332:3;H312:3;H320:1;H319:2
53484,Potassium tetrafluoroaluminate,238-485-8,14484-69-6,Eye Irrit. 2;Acute Tox. 4;Lact.;STOT RE 1;Aquatic Chronic 3,REACH registration C&L,16,H332:11;H362:9;H319:14;H412:11;H372:9;H315:3;H335:3;Not classified:2
53486,mono[2-(dimethylamino)ethyl]monohydrogen-2-(hexadec-2-enyl)butanedioate and/or mono[2-(dimethylamino)ethyl]monohydrogen-3-(hexadec-2-enyl)butanedioate,415-880-5,779343-34-9,Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H315:0;H400:0;H318:0;H317:0;H410:0
53488,"4'-Bromo-[1,1'-biphenyl]-4-ol acetate",617-550-8,84244-98-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
53491,bromoethylene,209-800-6,593-60-2,Press. Gas;Flam. Gas 1;Carc. 1B,Harmonised C&L,0,Not classified:0;H220:0;H350:0
53493,"cis-5,8,11,14,17-Eicosapentaenoic acid",600-528-7,10417-94-4,Skin Corr. 1B,Notified C&L,40,H314:40
53494,Dodecylphosphonic acid,225-897-8,5137-70-2,Skin Corr. 1B;Eye Dam. 1;STOT RE 2,REACH registration C&L,61,H373:1;H318:2;H314:61;H290:1
53498,Calcium diicosanoate,244-900-3,22302-43-8,Not Classified,Notified C&L,2,Not classified:2
53500,Pentyl hexanoate,208-732-4,540-07-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1466,H315:1465;H319:1465;Not classified:1
53502,"Fatty acids, C22-unsatd., dimers, hydrogenated",500-678-2,162260-07-3,Not Classified,Notified C&L,23,Not classified:23
53506,"6'-[ethyl(p-tolyl)amino]-2'-methylspiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one",255-715-2,42228-32-0,Aquatic Chronic 4,Notified C&L,2,H413:2
53507,Erbium tetraoxide vanadium,237-037-9,13596-17-3,Not Classified,REACH registration C&L,2,Not classified:2
53508,3-Bromo-5-iodobenzoic Acid,606-154-0,188815-32-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H315:45;H319:45;H335:44
53509,"9-Octadecenamide, N,N-dibutyl-, (Z)-, sulfonated",288-505-4,85736-94-3,Not Classified,REACH registration C&L,2,Not classified:2
53513,"2',3,4,5-Tetrafluor-4''-pentyl-1,1':4',1''-terphenyl",608-771-0,326894-64-8,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
53514,Metenolone,205-812-0,153-00-4,Acute Tox. 4;Carc. 2;Repr. 1A;Lact.,REACH registration C&L,1,H351:1;H302:1;H360:1;H362:1
53516,"Oils, fish, sulfated, sodium salts",262-992-3,61788-64-5,Aquatic Chronic 3,REACH registration C&L,66,H412:18;H315:34;H318:34;Not classified:14
53524,"4,4'-dithiodipyridine",220-158-6,2645-22-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:44;H319:44;H335:43;H302:1
53528,N-(4-hydroxyphenyl)glycine,204-580-8,122-87-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:43;H319:43;H335:42
53529,"Vinegar, ext.",290-419-7,90132-02-8,Flam. Liq. 3;Skin Corr. 1,Notified C&L,89,H314:89;H226:89
53540,(2-butoxymethylethoxy)propanol,252-776-7,35884-42-5,Not Classified,Notified C&L,10,Not classified:10
53544,"4,4'-dinitrobiphenyl",216-210-2,1528-74-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:2;H302:2;H312:2;H315:1;H319:1;H335:1
53546,Chrome tin orchid cassiterite,269-104-3,68187-53-1,Not Classified,REACH registration C&L,16,Not classified:15;H373:1
53547,"Leucomycin V, 3B,9-diacetate 3,4B-dipropanoate",259-879-6,55881-07-7,Not Classified,Notified C&L,1,Not classified:1
53548,2-tetradecyloctadecan-1-ol,251-110-2,32582-32-4,Not Classified,REACH registration C&L,3,Not classified:2;H332:1;H302:1;H312:1
53550,"3,5-dichloro-3-pyridylamine",224-143-5,4214-74-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H315:46;H319:46;H335:45;H332:6;H302:7;H312:6
53552,Disodium 4-[2-[(1-oxoundec-10-enyl)amino]ethyl] 2-sulphonatosuccinate,247-873-6,26650-05-5,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,4,H315:4;H319:3;H412:2;H318:1
53555,Nitrocyclohexane,214-354-0,1122-60-7,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,39,H315:39;H319:39;H311:38;H331:39;H335:38;H301:39
53557,2-cyanoethyl 3-oxobutanoate,613-755-1,65193-87-5,Not Classified,REACH registration C&L,38,Not classified:4;H302:34;H314:34
53559,"Hydrocarbons, C8-C10, n-alkanes, isoalkanes, cyclics, aromatics (2-25%)",928-136-4,,Flam. Liq. 3;Asp. Tox. 1;Aquatic Chronic 2,Notified C&L,2,H411:2;H304:2;H336:2;H226:2
53560,"White mineral oil (petroleum), light",295-550-3,92062-35-6,Asp. Tox. 1,Notified C&L,147,H304:116;Not classified:31
53562,"7,7,9(or 7,9,9)-trimethyl-4,13-dioxo-3,14-dioxa-5,12-diazahexadecane-1,16-diyl bismethacrylate",276-957-5,72869-86-4,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,219,H411:49;H317:217;H315:2;H319:2;H335:1;H412:4;Not classified:1
53567,"4,4'-methylenebis[N-(4-chlorophenyl)-3-hydroxynaphthalene-2-carboxamide]",430-350-3,192463-88-0,Aquatic Chronic 4,Harmonised C&L,0,H413:0
53568,1-(chloromethyl)-2-(trifluoromethyl)benzene,244-560-6,21742-00-7,Skin Corr. 1B;STOT SE 3,Notified C&L,45,H335:40;H314:45;H319:1;H290:1;H318:1
53569,"Sodium 5,6,9,14,15,18-hexahydro-5,9,14,18-tetraoxoanthrazinesulphonate",215-371-6,1324-29-4,Not Classified,Notified C&L,83,Not classified:83
53570,"2-hydroxy-4-isopropyl-2,4,6-cyclohepta-2,4,6-trien-1-one",207-880-7,499-44-5,Acute Tox. 4,Notified C&L,166,H302:166;H318:2
53574,4-chlorobutane-1-sulphonyl chloride,216-648-4,1633-84-7,Skin Corr. 1B,Notified C&L,2,H314:2
53576,Hydrocortisone 21-acetate,200-004-4,50-03-3,Repr. 2,Notified C&L,172,H361:160;H332:19;H302:19;H312:18;H373:16;H360:10;H372:3;H311:3;H315:2;H319:2;H335:1
53579,"(2S,3R,4S,5R)-oxane-2,3,4,5-tetrol",614-092-0,6763-34-4,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
53580,Cimepanol,249-661-9,29474-12-2,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
53581,5-Hexynenitrile,604-677-9,14918-21-9,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H315:39;H332:44;H319:39;H302:44;H312:44;H226:44;H335:39
53582,2'-nitrobenzanilide,211-978-5,728-90-5,Eye Irrit. 2,Notified C&L,38,H319:38
53583,1-(2-furoyl)piperazine,254-823-7,40172-95-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,REACH registration C&L,90,H315:89;H332:2;H319:89;H302:3;H312:2;H335:89
53588,"1,2-benzisothiazol-3(2H)-one;1,2-benzisothiazolin-3-one",220-120-9,2634-33-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1;Aquatic Acute 1,Harmonised C&L,0,H315:0;H400:0;H302:0;H318:0;H317:0
53591,"2,5-diethoxytetrahydrofuran",222-026-3,3320-90-9,Flam. Liq. 3,Notified C&L,38,H226:38
53598,"Pentasodium bis[4-[[6-[[6-anilino-4-chloro-1,3,5-triazin-2-yl]amino]-1-hydroxy-3-sulpho-2-naphthyl]azo]-3-hydroxy-7-nitronaphthalene-1-sulphonato(4-)]cobaltate(5-)",278-176-5,75284-36-5,Not Classified,Notified C&L,3,Not classified:3
53599,Levomepromazine maleate,230-412-8,7104-38-3,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,32,H400:26;H410:27;H302:32;H317:29;H315:1;H319:3;H335:1
53600,"2,2,6,6-tetrachloro-1-hydroxycyclohexanecarboxamide",217-030-7,1724-30-7,Acute Tox. 4,Notified C&L,38,H302:38
53606,Aluminium dodecyl sulphate,240-571-5,16509-02-7,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,Notified C&L,8,H302:8;H314:8;H318:8
53609,"1,1,1,2,3,4,5,5,5(or1,1,1,3,4,4,5,5,5)-nonafluoro-4(or2)-(trifluoromethyl)pent-2-ene",283-527-0,84650-68-0,Acute Tox. 4,Notified C&L,2,H302:2;H400:1;H411:1
53610,"1,4-dinitrobenzene",202-833-7,100-25-4,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H330:0;H400:0;H373:0;H300:0;H310:0;H410:0
53615,"Waste solids, precious metal refining",308-526-5,98072-70-9,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1;Carc. 1A;Repr. 1A;STOT RE 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H332:1;H360:2;H350:2;H400:2;H373:1;H302:1;H317:1;H334:1;H410:2
53617,1-chloroindan,252-480-8,35275-62-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H332:1;H319:1;H302:1;H312:1;H335:1
53621,"Hexanoic acid, 6-hydroxy-, methyl ester",610-255-5,4547-43-7,Eye Irrit. 2,Notified C&L,85,H319:85;H315:2;H335:2
53622,"Fatty acids, C16-18 and C18-unsatd., C16-18-alkyl esters",285-532-3,85116-80-9,Not Classified,Notified C&L,5,Not classified:5
53623,2-[bis(2-hydroxyethyl)amino]ethyl stearate,233-585-8,10248-74-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,5,H315:4;H319:4;Not classified:1
53628,"1-bromotricyclo[3.3.1.13,7]decane",212-200-7,768-90-1,Not Classified,REACH registration C&L,4,Not classified:2;H332:1;H302:1;H312:1;H315:1;H319:1;H335:1
53629,1-[4-(piperidin-1-yl)phenyl]ethan-1-one,233-746-2,10342-85-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
53630,"5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-benzopyrone",208-291-8,520-34-3,Not Classified,REACH registration C&L,42,Not classified:2;H302:40
53631,4-methylquinolin-2-ol,210-139-0,607-66-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:43;H319:43;H335:42
53633,1-(4-(ACETYLOXY)-3-((ACETYLOXY)METHYL)PHENYL)ETHANONE,921-042-4,,Acute Tox. 4;Skin Sens. 1A;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,2,H411:1;H302:2;H317:2;H318:2;H315:1;H400:1;H319:1;H373:1;H410:1
53634,chloroacetaldehyde,203-472-8,107-20-0,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 2;Carc. 2;Aquatic Acute 1,Harmonised C&L,0,H330:0;H400:0;H314:0;H351:0;H311:0;H301:0
53635,"Benzenesulfonic acid, 4-C10-14-alkyl derivs., calcium salts",290-635-1,90194-26-6,Skin Irrit. 2;Eye Dam. 1,Notified C&L,389,H315:366;H318:366;H412:172;H413:23;H317:23
53641,"Lignosulfonic Acid, Sodium Salt, Sulfomethylated",614-547-3,68512-34-5,Not Classified,Notified C&L,145,Not classified:102;H319:43
53643,"Tetrasodium [μ-[[7,7'-(carbonyldiimino)bis[4-hydroxy-3-[(2-hydroxy-5-sulphophenyl)azo]naphthalene-2-sulphonato]](8-)]]dicuprate(4-)",239-429-5,15418-16-3,Not Classified,Notified C&L,30,Not classified:30
53645,"3,5-DIMETHOXY-4-(1-METHYLPROPOXY)BENZALDEHYDE",607-081-7,224586-49-6,Acute Tox. 4,REACH registration C&L,1,H302:1
53648,"Nymphaea odorata, ext.",290-097-8,90064-35-0,Not Classified,Notified C&L,88,Not classified:88
53654,"1,8-dichloronaphthalene",218-101-5,2050-74-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 2,Notified C&L,38,H315:38;H411:38;H302:38;H318:38;H335:38
53656,"2,6-dichloro-p-benzoquinone",211-810-0,697-91-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:44;H319:44;H335:42;H302:6
53657,"2,4-diisopropylphenol",220-906-1,2934-05-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:39;H319:39;H335:39;H302:1
53660,p-(2-bromoethyl)benzenesulphonic acid,259-094-9,54322-31-5,Skin Corr. 1C;Eye Dam. 1,Notified C&L,1,H318:1;H314:1
53664,α-ethylcyclohexane-1-methanol,241-295-8,17264-02-7,,Notified C&L,5,H315:5;H319:5;H335:5
53669,Methyl 2-(formylamino)benzoate,255-287-7,41270-80-8,Not Classified,Notified C&L,88,Not classified:88
53677,Tin chloride,215-689-5,1344-13-4,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Repr. 2;STOT RE 2,Notified C&L,1,H315:1;H373:1;H361:1;H318:1;H317:1
53683,5-amino-1-phenyl-1H-pyrazole-4-carbonitrile,226-253-9,5334-43-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H315:43;H332:43;H319:43;H302:43;H312:43;H335:43
53687,Diallyldimethylsilane,214-199-9,1113-12-8,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:40;H319:40;H335:39;H225:40
53688,"Octadecadienoic acid, compound with succinic anhydride (1:1)",285-091-7,85029-65-8,Not Classified,Notified C&L,2,Not classified:2
53691,4-nitrobenzyl-isothiocyanate,218-359-9,2131-61-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,46,H315:42;H319:42;H317:40;H334:41;H335:42;H332:6;H302:6;H312:6;H314:4;H331:1;H301:1
53692,1-benzyl-4-piperidylamine,256-620-9,50541-93-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H315:47;H319:47;H335:42;H302:4;H312:4;H314:4;H318:1
53693,"1-[4-(trans-4-Ethylcyclohexyl)-1-cyclohexen-1-yl]-3,5-difluorbenzen",612-166-7,615257-52-8,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
53694,Trypsinogen,232-651-3,9002-08-8,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1,Notified C&L,38,H315:38;H319:38;H334:38
53695,"1,3,3-trimethyl-2-[(methylphenylhydrazono)methyl]-3H-indolium nitrate",284-142-0,84788-03-4,Acute Tox. 4;Eye Dam. 1,Notified C&L,2,H302:2;H318:2
53701,(carboxymethylthio)succinic acid,202-778-9,99-68-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,93,H315:93;H319:93;H335:38
53704,Urea hydrochloride,208-059-6,506-89-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,13,H315:10;H319:9;H335:9;H318:3;H290:2;H351:1;H302:2;H314:1
53707,2-Fluoro-4-methylaniline,610-237-7,452-80-2,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,46,H315:45;H319:45;H311:44;H331:39;H335:39;H301:41;H332:5;H373:5;H302:5;H330:1;H312:1
53708,1-naphthylammonium chloride,209-014-3,552-46-5,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,43,H411:43;H302:43;H350:4;H371:1;H319:1;H311:1
53710,"Glycine, N-methyl-, N-coco acyl derivs., sodium salts",263-193-2,61791-59-1,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,63,H315:59;H318:13;H319:50;H335:39
53711,"Chicken, ext.",296-519-7,92731-19-6,Not Classified,Notified C&L,35,Not classified:35
53712,"Boric acid, ester with 1,4-butanediol and 2-ethyl-1,3-hexanediol",286-300-4,85204-07-5,Eye Irrit. 2,Notified C&L,1,H319:1
53717,3-methylbut-3-en-1-ol,212-110-8,763-32-6,Flam. Liq. 3;Skin Sens. 1;Eye Dam. 1;Carc. 1B;STOT RE 2,REACH registration C&L,431,H350:22;H373:36;H318:423;H317:13;H226:431;H315:5;H319:8;H335:4
53723,"6-(2,3-dimethylmaleimido)hexyl methacrylate",404-870-6,63740-41-0,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H317:0
53726,"Soaps, stocks, coconut-oil, acidulated",296-495-8,92704-61-5,Not Classified,Notified C&L,3,Not classified:3
53734,"Gases (petroleum), straight-run naphtha catalytic reforming off;Petroleum gas;[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and fractionation of the total effluent. It consists of methane, ethane, and propane.]",272-882-7,68919-09-5,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H350:0;Not classified:0;H220:0;H340:0
53736,2-[1-(ethoxyimino)butyl]-5-(2-ethylthiopropyl)-3-hydroxycyclohex-2-en-1-one,277-682-3,74051-80-2,Not Classified,Notified C&L,3,Not classified:3
53737,Triacetoxy-tert-butoxysilane,236-111-8,13170-22-4,Skin Corr. 1B;Eye Dam. 1,Notified C&L,13,H318:13;H314:13
53738,"1-ethyl-1,3-diphenylurea",264-940-5,64544-71-4,Acute Tox. 4;Skin Sens. 1,Notified C&L,38,H302:38;H317:38
53742,3-(amidinothio)propionic acid,226-430-0,5398-29-8,Acute Tox. 3;Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,156,H412:156;H317:156;H301:84;H302:72;H318:70
53745,Ammonium dihydrogenorthophosphate,231-764-5,7722-76-1,Not Classified,REACH registration C&L,1108,Not classified:953;H319:138;H315:70;H335:44;H412:16;H316:1;H320:1
53747,2-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridine,429-800-1,95737-68-1,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
53748,"2,6-xylyl isothiocyanate",242-906-0,19241-16-8,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H315:38;H319:38;H302:42;H317:38;H335:38;H332:4;H312:4;H314:4
53750,"Estra-1,3,5(10)-triene-3,17-diol (17β)-, 3-[bis(2-chloroethyl)carbamate] 17-(dihydrogen phosphate), disodium salt",257-735-7,52205-73-9,Carc. 2;Repr. 1B,Notified C&L,3,H351:2;H361:2;H360:2;H373:1
53753,"Guarana, ext.",284-512-1,84929-28-2,Flam. Liq. 3,Notified C&L,1384,H226:1313;Not classified:69;H302:2;H301:1
53757,2-propoxyethylamine,255-699-7,42185-03-5,Acute Tox. 4;Eye Dam. 1,Notified C&L,41,H302:38;H318:39;H314:3;H226:2
53759,strontium chromate,232-142-6,7789-06-2,Acute Tox. 4;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H302:0;H350:0
53760,"halosulfuron-methyl (ISO); methyl 3-chloro-5-{[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]sulfamoyl}-1-methyl-1H-pyrazole-4-carboxylate",600-130-3,100784-20-1,Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H400:0;H410:0;H360:0
53762,Tungsten dioxide,234-842-7,12036-22-5,Not Classified,REACH registration C&L,16,Not classified:2;H335:14;H413:3
53764,"flurtamone (ISO);(RS)-5-methylamino-2-phenyl-4-(α, α,α-trifluoro-m-tolyl)furan-3(2H)-one",619-224-0,96525-23-4,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
53765,"4,4'-thiodianiline and its salts",205-370-9,139-65-1,Acute Tox. 4;Carc. 1B;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H302:0;H350:0
53774,"(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl-(1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)-(1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)",617-522-5,84030-86-4,Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,79,H400:79;H410:79;H302:79;H332:79
53775,3-Fluor-1-[4-(trans-4-propylcyclohexyl)-1-cyclohexen-1-yl]-benzen,617-388-8,82832-37-9,Aquatic Chronic 4,REACH registration C&L,2,H413:2
53776,Crotonic acid,223-077-4,3724-65-0,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1,Notified C&L,1759,H302:1676;H312:1608;H314:1630;H318:1531;H315:98;H412:83;H311:107;H400:14;H319:15;H410:11;H335:14;Not classified:5
53778,3-chloroaniline,203-581-0,108-42-9,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT RE 2;Aquatic Acute 1,REACH registration C&L,157,H315:1;H400:152;H319:5;H373:152;H311:104;H331:99;H301:105;H410:102;H330:6;H350:3;H317:3;H372:4;H370:1
53779,p-bromopropiophenone,233-745-7,10342-83-3,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:43;H319:43;H302:39;H317:39;H335:43
53780,"Amines, rosin, compds. with 9-(2-carboxyphenyl)-3,6-bis(diethylamino)xanthylium chloride and disodium hydrogen bis[4-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-3-hydroxy-1-naphthalenesulfonato(3-)]chromate(3-)",308-114-5,97862-65-2,Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,2376,H411:2374;H302:2374;Not classified:2
53783,1-methyl-3-(2-methylpropyl)cyclohexanol,434-380-8,215231-33-7,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1324,H315:1324;H319:1324;H412:2;H411:1322
53787,"(Z)-(2,4-difluorophenyl)piperidin-4-ylmethanone oxime monohydrochloride",424-740-2,138271-16-6,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H302:0;H318:0
53788,"2,6,10,14-tetramethylpentadecane",217-650-8,1921-70-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,45,H315:44;H319:43;Not classified:1
53790,Methyl chloroglyoxylate,227-307-4,5781-53-3,Flam. Liq. 3;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,49,H318:6;H314:49;H226:49;H302:4
53793,[(methylthio)methyl]oxirane,256-238-2,45378-62-9,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 3;Carc. 1A;Repr. 2,REACH registration C&L,1,H315:1;H350:1;H361:1;H318:1;H317:1;H311:1;H331:1;H301:1
53795,"Sodium 3-(pyridin-2-yl)-1,2,4-triazine-5,6-diyl]bis(benzene-4,4'-sulphonate)",274-196-3,69898-45-9,,Notified C&L,7,H315:7;H319:7;H335:5
53798,"1,1,3,3-tetramethylguanidine",201-302-7,80-70-6,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,332,H302:326;H318:141;H314:327;H226:315;Not classified:7;H332:4;H290:4;H312:1;H331:1
53799,"4-(3,4-DICHLOROPHENYL)-3,4-DIHYDRO-1-(2H)-NAPHTHALENONE",406-300-1,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,4,H315:3;H319:3;H335:3;H410:1
53800,Clofibrate,211-277-4,637-07-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,40,H315:39;H335:39;H302:40;H318:39;H411:1
53803,Phenprocoumon,207-108-9,435-97-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT SE 1,Notified C&L,3,H331:3;H370:1;H311:3;H301:3;H315:1;H360:1;H362:1;H319:1
53806,Europium(III) fluoride,237-368-9,13765-25-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,217,H315:217;H319:217;H335:217;H332:39;H302:39;H312:39
53813,1-benzyl-1H-imidazole,224-200-4,4238-71-5,,Notified C&L,5,H315:5;H319:5;H335:4
53816,"1,4-benzodioxan-6-yl methyl ketone",220-726-3,2879-20-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H315:1;H319:2;H335:1
53823,Indole-3-carbaldehyde,207-665-8,487-89-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,93,H315:92;H319:92;H335:91;Not classified:1
53824,Guaiacum (resin),232-535-2,9000-29-7,Not Classified,Notified C&L,29,Not classified:29
53825,"Ledum palustre, ext.",289-997-3,90063-39-1,Flam. Liq. 2;Eye Irrit. 2,REACH registration C&L,5,H319:3;H225:2;H315:3;H304:2;H317:2;H226:3;H410:2
53829,Tricopper phosphide,234-647-7,12019-57-7,Aquatic Chronic 4,Notified C&L,19,H413:19
53832,"Quaternary ammonium compounds, (2-hydroxy-1,3-propanediyl)bis[coco alkyldimethyl, dichlorides",263-006-4,61788-79-2,Skin Irrit. 2;Eye Dam. 1,Notified C&L,2,H315:1;H318:2;H400:1;H410:1;H314:1;H302:1;H335:1
53834,Tris[oxalato(2-)]dilutetium,222-328-5,3426-45-7,Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H302:1;H312:1;Not classified:1
53835,"(E,E)-tetradeca-9,11-dienyl acetate",259-287-8,54664-98-1,Skin Irrit. 2,Notified C&L,5,H315:5
53836,2-pyridone,205-520-3,142-08-5,Not Classified,Notified C&L,180,Not classified:88;H301:91;H315:51;H319:51;H335:50
53837,1(4)-butanesultone,216-647-9,1633-83-6,,REACH registration C&L,142,H351:135;H302:141;H315:85;H319:85;H412:84;H341:90;H335:85;H332:1;H312:1;H317:1;Not classified:1
53838,"4-ethyl-6-(2,6,6-trimethylcyclohex-2-en-1-yl)hex-2-ene-1,4-diol",302-404-5,94108-64-2,Not Classified,Notified C&L,10,Not classified:10
53841,4-Bromo-2-methylanisole,604-620-8,14804-31-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H315:3;H319:3;H335:2
53842,"1,6-Hexanediamine, N1,N1,N6,N6-tetramethyl-, propoxylated (>1 < 4,5 mol PO)",605-146-4,158451-78-6,Skin Corr. 1;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,86,H318:86;H317:85;H314:86
53843,Thiamine hydrochloride,200-641-8,67-03-8,Eye Irrit. 2,REACH registration C&L,263,H319:16;Not classified:245;H315:13;H335:11;H302:2
53851,4'-(thiazol-2-ylsulphamoyl)acetanilide,204-864-1,127-76-4,Not Classified,REACH registration C&L,3,Not classified:2;H315:1;H319:1;H302:1;H335:1
53852,Lithium isooctadecanoate,283-815-6,84731-55-5,Not Classified,REACH registration C&L,7,Not classified:7
53854,Tin antimony grey cassiterite,269-105-9,68187-54-2,Not Classified,REACH registration C&L,238,Not classified:79;H302:158;H332:158;H411:74;H373:1
53856,Trilead bis(carbonate) dihydroxide,215-290-6,1319-46-6,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Chronic 1,REACH registration C&L,377,H332:377;H360:377;H373:377;H302:377;H410:377;H400:371
53857,Methylphosphonic acid,213-607-2,993-13-5,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,79,H302:40;H314:79;H318:3;H290:1
53858,Sodium 1-hydroxyethanesulphonate,213-037-4,918-04-7,Skin Sens. 1,Notified C&L,84,H317:83;H315:1;H319:1;H302:1;H335:1
53859,"(1R,6S)- 4,7,7-trimethylbicyclo[4.1.0]hept-3-en-2-one",606-984-3,22327-32-8,Not Classified,REACH registration C&L,1,Not classified:1
53860,"Balsams, Canada, sulfurized, palladium salts",292-708-3,90989-51-8,Flam. Sol. 1,Notified C&L,1,H228:1
53865,"2-chloro-3',4'-dihydroxyacetophenone",202-754-8,99-40-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,51,H315:51;H319:51;H335:50
53869,Cefradine,254-137-8,38821-53-3,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,42,H315:42;H319:42;H317:41;H334:41;H335:41;H362:1;H361:1
53870,"4-bromo-2,6-di-tert-butylphenol",214-521-8,1139-52-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:44;H319:44;H335:43
53873,Digallium trisulphate,236-816-0,13494-91-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:39
53877,"(9Z,12Z)-1,1,3,3-tetrabutyl-1,3-bis(octadeca-9,12-dienoyloxy)distannoxane",305-143-5,94349-26-5,Muta. 2;Repr. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,55,H360:55;H400:55;H341:55;H372:55;H410:55
53878,L-homoserine,211-590-6,672-15-1,Not Classified,Notified C&L,3,Not classified:1;H315:2;H319:2;H335:2
53879,"N-(2,2,6,6-tetramethyl-1-oxylpiperidin-4-yl)acetamide;(4-acetamido-2,2,6,6-tetramethyl-1-piperidinyl)oxidanyl",423-840-3,14691-89-5,Acute Tox. 4,Harmonised C&L,0,H302:0
53881,Trichlorotoluene,250-252-2,30583-33-6,,Notified C&L,33,Not classified:33
53882,"3,3,3-trichloro-2,2-dihydroxypropionic acid",277-331-4,73257-73-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
53890,"Amines, hydrogenated tallow alkyl, ethoxylated",612-385-8,61790-82-7,Not Classified,Notified C&L,67,Not classified:33;H411:22;H315:12;H410:6;H318:13;H400:11;H302:2
53893,(cyclopropylmethyl)trimethylammonium iodide,277-566-2,73664-02-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
53894,tert-butyl [2-({[1-methyl-5-(tritylamino)-1H-pyrazol-4-yl]carbamoyl}amino)ethyl]carbamate,614-818-6,689293-69-4,Not Classified,Notified C&L,2,Not classified:1;H315:1;H319:1;H335:1
53895,"[2,2-bis(2-methylpropoxy)ethyl]benzene",269-851-5,68345-22-2,Not Classified,Notified C&L,89,Not classified:88;H315:1;H319:1
53898,Aluminium fluoride oxide,237-036-3,13596-12-8,Not Classified,Notified C&L,7,Not classified:7
53901,"1,3,5-triazine-2,4,6(1H,3H,5H)-trithione, trisodium salt",241-749-5,17766-26-6,Eye Irrit. 2,REACH registration C&L,70,H319:70;H302:18;H412:6
53903,Trilithium bis[3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)]chromate(3-),280-296-8,83249-27-8,Not Classified,Notified C&L,4,Not classified:3;H411:1;H319:1;H317:1
53908,"9-Octadecen-1-ol, (Z)-, reaction products with hydrogen sulfide, sulfur and 2,4,4-trimethylpentene, reaction products with phosphorus oxide (P2O5), compds. with tert-dodecanamine (1:1)",291-766-7,90480-33-4,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,33,H411:33;H302:33;H314:33;H318:33
53911,"N-[2-[(2-bromo-4,6-dinitrophenyl)azo]-5-(diallylamino)-4-methoxyphenyl]acetamide",257-486-4,51868-46-3,Skin Sens. 1B,REACH registration C&L,116,H317:52;H315:43;H318:43;Not classified:21
53912,"2-Propenoic acid, docosyl ester, polymer with eicosyl 2-propenoate and octadecyl 2-propenoate",608-039-0,27029-57-8,Not Classified,Notified C&L,2,Not classified:1;H315:1;H319:1
53914,"Hydrogen [N,N-bis(carboxymethyl)glycinato(3-)-N,O,O',O'']nickelate(1-)",252-235-5,34831-03-3,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H351:1;H302:1;H317:1;H334:1;H410:1
53920,"2,2'-difluorobenzophenone",206-439-6,342-23-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H302:1;H335:1
53925,"4,5-dihydroxy-m-anisic acid",223-512-8,3934-84-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1;H312:1
53928,"(1α,2β,3α,4β,5α,6β)-1,2,3,4,5,6-hexachlorocyclohexane",206-271-3,319-85-7,Acute Tox. 3;Acute Tox. 4;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,9,H400:6;H351:6;H312:6;H410:6;H301:8;H330:2;H311:2;Not classified:1
53930,"Methyl (2S-trans)-7-chloro-6,7,8-trideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-L-threo-α-D-galacto-octopyranoside, 2-(dihydrogen phosphate)",246-433-0,24729-96-2,Acute Tox. 4,Notified C&L,211,H302:210;H316:29;H317:32;H319:45;H361:10;H315:2;H335:2
53931,"Potassium sodium 7-hydroxy-8-[[4-[1-[4-[(4-hydroxyphenyl)azo]phenyl]cyclohexyl]phenyl]azo]naphthalene-1,3-disulphonate",276-881-2,72828-67-2,Skin Sens. 1;Aquatic Chronic 1,Notified C&L,2,H411:2;H410:2;H317:2
53932,"Diisopropyl-1,1'-biphenyl",273-683-8,69009-90-1,Skin Irrit. 2;Aquatic Chronic 4,Notified C&L,600,H315:536;H413:537;Not classified:63
53936,1-cyclohexylethyl butyrate,264-158-4,63449-88-7,Aquatic Chronic 2,REACH registration C&L,235,H411:11;H315:224;H319:224
53941,"Nitriles, tallow, hydrogenated",263-122-5,61790-29-2,Skin Irrit. 2;Aquatic Chronic 1,Notified C&L,31,H315:31;H410:31
53943,"2,6-Difluor-3-nitro-1-(trifluormethoxy)benzol",620-076-4,153338-22-8,Skin Corr. 1B;Skin Sens. 1;Resp. Sens. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H334:1;H317:1;H314:1
53944,"6-methyl-1,2,3-oxathiazin-4(3H)-one 2,2-dioxide, potassium salt",259-715-3,55589-62-3,Not Classified,REACH registration C&L,175,Not classified:174;H319:1
53947,"1,3-Pentanediol, 2-methyl-",604-684-7,149-31-5,Not Classified,Notified C&L,5,Not classified:5
53948,Diethyl methylphosphonate,211-667-4,683-08-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H315:42;H319:42;H335:42
53950,"4-[4-(1,3-dihydroxyprop-2-yl)phenylamino]-1,8-dihydroxy-5-nitroanthraquinone",406-057-1,114565-66-1,Skin Sens. 1;Carc. 2;Aquatic Chronic 4,Harmonised C&L,0,H351:0;H413:0;H317:0
53951,Henicosanol,239-673-2,15594-90-8,Not Classified,Notified C&L,3,Not classified:3
53953,3-methyl-4-pyrrolidin-1-ylaniline monohydrochloride,268-987-2,68155-75-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
53955,2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethyl oleate,233-293-0,10108-25-5,,Notified C&L,1,Not classified:1
53959,"ß-Cyclodextrin, acetyl",418-780-1,,Not Classified,Notified C&L,1,Not classified:1
53961,chlordimeform (ISO);N,228-200-5,6164-98-3,Acute Tox. 4;Acute Tox. 4;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H351:0;H302:0;H312:0;H410:0
53962,Cobalt molybdenum oxide,235-737-9,12640-46-9,Not Classified,Notified C&L,7,Not classified:7
53967,"N2-[(1,1-dimethylethoxy)carbonyl]-N6-[(phenylmethoxy)carbonyl]-L-lysine",219-221-0,2389-45-9,Not Classified,Notified C&L,1,Not classified:1
53968,hydrogen,215-605-7,1333-74-0,Press. Gas;Flam. Gas 1,Harmonised C&L,0,Not classified:0;H220:0
53969,Sodium dinonylnaphthalenesulphonate,248-022-1,26834-28-6,Skin Irrit. 2;Eye Dam. 1,Notified C&L,59,H315:30;H318:29;Not classified:29
53972,"4-hydroxy-3,5-dimethoxybenzamide",221-407-1,3086-72-4,Eye Irrit. 2,Notified C&L,43,H319:43;H341:5
53978,Dimethyl phthalate,205-011-6,131-11-3,Not Classified,REACH registration C&L,2002,Not classified:1931;H319:49;H331:17;H315:5;H361:5;H332:2;H336:4;H320:1;H402:1;H412:1;H335:1
53979,2-(4-(4-cyano-3-methylisothiazol-5-ylazo)-N-ethyl-3-methylanilino)ethyl acetate,405-480-9,110260-50-9,Acute Tox. 4;Skin Irrit. 2;STOT RE 2;Aquatic Chronic 4,Harmonised C&L,0,H315:0;H373:0;H302:0;H413:0
53981,6-hydroxy-1-naphthoic acid,407-390-5,2437-17-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,32,H315:32;H319:32;H335:31
53986,"N,N''-methylenebis[N'-[3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]urea]",254-372-6,39236-46-9,Skin Sens. 1B,REACH registration C&L,555,H317:387;Not classified:119;H319:49;H350:1
53991,2-methyl-6-nitrobenzoxazole,227-149-6,5683-43-2,Acute Tox. 4;Eye Dam. 1,Notified C&L,42,H302:38;H318:38;H315:4;H319:4;H335:4
53994,Trimetazidine dihydrochloride,236-117-0,13171-25-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,109,H315:102;H319:102;H302:107;H335:100;H332:5;H312:3;H412:1;Not classified:1
53997,Gentamicin,215-765-8,1403-66-3,Skin Sens. 1;Resp. Sens. 1,Notified C&L,85,H317:48;H334:48;H400:37;H410:37;H360:37;H372:37
54000,"Dihydro-3-octadecylfuran-2,5-dione",256-316-6,47458-32-2,Eye Irrit. 2,Notified C&L,39,H319:39;H315:1
54005,"N,N'-[(methylimino)dipropane-1,3-diyl]dioleamide",256-233-5,45320-65-8,Aquatic Chronic 4,REACH registration C&L,2,H413:2
54006,4-pentyloxybenzoyl chloride,253-230-0,36823-84-4,,Notified C&L,4,H314:4
54009,Ruthenium (IV) oxide,234-840-6,12036-10-1,Ox. Sol. 2,REACH registration C&L,292,H272:52;H413:85;H319:86;H271:36;Not classified:33;H373:1;H371:1;H315:1;H335:1
54011,2-ethoxypyridine,238-553-7,14529-53-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,43,H315:43;H335:42;H302:38;H318:38;H319:5;H226:5
54014,"Amines, C16-18 and C18-unsatd. alkyl, O,O-di-Bu phosphorothioates",307-923-0,97808-07-6,Not Classified,Notified C&L,3,Not classified:3
54015,"2-[1-(3,3-dimethylcyclohexyl)ethoxy]-2-methylpropyl cyclopropanecarboxylate",460-490-0,477218-42-1,Skin Sens. 1B;STOT RE 2;Aquatic Chronic 1,REACH registration C&L,1289,H373:2;H317:1289;H410:1288;H411:1
54016,Cefalotin,205-815-7,153-61-7,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,45,H317:45;H334:45
54017,"1H-Imidazole-1-ethanamine, 4,5-dihydro-, 2-(C15-17 and C15-17-unsatd. alkyl) derivs., acetates",288-502-8,85736-91-0,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,11,H315:10;H400:7;H319:7;H314:8;H318:10;H410:7;H302:4;H411:1
54020,"19-hydroxyandrost-4-ene-3,17-dione",208-116-5,510-64-5,Repr. 2,Notified C&L,45,H361:38;H351:7;H360:7;H362:7;H302:1
54021,"Sodium p-[4-[[5-chloro-2-(2-chlorophenoxy)phenyl]azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonate",280-354-2,83270-32-0,Not Classified,Notified C&L,1,Not classified:1
54024,"2',4'-dihydroxyacetophenone",201-945-3,89-84-9,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,REACH registration C&L,48,H315:47;H335:46;H318:46;H302:1;H319:1
54025,"4-nitrobenzene-1,2-diamine monohydrochloride",258-429-6,53209-19-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Muta. 2,Notified C&L,1,H332:1;H302:1;H312:1;H341:1
54027,"1,3-(difurfuryl)thiourea",233-586-3,10248-89-2,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
54035,7-methyl-2-quinolone,223-761-2,4053-35-4,Acute Tox. 5;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H303:1;H335:1
54042,Diacetamate,220-077-6,2623-33-8,Not Classified,REACH registration C&L,4,Not classified:2;H315:1;H319:1;H302:1
54046,thallium thiocyanate,222-571-7,3535-84-0,Acute Tox. 2;Acute Tox. 4;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H330:0;H373:0;H411:0;H300:0;H312:0
54049,(S)-N-[3-methyl-1-[(2-naphthylamino)carbonyl]butyl]benzamide,305-314-4,94441-89-1,Carc. 2,Notified C&L,38,H351:38
54052,Butylhydrazine oxalate,255-050-8,40711-41-9,Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H302:38;H312:38
54054,"Hydrolase, γ-glutamyl",232-978-1,9074-87-7,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38;H334:38
54055,"2-bromo-1,3,5-trimethoxybenzene",214-464-9,1131-40-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H332:1;H319:1;H302:1;H312:1;H335:1
54056,Ethyl 4-iodobenzoate,610-760-0,51934-41-9,Eye Irrit. 2,Notified C&L,44,H319:44;H315:6;H335:1
54057,Piperidin-4-ol,226-373-1,5382-16-1,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,75,H315:58;H318:12;H319:47;H335:46;H314:17;H332:1;H302:1;H312:1
54062,N-[4-[(2-hydroxyethyl)sulphonyl]phenyl]acetamide,248-433-6,27375-52-6,Not Classified,REACH registration C&L,33,Not classified:33
54063,"Tetrasodium 8-(4-chloro-6-(4-(2-(sulfonatooxy)ethylsulfonyl)anilino)-1,3,5-triazin-2-ylamino)-1-hydroxy-2-(2-sulfonatophenylazo)naphthalene-2,7-disulfonate",401-090-8,,Not Classified,REACH registration C&L,4,Not classified:4
54069,"2,4-bis(1-methyl-1-phenylethyl)phenol",220-466-0,2772-45-4,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,41,H400:1;H410:1;H318:1;H319:39;H413:38;H315:1;Not classified:1
54071,3-methoxybutyric acid,233-028-9,10024-70-1,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H315:1;H335:1;H318:1
54073,5-nitroindole,228-153-0,6146-52-7,Acute Tox. 4;Eye Dam. 1,Notified C&L,46,H302:40;H318:39;H317:4;H341:7;H315:1;H332:1;H319:1;H312:1;H335:1
54074,3-aminohexahydro-2H-azepin-2-one,211-584-3,671-42-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,41,H315:41;H332:40;H319:41;H302:40;H335:40;H312:2
54075,"4,6-dichloropyrimidine",214-770-2,1193-21-1,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4;STOT SE 3;Aquatic Chronic 1,REACH registration C&L,247,H332:201;H410:201;H314:247;H302:201;H312:201;H318:169;H317:201;H335:201;H400:198
54077,"3-[[2-(acetylamino)-4-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]phenyl]azo]naphthalene-1,5-disulphonic acid",229-453-4,6539-67-9,,Notified C&L,2,Not classified:2
54082,2-isobutylthiazole,242-470-1,18640-74-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1591,H315:1590;H319:1590;H302:1288;H335:300;H226:153
54085,"N-(3,4-dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)acetamide",205-374-0,139-76-4,Not Classified,REACH registration C&L,1,Not classified:1
54087,"Leonurus cardiaca, ext.",289-999-4,90063-41-5,Not Classified,Notified C&L,3,Not classified:1;H226:2;H319:1
54089,"1,2-Bis-[4-{3-(4-methoxy-phenylazo)-4-hydroxy-naphthtalenyl-amino}-6-fluoro-[1,3,5]triazine-2-ylamino]-alkane, polysulfo-, Na-salt",415-760-2,,Not Classified,Notified C&L,1,Not classified:1
54090,o-[[(2-hydroxyphenyl)imino]methyl]phenol,217-166-7,1761-56-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H302:38;H335:38
54091,"N-hydroxy-N,N-dimethylamine hydrochloride",240-691-8,16645-06-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,38,H315:38;H319:38
54098,"reaction mass of: ((Z)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid;di-((E)-3,7-dimethyl-2,6-octadienyl) butandioate;di-((Z)-3,7-dimethyl-2,6-octadienyl) butandioate;(Z)-3,7-dimethyl-2,6-octadienyl butandioate;((E)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid",415-190-4,,Skin Sens. 1,Harmonised C&L,0,H317:0
54099,[3-[[1-[anilinocarbonyl]-2-oxopropyl]azo]-2-hydroxy-5-nitrobenzene-1-sulphonato(3-)]chromium,233-747-8,10343-55-2,Not Classified,Notified C&L,2,Not classified:2
54100,2-methylpiperidine,203-642-1,109-05-7,Flam. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,47,H315:40;H225:47;H302:41;H318:41;H335:39;H314:7;H319:1
54105,"Fatty acids, coco, Me esters, distn. residues, sulfonated, ammonium salts",309-689-5,100684-17-1,Skin Irrit. 2,Notified C&L,28,H315:28
54110,dinickel hexacyanoferrate,238-946-3,14874-78-3,Skin Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0,H350:0;H400:0;H317:0;H372:0;H410:0
54111,4-decenoic acid,247-599-7,26303-90-2,,Notified C&L,2,H315:2;H319:2;H335:1
54112,"Betaines, coco alkyldimethyl(3-sulfopropyl)",269-225-1,68201-55-8,Skin Corr. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,71,H400:2;H410:2;H318:2;H314:2;H315:69;H319:69;H300:14
54113,"3,4-Dihydro-5-hydroxy-1H-quinolin-2-one",608-474-6,30389-33-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H332:1;H319:1;H302:1;H312:1;H335:1
54116,Tert-butyl tert-butyldimethylsilyl [(2S)-2-(benzyloxy)propylidene]carbonohydrazonate,925-662-6,,Not Classified,Notified C&L,1,Not classified:1
54118,"Chromate(2-), [4-[(5-chloro-2-hydroxy-3-nitrophenyl)azo]-2,4-dihydro-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)][3-[[1-(3-chlorophenyl)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl]azo]-4-hydroxy-5-nitrobenzenesulfonato(3-)]-, disodium",276-292-0,72017-66-4,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,213,H400:122;H410:122;H411:83;H336:83;H226:83;Not classified:8
54120,"2,5-xylenol",202-461-5,95-87-4,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H314:0;H311:0;H301:0
54124,Isobutyl 4-hydroxybenzoate,224-208-8,4247-02-3,Skin Sens. 1B,REACH registration C&L,527,H317:1;Not classified:457;H318:36;H315:25;H319:25;H400:5;H411:2;H335:2;H302:1
54127,"Propanoic acid, 2-bromo-2-methyl-, 2-hydroxyethyl ester",606-170-8,189324-13-8,Acute Tox. 4;Eye Dam. 1,Notified C&L,38,H302:38;H318:38
54130,"N,N-diisopropyl-3-(2-methoxy-5-methylphenyl)-3-phenylpropanamine fumarate",603-018-2,124935-89-3,Acute Tox. 4,Notified C&L,5,H302:5
54134,"(3E)-3-[[4-(2-carboxyethylcarbamoyl)phenyl]hydrazinylidene]-6-oxocyclohexa-1,4-diene-1-carboxylic acid",617-116-8,80573-04-2,Not Classified,Notified C&L,1,Not classified:1
54137,"Fatty acids, C22-unsatd., dimers",500-677-7,162260-06-2,Not Classified,Notified C&L,1,Not classified:1
54138,"2,4,6-trimethylbenzophenone",403-150-9,954-16-5,Acute Tox. 4;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H319:0;H302:0;H410:0
54141,Sucrose tripalmitate,248-026-3,26836-42-0,Not Classified,Notified C&L,1,Not classified:1
54142,1-[[4-[(dimethylphenyl)azo]dimethylphenyl]azo]-2-naphthol,215-295-3,1320-06-5,Not Classified,Notified C&L,2072,Not classified:2072
54144,"Residues (petroleum), steam-cracked;Heavy Fuel oil;[A complex combination of hydrocarbons obtained as the residual fraction from the distillation of the products of a steam cracking process (including steam cracking to produce ethylene). It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C",265-193-8,64742-90-1,Carc. 1B,Harmonised C&L,0,H350:0
54146,"Amines, C16-18-unsatd. alkyl",297-812-2,93762-95-9,Acute Tox. 4;Skin Corr. 1B;STOT SE 3;STOT RE 2;Aquatic Acute 1,Notified C&L,31,H400:31;H373:31;H314:31;H302:31;H335:31
54151,Mecillinam,251-277-1,32887-01-7,Not Classified,Notified C&L,1,Not classified:1
54152,"Tar, brown-coal, low-temp.;[A tar obtained from low temperature carbonization and low temperature gasification of brown coal. Composed primarily of aliphatic, naphthenic and cyclic aromatic hydrocarbons, heteroaromatic hydrocarbons and cyclic phenols.]",309-886-6,101316-84-1,Carc. 1A,Harmonised C&L,0,H350:0
54153,"Amines, N-soya alkyltrimethylenedi-",263-199-5,61791-67-1,Not Classified,Notified C&L,1,Not classified:1
54154,Tetrabutylammonium fluoride,207-057-2,429-41-4,Skin Corr. 1B,Notified C&L,90,H314:90;H335:34;H318:34;H301:6;H311:2;H332:1;H302:2;H312:1;H225:2;H351:1
54155,"5,7-dihydroxy-2-(4-hydroxyphenyl)-4-benzopyrone",208-292-3,520-36-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,77,H315:52;H319:52;H335:51;Not classified:25
54159,prop-2-yn-1-ol;propargyl alcohol,203-471-2,107-19-7,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3;Aquatic Chronic 2,Harmonised C&L,0,H226:0;H314:0;H411:0;H311:0;H331:0;H301:0
54162,methyl 3-[(2-methoxy-2-oxoethyl)sulfamoyl]thiophene-2-carboxylate,600-780-8,106820-63-7,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,REACH registration C&L,3,H332:2;H319:1;H302:2;H312:2;Not classified:1
54164,3-butyl-1-nitro-3-nitrosoguanidine,235-857-1,13010-08-7,Flam. Sol. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 1B,Notified C&L,38,H315:38;H335:38;H350:38;H319:38;H228:38
54166,2-chloro-1-(piperidin-1-yl)ethan-1-one,604-393-5,1440-60-4,Acute Tox. 4,Notified C&L,40,H302:38;H315:2;H319:1;H335:2;H318:1
54167,"7,8-didehydrocholesterol",207-100-5,434-16-2,Aquatic Chronic 4,REACH registration C&L,3,H413:1;Not classified:2
54168,"Fatty acids, rape-oil, compds. with ethanolamine",297-440-0,93572-11-3,Not Classified,Notified C&L,2,Not classified:2
54170,O-(2-methylpropyl) prop-2-en-1-ylcarbamothioate,434-440-3,,Acute Tox. 4;Skin Sens. 1B;Repr. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H400:2;H373:2;H361:2;H302:2;H317:2;H410:2
54174,Triforine,247-872-0,26644-46-2,Acute Tox. 4,Notified C&L,194,H302:156;H332:38
54175,Tungsten sulfide,235-734-2,12627-71-3,Not Classified,Notified C&L,4,Not classified:4
54182,"cis,trans-hexa-2,4-diene",209-757-3,592-46-1,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H315:43;H319:43;H335:43;H225:45
54183,"Quaternary ammonium compounds, di-C12-18-alkyldimethyl, chlorides",269-924-1,68391-05-9,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,263,H400:120;H314:227;H411:58;H302:71;H318:45;H226:6;H315:36;H410:49;H290:2;H336:2;H301:2
54184,"cis-α,α,5-trimethyl-5-vinyltetrahydrofuran-2-methanol",227-814-0,5989-33-3,Acute Tox. 4;Skin Irrit. 2,Notified C&L,113,H315:113;H302:113;H319:25
54185,REACTIVE YELLOW AE 3800,414-300-8,,Not Classified,Notified C&L,1,Not classified:1
54187,2-fluoroacetamide,211-363-1,640-19-7,Acute Tox. 2;Acute Tox. 3,Harmonised C&L,0,H300:0;H311:0
54188,4-guanidinobenzoic acid hydrochloride,255-956-3,42823-46-1,Acute Tox. 4,REACH registration C&L,5,H302:5;H315:1;H319:1;H335:1
54190,"Benzoic acid, 4-(5-hexen-1-yloxy)-, 4-methoxyphenyl ester",616-342-4,76487-58-6,Not Classified,Notified C&L,1,Not classified:1
54191,"Gases (petroleum), gas oil diethanolamine scrubber off;Refinery gas;[A complex combination produced by desulfurization of gas oils with diethanolamine. It consists predominantly of hydrogen sulfide, hydrogen and aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.]",295-397-2,92045-15-3,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H350:0;Not classified:0;H220:0;H340:0
54192,"Glycerides, C12-18 mono- and di-",293-209-3,91052-49-2,Not Classified,REACH registration C&L,8,Not classified:8
54193,"Sulfuric acid magnesium salt (1:1), heptahydrate",600-073-4,10034-99-8,Not Classified,Notified C&L,428,Not classified:428
54195,"3,5,7-trihydroxy-2-(4-methoxyphenyl)-4-benzopyrone",207-738-4,491-54-3,Not Classified,Notified C&L,1,Not classified:1
54197,"Decanoic acid, branched, reaction products with diethanolamine",291-162-3,90342-26-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
54198,"4-[[4-(dimethylamino)phenyl][4-(dimethyliminio)cyclohexa-2,5-dien-1-ylidene]methyl]-N-ethyl-N,N-dimethylanilinium bromide chloride, compound with zinc chloride",230-415-4,7114-03-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H315:42;H319:42;H335:42;H351:2;H411:3;H314:4;H400:1;H302:1;H318:1;H410:1;Not classified:1
54200,"Benzenesulfonic acid, di-C10-18-alkyl derivs., sodium salts",298-640-0,93820-59-8,Eye Irrit. 2,Notified C&L,601,H319:566;H413:125;Not classified:18;H302:17;H332:17
54202,"Clarified oils (petroleum), hydrodesulfurized catalytic cracked;Heavy Fuel oil; [A complex combination of hydrocarbons obtained by treating catalytic cracked clarified oil with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly greater than C",269-782-0,68333-26-6,Carc. 1B,Harmonised C&L,0,H350:0
54206,"3-amino-7-nitronaphthalene-1,5-disulphonic acid",241-525-7,17527-17-2,Eye Irrit. 2,Notified C&L,38,H319:38
54208,Pyridine-2-carboxylic acid 1-oxide,212-528-0,824-40-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:39;H302:1
54209,Procainamide hydrochloride,210-381-7,614-39-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H315:43;H319:43;H302:46;H335:43;H332:1;H361:1;H370:1
54211,2-isopropyl-p-cresol,224-611-9,4427-56-9,Not Classified,Notified C&L,89,Not classified:88;H315:1;H304:1;H319:1;H302:1;H311:1;H331:1
54212,"Tail gas (petroleum), catalytic polymn. naphtha fractionation stabilizer;Petroleum gas;[A complex combination of hydrocarbons from the fractionation stabilization products from polymerization of naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.]",269-618-8,68307-99-3,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H350:0;Not classified:0;H220:0;H340:0
54214,Calcium acetate hydrate,601-314-6,114460-21-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H315:40;H319:40;H335:40;Not classified:7
54221,"2-hydroxy-1,2-di-2-pyridylethanone",214-526-5,1141-06-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
54223,1-(4-chlorophenyl)cyclohexanecarboxylic acid,261-481-2,58880-37-8,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H315:39;H335:39;H318:38;H319:1
54229,"Sodium [2S-(2α,5α,6β)]-6-[[[3-(2-chloro-6-fluorophenyl)-5-methylisoxazol-4-yl]carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",217-428-0,1847-24-1,Skin Sens. 1;Resp. Sens. 1,Notified C&L,58,H317:56;H334:56;H360:1;H302:1
54235,"Stilbene-4,4'-dicarboxylic acid",202-838-4,100-31-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:44;H319:44;H302:38;H335:43
54238,"1-ethyl-2-[5-(1-ethyl-2(1H)-quinolylidene)penta-1,3-dienyl]quinolinium iodide",238-040-8,14187-31-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H315:38;H332:38;H319:38;H302:38;H312:38;H335:38
54239,"2-[(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)methyl]-N,N-diethyl-1-phenyl-",921-437-1,,Not Classified,REACH registration C&L,1,Not classified:1
54240,"(±)-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide",253-911-2,38396-39-3,Acute Tox. 2;Acute Tox. 2;Acute Tox. 1,Notified C&L,1,H300:1;H310:1;H330:1
54255,Cobalt chromite green spinel,269-101-7,68187-49-5,Not Classified,REACH registration C&L,206,Not classified:187;H317:18;H373:1;H351:1
54258,"(1α,2α,3α,4β,5α,6β)-1,2,3,4,5,6-hexachlorocyclohexane",206-272-9,319-86-8,Acute Tox. 3;Acute Tox. 4;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,9,H400:6;H351:6;H312:6;H410:6;H301:6;H302:2;Not classified:1
54259,"6-chloro-3-methylpyrimidine-2,4(1H,3H)-dione",610-113-2,4318-56-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,49,H315:49;H319:49;H335:47;H317:1
54264,Benzonatate,203-194-7,104-31-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H302:1;H335:1
54265,Barium iodide dihydrate,616-535-3,7787-33-9,Acute Tox. 4;Acute Tox. 4,Notified C&L,43,H302:43;H332:43;H371:1;H312:1;H317:1;H334:1
54266,3-methyl-3-phenylpiperidine,243-260-2,19735-13-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H302:1;H335:1
54267,C.I. Vat Brown 84,606-788-8,215173-67-4,Not Classified,Notified C&L,1,Not classified:1
54273,"9-Octadecen-1-ol, (Z)-, reaction products with hydrogen sulfide, sulfur and 2,4,4-trimethylpentene, reaction products with phosphorus oxide (P2O5), compds. with 1-tridecanamine (1:1)",291-767-2,90480-34-5,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,33,H411:33;H302:33;H314:33;H318:33
54277,Cyclobutanol,220-858-1,2919-23-5,Flam. Liq. 2,Notified C&L,46,H225:44;H302:1;H226:2;H315:1;H335:1;H318:1
54278,4-bromobenzamide,211-817-9,698-67-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:44;H319:44;H335:43
54279,Disodium hexabromoiridate,249-069-0,28529-99-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:44;H319:44;H335:44
54282,3-iodoaniline,210-922-7,626-01-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,46,H315:45;H332:46;H302:46;H312:46;H335:39;H319:6
54285,D-2-amino-4-(ethylthio)butyric acid,208-612-1,535-32-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
54289,"5-(2-amino-5-cyano-6-[2-(2-hydroxyethoxy)ethylamino]-4-methylpyridin-3-ylazo)-3-methyl-2,4-dicarbonitrilethiophene",410-530-8,,Skin Sens. 1,Harmonised C&L,0,H317:0
54291,"3,5-diiodothyronine",213-867-7,1041-01-6,Aquatic Chronic 3,REACH registration C&L,52,H412:2;H302:49;H373:1
54293,"[(3,5,6-trichloro-2-pyridyl)oxy]acetic acid, compound with triethylamine (1:1)",260-625-1,57213-69-1,Flam. Liq. 3;Eye Irrit. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,55,H400:55;H319:55;H373:55;H226:55;H410:55
54302,"N-(2,4-dinitrophenyl)glycine",214-114-5,1084-76-0,Flam. Sol. 1,Notified C&L,1,H228:1
54304,1-methyl-4-[(methylphenylhydrazono)methyl]pyridinium sulphate (2:1),303-183-8,94159-08-7,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,1,H411:1;H302:1
54306,2-methylbutyl valerate,259-716-9,55590-83-5,Not Classified,Notified C&L,4,Not classified:4
54310,"Decane-1,10-diol",203-975-2,112-47-0,Not Classified,REACH registration C&L,44,Not classified:44
54313,2-ethyl-5(or6)-methylpyrazine,253-175-2,36731-41-6,Acute Tox. 4,Notified C&L,1350,H302:1350;H315:38;H319:38;H226:38;H335:38
54314,"chlorfenethol (ISO);1,1-bis (4-chlorophenyl) ethanol",201-246-3,80-06-8,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H302:0
54315,"1,2-naphthoquinone",208-360-2,524-42-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H315:42;H319:42;H302:40;H335:41;Not classified:3;H301:2;H332:1;H312:1
54316,"N,N'-Di-(benzyloxycarbonyl)-hydrazine",611-069-7,5394-50-3,Aquatic Acute 1,Notified C&L,39,H400:38;H315:1;H319:1;H335:1
54319,"2-Pyrimidinamine, 4-chloro-6-(1-methylethyl)-",615-993-1,73576-33-7,Not Classified,Notified C&L,11,Not classified:6;H315:5;H319:5;H335:5
54322,"Tris(2-ethylhexyl) benzene-1,2,4-tricarboxylate",222-020-0,3319-31-1,Not Classified,REACH registration C&L,368,Not classified:297;H361:48;H315:17;H319:17;H335:17;H413:6
54323,"2-Butenedioic acid (2E)-, polymer with 2-methyloxirane and oxirane",614-446-4,68400-72-6,Eye Irrit. 2,Notified C&L,1,H319:1
54327,Pasiniazid,218-183-2,2066-89-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H302:38;H335:38
54328,2-Amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide,608-455-2,302964-24-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H315:1;H319:1;H302:1;H371:1;H373:1;H341:1;H351:1;H301:1
54329,Gadolinium trifluoride,237-369-4,13765-26-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:39;H319:39;H335:39;H301:4;Not classified:1
54331,4-(p-methoxyphenyl)butan-2-ol,267-891-8,67952-38-9,Not Classified,Notified C&L,1,Not classified:1
54332,Sodium [3-hydroxy-4-[(1-hydroxy-8-sulpho-2-naphthyl)azo]naphthalene-1-sulphonato(4-)]chromate(1-),275-033-9,70942-15-3,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,14,H411:12;H317:13;H334:2
54340,1-(benzyl)pyrrolidin-3-ol,212-273-5,775-15-5,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H315:41;H319:40;H335:40;H301:39;H318:1
54345,Ammonium ethyl carbamoylphosphonate,247-363-3,25954-13-6,Acute Tox. 4;Eye Irrit. 2,Notified C&L,54,H319:38;H312:38;H336:13;Not classified:3
54349,Trifluoromethanesulphonic (2H)acid,266-221-1,66178-41-4,Acute Tox. 4;Skin Corr. 1B,Notified C&L,38,H302:38;H314:38
54352,Trifluoromethane,200-872-4,75-46-7,Press. Gas (Liq.),REACH registration C&L,330,H280:330;H315:1;H319:1;H335:1
54357,4-(4'-chlorobenzyl)pyridine,224-560-2,4409-11-4,,Notified C&L,5,H315:5;H319:5
54361,Chelidonine,207-504-1,476-32-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,41,H332:38;H302:38;H312:38;H330:2;H311:2;H301:3
54363,Quinoline-3-carboxylic acid,229-337-3,6480-68-8,,Notified C&L,7,H315:7;H319:7;H335:6
54364,5-(Ethylthio)-1H-tetrazole,618-305-8,89797-68-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H315:51;H319:51;H335:50;H228:1;H332:1;H302:1;H312:1
54369,4-amino-2-methylpyrimidine-5-methylamine,202-384-7,95-02-3,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,3,H315:3;H318:2;H317:2;H319:1
54372,"Fatty acids, C18-unsatd., dimers, hydrogenated, polymers with 1,6-hexanediol",605-038-7,156064-92-5,Not Classified,Notified C&L,88,Not classified:88
54375,Methyl 4-amino-5-nitro-o-anisate,261-703-8,59338-84-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,REACH registration C&L,4,H315:4;H332:3;H319:4;H302:3;H312:3;H335:4
54379,Propiolic acid,207-437-8,471-25-0,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B,REACH registration C&L,47,H301:47;H314:47;H311:3;H226:43;H310:44;H412:4;H318:1
54381,"Rape oil, potassium salt",269-226-7,68201-56-9,Not Classified,Notified C&L,6,Not classified:6
54387,(±)-N-[3-acetyl-4-[2-hydroxy-3-[(isopropyl)amino]propoxy]phenyl]butyramide monohydrochloride,251-980-3,34381-68-5,Acute Tox. 4;Acute Tox. 4,Notified C&L,85,H312:40;H332:38;H319:44;H317:26;H362:18;H302:2;Not classified:1
54393,Dimethylthiophosphinic chloride,213-606-7,993-12-4,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,Notified C&L,1,H332:1;H314:1;H302:1;H312:1;H318:1
54394,Quartz (SiO2),238-455-4,14808-60-7,Not Classified,Notified C&L,3236,Not classified:904;H350:552;H373:1027;H372:893;H332:130;H351:126;H335:43;H341:30;H302:25;H371:9;H370:18;H319:6;H315:3;H413:1
54395,"Nonane-1,9-diol",223-517-5,3937-56-2,Aquatic Chronic 3,REACH registration C&L,8,H412:3;Not classified:3;H315:2;H319:2;H335:2
54397,Methyl 4-phenylbutyrate,218-067-1,2046-17-5,Not Classified,Notified C&L,88,Not classified:88
54400,(2RS)-1-(9H-Carbazol-4-yloxy)-3-((2-(2-methoxyphenoxy)ethyl]amino]propan-2-ol,615-871-8,72956-09-3,Aquatic Chronic 2,Notified C&L,111,H411:98;H361:4;H332:4;H362:2;H412:2;H302:5;H400:4;H410:6;H317:4;H312:2;H334:1;H315:1;H319:1;H335:1;H370:1
54403,"Residues (petroleum), steam-cracked, distillates;Heavy Fuel oil;[A complex combination of hydrocarbons obtained during the production of refined petroleum tar by the distillation of steam cracked tar. It consists predominantly of aromatic and other hydrocarbons and organic sulfur compounds.]",292-657-7,90669-75-3,Carc. 1B,Harmonised C&L,0,H350:0
54407,2-ethyl-2-phenylbutyronitrile,226-257-0,5336-57-2,Acute Tox. 4,REACH registration C&L,39,H302:1;H301:39
54408,"5-fluoro-2,4-dinitroaniline",206-700-4,367-81-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H315:41;H319:41;H335:40;H311:1;H331:1;H301:1;H332:1;H302:1;H312:1
54413,"Glycine, N-(2-aminoethyl)-N-[2-[(carboxymethyl)amino]ethyl]-, N,N'-bis(C8-18-branched and linear alkyl) derivs., dihydrochlorides",309-299-5,100208-93-3,Not Classified,Notified C&L,7,Not classified:7
54415,"Lentil, ext.",289-998-9,90063-40-4,Not Classified,REACH registration C&L,1,Not classified:1
54420,"Stevia rebaudiana, ext.",294-422-4,91722-21-3,Not Classified,Notified C&L,38,Not classified:38
54423,reaction mass of: cis-9-octadecenedioic acid;cis-9-cis-12-octadecadienedioic acid;hexadecanedioic acid;octadecanedioic acid,422-260-8,,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H318:0
54426,"Formamide, N,N'-1,6-hexanediylbis[N-(2,2,6,6-tetramethyl-4-piperidinyl)-",602-984-2,124172-53-8,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,16,H319:16;H412:16
54427,Indole,204-420-7,120-72-9,Acute Tox. 4;Acute Tox. 3;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,1853,H302:1853;H318:93;H317:7;H311:1835;H315:46;H400:66;H335:45;H319:18;H312:17;Not classified:4;H332:2;H410:1
54429,Dilithium molybdate,236-977-7,13568-40-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,381,H315:349;H319:353;H335:353;H413:25;Not classified:2;H302:1
54430,6-amino-1H-pyrimidin-4-one,214-771-8,1193-22-2,,Notified C&L,9,H315:9;H319:9;H335:8
54432,trans-2-methylcyclopentan-1-ol,246-652-1,25144-04-1,Flam. Liq. 3,Notified C&L,39,H226:39
54433,"Grape, red, ext.",284-511-6,84929-27-1,Not Classified,Notified C&L,208,Not classified:173;H225:32;H226:3;H319:1
54435,"Poly(oxy-1,2-ethanediyl), α-sulfo-ω-(dodecyloxy)-, magnesium salt (2:1)",613-078-1,62755-21-9,Skin Irrit. 2;Eye Dam. 1,Notified C&L,36,H315:36;H318:36
54437,Dibenzyl disulphide,205-764-0,150-60-7,Not Classified,Notified C&L,156,Not classified:112;H317:44;H319:2
54439,Sodium 4-ethoxycarbonylphenoxide,252-487-6,35285-68-8,Eye Irrit. 2,REACH registration C&L,228,H319:50;H318:176;H314:1;Not classified:1;H315:1
54444,(benzothiazol-2-ylthio)acetic acid,228-565-0,6295-57-4,Acute Tox. 4;Eye Dam. 1;Repr. 2;Aquatic Chronic 3,REACH registration C&L,51,H361:10;H412:10;H302:50;H318:10;H411:40;H319:41;H315:1
54445,4-[(3-methylphenyl)amino]pyridine-3-sulfonamide,615-805-8,72811-73-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,45,H315:4;H319:42;H335:4;Not classified:3
54455,1-bromonaphthalene-2-carbaldehyde,222-180-1,3378-82-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:40;H319:40;H335:38
54460,"Trisodium 5-amino-3-[[4'-[(7-amino-1-hydroxy-3-sulphonato-2-naphthyl)azo][1,1'-biphenyl]-4-yl]azo]-4-hydroxynaphthalene-2,7-disulphonate",219-384-8,2429-73-4,Eye Irrit. 2,Notified C&L,1,H319:1
54461,"11-cyclopropyl-4-methyl-5,11-dihydro-6H- dipyrido[3,2-b:2′,3′-e][1,4]diazepin-6-one",603-345-0,129618-40-2,Aquatic Chronic 3,Notified C&L,23,H412:22;H302:4;H361:1;H350:1
54462,2-p-tolylbenzoxazole,212-643-6,835-71-2,Not Classified,Notified C&L,31,Not classified:31
54464,1-[(4-chlorophenyl)sulfanyl]propan-2-one,607-811-4,25784-83-2,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,40,H315:40;H400:2;H319:2;H317:2;H410:2;H335:38;H302:38;H318:38
54466,5-phenylhydantoin,201-890-5,89-24-7,Acute Tox. 4;Repr. 2,Notified C&L,3,H361:3;H302:3
54467,"Alcohols, C16 (even numbered, C18 unsaturated), ethoxylated",614-341-3,68155-01-1,Flam. Liq. 2;Repr. 1A;STOT RE 2,Notified C&L,185,H373:156;H360:156;H225:156;H315:22;H302:4;H318:4;Not classified:3
54468,Sucrose distearate,248-317-5,27195-16-0,Not Classified,Notified C&L,37,Not classified:37
54471,"Butanoic acid, 3-oxo-, ethyl ester, polymer with 2,2-dimethyl-1,3-propanediol and 2-propanol aluminum salt",601-351-8,115271-29-9,Not Classified,Notified C&L,8,Not classified:8
54474,4-cyclohexylphenol,214-465-4,1131-60-8,Aquatic Chronic 2,REACH registration C&L,107,H411:69;H315:38;H400:38;H410:38;H318:72;H335:38
54476,"N-(2-methoxyethyl)-2,6-xylidine",256-626-1,50563-55-8,Acute Tox. 4,Notified C&L,156,H302:156
54477,Potassium sodium tartrate,206-156-8,304-59-6,Not Classified,REACH registration C&L,120,Not classified:120
54479,C,404-750-3,119415-07-5,Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H302:0;H314:0
54482,2-propylvaleric acid,202-777-3,99-66-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Repr. 1A,REACH registration C&L,283,H315:273;H302:283;H360:240;H318:172;H319:101;H335:40;H314:5;H332:1;H312:1
54485,3-(phenylmethyl)heptan-4-one,231-317-4,7492-37-7,Not Classified,Notified C&L,88,Not classified:88
54488,"Tricyclo[8.2.2.24,7]hexadeca-1(12),4,6,10,13,15-hexaene",216-644-2,1633-22-3,Skin Sens. 1B;STOT RE 2,REACH registration C&L,2,H373:2;H317:2
54489,"2,7,9-trimethylacridine-3,6-diamine monohydrochloride",224-148-2,4215-95-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H302:38;H335:38
54490,"reaction mass of: 1,5-bis[(2-ethylhexyl)amino]-9,10-anthracenedione;1-[(2-ethylhexyl)amino]-5-[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracenedione;1,5-bis[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracenedione;1-[(2-ethylhexyl)amino]-5-[(3-methoxypropyl)amino]-9,10-anthracene dione;1-[3-[(2-ethylhexyl)oxy]propyl]amino-5-[(3-methoxypropyl)amino]-9,10-anthracenedione;1,5-bis[(3-methyloxypropyl)amino]-9,10-anthracenedione",426-050-7,165038-51-7,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
54494,"(1R)-6,6-dimethylbicyclo[3.1.1]hept-2-ene-2-methanol",243-409-1,19894-97-4,Not Classified,Notified C&L,2,Not classified:2
54495,Guar gum,232-536-8,9000-30-0,Not Classified,Notified C&L,608,Not classified:543;H319:64;H412:1
54496,Cyclopenten-2-one,213-213-0,930-30-3,Flam. Liq. 3,Notified C&L,47,H226:47;H335:6;H315:2;H319:2;H302:3;H332:1;H314:1;H312:1
54498,Iso-Butylated Urea Formaldehyde Resin,614-201-1,68002-18-6,Aquatic Chronic 4,Notified C&L,288,H413:216;H411:71;H314:1
54499,Vanadium dioxide,234-841-1,12036-21-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,214,H315:213;H319:214;H330:4;H335:5;H301:4;H332:1;H413:1
54503,Tributylmethylammonium iodide,221-402-4,3085-79-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:38
54510,Diclofop,609-871-7,40843-25-2,Acute Tox. 4,Notified C&L,38,H302:38
54511,"1,3,5-triazine-2,4,6-triamine phosphate",255-449-7,41583-09-9,Not Classified,REACH registration C&L,157,Not classified:157
54513,"4-methoxy-2-nitrobenzenediazonium chloride, compound with zinc chloride",271-316-6,68540-81-8,Not Classified,Notified C&L,1,Not classified:1
54516,Sulfacetamide,205-640-6,144-80-9,Skin Sens. 1;STOT SE 3,Notified C&L,100,H335:91;H317:91;H341:5;Not classified:4;H302:1
54520,Triphenylacetic acid,209-873-4,595-91-5,Aquatic Chronic 4,Notified C&L,42,H413:40;H315:2;H319:2
54524,2-(formylamino)-3-thiophenecarboxylic acid;2-formamido-3-thiophenecarboxylic acid,431-930-9,43028-69-9,Acute Tox. 4;Skin Sens. 1,Harmonised C&L,0,H302:0;H317:0
54530,"Propane-1,2,3-triyl tridocosanoate",242-471-7,18641-57-1,Not Classified,Notified C&L,61,Not classified:61
54532,"1-(2-amino-5-chloro-phenyl)-2,2,2-trifluoro-ethane-1,1-diol;hydrochloride",605-687-6,173676-59-0,Skin Corr. 1C,Notified C&L,1,H314:1
54535,"Caesalpinia sappan, ext.",289-637-5,89958-14-5,Not Classified,Notified C&L,2,Not classified:2
54536,"1,1'-[but-2-yne-1,4-diylbis(oxy)]bispropan-2-ol",216-527-6,1606-87-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1;H312:1
54538,BENZANOL BRILLIANT YELLOW S,603-607-4,1324-96-5,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 4,Notified C&L,38,H302:38;H413:38;H317:38
54544,(1R-cis)-2-methyl-5-(1-methylvinyl)cyclohex-2-en-1-yl acetate,230-414-9,7111-29-7,Not Classified,Notified C&L,25,Not classified:25
54546,2-(biphenyl-4-yl)-5-phenyloxazole,212-711-5,852-37-9,Acute Tox. 3;Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,38,H319:38;H413:38;H301:38
54551,Tuaminoheptane,204-655-5,123-82-0,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H315:39;H319:39;H335:39;H226:46;H332:6;H314:7;H302:6;H312:6;H318:2;Not classified:1
54554,methyl 4-acetamido-5-iodo-2-methoxybenzoate,606-440-5,201214-53-1,Not Classified,REACH registration C&L,5,Not classified:4;H332:1;H302:1;H312:1
54557,"Tail gas (petroleum), catalytic cracked distillate and catalytic cracked naphtha fractionation absorber;Petroleum gas;[The complex combination of hydrocarbons from the distillation of the products from catalytic cracked distillates and catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.]",269-617-2,68307-98-2,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H350:0;Not classified:0;H220:0;H340:0
54560,"2-(3,4-Dimethoxyphenyl)-4,4-dimethyl-2-oxazoline",611-477-5,57193-17-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
54561,Perchloryl fluoride,231-526-0,7616-94-6,Ox. Gas 1;Acute Tox. 2,Notified C&L,1,H270:1;H330:1
54563,Octadecyl 12-hydroxyoctadecanoate,253-231-6,36826-83-2,Not Classified,Notified C&L,127,Not classified:127
54567,"Ethanol, 2,2'-[[4-[2-(2-bromo-6-chloro-4-nitrophenyl)diazenyl]-3-chlorophenyl]imino]bis-",602-298-3,12223-16-4,Not Classified,Notified C&L,1,Not classified:1
54570,Tolperisone,211-976-4,728-88-1,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2B;Acute Tox. 4;Aquatic Acute 2,REACH registration C&L,2,H332:2;H302:2;H312:2;H320:2;H401:2
54571,Heptyl isothiocyanate,224-610-3,4426-83-9,,Notified C&L,5,H332:5;H302:5;H312:5;H314:4;H315:1;H319:1;H335:1
54574,"3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl 3-dibutylaminopropionate",402-910-7,,Not Classified,Notified C&L,31,Not classified:31
54575,"3,7-dimethyl-6-octenyl phenylacetate",205-373-5,139-70-8,Not Classified,Notified C&L,90,Not classified:90
54576,"4-(trans-4-Ethylcyclohexyl)-2,3',4',5'-tetrafluorbiphenyl",605-735-6,174805-87-9,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
54580,thymol,201-944-8,89-83-8,Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H302:0;H314:0
54581,"Cyclohexanol, 4-(3-methylbutyl)-",686-263-8,830322-14-0,Aquatic Chronic 2,Notified C&L,40,H411:39;H315:13;H318:13;Not classified:1;H319:1
54583,Sodium hydroxy[2-hydroxy-5-nitro-3-[[2-oxo-1-(phenylcarbamoyl)propyl]azo]benzenesulphonato(3-)]chromate(1-),233-748-3,10343-58-5,Not Classified,Notified C&L,2109,Not classified:2107;H315:2;H319:2
54586,L-menthyl acetate,220-076-0,2623-23-6,Aquatic Chronic 2,REACH registration C&L,533,H411:530;Not classified:2;H315:2;H319:1;H317:1;H335:1
54592,"Glucanase, β-",232-979-7,9074-98-0,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,1289,H317:2;H334:1289
54595,"Benzenemethanol, 2,3-difluoro-",922-760-0,75853-18-8,,Notified C&L,4,H315:4;H319:4;H335:4
54596,3-methyl-1-phenylpyrazol-5-ylamine,214-463-3,1131-18-6,Aquatic Chronic 3,REACH registration C&L,58,H412:15;H315:41;H319:41;H335:40;H302:12;Not classified:2
54599,1-(2-hydroxy-4-methylphenyl)pentan-1-one,605-699-1,173851-66-6,Acute Tox. 4;Acute Tox. 4;Eye Dam. 1,Notified C&L,39,H302:38;H312:38;H318:38;H315:1;H319:1;H335:1
54600,(E)-octadec-11-en-9-ynoic acid,209-179-1,557-58-4,Not Classified,Notified C&L,1,Not classified:1
54601,"Amines, C8-18 and C18-unsatd. alkyl, ethoxylated",614-488-3,68439-72-5,Acute Tox. 4;Skin Corr. 1B,Notified C&L,25,H302:25;H314:25
54602,Tara gum,254-409-6,39300-88-4,Not Classified,REACH registration C&L,1,Not classified:1
54604,"(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoic acid",431-620-3,,Not Classified,REACH registration C&L,4,Not classified:1;H412:3;H318:3
54606,"3,5-bis(trifluoromethyl)benzenesulphonyl chloride",254-371-0,39234-86-1,Skin Corr. 1B,Notified C&L,48,H314:48;H290:1;H318:1;H319:1;H335:1
54609,"2,5,6-trimethylbenzothiazole",227-148-0,5683-41-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
54611,(methoxymethylene)malononitrile,211-597-4,672-81-1,Acute Tox. 3;Skin Sens. 1;Resp. Sens. 1,Notified C&L,1,H317:1;H334:1;H301:1
54615,Mecobalamin,236-535-3,13422-55-4,Not Classified,Notified C&L,6,Not classified:6
54618,"3,3'-oxybis(ethyleneoxy)bis(propylamine)",224-207-2,4246-51-9,Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,401,H318:190;H317:182;H314:395;H412:89;H290:12;Not classified:8;H319:3;H315:1
54619,Neomycin,215-766-3,1404-04-2,Repr. 2;STOT RE 2,Notified C&L,1,H361:1;H373:1
54621,deceth-4 phosphate,618-395-9,9004-80-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
54624,Rutoside,205-814-1,153-18-4,Not Classified,REACH registration C&L,55,Not classified:11;H315:40;H319:40;H335:40;H302:4
54625,"(2,2-diethoxyethoxy)benzene",251-041-8,32438-31-6,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
54626,N-methyl-N-(6-methylhept-5-en-2-yl)formamide,917-791-1,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1;H302:1
54627,"iodosulfuron-methyl-sodium;sodium ({}{[5-iodo-2-(methoxycarbonyl)phenyl]sulfonyl}}carbamoyl)(4-methoxy-6-methyl-1,3,5-triazin-2-yl)azanide",604-422-1,144550-36-7,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
54630,2-methylpyridine;2-picoline,203-643-7,109-06-8,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Harmonised C&L,0,H332:0;H319:0;H302:0;H312:0;H226:0;H335:0
54636,"Tar brown-coal;[An oil distilled from brown-coal tar. Composed primarily of aliphatic, naphthenic and one- to three-ring aromatic hydrocarbons, their alkyl derivates, heteroaromatics and one- and two-ring phenols boiling in the range of approximately 150 °C to 360 °C (302 °F to 680 °F).]",309-885-0,101316-83-0,Carc. 1A,Harmonised C&L,0,H350:0
54639,"1,3-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-, diazotized, coupled with diazotized 2-amino-4,6-dinitrophenol, diazotized 4-amino-5-hydroxy-2,7-naphthalenedisulfonic acid, diazotized 4-amino-3-methylbenzenesulfonic acid, diazotized 4-nitrobenzenamine and resorcinol, sodium salts",276-684-1,72480-09-2,Eye Irrit. 2,REACH registration C&L,16,H319:3;H412:11;Not classified:2
54640,"Fatty acids, C16-18, esters with sorbitol",276-951-2,72869-62-6,Not Classified,Notified C&L,61,Not classified:60;H412:1
54641,"Lyase, pectin",232-894-5,9033-35-6,Resp. Sens. 1,REACH registration C&L,10,H334:10;H317:1
54643,"cis,trans-hexa-1,4-diene",209-756-8,592-45-0,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H315:43;H319:43;H335:42;H225:46;H304:4
54649,Calcium selenide,215-141-5,1305-84-6,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1,Notified C&L,170,H400:170;H373:170;Not classified:170;H331:170;H410:170;H301:170
54650,4-hydroxypiperidinium chloride,226-374-7,5382-17-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:38
54653,4-chloropyridine hydrochloride,230-946-1,7379-35-3,Eye Irrit. 2,REACH registration C&L,95,H319:92;H315:47;H302:55;H335:44;H301:1;H332:1
54660,"Fuel oil, heavy, high-sulfur;Heavy Fuel oil;[A complex combination of hydrocarbons obtained by the distillation of crude petroleum. It consists predominantly of aliphatic, aromatic and cycloaliphatic hydrocarbons having carbon numbers predominantly higher than C",295-396-7,92045-14-2,Carc. 1B,Harmonised C&L,0,H350:0
54661,"2-hydroxy-1-(1H-imidazol-1-yl)-2,2-diphenylethanone",604-951-8,15441-11-9,Not Classified,REACH registration C&L,2,Not classified:2
54662,N-(3-aminophenyl)propionamide,245-369-0,22987-10-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
54666,"bis(2-ethylhexyl) (4-hydroxy-3,5-dimethoxybenzyl)malonate",471-510-2,,Not Classified,Notified C&L,1,Not classified:1
54667,Lead dipicrate,229-335-2,6477-64-1,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H332:1;H360:1;H400:1;H373:1;H302:1;H410:1
54669,3-Iodo-4-methylbenzoic acid,617-423-7,82998-57-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H315:46;H319:46;H335:45
54670,N-(4-Fluorophenyl)-2-hydroxy-N-(1-methylethyl) acetamide,611-084-9,54041-17-7,Acute Tox. 4;Eye Irrit. 2;Repr. 2;Aquatic Chronic 3,REACH registration C&L,2,H361:2;H319:2;H302:2;H412:2
54671,Bis(4-nonylphenyl) tridecyl phosphite,284-120-0,84787-78-0,Skin Irrit. 2,Notified C&L,1,H315:1
54673,C.I. Reactive Orange 91,618-723-0,91254-18-1,Not Classified,Notified C&L,1,Not classified:1
54676,"zinc hexacyanocobaltate(III), tertiary butyl alcohol/polypropylene glycol complex",425-240-7,,Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H318:0
54678,2-chloromethyl-p-xylene,212-529-6,824-45-3,Skin Corr. 1B;STOT SE 3,Notified C&L,45,H335:39;H314:45;H290:1;H318:1;H227:1
54683,"Sodium 4-[[3-[(dimethylphenyl)azo]-2,4-dihydroxyphenyl]azo]benzenesulphonate",215-296-9,1320-07-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H315:40;H319:40;H335:38;Not classified:5;H412:1
54685,"1H-1,4,7-Triazonine, octahydro-1,4,7-tris[(4-methylphenyl)sulfonyl]-",610-880-3,52667-89-7,Not Classified,REACH registration C&L,1,Not classified:1
54689,"3-acetyl-6-methyl-2H-pyran-2,4(3H)-dione;dehydracetic acid",208-293-9,520-45-6,Acute Tox. 4,Harmonised C&L,0,H302:0
54692,"4,5-dihydroxyimidazolidin-2-one",223-070-6,3720-97-6,,Notified C&L,2,Not classified:1;H315:1;H319:1
54693,5-chloro-o-anisidine,202-385-2,95-03-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,88,H315:56;H332:49;H319:56;H302:80;H312:49;H335:51;H412:31;H373:5;H311:8;H301:8;H331:4
54695,"Naphthalene-2,6-dicarboxylic acid",214-527-0,1141-38-4,Not Classified,REACH registration C&L,15,Not classified:13;H315:2;H319:2
54696,4-chloro-6-nitro-o-cresol,217-165-1,1760-71-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H332:1;H319:1;H302:1;H312:1;H335:1
54697,LEPTOSPERMUM SCOPARIUM OIL,425-630-7,223749-44-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:2;H302:2
54702,N'-nitro-N-nitroso-N-propylguanidine,235-856-6,13010-07-6,Flam. Sol. 1;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Carc. 1B,Notified C&L,38,H315:38;H335:38;H350:38;H319:38;H311:38;H331:38;H228:38;H301:38
54703,allyl alcohol,203-470-7,107-18-6,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Aquatic Acute 1,Harmonised C&L,0,H315:0;H225:0;H400:0;H319:0;H311:0;H331:0;H335:0;H301:0
54706,Tetrabutylammonium tetrafluoroborate,207-058-8,429-42-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,96,H315:92;H319:53;H335:91;H302:44;H318:39;H314:2;H410:1;H331:1;H311:1;H301:1;Not classified:1
54711,Oxalic [2H]acid,218-181-1,2065-73-8,Acute Tox. 4;Acute Tox. 4;Eye Dam. 1,Notified C&L,38,H302:38;H312:38;H318:38
54714,1-ethyl-2-methyl-1H-benzimidazol-5-amine dihydrochloride,277-568-3,73688-69-4,Eye Dam. 1,Notified C&L,38,H318:38
54715,Bis(isocyanatomethyl)cyclohexane,255-693-4,42170-25-2,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 3;Resp. Sens. 1;STOT SE 3,Notified C&L,75,H315:75;H319:70;H302:70;H317:75;H334:74;H331:55;H335:68;H330:20;H370:5;H412:5;H318:5;H372:5
54716,Disilver selenide,215-099-8,1302-09-6,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H400:38;H373:38;H331:38;H410:38;H301:38
54720,"Carbamic acid, [(1S,2R)-2-hydroxy-3-[(2-methylpropyl)[(4-nitrophenyl)sulfonyl]amino]-1-(phenylmethyl)propyl]-, 1,1-dimethylethyl ester",467-070-6,,Not Classified,REACH registration C&L,3,Not classified:3
54721,"Vanilla fragrans, ext.",283-521-8,84650-63-5,Skin Sens. 1,Notified C&L,1532,H317:1498;H226:100;H319:18;H225:6;Not classified:5;H315:1;H335:1
54724,"Pyranthrene-8,16-dione",204-906-9,128-70-1,Aquatic Chronic 4,Notified C&L,49,H413:38;Not classified:11
54726,Nandrolone,207-101-0,434-22-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,43,H332:40;H302:42;H312:40;H341:1;H351:1;H360:1;H372:1
54727,2-Formamidothiazole-4-acetylchloridehydrochloride,441-820-2,,Acute Tox. 4;Skin Corr. 1C;Aquatic Chronic 3,Notified C&L,1,H412:1;H302:1;H314:1
54728,"Methyl 2,4-dihydroxy-m-toluate",251-618-4,33662-58-7,Not Classified,Notified C&L,151,Not classified:77;H315:39;H319:39;H302:39;H335:39;H317:35
54729,"thiometon (ISO);S-2-ethylthioethyl O,O-dimethyl phosphorodithioate",211-362-6,640-15-3,Acute Tox. 3;Acute Tox. 4,Harmonised C&L,0,H312:0;H301:0
54730,"8-(2,2-dimethoxyethoxy)-2,6-dimethyloct-2-ene",255-564-2,41847-86-3,Not Classified,REACH registration C&L,12,Not classified:12
54733,"(S)-p-mentha-1,8-diene;l-limonene",227-815-6,5989-54-8,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H315:0;H400:0;H317:0;H226:0;H410:0
54738,Ethyl dichloroacetate,208-611-6,535-15-9,Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H319:38;H312:38;H332:38;H335:38
54741,"Disodium 2,5-dichloro-4-[4-[[5-[[(dodecyloxy)carbonyl]amino]-2-sulphonatophenyl]azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonate",276-127-2,71873-51-3,Skin Sens. 1B;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,44,H400:44;H319:4;H317:4;H410:44
54744,"Isooctadecanoic acid, monoester with propane-1,2-diol",269-027-5,68171-38-0,Not Classified,REACH registration C&L,22,Not classified:22
54745,(1α5α6α)-6-nitro-3-benzyl-3-azabicyclo[3.1.0]hexane methanesulfonate salt,426-740-8,,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H302:0;H318:0
54747,5-nitro-2-furaldehyde,211-816-3,698-63-5,Flam. Sol. 1;Skin Irrit. 2;Eye Irrit. 2;Muta. 2;STOT SE 2,REACH registration C&L,49,H315:4;H371:2;H335:3;H319:3;H341:7;H228:44
54748,2-diphenylphosphinobenzoic acid,241-293-7,17261-28-8,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;STOT RE 1;Aquatic Chronic 2,REACH registration C&L,51,H332:46;H373:5;H411:5;H302:6;H317:5;H372:5;H315:46;H319:46;H335:45;H331:1
54753,"4,4'-(vinylene-1,2-diyl)biscyclohexene",241-526-2,17527-28-5,,Notified C&L,38,Not classified:38
54754,"Distillates (petroleum), hydrodesulfurized light catalytic cracked;Cracked gasoil;[A complex combination of hydrocarbons obtained by treating light catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C",269-781-5,68333-25-5,Carc. 1B,Harmonised C&L,0,H350:0
54758,Sodium dioxoarsenate,232-070-5,7784-46-5,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Carc. 1A;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,115,H350:112;H400:94;H300:90;H310:91;H311:72;H331:115;H410:113;H301:77;Not classified:1;H412:1;H411:1;H312:1;H372:1
54761,"2,4-dichloro-1-naphthol",218-103-6,2050-76-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:38
54767,"Distillates (petroleum), steam-cracked;Cracked kerosine;[A complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C",265-194-3,64742-91-2,Asp. Tox. 1,Harmonised C&L,0,H304:0
54769,"2,4,6-trimethylcyclohex-3-enecarbaldehyde",215-833-7,1423-46-7,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,180,H315:28;H319:142;H412:142;H317:142;H400:38;H334:38
54770,"Nitriles, tallow",263-120-4,61790-28-1,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 3,Notified C&L,59,H315:59;H410:34;H400:59;H412:33
54771,7-isopropyl-4-methyloxepan-2-one,207-882-8,499-54-7,Not Classified,Notified C&L,88,Not classified:88
54772,1-(chloromethoxy)-2-methylpropane,251-864-2,34180-11-5,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B;STOT SE 3,Notified C&L,1,H335:1;H302:1;H314:1;H226:1
54773,"Oils, animal, sulfonated, sodium salts",305-979-0,95371-11-2,Not Classified,REACH registration C&L,33,Not classified:31;H315:2;H319:2
54775,"Cyclohepta-1,3-diene",223-762-8,4054-38-0,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,38,H304:38;H225:38
54776,[(2-aminoethyl)amino]lithium,217-429-6,1847-46-7,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1B,Notified C&L,26,H302:26;H225:26;H314:26
54781,Ethyl 5-methyl-1-phenyl-1H-pyrazole-4-carboxylate,289-479-7,89193-16-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H332:1;H319:1;H302:1;H312:1;H335:1
54789,Somatotropin (human),235-735-8,12629-01-5,Acute Tox. 3;Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Repr. 2,Notified C&L,30,H332:29;H361:30;H312:29;H317:29;H301:29
54790,Ethyldimethyl[3-[(1-oxooctadecyl)amino]propyl]ammonium ethyl sulphate,267-360-0,67846-16-6,Acute Tox. 4;Eye Dam. 1,Notified C&L,8,H302:8;H318:8
54791,"P,P'-dimethyl dihydrogen diphosphate",247-871-5,26644-00-8,Skin Corr. 1B,Notified C&L,121,H314:76;H317:40;H301:40;Not classified:5
54796,Iron cobalt black spinel,269-102-2,68187-50-8,Not Classified,REACH registration C&L,315,Not classified:263;H302:52;H317:52
54800,(1S)-3-(methylamino)-1-(2-thienyl)propan-1-ol,601-437-5,116539-55-0,Acute Tox. 4;Skin Corr. 1A;Aquatic Chronic 3,Notified C&L,40,H412:36;H302:37;H314:36;Not classified:2;H332:1;H318:1;H315:2;H319:2;H335:1
54802,"4-(trans-4-Propylcyclohexyl)-2,3',4',5'-tetrafluorbiphenyl",605-697-0,173837-35-9,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
54806,"2,2',2''-nitrilotriethanol citrate",249-576-7,29340-81-6,Not Classified,REACH registration C&L,600,Not classified:33;H319:567;H412:567
54808,"Gases (petroleum), catalytic-cracked naphtha debutanizer bottoms, C3-5-rich;Petroleum gas;[A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]",270-754-5,68477-72-5,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H350:0;Not classified:0;H220:0;H340:0
54809,"Copper hydroxide sulfate (Cu4(OH)6(SO4)), hydrate (1:[?])",682-362-5,12527-76-3,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,258,H400:258;H410:256;H302:258;H411:1
54812,Propanesulphonyl chloride,233-414-7,10147-36-1,Skin Corr. 1B;Eye Irrit. 2A,REACH registration C&L,44,H319:41;H314:44;H341:1;H290:1;H318:1
54815,"Trans 2,6,6-trimethyl-3-cyclohexen-1-yl]trichloroethanone",918-495-5,,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,1,H315:1;H304:1;H225:1;H411:1;H336:1
54817,"1,3-dinitrobenzene",202-776-8,99-65-0,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H330:0;H400:0;H373:0;H300:0;H310:0;H410:0
54821,"Fatty acids, coco, reaction products with wheat protein hydrolyzates, potassium salts",605-258-3,161572-19-6,Not Classified,Notified C&L,1,Not classified:1
54822,BUTYLATED FORMALDEHYDE UREA RESIN,614-202-7,68002-19-7,Aquatic Chronic 4,Notified C&L,318,H413:242;H411:74;H412:1;Not classified:1
54824,"7-[(5-chloro-2,6-difluoro-4-pyrimidinyl)amino]-4-hydroxy-3-[(4-methoxy-2-sulphophenyl)azo]naphthalene-2-sulphonic acid, sodium salt",286-839-5,85391-83-9,Skin Sens. 1B;Resp. Sens. 1,REACH registration C&L,46,H317:46;H334:46
54825,2-(2-hexyldecyloxy)benzamide,431-230-3,202483-62-3,Aquatic Chronic 4,Harmonised C&L,0,H413:0
54830,"(1-phenylethyl)[1-(3,4-xylyl)ethyl]benzene",260-626-7,57213-94-2,Not Classified,Notified C&L,12,Not classified:12
54831,"1,2-dibromo-4,5-difluorobenzene",265-021-1,64695-78-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H315:46;H319:46;H335:45;H226:38;H228:3
54835,Lycorine,207-503-6,476-28-8,Acute Tox. 3,Notified C&L,1,H301:1
54841,"2-Pyridinecarboxamide, 4-chloro-N-methyl-",606-888-1,220000-87-3,,Notified C&L,8,H315:8;H319:8;H335:7;H332:2;H302:2;H312:2
54843,"1H-1,2,4-triazole, sodium salt",255-280-9,41253-21-8,Acute Tox. 4;Eye Dam. 1;Repr. 2,REACH registration C&L,179,H361:138;H302:138;H318:138;H315:41;H319:41;H335:40;H412:34
54847,"(2E,4E,7S)-11-methoxy-3,7,11-trimethyldodeca-2,4-dienoic acid, ammonium salt (1:1)",619-006-5,942519-41-7,Not Classified,REACH registration C&L,2,Not classified:2
54848,5-nitro-2-(2-methyl-4-(diethylamino)phenylazo)thiazole,435-600-5,,Flam. Sol. 1;Skin Sens. 1B,REACH registration C&L,476,H228:30;H317:476;H373:3;H319:3;H413:3
54851,"sulfosulfuron (ISO);1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethylsulfonylimidazo[1,2-a]pyridin-3-yl)sulfonylurea",604-251-2,141776-32-1,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
54852,"Phosphonium, [(2E,4E)-5-[(4R)-4-hydroxy-2,6,6-trimethyl-1-cyclohexen-1-yl]-3-methyl-2,4-pentadienyl]triphenyl-, chloride",616-370-7,76686-31-2,Acute Tox. 3,REACH registration C&L,1,H301:1
54854,barium calcium cesium lead samarium strontium bromide chloride fluoride iodide europium doped,431-780-4,199876-46-5,Acute Tox. 4;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H373:0;H302:0
54855,"1,3,5-trichloro-2,4,6-trifluorobenzene",206-273-4,319-88-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:43;H319:43;H335:43
54857,Heptadecan-9-one,208-734-5,540-08-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
54861,"1,4,7,10-tetraoxacyclododecane-2-methanol",278-224-5,75507-26-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:44;H319:44;H335:43
54862,"methyl (7R,10S,13S,17R)-10,13-dimethyl-3,5'-dioxospiro[2,6,7,8,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthrene-17,2'-oxolane]-7-carboxylate",619-164-5,95716-70-4,Not Classified,REACH registration C&L,2,Not classified:2
54867,Aluminium tristearate,211-279-5,637-12-7,Not Classified,REACH registration C&L,422,Not classified:419;H315:3;H319:3;H335:3
54868,"Tar, coal, high-temp., residues;Coal Tar Solids Residue;[Solids formed during the coking of bituminous coal to produce crude bituminous coal high temperature tar. Composed primarily of coke and coal particles, highly aromatized compounds and mineral substances.]",309-726-5,100684-51-3,Carc. 1B,Harmonised C&L,0,H350:0
54874,3-iodophenol,210-923-2,626-02-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H315:45;H319:45;H335:44
54875,"3S)-TETRAHYDRO-3-FURANYL [(1S,2R)-2-HYDROXY-3-[(2-METHYLPROPYL)[(4-NITROPHENYL )SULFONYL]AMINO]-1-(PHENYLMETHYL)PROPYL]CARBAMATE",605-202-8,160231-69-6,Aquatic Chronic 1,Notified C&L,1,H410:1
54882,"2-(Diphenylmethyl)-1-azabicyclo[2,2,2]octan-3-one",608-752-7,32531-66-1,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H315:1;H410:1;H400:1
54883,4-hydroxy-3-pyridinesulphonic acid,257-243-2,51498-37-4,Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,10,H318:2;H314:6;H319:4;H315:2;H332:1;H302:1;H312:1;H335:1
54888,Chlorodifluoromethane,200-871-9,75-45-6,Press. Gas (Liq.),REACH registration C&L,325,H280:231;H059:88;Not classified:60;H420:75;H302:25;H361:10;H336:1
54891,"Dodecylbenzenesulphonic acid, compound with 2-aminoethanol (1:1)",248-024-2,26836-07-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,136,H315:97;H319:36;H302:86;Not classified:44;H318:81;H412:21;H314:20;H335:25;H312:1
54895,Droperidol,208-957-8,548-73-2,Acute Tox. 4,Notified C&L,39,H302:39;H332:1;H312:1
54896,"α,2-pyridyl-2,8-bis(trifluoromethyl)quinoline-4-acetonitrile",280-130-4,83012-12-8,Acute Tox. 3;Aquatic Chronic 4,Notified C&L,38,H413:38;H301:38
54898,"Glutamyltransferase, γ-",232-931-5,9046-27-9,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,47,H315:38;H319:38;H335:38;H334:47
54899,IN2-(benzyloxycarbonyl)-N6-(tert-butoxycarbonyl)-L-lysine,219-223-1,2389-60-8,Not Classified,Notified C&L,3,Not classified:3
54902,4-(1-phenylethyl)-m-xylene,228-202-6,6165-52-2,Not Classified,Notified C&L,1,Not classified:1
54903,"N,N'-ethylenedianiline",205-765-6,150-61-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:39;H319:39;H335:38;H332:5;H302:5;H312:5
54914,"2,4-Difluoro-3-(trifluoromethoxy)aniline",620-086-9,153338-24-0,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H332:1;H319:1;H302:1;H311:1;H335:1
54915,"Dihydro-3-(tripropenyl)furan-2,5-dione",295-556-6,92077-08-2,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1A;Eye Dam. 1;STOT RE 2,Notified C&L,34,H315:34;H373:34;H302:34;H318:34;H317:34
54918,Tungsten disulphide,235-243-3,12138-09-9,Not Classified,REACH registration C&L,118,Not classified:38;H315:80;H319:80;H335:80
54923,"bisphenol A;4,4’-isopropylidenediphenol",201-245-8,80-05-7,Eye Dam. 1;Skin Sens. 1;STOT SE 3;Repr. 1B,Harmonised C&L,0,H335:0;H318:0;H360:0;H317:0
54929,tetraammonium 5-(4-(7-amino-1-hydroxy-3-sulfonato-2-naphthylazo)-6-sulfonato-1-naphthylazo)isophthalate,405-130-5,128351-36-0,Skin Sens. 1,Harmonised C&L,0,H317:0
54932,"1,2-dibutoxyethane",203-976-8,112-48-1,Eye Irrit. 2,Notified C&L,3,H319:2;Not classified:1
54934,3-methyl-1-phenyl-5-pyrazolone,201-891-0,89-25-8,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,216,H315:101;H411:11;H317:134;H412:86;H319:48;H302:54;H335:55;H413:35;Not classified:15;H371:1
54936,"Soaps, stocks, corn-oil, acidulated, hydrogenated",296-497-9,92704-63-7,Not Classified,Notified C&L,1,Not classified:1
54939,Sodium diisobutyldithiophosphinate,236-419-2,13360-78-6,Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,15,H318:15;H317:15
54940,Morpholine hydrochloride,233-029-4,10024-89-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:43;H319:43;H312:42;H335:43;H413:1;H302:1
54944,"Resin acids and Rosin acids, fumarated, sodium salt",269-227-2,68201-59-2,Not Classified,Notified C&L,52,Not classified:30;H317:22
54948,Phosphocreatine,200-643-9,67-07-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
54953,Lithium tetradeuteridoaluminate,237-980-6,14128-54-2,Water-react. 1;Acute Tox. 3;Skin Corr. 1A,Notified C&L,46,H260:45;H314:45;H301:38;H224:4;H302:4;H336:4;H261:1
54954,"Distillates (petroleum), cracked, ethylene manuf. by-product, C9-10 fraction",305-586-4,94733-07-0,Flam. Liq. 3;Acute Tox. 4;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;STOT SE 3;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,152,H315:145;H332:23;H304:62;H340:127;H350:135;H400:38;H319:62;H410:38;H351:20;H361:113;H302:42;H372:28;H226:126;H335:24;H336:22;H373:100;H411:107;H331:4;H341:4;Not classified:1
54958,Chromium methacrylate complexes~,601-030-2,111031-82-4,Skin Sens. 1;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,13,H400:13;H410:13;H317:13;H350:13
54959,"Oils, neat's-foot, sulfated, sodium salts",262-999-1,61788-70-3,Not Classified,Notified C&L,6,Not classified:3;H319:3
54960,N-ethyltoluene-2-sulphonamide,214-073-3,1077-56-1,Not Classified,Notified C&L,54,Not classified:33;H311:18;H412:1;H302:1;H319:2;H315:1;H335:1
54963,"O,O-dihexyl hydrogen dithiophosphate",201-129-7,78-64-8,Not Classified,Notified C&L,1,Not classified:1
54965,"4-chloro-1,2-dihydro-1-phenylpyridazine-3,6-dione",216-919-7,1698-55-1,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
54968,"Commiphora myrrha, ext.",284-510-0,84929-26-0,Flam. Liq. 3;Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,103,H412:7;H302:84;H226:8;Not classified:18;H304:4;H315:1;H317:1;H410:1
54970,6-hydroxy-1H-pyrimidin-4-one,214-772-3,1193-24-4,Not Classified,REACH registration C&L,82,Not classified:37;H315:45;H319:45;H335:44
54971,4-[[4-(hexyloxy)benzylidene]amino]benzonitrile,252-486-0,35280-78-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1;H302:1
54972,Tienilic acid,254-826-3,40180-04-9,STOT SE 3,Notified C&L,1,H335:1
54973,Cyclooctylamine,226-694-7,5452-37-9,Skin Corr. 1B,Notified C&L,44,H314:44;H318:1;H227:1
54976,"2-amino-6-methyl-4-propyl-1,2,4-triazolo[1,5-a]pyrimidin-5(4H)-one",248-383-5,27277-00-5,Aquatic Chronic 3,REACH registration C&L,91,H412:2;H301:89
54978,"3,4-dimethylcyclopentane-1,2-dione",236-810-8,13494-06-9,Not Classified,Notified C&L,1453,Not classified:1451;H302:2;H315:1;H319:1
54980,"7-[4-(diethylamino)-2-ethoxyphenyl]-7-(1-ethyl-2-methyl-1H-indol-3-yl)furo[3,4-b]pyridin-5(7H)-one",274-194-2,69898-40-4,Not Classified,Notified C&L,1,Not classified:1
54981,Nicotinaldehyde O-propyloxime,228-437-4,6267-23-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
54982,Ethyl 1-methylpiperidine-2-carboxylate,250-311-2,30727-18-5,Skin Corr. 1B,Notified C&L,40,H314:39;H315:1;H319:1;H318:1
54985,"Disodium 3-[[4'-[(6-amino-1-hydroxy-3-sulphonato-2-naphthyl)azo]-3,3'-dimethyl[1,1'-biphenyl]-4-yl]azo]-4-hydroxynaphthalene-1-sulphonate",219-383-2,2429-72-3,Skin Sens. 1;Carc. 2,Notified C&L,16,H351:16;H317:16
54987,1-aminopyridinium iodide,228-566-6,6295-87-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:44;H319:44;H335:43
54988,Bis(methacryloyloxyethyl) hydrogen phosphate,251-040-2,32435-46-4,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,650,H315:632;H319:618;H412:443;H335:80;H317:48;Not classified:16;H318:16;H314:2
54989,3-dodecyldihydrofuran-2(3H)-one,277-333-5,73263-36-2,Not Classified,Notified C&L,88,Not classified:88
54994,N-(2-Amino-4-chlorophenyl)anthranilic acid,614-200-6,67990-66-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
54995,"(9Z,12Z,15Z)-1,1,3,3-tetrabutyl-1,3-bis(octadeca-9,12,15-trienoyloxy)distannoxane",305-141-4,94349-25-4,Muta. 2;Repr. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,55,H360:55;H400:55;H341:55;H372:55;H410:55
54997,"Butanedioic acid, sulfo-, 4-[2-[(2-hydroxyethyl)amino]ethyl] ester, N-C18-unsatd. acyl derivs., disodium salts",308-072-8,97862-28-7,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,39,H315:39;H319:39;H412:1
55000,"Terpenes and Terpenoids, turpentine-oil residues",273-108-0,68938-00-1,Not Classified,Notified C&L,89,Not classified:88;H315:1;H332:1;H304:1;H319:1;H411:1;H302:1;H312:1;H317:1;H226:1
55001,Levomepromazine hydrochloride,214-978-3,1236-99-3,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,26,H411:25;H302:26;H317:25;H319:1
55002,Talc (Mg3H2(SiO3)4),238-877-9,14807-96-6,Not Classified,REACH registration C&L,4649,Not classified:4441;H350:52;H332:98;H319:65;H372:33;H302:6;H335:6;H331:1
55003,DL-threonine,201-300-6,80-68-2,Not Classified,Notified C&L,127,Not classified:109;H315:18;H319:18;H302:18;H335:18
55004,(4-tolylsulphonyl)acetic acid,223-518-0,3937-96-0,,Notified C&L,7,H315:7;H319:7;H335:6
55009,"Residues (petroleum), vacuum, light;Heavy Fuel oil;[A complex residuum from the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C",292-658-2,90669-76-4,Carc. 1B,Harmonised C&L,0,H350:0
55010,"5,5-dibutyl-3,3,7,7-tetramethoxy-2,4,6,8-tetraoxa-3,7-disila-5-stannanonane",302-825-4,94134-56-2,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1;Acute Tox. 4;Muta. 2;Repr. 1B;STOT SE 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H332:1;H360:1;H370:1;H400:1;H341:1;H314:1;H302:1;H317:1;H372:1;H226:1;H410:1
55011,"Pyroligneous acids, hickory",277-726-1,74113-74-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1450,H315:1338;H319:1338;H314:112;H318:36
55013,"Disulfide, bis(4-fluorophenyl)",609-845-5,405-31-2,,Notified C&L,4,H315:4;H319:4;H335:4
55014,6-bromohexanonitrile,229-570-0,6621-59-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H315:45;H319:45;H335:40;H332:5;H302:5;H312:5;Not classified:2
55015,Etamivan,206-157-3,304-84-7,Acute Tox. 3,Notified C&L,40,H301:40
55018,Cholest-5-ene-3-beta-yl benzoate,210-064-3,604-32-0,Not Classified,Notified C&L,2,Not classified:2
55019,4-methoxyphenethylamine,218-066-6,2045-79-6,Skin Corr. 1B,Notified C&L,100,H314:99;H318:40;Not classified:1
55020,"2,6-Octadienal, 3,7-dimethyl-, acid-isomerized",291-768-8,90480-35-6,Flam. Liq. 2;Skin Irrit. 2;Skin Sens. 1B;Repr. 2;Aquatic Chronic 2,REACH registration C&L,1632,H315:1593;H225:1541;H361:12;H411:12;H317:1349;H412:1586;H319:224;Not classified:33;H226:56
55025,"1,2-dihydro-3H-1,2,4-triazol-3-one",213-214-6,930-33-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,9,H315:7;H319:7;H302:7;H411:2;H318:2;H360:2
55027,Diisopropylcyanamide,221-401-9,3085-76-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H315:39;H332:39;H319:39;H302:39;H312:39;H335:38
55028,Alpha-cyano-m-hydroxycinnamic acid,259-289-9,54673-07-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H315:39;H332:39;H319:39;H302:39;H312:39;H335:38
55029,"1,2,3,4-tetrahydro-1,5-dimethylnaphthalene",244-446-6,21564-91-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
55030,"Pyridine-3,4-dicarbonitrile",216-645-8,1633-44-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42,H315:42;H332:38;H319:42;H302:42;H312:38;H335:42
55042,"Rape oil, sulfurized",268-883-7,68153-37-7,Not Classified,Notified C&L,648,Not classified:648
55043,"Silicic acid, sodium salt",215-687-4,1344-09-8,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,3841,H315:2778;H318:2307;Not classified:326;H319:1066;H335:1721;H314:718;H290:486;H302:971;H317:1;H332:2;H400:3;H410:2;H350:1;H312:1
55044,Hydroxybutyl methacrylate,249-808-7,29721-79-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:39
55047,Thiobenzamide,218-765-6,2227-79-4,Acute Tox. 3,Notified C&L,45,H301:45;H315:1;H332:1;H319:1;H335:1
55051,"omethoate (ISO);O,O-dimethyl S-methylcarbamoylmethyl phosphorothioate",214-197-8,1113-02-6,Acute Tox. 3;Acute Tox. 4;Aquatic Acute 1,Harmonised C&L,0,H400:0;H312:0;H301:0
55055,5-(aminosulphonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide monohydrochloride,245-826-4,23694-14-6,Not Classified,REACH registration C&L,3,Not classified:3
55058,2-Chloro-4-(trifluoromethyl)pyridine,617-242-3,81565-18-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,203,H315:203;H319:203;H335:202;H332:6;H302:7;H312:7;H226:9;H301:1;H331:1
55063,Tetraphenyltin,209-872-9,595-90-4,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,78,H400:75;H311:78;H331:71;H410:75;H301:78;H330:7
55065,Sulfamethizole,205-641-1,144-82-1,Skin Sens. 1,Notified C&L,76,H317:75;H315:2;H319:2;H335:1
55069,"2,2'-but-2-ynylenedioxydiethanol",216-526-0,1606-85-5,Acute Tox. 4,Notified C&L,103,H302:63;H315:38;H319:39;H335:38;Not classified:2
55071,PEG-8 laurate,618-396-4,9004-81-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,229,H315:170;H319:170;H302:170;H335:170;Not classified:59
55076,5-FLUORO-2-METHYLPHENOL,610-240-3,452-85-7,,Notified C&L,10,H302:7;H312:7;H314:7;H315:3;H319:3;H335:3;H318:1;H227:1
55077,"N,N-dimethylpyridin-2-amine",227-147-5,5683-33-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:44;H319:44;H335:43;H302:5;H332:1;H312:1;H226:1
55079,L-(+)-α-phenylglycine,220-909-8,2935-35-5,Not Classified,Notified C&L,3,Not classified:1;H315:2;H319:2;H335:2
55082,Triethyl trithioorthoformate,228-439-5,6267-24-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H315:2;H319:2;H335:1
55084,Oligomycin,215-767-9,1404-19-9,Acute Tox. 4,Notified C&L,2,H302:1;H370:1;H301:1
55085,"Methylium, bis[4-(dimethylamino)phenyl][4-(ethylamino)-3- methylphenyl]-, acetate",615-715-9,72102-66-0,Acute Tox. 4;Eye Dam. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,83,H400:83;H302:83;H318:83;H372:83;H410:83
55086,"(1S,4R,6R,7R)-(4-nitrophenylmethyl)3-methylene-1-oxo-7-phenylacetamido-cepham-4-carboxylateido-penam-3-carboxylate",412-800-0,76109-32-5,Resp. Sens. 1,Harmonised C&L,0,H334:0
55089,"Hydrocarbons, C13-C16, isoalkanes, cyclics, <2% aromatics",918-973-3,,Asp. Tox. 1,REACH registration C&L,1,H304:1
55090,Undecan-6-one,213-150-9,927-49-1,Not Classified,Notified C&L,5,Not classified:5
55093,"2-Pentanone, 4-methyl-, peroxide",253-396-4,37206-20-5,Org. Perox. D;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 3,Notified C&L,9,H315:9;H319:8;H302:9;H317:9;H331:8;H242:9;H332:1;H318:1
55099,"solvent naphtha (petroleum), medium aliph.;Straight run kerosine;[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140 °C to 220 °C (284 °F to 428 °F).]",265-191-7,64742-88-7,Asp. Tox. 1;STOT RE 1,Harmonised C&L,0,H304:0;H372:0
55100,Copper titanium trioxide,234-641-4,12019-08-8,Not Classified,Notified C&L,1,Not classified:1
55101,3-phenylpropyl isovalerate,226-692-6,5452-07-3,Not Classified,Notified C&L,2,Not classified:2
55102,3-oxo-4-aza-5α-androstane-17β-carboxylic acid,407-820-1,103335-55-3,Aquatic Chronic 3,REACH registration C&L,4,H412:1;H361:3;H373:1;H302:1
55104,N-[3-(dodecylamino)propyl]glycine hydrochloride,298-216-5,93778-80-4,Not Classified,Notified C&L,11,Not classified:11
55108,N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-(ethylsulphonyl)-2-methoxybenzamide monohydrochloride,245-829-0,23694-17-9,Acute Tox. 4,Notified C&L,1,H302:1
55109,"Glycerides, tallow mono-, sulfosuccinates, sodium salts",263-197-4,61791-65-9,Not Classified,Notified C&L,2,Not classified:2
55110,p-menth-4(8)-en-3-one,201-943-2,89-82-7,Acute Tox. 4,Notified C&L,336,H302:325;H411:11;H304:11;H317:11;H226:11;Not classified:2;H351:1;H412:1
55111,Ammonium 2-ethylhexyl sulphate,274-625-4,70495-37-3,Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,2,H318:2;H314:2
55113,"N,N,N-trimethyltetradecan-1-aminium oxalate",453-080-8,154858-16-9,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1A;Aquatic Acute 1;Aquatic Chronic 4,REACH registration C&L,33,H400:33;H413:2;H314:33;H302:33;H317:33;H410:33
55114,1-(2-bromo-5-fluorophenyl)ethan-1-one,600-114-6,1006-33-3,,Notified C&L,2,H332:1;H302:1;H312:1;H315:1;H319:1;H335:1
55116,S-benzylthiouronium chloride,208-688-6,538-28-3,Acute Tox. 2,Notified C&L,45,H300:45
55118,"2-((3,5-dimethylhex-3-en-2-yl)oxy)-2-methylpropan-1-ol",614-096-2,676532-52-8,Not Classified,REACH registration C&L,2,Not classified:2
55120,PIGMENT RED 3092C,419-370-3,,Not Classified,REACH registration C&L,85,Not classified:85
55133,"Philadelphus coronarius, ext.",304-839-6,94279-93-3,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,1,H319:1;H226:1
55136,"Quaternary ammonium compounds, C12-18-alkyltrimethyl, chlorides",269-922-0,68391-03-7,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1,Notified C&L,31,H400:31;H302:31;H314:31;H318:28
55139,Benzyl(hexadecyl)bis(2-hydroxypropyl)ammonium chloride,265-537-7,65151-48-6,Skin Corr. 1B;Aquatic Chronic 2,Notified C&L,1,H411:1;H314:1
55140,"2,6-dimethyloctane, hexadehydro derivative",249-805-0,29714-87-2,Skin Irrit. 2,Notified C&L,51,H315:38;H304:13
55142,Leishman's stain,235-732-1,12627-53-1,Eye Irrit. 2,Notified C&L,2,H319:2
55144,"3,5-dimethyl-1-phenyl-1H-pyrazole",214-462-8,1131-16-4,Acute Tox. 4,Notified C&L,41,H302:39;H315:3;H332:1;H319:3;H312:1;H335:2
55146,2-[bis(phenylmethyl)amino]ethanol,202-911-0,101-06-4,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1,Notified C&L,41,H400:41;H302:41;H314:41
55147,"Endo-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl formate",231-319-5,7492-41-3,Not Classified,Notified C&L,88,Not classified:88
55149,2-[(3-butyl-1-isoquinolyl)oxy]ethyl(dimethyl)ammonium chloride,220-468-1,2773-92-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;Not classified:1;H302:1;H312:1
55155,3-bromo-4-fluorobenzoyl chloride,211-596-9,672-75-3,Skin Corr. 1B,Notified C&L,1,H314:1
55156,Chlorodimethyloctadecylsilane,242-472-2,18643-08-8,Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,57,H318:5;H314:53;Not classified:5;H228:1;H335:2;H290:1
55158,"N,N''-(4-methyl-m-phenylene)bis[N',N'-dimethylurea]",241-523-6,17526-94-2,Not Classified,REACH registration C&L,70,Not classified:68;H413:2
55160,"disodium (E)-1,2-bis-(4-(4-methylamino-6-(4-methylcarbamoylphenylamino)-1,3,5-triazin-2-ylamino)phenyl-2-sulfonato)ethene",427-310-2,180850-95-7,Eye Dam. 1,Harmonised C&L,0,H318:0
55161,Linalyl octanoate,233-026-8,10024-64-3,Not Classified,Notified C&L,280,Not classified:280
55162,Z-78,482-050-7,,Eye Dam. 1;Aquatic Chronic 4,Notified C&L,442,H318:442;H413:442
55163,formaldehyde …%,200-001-8,50-00-0,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 3;Muta. 2;Carc. 1B,Harmonised C&L,0,H350:0;H341:0;H314:0;H317:0;H311:0;H331:0;H301:0
55167,"Phosphoric acid, mono- and di-C6-10-alkyl esters",269-616-7,68307-94-8,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,252,H315:2;H319:2;H318:164;H314:244;Not classified:6
55169,(E)-chalcone,210-383-8,614-47-1,Acute Tox. 4;Eye Irrit. 2;STOT SE 3,Notified C&L,131,H319:131;H302:131;H335:131;H315:4
55171,"Chromate(4-), [2-hydroxybenzoato(2-)-O1,O2][4-hydroxy-3-[(2-hydroxy-5-nitro-3-sulfophenyl)azo]-6-[(3-sulfophenyl)amino]-2-naphthalenesulfonato(5-)]-, potassium sodium",604-203-0,140835-91-2,,Notified C&L,33,Not classified:33
55173,"Lauric acid, monoester with propane-1,2-diol",248-315-4,27194-74-7,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,256,H400:38;H410:37;H401:2;Not classified:218
55174,[4-[(4-aminocyclohexyl)methyl]cyclohexyl]carbamic acid,236-239-4,13253-82-2,Acute Tox. 4,Notified C&L,20,H302:19;H315:2;H319:2;H335:2;Not classified:1
55177,Dititanium tris(sulphate),233-749-9,10343-61-0,Not Classified,REACH registration C&L,10,Not classified:6;H314:4
55180,"S-(2,5-dimethyl-3-furyl) ethanethioate",259-799-1,55764-22-2,Not Classified,Notified C&L,88,Not classified:88
55183,2-methylpiperazine,203-644-2,109-07-9,Flam. Sol. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H315:41;H228:48;H335:41;H319:41;H314:8;H318:2
55185,"2,4-dichloro-3,5-dinitrobenzoic acid",258-136-3,52729-03-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
55189,"(1,1'-biphenyl)sodium",225-894-1,5137-46-2,Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H400:38;H410:38;H314:39;H318:1
55192,"3,3-bis(4-hydroxy-1-naphthyl)phthalide",209-875-5,596-01-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
55194,"Linseed oil, polymer with maleic anhydride, methanol and soybean oil",609-320-0,369376-14-7,Not Classified,Notified C&L,71,Not classified:71
55195,"3,6-Acridinediamine, N6,N6,2-trimethyl-, monohydrochloride",611-093-8,5409-37-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H315:38;H400:38;H319:38;H410:38;H302:38;H335:38
55196,"(2E,6Z)-nona-2,6-dien-1-al",209-178-6,557-48-2,Skin Irrit. 2;Skin Sens. 1B,Notified C&L,1519,H315:1400;H317:1408;Not classified:105;H319:33;H335:5
55197,"N,N'-ethylenebis[N-(carboxymethyl)aminoacetic] acid, potassium salt",230-943-5,7379-27-3,Eye Irrit. 2;Acute Tox. 4;Repr. 2,Notified C&L,108,H361:83;H319:108;H332:83;H302:25;H412:25
55198,4-nitrophenyl isocyanate,202-836-3,100-28-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3,Notified C&L,48,H315:48;H332:43;H319:48;H302:47;H334:46;H335:48;H331:4
55200,2-chloro-6-methoxy-3-nitropyridine,253-989-8,38533-61-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H315:42;H319:42;H335:41
55201,"dinocap (ISO);(RS)-2,6-dinitro-4-octylphenyl crotonates and (RS)-2,4-dinitro-6-octylphenyl crotonates in which “octyl” is a reaction mass of 1-methylheptyl, 1-ethylhexyl and 1-propylpentyl groups",254-408-0,39300-45-3,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Acute Tox. 4;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H315:0;H332:0;H360:0;H400:0;H373:0;H302:0;H317:0;H410:0
55205,"4,6-diphenyl-1,3,5-triazin-2(1H)-one",606-251-8,1917-44-8,Aquatic Chronic 2,REACH registration C&L,85,H411:85
55206,LITSEA CUBEBA OIL,614-741-8,68855-99-2,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,168,H315:167;H304:92;H400:85;H317:115;H226:125;H410:60;H319:69;H411:69;Not classified:1
55213,"Silver, acetylacetone 6-methyl-2,4-heptanedione complexes",306-127-0,96152-54-4,Pyr. Sol. 1,Notified C&L,1,H250:1
55214,"Siloxanes and Silicones, di-Me, 3-(2-oxiranylmethoxy)propyl group- terminated",620-296-0,102782-97-8,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,30,H315:28;H319:28;H317:28;H334:3;Not classified:2
55218,Ethyl 2-chloropropionate,208-610-0,535-13-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,78,H315:77;H319:77;H335:76;H226:78
55219,3-Decanol,605-062-8,1565-81-7,Eye Irrit. 2,Notified C&L,1,H319:1
55221,Decahydro-2-naphthyl isobutyrate,267-506-3,67874-78-6,Not Classified,Notified C&L,88,Not classified:88
55224,"5-bromobenzo-1,3-dioxole",220-123-5,2635-13-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H315:45;H319:45;H335:44
55227,mix-cresol,215-293-2,1319-77-3,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B,Harmonised C&L,0,H314:0;H311:0;H301:0
55229,"5',5'''-[ethylenebis(p-phenyleneazo)]bis[1',2'-dihydro-6'-hydroxy-4'-methyl-2'-oxo-1,3'-bipyridinium] dilactate",275-139-5,71032-99-0,Eye Dam. 1,REACH registration C&L,40,H318:2;H373:2;H412:2;Not classified:37
55234,"1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecaboylic acid",619-317-6,98079-51-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1;H312:1
55235,4'-Fluoro-3'-methoxyacetophenone,613-561-7,64287-19-0,,Notified C&L,7,H315:7;H319:7;H335:7
55239,"Sodium 1-(carboxymethyl)-4,5-dihydro-1-(2-hydroxyethyl)-2-undecyl-1H-imidazolium hydroxide",248-028-4,26837-33-2,Eye Irrit. 2,Notified C&L,2,H319:2
55241,4-isopropyl-1-methylcyclohexene,226-841-5,5502-88-5,Flam. Liq. 3;Asp. Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,13,H304:13;H400:13;H411:2;H226:13;H410:13
55243,4-ethyl-5-methylthiazole,257-904-5,52414-91-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,88,H315:88;H319:88;H302:88;H335:88
55244,Psilocybine,208-294-4,520-52-5,Acute Tox. 4,Notified C&L,1,H302:1
55248,"3-(3,4-dimethoxyphenyl)propionic acid",218-288-3,2107-70-2,,Notified C&L,5,H315:5;H319:5;H335:5
55250,"Nigella sativa, ext.",290-094-1,90064-32-7,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,2,H315:1;H304:1;H411:1;H317:2;H226:1;H412:1
55251,"Tar acids, brown-coal, crude;Crude Phenols;[An acidified alkaline extract of brown coal tar distillate. Composed primarily of phenol and phenol homologs.]",309-888-7,101316-86-3,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
55253,"[(2-Hydroxyethylsulphamoyl)(sulphamoyl)(sulphophthalocyaninato)]copper(II), mixed isomers, sodium salt.",456-310-5,,Eye Dam. 1,Notified C&L,1,H318:1
55257,"Di(methyl)[1-methyl-3,3-diphenylallyl]ammonium chloride",259-432-5,55011-89-7,Acute Tox. 3,Notified C&L,39,H301:39;Not classified:1;H332:1
55258,"Bis[hydrogen [4-[4-(diethylamino)-5'-hydroxy-2',4'-disulphonatobenzhydrylidene]cyclohexa-2,5-dien-1-ylidene]diethylammonium], calcium salt",222-573-8,3536-49-0,Not Classified,REACH registration C&L,160,Not classified:160
55259,"Bis[5'α-benzyl-9,10α-dihydro-12'-hydroxy-2'-methylergotaman-3',6',18-trione] [R-(R*,R*)]-tartrate",227-816-1,5989-77-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H332:38;H302:38;H312:38;H331:1;H311:1;H301:1
55261,"(2,3,5,6-2H4)terephthalic acid",262-050-1,60088-54-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
55264,"1,2,4-benzotriazin-3-amine 1-oxide",226-559-2,5424-06-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H315:38;H335:38;H302:38;H318:38
55265,"cis,trans-hexa-1,3-diene",209-759-4,592-48-3,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:38;H319:38;H335:38;H225:39;H304:1
55266,C.I. Acid Black 194,612-717-1,61931-02-0,Aquatic Chronic 2,Notified C&L,93,H411:84;Not classified:8;H315:1;H319:1
55267,Methyl thenoate,226-371-0,5380-42-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H315:1;H319:1;H335:1;H332:1;H302:1;H312:1
55268,Silver (II) oxide,215-098-2,1301-96-8,Ox. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,77,H315:41;H272:45;H335:40;H319:41;Not classified:32;H314:4
55270,"Gases (petroleum), catalytic reformed straight-run naphtha stabilizer overheads;Refinery gas;[A complex combination of hydrocarbons obtained from the catalytic reforming of straight-run naphtha followed by fractionation of the total effluent. It consists of hydrogen, methane, ethane and propane.]",270-999-8,68513-14-4,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H350:0;Not classified:0;H220:0;H340:0
55274,4-phenyl-5-tetradecylthiazol-2-amine,264-881-5,64415-14-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
55275,"Methyl 2,5-Dibromobenzoate",611-518-7,57381-43-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:43;H319:43;H335:42
55279,"Chlorinated 2,8-dimethylphenoxathiin",922-625-6,,Not Classified,Notified C&L,1,Not classified:1
55281,Methanetrisulphonic acid,259-097-5,54322-33-7,Not Classified,REACH registration C&L,2,Not classified:2
55284,"2-amino-N,3-dimethylbenzamide",617-960-7,870997-57-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H302:1;H335:1
55287,"Tris(2,4-ditert-butylphenyl) phosphite",250-709-6,31570-04-4,Not Classified,REACH registration C&L,1352,Not classified:1219;H412:110;H312:68;H413:16;H411:5;H315:3;H319:2
55288,2-chlorophenyl isocyanate,222-023-7,3320-83-0,Skin Corr. 1C;Skin Sens. 1A;Eye Dam. 1;Acute Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,49,H330:45;H400:5;H314:49;H318:6;H317:44;H410:5;H411:5;H334:6
55290,Chroman-4-one,207-736-3,491-37-2,,Notified C&L,2,H315:2;H319:2;H335:2
55292,"N-(4,5-dihydro-5-thioxo-1,3,4-thiadiazol-2-yl)acetamide",251-275-0,32873-56-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H315:2;H319:2;H335:1;H302:1;H334:1
55293,1-iododecane,218-104-1,2050-77-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,45,H315:44;H319:45;H335:39;H413:38;H332:1;H302:1;H312:1
55299,"4,4'-(propane-1,3-diyl)bis(1-methylpiperidine)",264-717-2,64168-11-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H315:38;H319:42;H335:42;H373:4
55302,"6,7,8,9,10,11-hexahydro-N,N-dimethyl-5H-cyclooct[b]indole-5-propylamine monohydrochloride",243-819-0,20432-64-8,,Notified C&L,1,H302:1
55303,(-)-α-methoxy-α-(trifluoromethyl)phenylacetic acid,241-292-1,17257-71-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:44;H319:44;H335:43
55307,"Mannich reaction product of diethylaminopropyl amine, nonylphenol, neodecanoic acid, oxiranylmethyl ester and formaldehyde",928-204-3,,Not Classified,Notified C&L,71,Not classified:71
55308,"Phenol, 2-ethoxy-4-(methoxymethyl)-",447-640-0,5595-79-9,Acute Tox. 4;Skin Sens. 1,Notified C&L,1311,H302:1311;H317:1311
55311,"2-chloro-4,6-xylidine",263-896-4,63133-82-4,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Carc. 2,Notified C&L,38,H315:38;H319:38;H351:38;H311:38;H331:38;H335:38;H301:38
55319,N-(3-(trimethoxysilyl)propyl)ethylenediamine,217-164-6,1760-24-3,Skin Sens. 1B;Eye Dam. 1;Acute Tox. 4;STOT RE 2,REACH registration C&L,1736,H373:47;H318:1018;H332:552;H317:1202;H335:39;Not classified:533;H315:490;H302:196;H412:405;H314:130;H411:151;H319:75;H334:18;H413:1
55321,But-3-yn-2-one,215-834-2,1423-60-5,Flam. Liq. 2;Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H315:47;H225:46;H319:43;H300:47;H335:46;H318:4;H330:2;H310:2;H226:1
55324,1-butyl-2-methylpyridinium bromide,402-680-8,26576-84-1,Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H302:0
55331,Thiethylperazine di(hydrogen maleate),214-648-9,1179-69-7,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,5,H400:4;H410:5;H302:5
55332,"Willow, Salix nigra, ext.",283-522-3,84650-64-6,Not Classified,Notified C&L,3,Not classified:3
55333,[No public or meaningful name is available],686-229-2,924626-15-3,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,25,H400:25;H410:25
55335,"[1S-(1α,2β,5α)]-[[5-methyl-2-(1-methylethyl)cyclohexyl]oxy]acetic acid",302-700-4,94133-41-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
55341,"Phosphoric acid, di-C8-18-alkyl esters, sodium salts",286-287-5,85203-95-8,Not Classified,Notified C&L,1,Not classified:1
55342,Tetrabutylammonium perchlorate,217-655-5,1923-70-2,Ox. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:43;H272:43;H335:42;H319:43
55345,Allyldichlorosilane,223-515-4,3937-28-8,,Notified C&L,1,H225:1;H314:1
55347,"Ethyl 2-amino-6-[(4-fluorobenzyl)amino]pyridine-3-carbamate, compound with maleic acid (1:1)",278-225-0,75507-68-5,Acute Tox. 4,Notified C&L,16,H302:16;H332:1
55348,"Sulfonic acids, C14-18-alkane hydroxy and C12-20-alkapolyene and C14-18-alkene and C12-20-alkene hydroxy, sodium salts",273-105-4,68937-98-4,Acute Tox. 4;Skin Sens. 1B;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,2,H319:1;H412:1;H302:1;H318:1;H317:1;Not classified:1
55353,"3-ethyl-2-[3-[3-[(3-ethyl-3H-benzothiazol-2-ylidene)methyl]-5,5-dimethylcyclohex-2-en-1-ylidene]prop-1-enyl]benzothiazolium iodide",281-047-6,83846-69-9,Not Classified,Notified C&L,1,Not classified:1
55355,"(1R, 3r, 5S)-3-hydroxyspiro[8-azoniabicyclo[3.2.1]octane-8,1’-pyrrolidinium]chloride",609-015-2,3464-71-9,Not Classified,REACH registration C&L,2,Not classified:2
55356,"Distillates (petroleum), solvent-refined hydrocracked light;Baseoil - unspecified;[A complex combination of hydrocarbons obtained by solvent dearomatization of the residue of hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",305-589-0,94733-09-2,Carc. 1B,Harmonised C&L,0,H350:0
55357,Carbetocin,253-312-6,37025-55-1,Skin Sens. 1;Repr. 2,Notified C&L,1,H361:1;H312:1;H332:1;H317:1
55358,[No public or meaningful name is available],453-170-7,,Not Classified,Notified C&L,1,Not classified:1
55360,(S)-3-Methyl-1-(2-piperidinophenyl)-1-butylamine,604-603-5,147769-93-5,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,1,H411:1;H302:1;H318:1
55361,"Propanoic acid, 2-bromo-, octyl ester, branched, reaction products with 4,4',4''-(1,3,5-triazine-2,4,6-triyl)tris[1,3-benzenediol]",439-020-3,,Not Classified,Notified C&L,1,Not classified:1
55366,"(3,4-diethoxyphenyl)acetonitrile",248-479-7,27472-21-5,Not Classified,REACH registration C&L,3,Not classified:1;H315:2;H319:2;H335:2;H332:1;H302:1;H312:1
55368,4-diethylaminobutyronitrile,226-259-1,5336-75-4,Acute Tox. 4,Notified C&L,38,H302:38
55370,"3-nitro-α,α,α,4-tetrafluorotoluene",206-702-5,367-86-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H315:47;H319:47;H335:41;H226:42;H332:5;H302:6;H311:5
55372,Isopropyl 4-hydroxybenzoate,224-069-3,4191-73-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,118,H315:32;H319:67;H317:2;H302:38;H318:39;Not classified:12;H335:6
55374,"1-(4-Hydroxyphenyl)heptane-1,3-dione",927-036-8,,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Acute Tox. 3;Aquatic Chronic 1,REACH registration C&L,1,H302:1;H312:1;H317:1;H331:1;H410:1;H313:1
55375,"monuron (ISO);3-(4-chlorophenyl)-1,1-dimethylurea",205-766-1,150-68-5,Acute Tox. 4;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H351:0;H410:0;H302:0;H400:0
55378,Bezafibrate,255-567-9,41859-67-0,Repr. 2,Notified C&L,105,H361:62;H302:53;H412:9;H373:1
55379,"Hydrocarbons, C11-C12, isoalkanes, < 2% aromatics",928-773-8,,Flam. Liq. 3;Asp. Tox. 1;Aquatic Chronic 4,Notified C&L,1,H304:1;H413:1;H226:1
55380,Lead silicate,245-090-4,22569-74-0,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Chronic 1,Notified C&L,1,H332:1;H360:1;H400:1;H373:1;H260:1;H302:1;H410:1
55381,Oct-7-enal,244-449-2,21573-31-9,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,2,H315:1;H318:1;H317:1;H226:2
55389,N-(4'-methoxybenzylidene)-4-butylaniline,247-527-4,26227-73-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:38
55391,Prop-2-ynyl benzenesulphonate,228-203-1,6165-75-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H315:44;H319:44;H335:44;H314:1
55396,"Chromate(5-), [6-(acetylamino)-4-hydroxy-3-[(2-hydroxy-5-nitro-3-sulfophenyl)azo]-2-naphthalenesulfonato(4-)][4-hydroxy-6-[(2-hydroxy-5-methylphenyl)azo]-3-[(2-hydroxy-5-nitro-3-sulfophenyl)azo]-2-naphthalenesulfonato(4-)]-, pentahydrogen",272-801-5,68912-09-4,Not Classified,Notified C&L,6,Not classified:6
55399,"1,2-bis(2-methoxyethoxy)ethane;TEGDME;triethylene glycol dimethyl ether;triglyme",203-977-3,112-49-2,Repr. 1B,Harmonised C&L,0,H360:0
55401,9H-Fluorene-9-acetic acid,613-090-7,6284-80-6,,Notified C&L,4,H315:4;H319:4;H335:4
55402,"Foots oil (petroleum), hydrotreated",295-394-6,92045-12-0,Carc. 1B,Harmonised C&L,0,H350:0
55403,Disperse Yellow 114,612-898-7,61968-66-9,Aquatic Chronic 4,Notified C&L,40,H413:32;Not classified:8
55404,Tetraethylammonium tetrafluoroborate,207-055-1,429-06-1,Eye Irrit. 2,REACH registration C&L,131,H319:128;H315:127;H332:126;H410:84;H302:127;H312:126;H335:127;Not classified:2;H314:1;H318:1
55406,Lomustine,235-859-2,13010-47-4,Acute Tox. 3;Carc. 1B,Notified C&L,41,H350:41;H301:41;H371:1;H370:1;H360:3;H340:3;H373:1;H372:2;H311:1;H331:1;H335:1
55408,Cinchonidine sulphate,208-362-3,524-61-8,Acute Tox. 4,Notified C&L,1,H302:1
55409,"4,4'-isopropylidenedicyclohexanol",201-244-2,80-04-6,Aquatic Chronic 3,REACH registration C&L,77,H412:10;H319:52;Not classified:13;H335:2;H318:2;H317:2
55411,Dioctadecyl ether,228-567-1,6297-03-6,Not Classified,REACH registration C&L,85,Not classified:85
55414,(6R-trans)-7-amino-3-[[[5-(carboxymethyl)-4-methyl-2-thiazolyl]thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,619-847-8,111298-82-9,Skin Sens. 1;Resp. Sens. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H317:1;H334:1
55415,Potassium hydrogen 4-sulphonatobenzoate,226-435-8,5399-63-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H315:42;H319:42;H335:42
55417,3-ethyl-3-[(2-ethylhexyloxy)methyl]oxetane,445-460-7,,Skin Corr. 1C;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H400:1;H410:1;H314:1;H315:1;H411:1
55421,5-bromovaleric acid,218-185-3,2067-33-6,Acute Tox. 4;Skin Corr. 1C,REACH registration C&L,55,H302:6;H314:14;H315:41;H319:41;H335:41;Not classified:1;H290:1;H318:1
55430,"4,5-bis(hydroxymethyl)-2-phenyl-1H-imidazole",262-911-1,61698-32-6,Acute Tox. 4,Notified C&L,89,H302:89;H319:35
55434,Methylphenylcarbamoyl chloride,224-288-4,4285-42-1,Skin Corr. 1B;Eye Dam. 1;STOT SE 3,Notified C&L,39,H335:39;H318:38;H314:39
55435,Tremella fuciformis mushroom extract,616-532-7,778577-37-0,Skin Irrit. 2,Notified C&L,1,H315:1
55437,5-Hydroxynicotinic Acid,622-583-6,27828-71-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H315:47;H319:47;H335:46;H332:1;H302:1;H312:1
55438,N-phenyl-N-[1-(phenylmethyl)-4-piperidinyl]acetamide,214-979-9,1237-52-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,38,H315:38;H400:38;H319:38;H302:38;H335:38
55439,Tricosan-12-one,208-735-0,540-09-0,Not Classified,Notified C&L,20,Not classified:20
55440,"1-hydroxybenzotriazole, monohydrated ;1-hydroxybenzotriazole, anhydrous",219-989-7,2592-95-2,Expl. 1.3,Harmonised C&L,0,H203:0
55441,"2-Oxazolidinone, 3-[(2S,4R)-4-bromo-2-(1-methylethyl)-1-oxo-4-[(2S,4S)-tetrahydro-4-(1-methylethyl)-5-oxo-2-furanyl]butyl]-4-(phenylmethyl)-(4S)",605-664-0,173154-00-2,Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,83,H319:83;H413:83
55442,"Proteinase, Aspergillus neutral",278-588-5,77000-13-6,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1,Notified C&L,25,H315:25;H319:25;H334:25
55443,"Phenol, 2,4-dinitro-, sulfurized",215-444-2,1326-82-5,Not Classified,Notified C&L,74,Not classified:38;H314:33;H315:3;H319:3
55446,"3,7-dihydro-7-methyl-1H-purine-2,6-dione",209-019-0,552-62-5,,Notified C&L,1,H302:1
55447,"N'-(ethylcarbonimidoyl)-N,N-dimethylpropane-1,3-diamine monohydrochloride",247-361-2,25952-53-8,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,249,H315:160;H400:27;H302:77;H317:40;H311:27;H410:27;H319:110;H373:8;Not classified:90;H335:132;H318:31;H334:8;H332:2;H312:2;H412:1
55448,Isopropylsulphonyl chloride,233-415-2,10147-37-2,Skin Corr. 1B,Notified C&L,45,H314:45;H290:1;H318:1
55452,3-dimethylaminobenzoic acid,202-775-2,99-64-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H315:41;H319:41;H335:40;H302:1
55460,Hexylbenzene,214-070-7,1077-16-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,45,H315:42;H319:42;H400:38;H335:42;Not classified:3
55462,5-chloropyridin-2-ol,224-146-1,4214-79-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:44;H319:44;H335:43
55467,"1,4-bis(p-tolylamino)anthraquinone",204-909-5,128-80-3,Not Classified,REACH registration C&L,2918,Not classified:2853;H315:61;H319:61;H335:58;H351:3;H373:3;H341:3;H317:3
55469,"Neodecanoic acid, zirconium salt",254-259-1,39049-04-2,Not Classified,REACH registration C&L,20,Not classified:20
55470,Hexamethylenediaminetetraacetic acid,216-642-1,1633-00-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,99,H315:99;H319:99;H335:98
55472,polyacrylate ester based on c16-18 fatty alcohols,610-908-4,52880-57-6,Eye Irrit. 2;STOT SE 3,Notified C&L,145,H319:112;H335:112;Not classified:33
55473,phosgene;carbonyl chloride,200-870-3,75-44-5,Press. Gas;Skin Corr. 1B;Acute Tox. 2,Harmonised C&L,0,Not classified:0;H314:0;H330:0
55474,"Quaternary ammonium compounds, (hydrogenated tallow alkyl)trimethyl, chlorides, compds. with bentonite",268-880-0,68153-34-4,Not Classified,Notified C&L,4,Not classified:2;H373:2
55475,Menthyl formate,218-768-2,2230-90-2,,Notified C&L,1,Not classified:1
55482,"Ethanol, 2,2'-iminobis-, N-[3-(branched tridecyloxy)propyl] derivs., N-oxides",270-831-3,68478-66-0,Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,18,H410:17;H317:18;H314:18;H411:1
55483,"2,4-dichlorobenzylamine",202-382-6,95-00-1,Skin Corr. 1B,Notified C&L,45,H314:45;H318:2
55484,4-(4-methylphenyl)phenol,607-882-1,26191-64-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3;Aquatic Chronic 2,Notified C&L,1,H315:1;H319:1;H411:1;H302:1;H335:1
55488,1-bromo-2-methoxyethane,229-339-4,6482-24-2,Flam. Liq. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H315:49;H319:49;H226:49;H335:48;H301:41;H302:1
55493,"Guanidine, cyano-, reaction products with formaldehyde",291-370-4,90387-93-2,Not Classified,Notified C&L,6,Not classified:6
55494,Chlorphenesin,203-192-6,104-29-0,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,389,H315:272;H319:222;Not classified:61;H335:137;H302:107;H318:46;H332:38;H312:1
55496,Trichloromethylgermane,213-604-6,993-10-2,,Notified C&L,4,H225:4;H314:4
55497,"Butanedioic acid, sulfo-, 4-[2-[(2-hydroxyethyl)amino]ethyl] ester, N-coco acyl derivs., disodium salts",308-071-2,97862-27-6,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H315:1;H319:1;H412:1
55501,Fluoren-2-ylamine,205-817-8,153-78-6,,Notified C&L,6,H351:4;H341:4;H315:1;H332:1;H319:1;H302:2;H312:1;H335:1
55503,"Gases (petroleum), C2-3-;Petroleum gas;[A complex combination of hydrocarbons produced by the distillation of products from a catalytic fractionation process. It contains predominantly ethane, ethylene, propane, and propylene.]",270-751-9,68477-70-3,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H350:0;Not classified:0;H220:0;H340:0
55508,Methyl 3-oxooctadecanoate,238-555-8,14531-34-1,Not Classified,REACH registration C&L,5,Not classified:5
55509,"triclosan;2,4,4'-trichloro-2'-hydroxy-diphenyl-ether;5-chloro-2-(2,4-dichlorophenoxy)phenol",222-182-2,3380-34-5,Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H315:0;H319:0;H400:0;H410:0
55510,"3,7-dimethyl-2-methyleneocta-6-enal",244-981-5,22418-66-2,Not Classified,Notified C&L,234,Not classified:234
55515,"L-Aspartic acid, N,N'-1,2-ethanediylbis-, sodium salt (1:3)",416-530-4,178949-82-1,Not Classified,Notified C&L,1,Not classified:1
55516,LAC TECH,479-140-3,144093-88-9,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,14,H315:14;H318:14;H317:14;H226:14
55519,"Protein hydrolyzates, cottonseed",309-350-1,100209-42-5,Not Classified,Notified C&L,17,Not classified:17
55522,Dioctyl adipate,204-652-9,123-79-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,69,H315:41;H319:41;Not classified:28
55523,"Slack wax (petroleum), acid-treated;[A complex combination of hydrocarbons obtained as a raffinate by treatment of a petroleum slack wax fraction with sulfuric acid treating process. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C",292-659-8,90669-77-5,Carc. 1B,Harmonised C&L,0,H350:0
55525,"Di-tert-butyl 1,1,4,4-tetramethyltetramethylene diperoxide",201-128-1,78-63-7,Org. Perox. C;Skin Irrit. 2,REACH registration C&L,400,H315:383;H242:310;H319:135;H220:52;H280:52;H226:62;H413:22
55526,"2-(2,6-dichlorophenoxy)propionic acid",246-650-0,25140-90-3,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H331:1;H311:1;H301:1
55533,4-(trifluoromethyl)benzophenone,211-974-3,728-86-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:44;H319:44;H335:44
55536,Solvent Red 122,602-483-9,12227-55-3,Not Classified,Notified C&L,10,Not classified:5;H411:5;H302:2
55542,"Spruce, Picea mariana, ext.",294-420-3,91722-19-9,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1,Notified C&L,333,H304:331;H317:332;H226:285;H400:98;H410:101;H411:47;H315:22;H319:24;H302:1
55543,3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylic acid,700-093-4,176969-34-9,Not Classified,REACH registration C&L,201,Not classified:43;H302:158;H315:2;H319:2;H335:2;H332:1
55547,"Disodium 5,5'-dimethyl-4,4'-bis[[2-oxo-1-[(phenylamino)carbonyl]propyl]azo][1,1'-biphenyl]-2,2'-disulphonate",219-386-9,2429-76-7,Not Classified,Notified C&L,5,Not classified:5
55548,"3,5-dinitrobenzoic acid",202-751-1,99-34-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,REACH registration C&L,109,H315:105;H319:108;H413:95;H302:108;H335:105;H228:5;H332:2;H317:1
55550,Naphazoline,212-641-5,835-31-4,Not Classified,REACH registration C&L,2,Not classified:2
55551,Acetoacetanilide,202-996-4,102-01-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;STOT RE 2,REACH registration C&L,487,H332:421;H373:420;H302:474;H312:459;Not classified:12;H372:11;H311:11;H341:1
55554,"Cabbage, ext.",289-635-4,89958-13-4,Eye Irrit. 2,Notified C&L,37,H319:25;Not classified:11;H226:1
55555,"2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11-icosafluoroundecyl acrylate",225-659-3,4998-38-3,,Notified C&L,4,H315:4;H319:4;H335:4
55557,"3,5-dimethylcyclopentane-1,2-dione",236-811-3,13494-07-0,Acute Tox. 4,Notified C&L,1599,H302:1599
55559,2-ethylbutyryl chloride,220-359-9,2736-40-5,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,46,H314:46;H226:43;H302:1;H290:2;H330:1;H301:1
55562,N-cyclohexyl-2-pyrrolidone,229-919-7,6837-24-7,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,131,H302:131;H312:131;H314:129;H318:87;H315:2;H332:1;H412:1;H319:1;H331:1
55563,3-methyl-1-isobutylbutyl acetate,233-588-4,10250-45-0,Aquatic Chronic 3,REACH registration C&L,1376,H412:2;Not classified:1374
55564,"β-Alanine, N-(3-ethoxy-3-oxopropyl)-N-methyl-, ethyl ester",613-167-5,6315-60-2,Skin Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1,H315:1;H411:1
55571,Trimethyl orthobenzoate,211-897-5,707-07-3,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,REACH registration C&L,56,H315:54;H319:55;H335:55;Not classified:1
55574,(3-methacrylamidopropyl)trimethylammonium chloride,257-182-1,51410-72-1,Not Classified,REACH registration C&L,108,Not classified:64;H315:44;H319:44;H335:44
55576,5-chloropyridin-3-ol,277-727-7,74115-12-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H315:45;H319:45;H335:44
55577,"N,N'-[dithiobis[2-(2-hydroxyethyl)-1-methylvinylene]]bis[N-[(4-amino-2-methyl-5-pyrimidinyl)methyl]formamide",200-644-4,67-16-3,Not Classified,REACH registration C&L,2,Not classified:2
55581,"Bis(1-phenylbutane-1,3-dionato-O,O')cobalt",237-981-1,14128-95-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H315:38;H332:38;H319:38;H302:38;H312:38;H335:38
55582,Diethoxymethylphenylsilane,212-275-6,775-56-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:44;H319:44;H335:39
55585,"4-(1(or 4 or 5 or 6)-methyl-8,9,10-trinorborn-5-en-2-yl)pyridine, reaction mass of isomers",402-520-7,125352-06-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H315:0;H400:0;H302:0;H312:0;H317:0;H410:0
55588,Cycloheptylamine,226-693-1,5452-35-7,Flam. Liq. 3;Skin Irrit. 2;STOT SE 3,Notified C&L,45,H315:38;H335:39;H226:44;H314:6;H318:1;Not classified:1
55589,sodium polysulphides,215-686-9,1344-08-7,Acute Tox. 3;Skin Corr. 1B;Aquatic Acute 1,Harmonised C&L,0,H400:0;H314:0;H301:0
55591,1-(1-isocyanato-1-methylethyl)-3-(1-methylethenyl)benzene,606-676-9,2094-99-7,Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Acute Tox. 2;Resp. Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,108,H330:108;H400:108;H373:108;H314:108;H318:56;H334:108;H317:108;H410:108
55601,4-methylnonan-1-oic acid,256-180-8,45019-28-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1444,H315:1311;H319:1311;H314:132;H317:38;H318:37;Not classified:1;H290:1
55602,2-allyloxymethyl-2-ethylpropanediol,211-662-7,682-11-1,Not Classified,REACH registration C&L,604,Not classified:117;H315:487;H319:487;H335:487
55603,(3-ammonio-4-methoxyphenyl)(2-hydroxyethyl)ammonium sulphate,280-734-8,83763-48-8,Acute Tox. 4;Skin Sens. 1A;Eye Irrit. 2A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,142,H400:13;H319:101;H373:73;H411:83;H302:140;H317:21;H410:21;H315:80;H412:40;H332:5;H312:5;H335:9;H331:1;H301:1;H314:1
55606,1-ethylpyrrolidin-3-ol,250-310-7,30727-14-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H315:48;H319:48;H335:38
55608,"Naphthalenesulfonic acid, diisononyl-, compd. with 1,1'-iminobis[2-propanol] (1:1)",600-884-3,108866-68-8,,Notified C&L,1,Not classified:1
55609,"6-tert-butyl-1,1-dimethylindan-4-yl methyl ketone",236-114-4,13171-00-1,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1550,H400:5;H410:5;Not classified:1545
55610,Methyl 6-methoxy-1H-benzotriazole-5-carboxylate,261-705-9,59338-86-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,2,H332:2;H302:2;H312:2
55613,"Phenol, 4,4'-(1-methylethylidene)bis-, polymer with 2-(chloromethyl)oxirane, dihydrogen phosphate, 2-(2-butoxyethoxy)ethyl ethers, compds. with 2-(dimethylamino)ethanol",600-696-1,1058725-58-8,Not Classified,Notified C&L,1,Not classified:1
55614,6-(morpholino)pyridin-3-amine,257-613-3,52023-68-4,,Notified C&L,6,H315:5;H319:5;H335:5;H331:1;H311:1;H301:1
55615,Sulfapyridine,205-642-7,144-83-2,Repr. 2,REACH registration C&L,48,H361:41;Not classified:6;H315:1;H319:1;H302:1;H335:1
55617,"Carboxylic acids, C1-8, sodium salts",267-064-1,67785-31-3,Not Classified,Notified C&L,1,Not classified:1
55619,4-(trifluoromethyl)benzothiazol-2-amine,262-211-6,60388-36-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H302:1;H335:1
55621,2-Fluoro-5-methylaniline,610-239-8,452-84-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H315:47;H319:47;H335:41;H332:7;H373:5;H302:7;H311:4;H312:3
55623,"N-(2-aminoethyl)piperazine-1,4-diethylamine",250-557-0,31295-54-2,,Notified C&L,35,Not classified:33;H400:1;H314:2;H302:1;H312:1;H317:1;H410:1
55627,Cyclopentanecarboxylic acid,222-269-5,3400-45-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H315:48;H319:48;H335:47
55632,"1-acetyl-6-bromo-1,2,3,4-tetrahydroquinoline",244-829-8,22190-40-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H302:1;H335:1
55633,2-chloroanthraquinone,205-010-0,131-09-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H315:51;H319:43;H335:42;H332:8;H400:8;H302:13;Not classified:8;H311:8;H331:8;H412:1
55635,phosphamidon (ISO);2-chloro-2-diethylcarbamoyl-1-methylvinyl dimethyl phosphate,236-116-5,13171-21-6,Acute Tox. 2;Acute Tox. 3;Muta. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H341:0;H300:0;H311:0;H410:0
55637,"Fatty acids, sunflower-oil, decyl esters",307-858-8,97766-00-2,Not Classified,Notified C&L,1,Not classified:1
55640,2-(1-methylethoxy)ethyl acetate,242-901-3,19234-20-9,Flam. Liq. 3;Acute Tox. 4;STOT RE 1;STOT RE 1;Aquatic Chronic 3,REACH registration C&L,2,H412:2;H302:2;H372:2;H226:2
55646,"1-Butanaminium, N-[bis(dibutylamino)methylene]-N-butyl, chloride, hydrochloride (1:1:1)",600-904-0,109201-84-5,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H315:1;H318:1;H301:1
55647,Chloro(3-isocyanatopropyl)dimethylsilane,241-131-5,17070-70-1,,Notified C&L,1,H330:1;H314:1;H302:1;H312:1;H334:1
55655,"Potassium 4-amino-3,5,6-trichloropyridine-2-carboxylate",219-829-6,2545-60-0,Aquatic Chronic 3,Notified C&L,211,H412:156;H317:156;H400:55;H319:55;H410:55
55656,Cyclobutanecarboxylic acid,223-072-7,3721-95-7,Skin Corr. 1B,REACH registration C&L,51,H314:49;H332:39;H302:39;H312:39;H315:2;H319:2;H335:2;H290:2;H318:2;H413:1
55661,6-isopropyl-3-methylcyclohex-2-enone,201-942-7,89-81-6,Not Classified,REACH registration C&L,1691,Not classified:15;H315:1676;H319:1;H302:1;H335:1
55663,Ethylnitrobenzene,250-083-4,30179-51-2,,Notified C&L,33,Not classified:33
55664,"Sodium bis[2,4-dihydro-4-[(2-hydroxy-4-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)]chromate(1-)",264-944-7,64560-69-6,Aquatic Chronic 2,REACH registration C&L,118,H411:87;Not classified:31;H319:1
55665,1-ethoxy-2-methoxyethane,225-893-6,5137-45-1,,Notified C&L,4,H315:4;H224:4;H319:4;H361:4;H335:4
55667,"26-(nonylphenoxy)-3,6,9,12,15,18,21,24-octaoxahexacosan-1-ol",255-695-5,42173-90-0,Acute Tox. 4;Eye Irrit. 2,Notified C&L,1348,H319:1323;H302:1348;H315:61;H412:25;H318:25
55668,Manganese strontium oxide (MnSrO3),601-795-2,12163-45-0,Not Classified,Notified C&L,2,Not classified:2
55672,"α,α,α',α'-tetrakis(trifluoromethyl)-m-xylene-α,α'-diol",212-354-5,802-93-7,,Notified C&L,6,H315:5;H319:5;H335:4;H314:1
55675,"2,3-Difluoro-4-methoxybenzoic acid",608-797-2,329014-60-0,,Notified C&L,6,H315:6;H319:6;H335:6
55677,"2,2,2-trifluoroacetophenone",207-103-1,434-45-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H315:47;H319:47;H335:46;H226:47
55678,Zinc thiocyanate,209-177-0,557-42-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 3,Notified C&L,1,H332:1;H412:1;H302:1;H312:1
55679,"Proteinase, Aspergillus alkaline",232-977-6,9074-07-1,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,190,H315:190;H319:190;H335:190;H334:190
55681,2-[methyl[(nonafluorobutyl)sulphonyl]amino]ethyl methacrylate,266-737-7,67584-59-2,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,4,H411:4;H317:4
55682,"Amines, C12-18-alkyldimethyl",269-923-6,68391-04-8,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,236,H400:235;H410:156;H302:235;H314:235;H318:71;Not classified:31;H315:1;H319:1;H335:1
55684,Tris(dodecylthio)methylstannane,257-696-6,52165-03-4,Not Classified,Notified C&L,6,Not classified:6
55685,Benzo[b]thiophene-3-acetic acid,214-461-2,1131-09-5,,Notified C&L,5,H315:5;H319:5;H302:5;H335:5
55686,2-iodosylbenzoic acid,206-159-4,304-91-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:44;H319:44;H335:43
55694,2-(1H-imidazol-1-yl)acetic acid,607-175-8,22884-10-2,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,44,H315:40;H335:40;H318:39;H332:3;H302:3;H312:3;H319:1;Not classified:1
55697,Dimethylphenylphosphine,211-595-3,672-66-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:42;H319:42;H335:42;H226:43
55698,"anilazine (ISO);2-chloro-N-(4,6-dichloro-1,3,5-triazin-2-yl)aniline",202-910-5,101-05-3,Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H315:0;H319:0;H400:0;H410:0
55701,Vinyl methacrylate,224-205-1,4245-37-8,Flam. Liq. 2,Notified C&L,43,H225:43;H315:5;H319:5;H335:4
55702,"Fatty acids, vegetable-oil, sulfated, sodium salts",262-996-5,61788-67-8,Eye Irrit. 2,REACH registration C&L,43,H319:39;Not classified:4
55703,"(7aS,13aR,13bR,13cS)-dodecahydro-1H,5H,10H-dipyrido[2,1-f:3′,2′,1′-ij][1,6]naphthyridin-10-one",610-750-6,519-02-8,Acute Tox. 4;Eye Irrit. 2,Notified C&L,42,H319:39;H302:42
55704,"Gibb-3-ene-1,10-dicarboxylic acid, 2,4a-dihydroxy-1-methyl-8-methylene-, 1,4a-lactone, (1α,2β,4aα,4bβ,10β)-",208-117-0,510-75-8,Skin Sens. 1,Notified C&L,2,H317:2
55710,"Fatty acids, macadamia nut-oil, esters with hydroxysteroids",607-147-5,227200-30-8,,Notified C&L,2,H413:2
55712,tert-butyl perbenzoate,210-382-2,614-45-9,Org. Perox. C;Skin Irrit. 2;Skin Sens. 1;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,1386,H315:1354;H332:934;H400:972;H412:619;H317:973;H242:1200;H240:83;Not classified:27;H410:38;H272:8;H411:5;H200:4;H319:8;H302:5;H241:2;H335:2;H224:1
55716,"reaction mass of (1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylic acid and (1S,3S)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylic acid",614-283-9,68127-59-3,Flam. Liq. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H227:1;H335:1;H319:1
55718,"Copper(2+), bis[N-[2-(amino-κN)ethyl]-1,2-ethanediamine-κN,κN']-",608-969-7,34314-13-1,Not Classified,Notified C&L,1,Not classified:1
55719,3-Pentenenitrile,605-402-5,16529-66-1,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 3,Notified C&L,38,H331:38;H302:38;H226:38
55720,"Oils, vegetable-oil, glyceride and tocopherol fraction",276-953-3,72869-74-0,Not Classified,Notified C&L,89,Not classified:89
55721,"4-chloronaphthalene-1,8-dicarboxylic anhydride",223-760-7,4053-08-1,,Notified C&L,4,H315:4;H319:4;H335:4
55723,"Flue dust, copper alloy-manufg., zinc oxide-contg.",273-755-9,69012-58-4,Not Classified,Notified C&L,7,Not classified:7;H410:2
55726,2-hexyldecanoic acid,246-885-9,25354-97-6,Skin Irrit. 2;Skin Sens. 1B;Aquatic Acute 1,REACH registration C&L,496,H315:495;H400:1;H317:2;H319:494;H335:52;H412:1
55729,2-(2-(4-methyl-3-cyclohexen-1-yl)propyl)cyclopentanone,619-182-3,95962-14-4,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,95,H400:92;H410:95
55730,"3,3',3'',3'''-[1,2-ethanediylidenetetrakis(oxy)]tetrakispropene",240-692-3,16646-44-9,Acute Tox. 4;Acute Tox. 4,Notified C&L,51,H302:51;H312:51;H315:2;H319:2;H226:1
55732,2-methylpyrazine,203-645-8,109-08-0,Flam. Liq. 3;Acute Tox. 4,Notified C&L,1657,H302:1657;H226:1657;H315:49;H319:49;H335:48;H318:1;H314:1;H332:1;H312:1
55734,"Sodium N,N'-ethane-1,2-diylbis[N-(carboxymethyl)glycinate",230-944-0,7379-28-4,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,31,H319:31;H302:31;H412:31
55735,"3,5,5-trimethylcyclohex-2-en-1-ol",207-433-6,470-99-5,Not Classified,Notified C&L,89,Not classified:88;H315:1;H319:1;H335:1
55736,2-piperidin-2-ylethanol,216-059-2,1484-84-0,Acute Tox. 4;Skin Corr. 1B,REACH registration C&L,78,H302:78;H314:77;H332:40;H312:40;H318:40;H315:1;H319:1;H335:1
55738,"Xysmalobium undulatum, ext.",295-234-5,91845-59-9,Acute Tox. 4,Notified C&L,1,H302:1
55739,Ammonium 4-acetoacetylamino-5-methoxy-2-methylbenzenesulphonate,276-769-3,72705-22-7,Not Classified,REACH registration C&L,122,Not classified:38;H317:84
55740,"2-[(2,3-epoxypropoxy)methyl]furan",226-372-6,5380-87-0,Acute Tox. 4,Notified C&L,1,H332:1
55741,"3,6-bis(diethylamino)-9-[2-(methoxycarbonyl)phenyl]xanthylium tetrachlorozincate",277-459-0,73398-89-7,Acute Tox. 3;Eye Dam. 1;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,750,H400:6;H318:715;H331:263;H410:6;H301:123;H411:708;H302:627;H330:465;H315:83;H319:16;H332:2;H412:1
55746,"1-Propanesulfonic acid, 2-methyl-, 2-[[1-oxo-3-[(γ-ω-perfluoro-C4-16-alkyl)thio]propyl]amino] derivs., sodium salts",269-100-1,68187-47-3,Not Classified,Notified C&L,18,Not classified:18
55751,"3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,14-pentacosafluorotetradecanol",254-373-1,39239-77-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
55754,"3,4,5,6,6-pentamethylhept-3-en-2-one",289-194-8,86115-11-9,Aquatic Chronic 2,Notified C&L,1473,H411:1386;H317:1380;H412:76;Not classified:11
55755,"Spiramycin, compd. with 4,4'-methylenebis[3-hydroxy-2-naphthalenecarboxylic acid]",266-981-4,67724-08-7,Not Classified,Notified C&L,2,Not classified:1;H315:1;H332:1;H319:1;H302:1;H312:1;H335:1
55756,4-Ethoxy-3-nitropyridine,605-864-8,1796-84-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
55758,2-(2-thienyl)pyridine,222-022-1,3319-99-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H315:46;H319:46;H335:45;H332:2;H302:2;H312:2
55761,"1,2-dihydro-1,5-dimethyl-4-(methylamino)-2-phenyl-3H-pyrazol-3-one",208-281-3,519-98-2,Acute Tox. 4,Notified C&L,3,H302:3
55763,Methyl cis-icos-11-enoate,219-226-8,2390-09-2,Not Classified,Notified C&L,2,Not classified:2
55766,"5-hydroxy-2-phenyl-1,3-dioxane",215-294-8,1319-88-6,Not Classified,Notified C&L,91,Not classified:89;H302:2
55767,Dimethirimol,226-021-7,5221-53-4,Acute Tox. 3,Notified C&L,128,H311:127;H412:1;H302:1;H312:1
55769,Sodium 2-nitrophenolate,212-527-5,824-39-5,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,118,H400:66;H410:67;H302:118;H319:51;H411:14;H242:13
55777,"Dimethyl 1,4-dihydro-2,6-dimethylpyridine-3,5-dicarboxylate",241-458-3,17438-14-1,Acute Tox. 4,Notified C&L,38,H302:38
55781,"5,7-dihydroxy-4-methyl-2-benzopyrone",218-289-9,2107-76-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H315:45;H319:45;H335:44;H302:1
55784,1-chloro-3-iodobenzene,210-920-6,625-99-0,,Notified C&L,8,H315:8;H319:8;H335:7
55785,"Phenol, p-chloro-m-trifluoromethyl-",613-117-2,6294-93-5,,Notified C&L,8,H302:6;H312:5;H314:6;H315:2;H332:1;H319:2;H335:1
55788,"Nigella damascena, ext.",290-093-6,90064-31-6,Skin Sens. 1,Notified C&L,1358,H317:1358;H400:25;Not classified:25
55792,"trans-1,3-dimethylcyclopentane",217-163-0,1759-58-6,Flam. Liq. 2;Acute Tox. 4;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H315:38;H304:38;H225:38;H319:38;H302:38;H335:38;H336:38;H224:4;Not classified:3
55793,Bis[2-(diethylamino)ethyl] adipate,240-610-6,16545-00-9,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,39,H315:39;H318:6;H319:33
55797,"(1S,2S,4R)-(-)-α,α-dimethyl-1-vinyl-o-menth-8-ene-4-methanol",211-360-5,639-99-6,Not Classified,Notified C&L,280,Not classified:280
55800,4-nitrophenetole,202-837-9,100-29-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1;H312:1
55804,4-(diethylamino)salicylaldehyde,241-745-3,17754-90-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,56,H315:47;H319:47;H335:46;H410:9;H317:9
55807,Diiron tris(glycerophosphate),215-097-7,1301-70-8,Not Classified,Notified C&L,2,Not classified:2
55810,"dichlorobis(η5-cyclopenta-2,4-dien-1-yl)hafnium",235-177-5,12116-66-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:39;H319:39;H335:38;H314:5;H371:1
55811,Hydroxocobalamin,236-533-2,13422-51-0,Not Classified,Notified C&L,1,Not classified:1
55812,"bis(1,1-dimethyl-2-propynyloxy)dimethylsilane",414-960-7,53863-99-3,Acute Tox. 4,Harmonised C&L,0,H332:0
55814,4-amino-2-methylpyrimidine-5-carbonitrile,211-814-2,698-29-3,Acute Tox. 4,REACH registration C&L,1,H302:1
55815,reaction mass of: tert-alkyl(C,403-720-7,117527-94-3,Aquatic Chronic 2,Harmonised C&L,0,H411:0
55817,5-Bromo-2-chlorobenzonitrile,611-519-2,57381-44-9,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3,Notified C&L,2,H315:1;H319:1;H311:2;H331:2;H301:2
55818,2-dodecoxyethyl hydrogen sulfate,618-398-5,9004-82-4,Acute Tox. 4;Eye Irrit. 2,Notified C&L,1160,H319:928;H302:773;H315:496;H318:229;H412:38;H317:32;H311:33;H335:2;H228:1;H411:1;H312:1
55820,Polymyxin B,215-768-4,1404-26-8,Acute Tox. 4,Notified C&L,38,H302:38
55821,"Sulfuric acid, manganese(2+) salt (1:1) monohydrate",600-072-9,10034-96-5,STOT RE 2;Aquatic Chronic 2,Notified C&L,1571,H411:1536;H373:1536;Not classified:33;H318:31;H302:5;H332:6;H413:1;H315:1;H319:1;H351:1;H311:1;H335:1;H301:1
55823,"Solvent naphtha (petroleum), light aliph.;Low boiling point naphtha;[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C",265-192-2,64742-89-8,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
55826,"4-(2,2-diphenylethenyl)-N,N-di-phenylbenzenamine",421-390-2,89114-90-9,Aquatic Chronic 4,Harmonised C&L,0,H413:0
55827,2-(2-chloroethyl)-1-methylpiperidinium chloride,261-480-7,58878-37-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H302:1;H335:1
55830,"Reaction mass of pentasodium 2-{[4-chloro-6-(ethyl{3-[(2-sulfonatoethyl)sulfonyl]phenyl}amino)-1,3,5-triazin-2-yl]amino}-5-hydroxy-6-({2-sulfonato-4-[(4-sulfonatophenyl)diazenyl]phenyl}diazenyl)naphthalene-1,7-disulfonate and tetrasodium 2-[(4-chloro-6-{ethyl[3-(vinylsulfonyl)phenyl]amino}-1,3,5-triazin-2-yl)amino]-5-hydroxy-6-({2-sulfonato-4-[(4-sulfonatophenyl)diazenyl]phenyl}diazenyl)naphthalene-1,7-disulfonate",459-580-2,,Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,1,H412:1;H317:1
55834,"1-methylcyclohexa-1,4-diene",224-329-6,4313-57-9,Flam. Liq. 2;Eye Irrit. 2,Notified C&L,43,H319:43;H225:43;H304:4;H315:1
55835,"4,6-O-ethylidene-α-D-glucose",236-198-2,13224-99-2,Not Classified,REACH registration C&L,5,Not classified:5
55838,Di-1-adamantylphosphine,603-463-2,131211-27-3,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,41,H315:41;H319:41;H311:40;H331:40;H335:40;H301:40
55840,2-methoxy-4-prop-1-enylphenetole,232-072-6,7784-67-0,Skin Sens. 1;Eye Irrit. 2,Notified C&L,38,H319:38;H317:38
55843,Oct-2-ynal,217-427-5,1846-68-0,Skin Sens. 1;Aquatic Acute 1,Notified C&L,38,H400:38;H317:38
55848,Calcium nitrate tetrahydrate,603-865-8,13477-34-4,Acute Tox. 4;Eye Dam. 1,Notified C&L,358,H302:186;H318:186;H371:135;H272:188;H373:135;H319:34;H315:7;H335:5;H271:2;Not classified:1
55850,1-amino-4-hydroxy-2-(2-methoxyethoxy)anthraquinone,241-820-0,17869-10-2,Not Classified,Notified C&L,7,Not classified:6;H412:1
55851,Serinol oxalate,607-313-7,24070-20-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
55853,Sulprostone,262-173-0,60325-46-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 1B,Notified C&L,64,H315:39;H319:39;H335:39;H360:64;H331:24;H300:24;H311:24
55857,"Estra-1,3,5,7,9-pentaene-3,17β-diol",215-835-8,1423-97-8,Carc. 1A;Repr. 1A;STOT RE 1,Notified C&L,1,H360:1;H372:1;H350:1
55858,Potassium toluene-p-thiosulphonate,249-065-9,28519-50-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:39;H319:39;H335:38;Not classified:1
55863,"Tar, coal, low-temp., distn. residues;Tar Oil, intermediate boiling;[Residues from fractional distillation of low temperature coal tar to remove oils that boil in a range up to approximately 300 °C (572 °F). Composed primarily of aromatic compounds.]",309-887-1,101316-85-2,Carc. 1B,Harmonised C&L,0,H350:0
55865,"Calciate(2-), ((N,N'-1,2-ethanediylbis(N-(carboxymethyl)glycinato))(4-)-N,N',O,O',ON,ON')-, disodium, hydrate, (OC-6-21)-",607-231-1,23411-34-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H315:39;H319:39;H335:39;Not classified:9
55866,Benzylurea,208-689-1,538-32-9,Not Classified,REACH registration C&L,5,Not classified:1;H315:4;H319:4;H335:4
55867,"Dicarbonyl(pentane-2,4-dionato-O,O')rhodium",238-947-9,14874-82-9,Flam. Sol. 1;Acute Tox. 3;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,186,H319:186;H411:3;H317:180;H228:142;H301:184;H413:83;H315:44;H335:44;H412:1
55873,reaction mass of: methyl {[5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl]methoxycarbonylmethylamino}acetate;methyl {[5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl]ethoxycarbonylmethylamino}acetate,424-290-7,188070-47-5,Skin Sens. 1,Harmonised C&L,0,H317:0
55874,Cyclohexylammonium bromide,247-526-9,26227-54-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,42,H315:42;H335:42;H302:42;H318:38;H319:4;H361:4
55876,Hex-3-ene,209-758-9,592-47-2,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,1,H304:1;H225:1
55878,3-aminopyrazine-2-carboxylic acid,226-558-7,5424-01-1,Eye Dam. 1,REACH registration C&L,48,H318:3;H315:45;H319:45;H335:44
55880,Molybdenum carbide,235-733-7,12627-57-5,Not Classified,Notified C&L,1,Not classified:1
55881,"N,N'-1,4-phenylenebis[3-oxobutyramide]",246-438-8,24731-73-5,Not Classified,REACH registration C&L,66,Not classified:66
55883,4-methyl-3-nitroanisole,241-500-0,17484-36-5,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
55885,1-amino-4-hydroxy-2-(4-methoxyphenoxy)anthraquinone,259-040-4,54243-60-6,Not Classified,Notified C&L,4,Not classified:4
55887,"4-chloro-3-methyl-1,2-oxazol-5-amine",605-455-4,166964-09-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H302:1;H335:1
55892,"1,5-dimethylbicyclo[3.2.1]octan-8-ol",262-174-6,60329-20-6,Not Classified,Notified C&L,1,Not classified:1
55896,"3,4-Difluoroanisole",601-348-1,115144-40-6,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:44;H319:44;H335:43;H226:44
55897,"2(1H)-Quinolinone, 8-hydroxy-",604-962-8,15450-76-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H315:47;H319:47;H335:46
55902,Isophthaloyl dichloride,202-774-7,99-63-8,Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Acute Tox. 3,REACH registration C&L,233,H331:158;H312:177;H314:167;H318:122;Not classified:56;H315:10;H319:9;H317:8;H335:9;H302:4;H290:1
55903,Mesterolone,215-836-3,1424-00-6,Carc. 2;Repr. 1A;Lact.;Aquatic Chronic 2,REACH registration C&L,40,H351:1;H360:1;H362:1;H411:1;H332:39;H302:39;H312:39
55904,"Potassium 1,4-dihydro-1,4-dioxonaphthalene-2-sulphonate",251-861-6,34169-62-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
55906,Melengestrol acetate,220-859-7,2919-66-6,Repr. 2,Notified C&L,39,H361:39
55907,1-(benzyl)pyrrolidin-3-one,212-274-0,775-16-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H315:48;H319:48;H335:43
55912,Dodecane-1-sulphonyl chloride,233-416-8,10147-40-7,Skin Corr. 1B,Notified C&L,44,H314:43;Not classified:1
55918,"L-Tryptophan, 1-[(1,1-dimethylethoxy)carbonyl]-",604-533-5,146645-63-8,Not Classified,Notified C&L,2,Not classified:2
55920,"Distillates (petroleum), solvent-refined hydrotreated heavy, hydrogenated;Baseoil - unspecified",305-588-5,94733-08-1,Carc. 1B,Harmonised C&L,0,H350:0
55922,Calcium dihydrogen bis[4-[(4-chloro-6-sulphonato-m-tolyl)azo]-3-hydroxy-2-naphthoate],257-731-5,52202-90-1,Not Classified,Notified C&L,1,Not classified:1
55927,5-(dithiolan-3-yl)valeric acid,214-071-2,1077-28-7,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,314,H315:18;H319:11;H411:10;H302:286;H317:10;Not classified:28;H412:25;H335:7;H332:2;H312:2
55931,4-chloro-N-[2-(4-hydroxyphenyl)ethyl]benzamide,255-566-3,41859-57-8,Not Classified,REACH registration C&L,3,Not classified:2;H302:1
55935,"N,N'-(o-phenylene)di(acetamide)",218-106-2,2050-85-3,Acute Tox. 4,Notified C&L,38,H302:38
55936,potassium permanganate,231-760-3,7722-64-7,Ox. Sol. 2;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H400:0;H410:0;H361:0;H302:0;H272:0
55940,"Sodium 3-diazo-3,4-dihydro-4-oxonaphthalene-1-sulphonate",264-719-3,64173-96-2,Self-react. D;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,10,H319:9;H412:7;H317:7;H242:9;H315:2;Not classified:1
55942,Benzyl isocyanate,221-640-9,3173-56-6,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,44,H315:44;H319:44;H317:40;H334:44;H226:44;H335:43;H330:4;H301:5;H311:1;H331:1
55945,"2,4-dihydroxybenzaldehyde",202-383-1,95-01-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H315:50;H319:50;H302:50;H335:48;Not classified:2
55951,Sodium propane-2-sulphonate,226-434-2,5399-58-6,,Notified C&L,1,H315:1;H319:1;H335:1
55952,"614-103-9 Formaldehyde, polymer with phenol and cashew nut shell liquid",614-103-9,67700-42-9,Skin Sens. 1B,Notified C&L,11,H317:11
55955,"Palladium, tris[μ-[(1,2-η:4,5-η)-(1E,4E)-1,5-diphenyl-1,4-pentadien-3-one]]di-, compd. with trichloromethane (1:1)",610-856-2,52522-40-4,Acute Tox. 4;Skin Irrit. 2;Carc. 2,Notified C&L,46,H315:40;H302:44;H351:44;H373:4;H311:1;H301:1;H228:1
55956,Tetraethylammonium hexafluorophosphate,207-056-7,429-07-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H315:42;H319:42;H335:42;H332:4;H302:4
55961,4-amino-α-diethylamino-o-cresol dihydrochloride,228-568-7,6297-14-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H315:38;H335:38;H302:38;H318:38
55965,"3-(chloromethyl)-1,2,4,5-tetramethylbenzene",231-087-5,7435-83-8,Skin Irrit. 2;STOT SE 3,Notified C&L,42,H315:38;H335:42;H314:4
55967,"26-(nonylphenoxy)-3,6,9,12,15,18,21,24-octaoxahexacosan-1-ol",247-816-5,26571-11-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,201,H315:153;H302:162;H411:99;H318:162;H412:63;H319:39
55968,Cyclooctyl methyl carbonate,262-912-7,61699-38-5,Not Classified,Notified C&L,246,Not classified:233;H412:13
55971,"N,N'-[(9,10-dihydro-9,10-dioxo-1,4-anthracenediyl)bis(imino-4,1-phenylene)]bisacetamide",278-226-6,75508-31-5,Not Classified,Notified C&L,2045,Not classified:2045
55973,6-methylpyridine-2-carbaldehyde,214-359-8,1122-72-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H315:46;H319:45;H335:44
55980,"2,4,6-tris(1-phenylethyl)phenol",242-128-1,18254-13-2,Not Classified,REACH registration C&L,92,Not classified:91;H315:1;H319:1;H411:1
55981,Hexadecyl palmitate,208-736-6,540-10-3,Not Classified,REACH registration C&L,185,Not classified:185
55985,Cefazolin,247-362-8,25953-19-9,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,56,H317:56;H334:56
55989,Hydrocortisone 21-(hydrogen succinate),218-612-3,2203-97-6,Repr. 2;STOT RE 2,REACH registration C&L,36,H361:10;H373:31;H360:24;Not classified:2
55991,m-diiodobenzene,210-921-1,626-00-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H315:46;H319:46;H335:45
55993,Cholest-5-en-3-β-yl acetate,210-066-4,604-35-3,Not Classified,REACH registration C&L,2,Not classified:2
55994,Isopropyl-β-D-thiogalactopyranoside,206-703-0,367-93-1,,Notified C&L,35,H332:18;H302:17;H312:17;Not classified:11;H315:6;H319:7;H335:7;H351:2;H311:1;H301:1
55997,Strontium carbonate,216-643-7,1633-05-2,Not Classified,REACH registration C&L,408,Not classified:405;H413:3
55998,4-ethoxyphenylurea,205-767-7,150-69-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
55999,"2,2'-vinylenebis[5-methylbenzoxazole]",213-866-1,1041-00-5,Not Classified,REACH registration C&L,156,Not classified:156
56000,"2,4(or 2,6)-dinitrophenol",275-732-9,71629-74-8,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H373:0;H311:0;H331:0;H410:0;H301:0
56004,2-fluoro-6-methoxybenzonitrile,302-047-5,94088-46-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H315:45;H319:45;H335:43;H332:6;H302:6;H312:6;H311:2;H331:2;H301:2
56005,Karaya gum,232-539-4,9000-36-6,Not Classified,Notified C&L,89,Not classified:89
56006,"(octahydro-4,7-methano-1H-indenediyl)bis(methylene) bismethacrylate",256-062-6,43048-08-4,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,136,H411:16;H317:16;H315:133;H319:133;H335:133
56007,2-Methyl-5-nitroimidazole,618-108-7,88054-22-2,Not Classified,Notified C&L,3,Not classified:1;H302:2
56009,"1,1,1-triphenylsilylamine",224-147-7,4215-80-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:39
56011,"2-Propenoic acid, hexyl ester, polymer with isodecyl 2-propenoate",611-934-9,60098-83-1,Not Classified,Notified C&L,6,Not classified:6
56013,"Ethanaminium, 2-amino-N-(2-aminoethyl)-N-(2-hydroxyethyl)-N-methyl-, N,N'-ditallow acyl derivs., Me sulfates (salts)",268-881-6,68153-35-5,Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,32,H315:32;H411:32
56015,Neomenthyl acetate,218-767-7,2230-87-7,Aquatic Chronic 2,Notified C&L,25,H411:25
56019,"(8α,9R)-9-hydroxycinchonanium chloride",208-361-8,524-57-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,39,H331:38;H311:38;H301:38;H302:1;H317:1
56020,2-chloro-6-fluorophenylacetonitrile,278-171-8,75279-55-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H315:43;H332:40;H319:43;H302:40;H312:41;H335:38;H300:4;H311:4;H331:4
56023,"4-chloro-2,8-bis(trifluoromethyl)quinoline",280-132-5,83012-13-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:40;H319:40;H335:40;H332:1;H302:1;H312:1
56026,4-(dimethylamino)piperidine-4-carboxamide dihydrochloride,306-703-1,97392-68-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H302:1;H335:1
56029,2-(2H-benzotriazol-2-yl)-p-cresol,219-470-5,2440-22-4,Skin Sens. 1B;Aquatic Chronic 1,REACH registration C&L,896,H410:315;H317:833;H413:483;Not classified:44;H411:14;H332:4;H319:1;H373:1
56031,"3-ethyl-2,5-dimethylpyrazine",236-417-1,13360-65-1,Acute Tox. 4,Notified C&L,1016,H302:1016;H226:2
56032,"reaction product of diphenylmethanediisocyanate, octylamine, oleylamine and cyclohexylamine (1:1.58:0.32:0.097)",430-980-9,,Aquatic Chronic 4,Harmonised C&L,0,H413:0
56033,"Gases (petroleum), catalytic-cracked gas oil depropanizer bottoms, C4-rich acid-free;Petroleum gas;[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked gas oil hydrocarbon stream and treated to remove hydrogen sulfide and other acidic components. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.]",270-752-4,68477-71-4,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H350:0;Not classified:0;H220:0;H340:0
56034,Trimethylsilane,213-603-0,993-07-7,Flam. Gas 1;Press. Gas (Comp.),REACH registration C&L,200,H220:162;H280:199;H315:40;H224:38;H319:40;H335:40
56035,"3,5,5-trimethylcyclohex-3-en-1-one",207-434-1,471-01-2,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2A;Acute Tox. 3;STOT SE 3;Carc. 2,REACH registration C&L,110,H319:110;H351:110;H302:110;H312:110;H331:110;H335:110
56037,1-(3-phenylpropylamino)guanidine hydrochloride,250-256-4,30598-34-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H315:38;H332:38;H319:38;H302:38;H312:38;H317:38;H335:38
56040,"dimethachlor (ISO);2-chloro-N-(2,6-dimethylphenyl)-N-(2-methoxyethyl)acetamide",256-625-6,50563-36-5,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H302:0;H317:0
56041,Synthon A,467-670-8,,Aquatic Chronic 4,Notified C&L,1,H413:1
56046,Ethylene di(S-thioacetate),204-653-4,123-81-9,Acute Tox. 4;Skin Sens. 1A;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,REACH registration C&L,104,H332:27;H319:41;H302:65;H312:27;H317:1;H335:39;H315:40;H301:33;H411:26;Not classified:6
56047,"A mixture of: propan-2-one-O,O'(methoxyvinylsilandiyl)dioxime; propan-2-one-O-(dimethoxyvinylsilyl)oxime; propan-2-one-O,O',O''-(vinylsilantriyl)trioxime",458-680-3,797751-44-1,Not Classified,REACH registration C&L,29,Not classified:29
56051,reaction mass of: branched triacontane;branched dotriacontane;branched tetratriacontane;branched hexatriacontane,417-030-9,151006-59-6,Aquatic Chronic 4,Harmonised C&L,0,H413:0
56052,2-Bromoaniline Hydrochloride,619-064-1,94718-79-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H315:1;H332:1;H319:1;H302:1;H312:1
56055,"Phenylicosane-1,3-dione",261-257-4,58446-52-9,Not Classified,Notified C&L,63,Not classified:62;H315:1;H319:1;H335:1
56057,6-chlorochroman-4-one,253-611-1,37674-72-9,Acute Tox. 4,Notified C&L,39,H302:39;H315:1;H319:1;H335:1
56058,2-phenylethanethiol,224-563-9,4410-99-5,Acute Tox. 4;Eye Irrit. 2,Notified C&L,116,H319:81;H302:104;Not classified:10;H315:2;H335:1
56059,"Hydrocarbons, C10, aromatics, >1% naphthalene",919-284-0,,Asp. Tox. 1;STOT SE 3;Carc. 2;Aquatic Chronic 2,REACH registration C&L,529,H351:529;H304:529;H411:529;H336:529
56060,Sodium pentane-1-sulphonate monohydrate,245-208-4,22767-49-3,Not Classified,Notified C&L,7,Not classified:3;H315:4;H319:4;H335:4
56061,"p,p'-dimethoxystilbene",225-189-9,4705-34-4,Eye Dam. 1;Aquatic Chronic 2,Notified C&L,38,H411:38;H318:38
56062,Diethoxy(dimethyl)silane,201-127-6,78-62-6,Flam. Liq. 2,REACH registration C&L,242,H225:237;H315:206;H319:206;H332:40;H335:27;Not classified:5;H318:1;H411:1
56063,"(S)-5,6,6a,7-tetrahydro-1,2,9,10-tetramethoxy-6-methyl-4H-dibenzo[de,g]quinoline",207-501-5,475-81-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:38;H319:38;H302:39;H335:38
56066,(R)-linalyl acetate,240-575-7,16509-46-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:2
56070,"Bupleurum falcatum, ext.",289-634-9,89958-12-3,Not Classified,Notified C&L,185,Not classified:184;H315:1;H304:1;H411:1;H317:1;H226:1
56071,3-(dimethylamino)propylurea,401-950-2,31506-43-1,Eye Dam. 1,Harmonised C&L,0,H318:0
56072,"3,5-dinitrobenzoyl chloride",202-750-6,99-33-2,Skin Corr. 1B,REACH registration C&L,50,H314:50;H332:2;H290:2;H341:3;H302:2;H312:2;H318:2;Not classified:2
56073,Strontium bis[2-chloro-5-[(2-hydroxy-1-naphthyl)azo]toluene-4-sulphonate],277-335-6,73263-40-8,Not Classified,Notified C&L,85,Not classified:85
56075,"Tetrasodium 3,3'-[(3,3'-dimethoxy[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonate]",219-385-3,2429-74-5,Carc. 1B,Notified C&L,41,H350:39;H351:1;H341:1;Not classified:1
56076,"Disodium (C9-11-isoalkyl, C10-rich) sulfosuccinate",620-258-3,815583-91-6,Eye Irrit. 2;Aquatic Chronic 1,Notified C&L,14,H319:14;H410:14
56080,Tetrachloro-μ-hydroxy[μ-myristato-O:O')]dichromium,239-730-1,15659-56-0,Eye Dam. 1,Notified C&L,50,H318:50;H315:1;H225:1;H336:1
56082,2-(O-aminooxy)ethylamine dihydrochloride,412-310-7,37866-45-8,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H317:0
56083,"Disodium [2S-(2α,5α,6β)]-6-(carboxylatophenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",225-360-8,4800-94-6,Skin Sens. 1;Resp. Sens. 1,Notified C&L,208,H317:207;H334:206;H332:1;H302:1;H341:1
56084,"3,5-dichloro-4-oxo-4H-pyridine-1-acetic acid",260-040-1,56187-37-2,,Notified C&L,4,H315:4;H319:4;H335:4
56085,"Pharmaceutical natural products, aloe",616-790-0,8001-97-6,Not Classified,Notified C&L,151,Not classified:151
56086,Tetroquinone,206-275-5,319-89-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
56087,"Benzenesulfonic acid, mono-C11-13-alkyl derivs., sodium salts",308-070-7,97862-26-5,Not Classified,Notified C&L,1,Not classified:1
56092,"3,3-dimethyl-1,5-dioxaspiro[5.5]undecane",211-898-0,707-29-9,Not Classified,Notified C&L,93,Not classified:93
56097,4-phenylbutyronitrile,218-068-7,2046-18-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,44,H332:43;H302:43;H312:43;H315:39;H319:39;H335:38;H301:1
56103,"clofentezine (ISO); 3,6-bis(o-chlorophenyl)-1,2,4,5-tetrazine",277-728-2,74115-24-5,Aquatic Chronic 1,Notified C&L,165,H410:126;H400:40;H312:38;H412:1
56104,Trisodium [5-[[4-[(3-chloro-2-hydroxy-5-sulphophenyl)azo]-3-hydroxyphenyl]azoxy]-2-[2-(4-nitro-2-sulphophenyl)vinyl]benzenesulphonato(5-)]cuprate(3-),274-550-7,70304-38-0,Aquatic Chronic 3,REACH registration C&L,20,H412:10;H319:8;Not classified:2
56110,"Zinc, isononanoate isooctanoate complexes, basic",282-790-9,84418-77-9,Not Classified,Notified C&L,1,Not classified:1
56113,Chlorocyclopentane,213-212-5,930-28-9,Flam. Liq. 2,REACH registration C&L,60,H225:59;H315:5;H304:4;H319:1;H412:1;H341:1;Not classified:1
56114,"1H-Indole-6-carboxylic acid, 2,3-dihydro-3-[[[4-[methyl[(4-methyl-1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene]-2-oxo-,methyl ester, (3Z)-, ethanesulfonate (1:1)",620-104-5,656247-18-6,Repr. 1B,Notified C&L,13,H360:13;H373:5;H411:1;H372:1
56117,3-(trifluoromethyl)benzophenone,211-973-8,728-81-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:43;H319:43;H335:43
56119,4-Tipranavir,606-791-4,215317-22-9,Aquatic Chronic 2,Notified C&L,1,H411:1
56121,"Silicic acid, aluminum calcium sodium salt",215-685-3,1344-01-0,Not Classified,REACH registration C&L,66,Not classified:60;H315:6;H319:6;H335:6
56123,"2,4-dichloro-1-isothiocyanatobenzene",229-527-6,6590-96-1,Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Resp. Sens. 1,Notified C&L,45,H318:40;H317:40;H314:44;H334:40;H332:6;H302:6;H312:5;H315:1;H319:1;H335:2
56131,"2,4,6,8,10-pentamethylcyclopentasiloxane",228-204-7,6166-86-5,Flam. Liq. 3,REACH registration C&L,114,H226:59;Not classified:55
56132,"Propanenitrile, 2-[bis(cyanomethyl)amino]-",480-240-4,185257-07-2,Acute Tox. 3;STOT RE 1;Aquatic Chronic 3,Notified C&L,84,H412:84;H372:84;H301:84
56135,"Carboxylic acids, di-, C10-12, compds. with triethanolamine",309-132-6,100084-94-4,Not Classified,Notified C&L,3,Not classified:2;H315:1;H319:1
56136,2-Amino-1-dodecanol,924-066-3,,Not Classified,REACH registration C&L,2,Not classified:2
56140,2-benzoxazol-2-ylphenol,212-642-0,835-64-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:38
56142,Trimethyl-3-[(1-oxoallyl)amino]propylammonium chloride,256-181-3,45021-77-0,Not Classified,REACH registration C&L,159,Not classified:7;H335:83;H317:83;H412:66;H319:3
56143,Diethyl vinylphosphonate,211-663-2,682-30-4,,Notified C&L,4,H301:4
56147,"3,4-Difluorobenzaldehyde",422-180-3,34036-07-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:2;H335:1;H302:1;H227:1
56149,Bis[2-[2-(2-butoxyethoxy)ethoxy]ethyl] hydrogen glutarate,265-805-3,65520-42-5,Not Classified,REACH registration C&L,92,Not classified:92
56151,Tetrabutylammonium chloride,214-195-7,1112-67-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,96,H315:63;H319:63;Not classified:33;H335:19;H302:5;H332:1;H312:1
56153,2-(2-(2-ethoxyethoxy)ethoxy)ethanol,203-978-9,112-50-5,Not Classified,REACH registration C&L,112,Not classified:63;H319:49
56154,"mesosulfuron-methyl (ISO); methyl 2-[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-α-(methanesulfonamido)-p-toluate;",606-653-3,208465-21-8,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
56155,"Trichloro-12,24-dihydro-5H-naphtho[2,3-h]naphth[2'',3'':6',7']indolo[2',3':6,7]anthra[2,1,9-mna]acridine-5,10,13,18,25-pentone",309-011-8,99688-45-6,Skin Sens. 1B,REACH registration C&L,1,H317:1
56157,4-isoquinolylamine,245-823-8,23687-25-4,Acute Tox. 4;Eye Irrit. 2,Notified C&L,41,H319:41;H302:40;H315:3;H332:1;H312:1;H335:2
56158,Dipentyl disulphide,203-979-4,112-51-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
56161,Urease,232-656-0,9002-13-5,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,45,H315:40;H319:42;H335:40;H334:42;Not classified:3
56162,2-(acryloylamino)-2-methylpropylphosphonic acid,618-202-8,88701-03-5,Met. Corr. 1;Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H314:1;H290:1;H318:1
56163,N-[3-(dimethylamino)propyl]propionamide,258-425-4,53201-66-4,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,2,H315:2;H335:2;H318:2
56164,"3,6-dimethylcyclohex-3-ene-1-carbaldehyde",267-186-5,67801-65-4,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 2,Notified C&L,1579,H315:1579;H302:1579;H411:1377;H317:1352;H319:215;H412:202
56165,(S)-3-(benzoylthio)-2-methylpropionic acid,276-764-6,72679-02-8,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,15,H315:14;H319:14;H360:9;H340:9;H350:9;H302:10;H335:9
56169,"Oils, animal, sulfurized",304-837-5,94279-91-1,Not Classified,Notified C&L,1,Not classified:1
56170,L-lysinium dihydrogen phosphate,303-298-3,94160-16-4,Not Classified,Notified C&L,1,Not classified:1
56171,"(3aα,4β,7β,7aα)-octahydro-4,7-methano-1H-indene",220-585-8,2825-82-3,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,3,H315:2;H304:2;H400:2;H319:2;H317:2;H226:3;H410:2
56172,"Octanoic acid, compound with cyclohexylamine (1:1)",301-889-0,94086-98-3,Not Classified,Notified C&L,1,Not classified:1
56176,"Oils, vegetable, reclaimed",273-618-3,68990-65-8,Not Classified,Notified C&L,52,Not classified:52
56179,(3S)-3-[4-(2-chloro-5-iodobenzyl)phenoxy]tetrahydrofuran,619-599-0,915095-94-2,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,3,H400:3;H410:3
56182,2-methylpent-3-en-1-oic acid,253-610-6,37674-63-8,Skin Corr. 1B,Notified C&L,1373,H314:1363;H318:36;H315:10;H319:10
56184,1-methyl-2-phenylbenzimidazole,220-073-4,2622-63-1,Acute Tox. 2;Eye Dam. 1,Notified C&L,38,H300:38;H318:38
56186,"1H-Benzimidazole, 5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)thio)-",615-997-3,73590-85-9,Skin Sens. 1;Aquatic Chronic 4,REACH registration C&L,49,H413:6;H317:9;H315:39;H319:39;H335:39;H410:3;H302:1
56197,2-methylallylidene diacetate,233-974-2,10476-95-6,Acute Tox. 4;Acute Tox. 2;Acute Tox. 2,Notified C&L,38,H302:38;H310:38;H330:38
56202,Isocyanomethane,209-806-9,593-75-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;STOT RE 2,Notified C&L,39,H332:38;H373:39;H302:38;H312:38;H315:1;H225:1;H330:1;H319:1;H311:1;H335:1;H301:1
56203,"4,5,6,7-tetrahydrothieno[3,2-c]pyridinium chloride",249-220-0,28783-41-7,Acute Tox. 4,REACH registration C&L,100,H302:92;H315:8;H319:8;H335:7
56204,"Fatty acids, tallow, compds. with N,N-dimethyl-1,3-propanediamine",287-536-0,85536-52-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
56205,Diethyl (phenylmethylene)malonate,226-137-8,5292-53-5,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,REACH registration C&L,2,H332:2;H319:2;H302:2;H312:2
56206,"Trachyspermum ammi, ext.",307-690-5,97676-13-6,Flam. Liq. 3;Acute Tox. 4;Asp. Tox. 1;Skin Corr. 1C;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,4,H304:4;H314:4;H411:4;H302:4;H318:3;H317:4;H226:3
56211,"1,4-dichloro-2-(trifluoromethyl)benzene",206-276-0,320-50-3,Skin Corr. 1B,Notified C&L,43,H314:43;H318:1
56213,"reaction mass of esters of 5,5',6,6',7,7'-hexahydroxy-3,3,3',3'-tetramethyl-1,1'-spirobiindan and 2-diazo-1,2-dihydro-1-oxo-5-sulfonaphthalene",413-840-1,121870-66-4,Self-react. C;Aquatic Chronic 4,Harmonised C&L,0,H413:0;H242:0
56214,(R)-4-oxo-4-[(1-phenylethyl)amino]butyric acid,244-567-4,21752-33-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
56224,"Ethanone, 2-chloro-1-(3-pyridinyl)-, hydrochloride (1:1)",612-590-2,61889-48-3,,Notified C&L,1,H315:1;H319:1;H302:1;H335:1
56225,Ethyl 3-pyridylacetate,254-707-6,39931-77-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:43;H319:43;H335:42
56229,Nisin,215-807-5,1414-45-5,Not Classified,Notified C&L,39,Not classified:39
56230,reaction mass of: calcium bis(C,430-180-1,,Skin Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0,H315:0;H411:0
56231,5-bromovanillic acid,228-685-3,6324-52-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H315:1;H335:1;H302:1;H318:1
56236,Bis(2-octyldodecyl) adipate,285-645-8,85117-94-8,Not Classified,Notified C&L,1,Not classified:1
56237,Trimethylvinylsilane,212-042-9,754-05-2,Flam. Liq. 2,REACH registration C&L,71,H225:71;H315:45;H319:45;H302:40;H335:43;H351:1;H413:1
56240,Dibromotetrafluoroethane,247-042-8,25497-30-7,Ozone 1,Notified C&L,6,H420:6
56242,3-nitropyridin-2-ol,228-709-2,6332-56-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:44;H319:44;H335:43;H341:4
56243,2-methylbutyl 3-methylbutenoate,308-193-6,97890-13-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1374,H315:1374;H319:1374;H335:1374
56244,"3,3,5-trimethylcyclohexanol",204-122-7,116-02-9,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1645,H315:1645;H319:1602;H412:1299;H318:43
56245,4-nitro-1-naphthylamine,212-277-7,776-34-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:40;H319:40;H335:39
56247,"Tallow, sulfonated, compds. with triethanolamine",295-533-0,92062-18-5,Not Classified,Notified C&L,3,Not classified:3
56249,"Linseed oil, epoxidized, polymer with acrylic acid",614-727-1,68783-72-2,Not Classified,Notified C&L,5,Not classified:5
56251,"(+-)-3-{2-[4-(6-FLUORO-1,2-BENZOXAZOL-3-YL)PIPERIDIN-1-YL]ETHYL}-9-HYDROXY-2-METHYL-6,7,8,9-TETRAHYDRO-4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE",620-493-1,144598-75-4,Acute Tox. 3,Notified C&L,50,H301:50;H361:2;H411:2;H336:2;H372:1;H412:1;H362:1
56253,OCTYL CHLOROACETATE,611-164-3,5451-98-9,Acute Tox. 4;Aquatic Acute 1,Notified C&L,38,H400:38;H302:38
56257,"1,2-dimethoxypropane",404-630-0,7778-85-0,Flam. Liq. 2,Harmonised C&L,0,H225:0
56260,"Caryophyllene, Reaction product with Acetic anhydride and acetic acid",925-425-7,,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,2,H411:2;H317:2
56261,2-octyldodecyl heptanoate,304-616-3,94277-33-5,Not Classified,Notified C&L,18,Not classified:18
56262,Creatine ethyl ester HCl,604-920-9,15366-32-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
56268,2-[(furan-2-ylmethyl)sulfanyl]-5-methylpyrazine,613-813-6,65530-53-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,152,H315:113;H319:113;H302:113;H318:39;H226:64
56272,"Sodium [4-[[dihydroxy[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]benzenesulphonato(3-)]cuprate(1-)",305-729-0,95009-01-1,Aquatic Chronic 2,REACH registration C&L,64,H411:42;H412:11;Not classified:11
56273,4-pentylphenol,239-015-4,14938-35-3,Skin Corr. 1B,Notified C&L,44,H314:43;H315:1;H319:1;H411:1;Not classified:1;H301:1;H400:1;H318:1
56275,"9-Octadecenoic acid, 12-hydroxy-, (9Z,12R)-, polymer with 1,2,3-propanetriol",608-428-5,29894-35-7,Not Classified,Notified C&L,69,Not classified:69
56276,Dipotassium hexafluorozirconate,240-985-6,16923-95-8,Acute Tox. 3;Eye Dam. 1,REACH registration C&L,167,H318:108;H301:160;H412:76;H315:38;H319:38;H335:38;H331:18;H314:16;H311:24;H300:6;Not classified:1
56277,Carbonylchlorobis(triphenylphosphine)iridium,238-941-6,14871-41-1,,Notified C&L,6,H332:4;H302:4;H312:4;H315:2;H319:2;H335:1;H311:1;H331:1;H301:1
56284,2-isopropylhydroquinone,219-080-5,2349-71-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H315:38;H335:38;H302:38;H318:38
56287,"2,2-diethoxy-N,N-dimethylacetamide",449-950-1,34640-92-1,Eye Irrit. 2,Harmonised C&L,0,H319:0
56292,Tetraethyl methylenebisphosphonate,216-764-5,1660-94-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H315:42;H319:42;H335:38
56300,"3,5,5-trimethylcyclohex-2-enone;isophorone",201-126-0,78-59-1,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;STOT SE 3;Carc. 2,Harmonised C&L,0,H319:0;H351:0;H302:0;H312:0;H335:0
56303,N-[3-(cyclohexylamino)-4-methoxyphenyl]acetamide,249-734-5,29633-64-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,38,H315:38;H319:38;H335:38;H413:38
56304,"Fatty acids, tall-oil, epoxidized, octyl esters",263-001-7,61788-72-5,Not Classified,Notified C&L,1,Not classified:1
56305,[No public or meaningful name is available],476-710-3,,Acute Tox. 4,Notified C&L,11,H302:11
56307,"2,6-bis(phenylmethoxy)benzonitrile",302-048-0,94088-47-8,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H315:38;H400:38;H410:38;H318:38;H335:38
56313,3-methyl-L-histidine,206-704-6,368-16-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
56316,Tributylpentylammonium bromide,253-314-7,37026-92-9,Acute Tox. 4,Notified C&L,38,H302:38
56319,2-acetyl-10-[2-(dimethylammonio)propyl]-10H-phenothiazinium maleate,231-228-0,7455-18-7,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,1,H411:1;H302:1;H317:1;H318:1
56328,"Soybean oil, potassium salt",274-068-7,69669-38-1,Eye Irrit. 2,Notified C&L,1,H319:1
56331,"sodium and potassium 4-(3-aminopropylamino)-2,6-bis[3-(4-methoxy-2-sulfophenylazo)-4-hydroxy-2-sulfo-7-naphthylamino]-1,3,5-triazine",416-280-6,156769-97-0,Skin Sens. 1,Harmonised C&L,0,H317:0
56333,Tetraoctylammonium perchlorate,246-969-5,25423-85-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
56334,"Polysulfides, di-tert-Bu",273-103-3,68937-96-2,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,679,H400:70;H410:70;H317:677;H412:501;H413:107;H315:49;H411:1
56335,"Formaldehyde, oligomeric reaction products with 4-tert-butylphenol and 1,3-cyclohexanedimethanamine",500-673-5,161308-31-2,Not Classified,Notified C&L,55,Not classified:55
56337,(S)-(+)-3-(Benzyloxycarbonyl)-5-oxo-4-oxazolidineacetic acid,607-253-1,23632-66-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
56340,Henicosan-11-ol,222-184-3,3381-26-8,Eye Irrit. 2,Notified C&L,39,H319:38;Not classified:1
56341,"Decanoic acid, mixed esters with hexanoic acid, octanoic acid and trimethylolpropane",268-595-1,68130-52-9,Not Classified,Notified C&L,9,Not classified:9
56349,"2,5-Furandione, polymer with ethene",618-429-2,9006-26-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1381,H315:1301;H319:1339;Not classified:42
56351,"3(or 4)-methylbenzene-1,2-diamine",248-145-0,26966-75-6,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Muta. 2;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,147,H350:147;H400:147;H341:147;H302:147;H312:147;H317:147;H410:7
56353,"1,3-Diisocyanato methylbenzene, 1,6-diisocyanato hexane polymer",613-208-7,63368-95-6,Skin Sens. 1,Notified C&L,155,H317:94;H334:59;Not classified:5;H335:3;H332:1
56355,Hexyl 2-furoate,254-377-3,39251-86-0,Not Classified,Notified C&L,88,Not classified:88
56357,"1,1'-Biphenyl,3',4',5'-trifluoro-2-nitro",619-856-7,1056196-56-5,Aquatic Chronic 2,REACH registration C&L,84,H411:84
56359,Mepenzolate bromide,200-992-7,76-90-4,Acute Tox. 4,Notified C&L,39,H302:39;H332:1;H312:1
56362,N-[2-[[2-[[2-[(2-aminoethyl)amino]ethyl]amino]ethyl]amino]ethyl]nonan-1-amide,247-649-8,26392-63-2,,Notified C&L,1,H335:1;H318:1;H314:1
56363,"Phosphoric acid, C16-20-alkyl esters, potassium salts",291-908-8,90506-46-0,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H315:1;H318:1
56364,2-(aminomethyl)propionic acid,205-644-8,144-90-1,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
56368,Tetravinylsilane,214-192-0,1112-55-6,Flam. Liq. 2;Acute Tox. 4;Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,46,H332:8;H225:46;H400:8;H361:8;H410:8;H315:38;H319:38;H335:38
56370,4-(hydroxyimino)valeric acid,230-103-8,6945-36-4,Acute Tox. 4,Notified C&L,38,H302:38
56372,"17-Hydroxy-1 alpha,2 alpha-methylene-4,6-pregnadiene-3,20-dione",606-682-1,2098-65-9,Not Classified,Notified C&L,1,Not classified:1
56373,3-(BENZYLTHIO)-PROPIONIC ACID,608-304-0,2899-66-3,Acute Tox. 4;Skin Sens. 1,Notified C&L,39,H302:39;H317:39
56375,Fluoranthene,205-912-4,206-44-0,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,84,H400:61;H410:60;H302:81;Not classified:9;H319:4;H332:2
56376,"α-d-Glucopyranose, 1-(dihydrogen phosphate), disodium salt",260-154-1,56401-20-8,Not Classified,Notified C&L,2,Not classified:2
56378,"Hydrogen [4-[4-(dimethylamino)-α-(3,6-disulphonato-1-naphthyl)benzylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium, sodium salt",229-217-0,6434-86-2,Not Classified,Notified C&L,21,Not classified:21
56379,"5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-(ethylsulfinyl)-1H-pyrazole-3-carbonitrile",446-630-3,181587-01-9,STOT RE 2;Aquatic Chronic 1,REACH registration C&L,2,H373:2;H410:2
56382,"Silicic acid, aluminum sodium salt",215-684-8,1344-00-9,Not Classified,REACH registration C&L,525,Not classified:510;H315:14;H319:14;H335:14;H332:1
56384,"Pyrochlore, antimony lead yellow",232-382-1,8012-00-8,Carc. 2;Repr. 1A;STOT RE 1;Aquatic Chronic 1,REACH registration C&L,12,H351:6;H410:12;H360:12;H372:6;H373:6;H332:1;H302:1
56389,"O,O-dipropyl chlorothiophosphate",219-757-5,2524-05-2,Acute Tox. 3;Eye Dam. 1,Notified C&L,38,H318:38;H301:38
56393,3-chloro-N-[2-[(2-cyano-4-nitrophenyl)azo]-5-(diethylamino)phenyl]propionamide,269-307-7,68214-65-3,Aquatic Chronic 2,Notified C&L,34,H411:31;Not classified:3
56395,"1,3-diisopropylbenzene",202-773-1,99-62-7,Not Classified,REACH registration C&L,15,Not classified:3;H400:12;H410:12;H361:11;H335:11;H336:11;H315:1;H319:1
56399,Sodium a-hydroxybenzylphosphinate,231-313-2,7492-18-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,40,H315:40;H319:40;H335:40
56401,Harmaline,206-152-6,304-21-2,STOT SE 2,Notified C&L,2,H371:1;Not classified:1
56402,2-methyl-4-phenylbutan-2-ol,203-074-4,103-05-9,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1689,H319:1329;H412:1329;Not classified:311;H318:39;H315:10
56403,C.I. Solvent Brown 43,612-086-2,61116-28-7,Not Classified,Notified C&L,5,Not classified:5
56406,Ethyl 2-chloroacetoacetate,210-180-4,609-15-4,Acute Tox. 3;Skin Corr. 1A;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,134,H400:89;H314:130;H318:89;H410:5;H301:5;H302:129;H226:41;H315:4;H319:4;H335:4;H412:1
56407,"Sebacic acid, compound with 2-aminoethanol",280-045-2,82801-62-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,42,H315:42;H319:42;H314:25
56408,N-(tert-butyloxycarbonyl)-L-threonine,219-987-6,2592-18-9,Not Classified,REACH registration C&L,7,Not classified:4;H315:3;H319:3;H335:3
56409,"1-BUTANESULFONAMIDE, 1,1,2,2,3,3,4,4,4-NONAFLUORO-N-METHYL-",614-396-3,68298-12-4,Acute Tox. 4;Eye Irrit. 2;Repr. 2;Aquatic Chronic 2,Notified C&L,38,H361:38;H319:38;H302:24;H411:24;H301:14
56410,m-chlorophenethylic alcohol,225-964-1,5182-44-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
56411,"1-phenylbutane-1,2,3-trione 2-oxime",229-869-6,6797-44-0,Acute Tox. 3,Notified C&L,42,H301:38;H315:4;H319:4;H335:4
56413,6-chlorobenzothiazole-2-thiol,257-321-6,51618-29-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H332:1;H319:1;H302:1;H312:1;H335:1
56415,"Disodium 4,5-dihydroxynaphthalene-2,7-disulphonate",204-972-9,129-96-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,14,H315:12;H319:12;H335:11;H318:6;Not classified:2
56416,methyl 3-isocyanatosulfonyl-2-thiophene-carboxylate,410-550-7,79277-18-2,Skin Sens. 1;Resp. Sens. 1;STOT RE 2,Harmonised C&L,0,H373:0;H317:0;H334:0
56418,4-methoxybenzothiazol-2-ylamine,226-763-1,5464-79-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,44,H332:39;H302:44;H312:39
56421,"Aspidospermidine-3-carboxylic acid, 2,3,6,7-tetradehydro-, methyl ester, (5α,12β,19α)-",224-615-0,4429-63-4,Acute Tox. 4,Notified C&L,1,H302:1
56422,Man-made vitreous (silicate) fibres with random orientation with alkaline and alkali earth oxides (Na2O+K2O+CaO+ MgO+BaO) content greater than 18% by weight and fulfilling one of the CLP Regulation Annex VI Note Q conditions,926-099-9,,Not Classified,REACH registration C&L,138,Not classified:138
56424,cis-dichloroethylene,205-859-7,156-59-2,Flam. Liq. 2;Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H332:0;H225:0
56425,"1,2-dichlorohexafluorocyclopentene",211-895-4,706-79-6,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,44,H315:44;H319:44;H331:38;H335:44;H301:42;H330:5;H302:1
56427,4-(4-hydroxyphenyl)butanoic acid,615-082-9,7021-11-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H302:1;H335:1
56429,5-chlorothiophene-2-carbaldehyde,230-708-7,7283-96-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,46,H332:40;H302:40;H312:40;H315:8;H319:8;H335:7
56430,"(R)-3-chloropropane-1,2-diol",435-560-9,57090-45-6,Met. Corr. 1;Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 2;Carc. 2;Repr. 1B;Repr. 1B;STOT SE 1;STOT SE 1;STOT RE 1;STOT RE 1,REACH registration C&L,4,H315:3;H370:3;H360:3;H290:3;H330:3;H351:3;H318:4;H372:3;H301:3;H331:1;H300:1;H311:1
56436,"disodium 7-[4-chloro-6-(N-ethyl-o-toluidino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)-2-naphthalenesulfonate",410-390-8,147703-64-8,Eye Dam. 1,Harmonised C&L,0,H318:0
56438,"2-phosphonobutane-1,2,4-tricarboxylic acid, sodium salt",254-894-4,40372-66-5,Not Classified,Notified C&L,83,Not classified:64;H319:19;H302:15;H332:15;H290:1
56439,Magnesium bis(dinonylnaphthalenesulphonate),248-777-7,28015-99-8,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,35,H315:2;H319:2;Not classified:33
56444,Ethyl (2-methoxyphenoxy)acetate,235-977-4,13078-21-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H332:1;H319:1;H302:1;H312:1;H335:1
56455,"(E)-3,7-dimethylocta-3,6-dienenitrile",247-752-8,26509-71-7,Muta. 1B;Aquatic Chronic 2,Notified C&L,10,H411:10;H340:10
56457,1-(4-morpholinophenyl)butan-1-one,413-790-0,,Aquatic Chronic 2,Harmonised C&L,0,H411:0
56459,"2,6-dimethylpyrazine",203-589-4,108-50-9,Flam. Liq. 3;Acute Tox. 4,Notified C&L,1680,H302:1678;H226:1596;H315:46;H335:45;H318:39;H228:50;H319:7;H314:1;H411:1;H301:1
56460,3-nitrobenzaldehyde,202-772-6,99-61-6,Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,176,H411:48;H302:47;Not classified:84;H315:52;H319:52;H335:49;H371:2;H301:2
56464,"Propyl 2,4-decadienoate",284-147-8,84788-08-9,Skin Irrit. 2,Notified C&L,1374,H315:1374
56466,Glycerol trimyristate,209-099-7,555-45-3,Not Classified,REACH registration C&L,5,Not classified:5
56469,Trisodium 8-[(7-amino-1-hydroxy-3-sulphonato-2-naphthyl)azo]-5-[[4-(phenylazo)-7-sulphonatonaphthyl]azo]naphthalene-2-sulphonate,233-374-0,10134-33-5,Not Classified,Notified C&L,4,Not classified:4
56473,"Propene, homopolymer, reaction products with methyl hydrogen maleate, lithium salts",500-438-7,159168-81-7,,Notified C&L,1,Not classified:1
56474,[No public or meaningful name is available],450-310-9,,Skin Irrit. 2;Aquatic Chronic 1,Notified C&L,1,H315:1;H410:1
56476,1-chloro-4-isocyanato-2-(trifluoromethyl) benzene,608-783-6,327-78-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47,H315:47;H332:44;H319:45;H302:46;H312:40;H335:45;H334:6;H331:1;H301:1;H400:1;H318:2;H317:2;H410:2;H330:1
56478,n-butyl acetate,204-658-1,123-86-4,Flam. Liq. 3;STOT SE 3,Harmonised C&L,0,H336:0;H226:0
56480,"Sodium 4-(2H-naphtho[1,2-d]triazol-2-yl)stilbene-2-sulphonate",229-131-3,6416-68-8,Not Classified,Notified C&L,5,Not classified:5
56487,Cadmium di(acetate),208-853-2,543-90-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,73,H332:73;H400:73;H302:73;H312:73;H410:73;H350:2;Not classified:1
56488,Diethyl N-[4-(methylamino)benzoyl]-D-glutamate,257-481-7,51865-66-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H315:1;H319:1;H302:1;H332:1
56489,2-fluorophenylacetonitrile,206-313-0,326-62-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,46,H315:45;H332:45;H319:45;H302:45;H312:45;H335:40;H226:4;H311:1;H331:1;H301:1
56492,"Benzenemethanaminium, N-(3-aminopropyl)-N,N-dimethyl-, N-coco acyl derivs., chlorides",263-079-2,61789-70-6,Skin Corr. 1C;Eye Dam. 1,Notified C&L,462,H318:442;H314:442;Not classified:20;H400:1;H412:1
56494,Oxcarbazepine,249-188-8,28721-07-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,100,H332:55;H302:96;H312:55;Not classified:3;H334:1;H411:1;H315:1;H319:1;H412:1;H335:1
56495,Dexamethasone 21-acetate,214-646-8,1177-87-3,Repr. 2;STOT RE 2,REACH registration C&L,90,H361:4;H373:20;H317:43;H360:44;H302:2;H315:1;H332:1;H319:1;H312:1;H320:1;H335:1;H362:2;H412:1;H372:2
56496,"Copper benzene-1,3,5-tricarboxylate",610-761-6,51937-85-0,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1,Notified C&L,38,H315:38;H319:38;H400:38;H301:38
56498,"Dibenzo[b,def]chrysene-7,14-dione",204-903-2,128-66-5,Not Classified,Notified C&L,1,Not classified:1
56501,"Xanthylium, 9-(2-carboxyphenyl)-3,6-bis(diethylamino)-, molybdatesilicate",263-778-2,62973-79-9,Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,2,H411:2;H318:2
56503,"2,4,6-trimethylstyrene",212-205-4,769-25-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,43,H332:38;H302:38;H312:38;H315:5;H319:5;H335:4
56512,"Butanedioic acid, mono[[6-[3-(3-carboxy-1-oxopropoxy)-3,4-dihydro-5,7-dihydroxy-4-oxo-2H-1-benzopyran-2-yl]-2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-1,4-benzodioxin-2-yl]methyl] ester, disodium salt, [2R-[2α,3β,6(2R*,3R*)]]-",259-554-9,55254-34-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1;H312:1
56513,1-deoxy-1-(methylamino)-D-glucitol 2-[2-methyl-3-(perfluoromethyl)anilino]nicotinate,255-836-0,42461-84-7,Acute Tox. 3;Eye Irrit. 2;Acute Tox. 2;Aquatic Chronic 2,Notified C&L,206,H411:159;H319:130;H330:158;H301:163;H315:40;H335:113;H318:72;H372:50;H373:20;H331:5;H302:3;H332:2;H412:1;Not classified:2
56514,Yttrium trinitrate,233-802-6,10361-93-0,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,119,H400:8;H410:8;H302:8;H318:43;H319:22;Not classified:53;H315:57;H272:58;H335:57
56520,"Hexane-2,4-dione",221-094-1,3002-24-2,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H331:1;H302:1;H311:1;H226:1
56525,1-(2-hydroxy-4-methylphenyl)ethan-1-one,230-040-6,6921-64-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:38
56528,Methyl 5-allyl-3-methoxysalicylate,287-929-7,85614-43-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H302:38;H335:38
56532,"(2Z)-3-amino-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)but-2-en-1-one",616-378-0,767340-03-4,Not Classified,Notified C&L,1,Not classified:1
56538,Methylaluminium dichloride,213-032-7,917-65-7,Water-react. 1;Skin Corr. 1B,Notified C&L,38,H260:38;H314:38
56543,3-benzyloxybenzyl alcohol,212-648-3,836-42-0,Skin Corr. 1B,Notified C&L,39,H314:39;H290:1;H318:1
56546,Dipotassium hydrogen phosphate (k2hpo4) trihydrate,605-492-6,16788-57-1,,Notified C&L,39,Not classified:39
56547,Ethyl isobutyrylacetate,230-491-9,7152-15-0,Flam. Liq. 3,Notified C&L,46,H226:46;H315:3;H319:3;H335:3
56550,(2-aminoethyl)trimethyl chloride hydrochloride,222-266-9,3399-67-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
56551,"2,5-dihydro-2,2,5,5-tetramethyl-1H-pyrrole-3-carboxamide",243-331-8,19805-75-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H315:42;H319:42;H335:42
56552,N-isopropyl-4-nitroaniline,246-721-6,25186-43-0,,Notified C&L,4,H332:4;H302:4;H312:4
56553,"4-[(1,5-dihydro-3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-ylidene)methyl]-2,4-dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one",225-184-1,4702-90-3,Repr. 2;Aquatic Chronic 4,REACH registration C&L,2392,H361:174;H413:174;Not classified:2218
56557,Hex-1-ene,209-753-1,592-41-6,Flam. Liq. 2;Asp. Tox. 1,REACH registration C&L,354,H304:257;H225:347;H315:23;H319:49;H335:27;H411:30;H336:17;Not classified:1
56558,"7-methoxy-1,2,3,4-tetrahydronaphthalen-1-one",229-916-0,6836-19-7,Aquatic Chronic 3,REACH registration C&L,1,H412:1
56565,Triethyl borate,205-760-9,150-46-9,Flam. Liq. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,80,H319:30;H335:29;H225:80;H315:27;H361:26;Not classified:2;H226:1;H400:1;H410:1
56566,"Ethyl 2,3-epoxy-3-p-tolylbutyrate",277-844-3,74367-97-8,Skin Irrit. 2,Notified C&L,88,H315:88
56574,7-isopropyl-1-methylphenanthrene,207-597-9,483-65-8,Aquatic Chronic 1,Notified C&L,41,H410:38;Not classified:3
56577,"Juniper, Juniperus procera, ext.",285-369-8,85085-40-1,Asp. Tox. 1;Aquatic Chronic 2,Notified C&L,4,H411:4;H304:4
56578,"Fatty acids, C12-22 and C16-18-unsatd., Me esters, mixed with rape oil, sulfurized",292-824-4,91001-54-6,,Notified C&L,1,Not classified:1
56582,"ethoate-methyl (ISO);ethylcarbamoylmethyl O,O-dimethyl phosphorodithioate",204-121-1,116-01-8,Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H302:0;H312:0
56583,N-phenylbenzene-p-diamine monohydrochloride,218-599-4,2198-59-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H315:39;H332:38;H319:39;H302:39;H312:38;H335:38
56586,"A mixture of :- N,N’-hexamethylenedi(docosanamide) and N,N’-hexamethylenedi(icosanamide) and N,N’-hexamethylenedi(stearamide) and N,N’-hexamethylenedi(palmitamide)",928-976-1,,Not Classified,Notified C&L,442,Not classified:442
56589,"reaction mass of 2-acryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate and 2-methacryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate",405-360-6,,Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H315:0;H412:0;H318:0;H317:0
56590,"3-decyldihydrofuran-2,5-dione",242-350-9,18470-76-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
56592,"1H-Indene-1,3(2H)-dione, 2-(2-quinolinyl)-, sulfonated, sodium salts",305-897-5,95193-83-2,Not Classified,REACH registration C&L,196,Not classified:187;H302:8;H319:1
56593,1-(4-chlorobutoxy)-2-methylbenzene,280-595-3,83732-48-3,Acute Tox. 3;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,38,H411:38;H319:38;H301:38
56594,"2,3,6-Trimethylcyclohexanol",918-414-3,58210-03-0,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1,H315:1;H319:1;H412:1
56597,2-ethyl-5-methylpyrazine,236-416-6,13360-64-0,Flam. Liq. 3;Acute Tox. 4,Notified C&L,1591,H302:1591;H226:1551;H315:41;H319:41;H335:3
56599,"(Z,Z)-1,1,3,3-tetramethyl-1,3-bis[(1-oxooctadec-9-enyl)oxy]distannoxane",256-113-2,43136-18-1,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,Notified C&L,15,H332:9;H319:9;H302:15;H312:9
56601,"[3S-(3α ,4aβ ,8aβ )]-N-(tert-Butyl)decahydro-3-isoquinolinecarboxamide",603-964-6,136465-81-1,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,38,H412:38;H302:38;H318:38
56603,1-pentyn-3-ol,224-063-0,4187-86-4,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,45,H301:45;H331:39;H311:40;H226:45;H315:1;H330:1;H319:1;H335:1
56607,"1,2,4,5-tetramethylbenzene",202-465-7,95-93-2,Flam. Sol. 1;Aquatic Chronic 4,Notified C&L,292,H228:263;H413:199;Not classified:24;H411:5;H400:1;H410:1
56608,2-naphthalen-2-yloxyethanol,609-139-7,35545-57-4,Acute Tox. 4,Notified C&L,375,H302:285;H315:90;H319:91;H411:25;H341:1;H335:1
56613,"Hexanedioic acid, mixed esters with decanoic acid, 12-hydroxyoctadecanoic acid, isostearic acid, octanoic acid, 3,3'-oxybis[1,2-propanediol] and stearic acid",406-144-4,,Not Classified,REACH registration C&L,5,Not classified:5
56614,Pentamethylsilylamine,218-222-3,2083-91-2,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,74,H225:74;H314:73;H260:22;H332:2;H312:2;H335:4;H318:4;H261:1;H400:1;H410:1;H411:1;H302:1
56618,"1,5,5-trimethylcyclohexene",207-969-0,503-46-8,Flam. Liq. 3,Notified C&L,25,H226:25
56623,(3-methoxyphenyl)boronic acid,600-467-6,10365-98-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H315:50;H319:50;H302:41;H335:49;H332:1;H312:1
56627,"Oxirane, 2,2',2''-[methylidynetris(phenyleneoxymethylene)]tris-",613-891-1,66072-38-6,Skin Irrit. 2;Skin Sens. 1,Notified C&L,15,H315:15;H317:15
56634,N-methyl-3-(triethoxysilyl)propylamine,227-934-3,6044-50-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
56637,1-naphthylacetonitrile,205-078-1,132-75-2,Not Classified,REACH registration C&L,49,Not classified:2;H315:44;H332:43;H319:44;H302:45;H312:43;H335:43;H311:2;H331:2;H301:2
56638,"3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3',6'-diyl diacetate",209-877-6,596-09-8,Not Classified,REACH registration C&L,2,Not classified:2
56644,"N-[(1,1-dimethylethoxy)carbonyl]-L-leucine",236-073-2,13139-15-6,Not Classified,Notified C&L,4,Not classified:3;H315:1;H319:1;H335:1
56651,4-methoxy-3-nitrophenyl phenyl ketone,279-997-1,82571-94-6,Aquatic Acute 1,Notified C&L,38,H400:38
56655,p-hydroxybenzenesulphonamide,216-408-9,1576-43-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:2;H335:1
56656,"2,3,5-trichloropyridine",407-270-2,16063-70-0,Aquatic Chronic 3,Harmonised C&L,0,H412:0
56659,[No public or meaningful name is available],460-370-8,,Eye Dam. 1,Notified C&L,1,H318:1
56660,"1-[4-(2,2-Dichlorocyclopropyl)phenyl]ethan-1-one",609-853-9,40641-93-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H302:1;H335:1
56662,"1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purine-7-acetic acid, compound with piperazine (2:1)",242-614-3,18833-13-1,Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H302:2;H332:2
56663,"(2E,4E)-hepta-2,4-dienal",224-328-0,4313-03-5,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1597,H315:1592;H319:1553;H302:1593;H311:1594;Not classified:3;H332:1;H331:1;H301:1
56666,"Fatty acids, tall-oil, reaction products with diethylenetriamine, acetates",268-887-9,68153-60-6,Skin Corr. 1C;Eye Dam. 1,Notified C&L,526,H318:441;H314:441;H315:85;H319:85;H400:22;H335:21
56667,"9-Octadecenoic acid (Z)-, sulfited, ammonium salts",309-502-7,100402-66-2,Eye Dam. 1,Notified C&L,28,H318:28
56669,"2,2-dimethyl-1,3-propanediyl bis(2-hexyldecanoate)",267-187-0,67801-67-6,Not Classified,Notified C&L,2,Not classified:2
56671,"2,3,3,3-tetrafluoro-2-[1,1,2,3,3,3-hexafluoro-2-(heptafluoropropoxy)propoxy]propionic acid",236-237-3,13252-14-7,Skin Corr. 1B;Acute Tox. 1;Resp. Sens. 1,Notified C&L,33,H334:33;H314:33;H330:33
56674,"2,5,6-triaminopyrimidin-4(1H)-one sulfate (1:1)",609-054-5,35011-47-3,Not Classified,REACH registration C&L,41,Not classified:1;H315:40;H319:40;H335:39
56675,Nonylnaphthalene,248-313-3,27193-93-7,,Notified C&L,1,Not classified:1
56676,"(3aα,4α,7α,7aα)-octahydro-4,7-methano-1H-indene",220-586-3,2825-83-4,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,3,H315:3;H304:2;H400:2;H319:3;H317:2;H226:2;H410:2;H332:1;H225:1;H411:1;H302:1;H335:1
56677,1-nitrosopyrrolidine,213-218-8,930-55-2,Acute Tox. 4;Carc. 2,Notified C&L,46,H351:42;H302:45;H350:3;Not classified:1
56682,C.I. Reactive Blue 21,602-657-4,12236-86-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H315:33;H319:33;H335:33;Not classified:17
56683,"3,4-dinitrobenzoic acid",208-433-9,528-45-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:43;H319:43;H335:42;H341:4;H331:1;H311:1;H301:1
56685,1-(4-methoxyphenyl)cyclopentanecarbonitrile,214-890-5,1206-15-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1;H312:1
56687,"(E)-(7R,11R)-3,7,11,15-tetramethylhexadec-2-ene-1-ol",416-120-5,150-86-7,Skin Irrit. 2;Aquatic Chronic 4,Harmonised C&L,0,H315:0;H413:0
56690,Benzyl L-alaninate hydrochloride,226-920-4,5557-83-5,Not Classified,Notified C&L,1,Not classified:1
56692,"Benzenesulfonic acid, 4-C10-13-sec-alkyl derivs., compds. with diethanolamine",284-904-2,84989-15-1,Skin Irrit. 2;Eye Dam. 1,Notified C&L,18,H315:18;H318:18;H302:5
56693,(Z)-tetradec-7-enal,265-493-9,65128-96-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:38;H319:38;H335:38;H332:1
56695,Diiron boride,234-490-4,12006-85-8,Not Classified,Notified C&L,1,Not classified:1
56696,Piperidinium chloride,228-033-8,6091-44-7,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,48,H315:3;H319:3;H301:48;H311:1;H331:1;H335:1
56697,"Fatty acids, C12-18 and C18-unsatd., reaction products with 2-[(2-aminoethyl)amino]ethanol",295-169-2,91844-99-4,Eye Dam. 1,Notified C&L,3,H318:2;H412:1
56700,1-ethylbenzimidazolin-2-one,233-148-1,10045-45-1,Acute Tox. 4;Eye Irrit. 2,Notified C&L,40,H319:40;H302:40;H315:1;H335:1
56701,9-octadecenyl dihydrogen phosphate,246-354-1,24613-61-4,Skin Irrit. 2;Eye Dam. 1,Notified C&L,54,H315:53;H318:53;Not classified:1
56703,"(9beta,11beta)-3,20-dioxo-9,11-epoxypregna-1,4,16-trien-21-yl acetate",600-439-3,103466-44-0,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1;Repr. 2,REACH registration C&L,3,H361:3;H302:3;H317:2;H334:2;H315:1;H332:1;H319:1;H312:1;H335:1
56712,Dodecylguanidine monohydrochloride,237-030-0,13590-97-1,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,74,H330:73;H400:73;H314:74;H302:74;H318:51;H410:70
56714,"2,2,2-trifluoroethylamine",212-041-3,753-90-2,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1B,Notified C&L,63,H302:50;H225:63;H314:62;H331:8;H332:6;H315:1;H319:1;H312:2;H335:1;H318:2
56717,Sucrose oleate,247-041-2,25496-92-8,Not Classified,Notified C&L,31,Not classified:31
56719,2-chloro-4-(1-phenylethyl)phenol,279-995-0,82566-19-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H302:1;H335:1
56729,Beeswax,232-383-7,8012-89-3,Not Classified,Notified C&L,341,Not classified:340;H317:1
56735,"Benzoic acid, compound with 2,2',2''-nitrilotriethanol (1:1)",236-002-5,13090-86-3,Not Classified,Notified C&L,26,Not classified:26
56736,Dysprosium trinitrate,233-410-5,10143-38-1,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,6,H400:4;H410:4;H318:4;H315:1;H272:1;H335:1;H319:1;H228:1;Not classified:1
56740,"Hydrazine, hydrate",600-285-7,10217-52-4,,Notified C&L,9,H350:8;H330:4;H400:7;H314:7;H300:4;H317:7;H311:7;H410:7;H226:4;H331:3;H301:3;Not classified:1
56741,Disodium 4-hydroxy-3-[(4-sulphonatonaphthyl)azo]naphthalenesulphonate,222-657-4,3567-69-9,Not Classified,REACH registration C&L,2313,Not classified:2220;H315:80;H319:80;H335:79;H412:13
56742,"Anthra[9,1,2-cde]benzo[rst]pentaphene-5,10-dione, chloro derivatives",215-378-4,1324-54-5,Not Classified,Notified C&L,12,Not classified:12
56743,Dimethyl selenide,209-807-4,593-79-3,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,44,H400:43;H373:43;H331:44;H410:43;H301:44;H311:1;H225:1
56747,Potassium ricinoleate,231-314-8,7492-30-0,Eye Irrit. 2,Notified C&L,76,H319:72;H411:25;H315:9;Not classified:4
56748,"3-[[1-benzyl-1H-indazol-3-yl]oxy]-N,N-dimethylpropylamine monohydrochloride",205-076-0,132-69-4,Acute Tox. 4;Eye Irrit. 2,Notified C&L,103,H319:100;H302:103;H315:1;H413:1
56751,"1H-Imidazole, monohydrochloride",604-535-6,1467-16-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,41,H315:41;H319:41;H335:1
56752,"5-methyl-1,3,4-thiadiazole-2(3H)-thione",249-667-1,29490-19-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,60,H315:59;H319:59;H335:58;H302:3;H332:1;H312:1
56753,"4,4'-(dichlorovinylidene)diphenol",238-940-0,14868-03-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H315:48;H319:48;H335:47
56754,Dibutyl dihydrogen diphosphate,249-299-1,28901-77-1,Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1,Notified C&L,1,H400:1;H318:1;H314:1
56755,Mercaptamine hydrochloride,205-858-1,156-57-0,Skin Corr. 1B;STOT SE 3,REACH registration C&L,129,H335:30;H314:6;H319:16;H302:107;H317:3;Not classified:19;H315:13;H332:2;H312:2
56757,5-methoxysalicylaldehyde,211-589-0,672-13-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H315:46;H319:46;H335:45
56762,(4-chlorobutyl)benzene,225-408-8,4830-93-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:38
56763,"Benzenesulfonic acid, 4-amino-, diazotized, coupled with Dyer’s mulberry (Chlorophora tinctoria) extract, sodium salts",285-231-7,85049-60-1,Not Classified,Notified C&L,1,Not classified:1
56766,"4,4-methylenebis-3-(chloro-2,6-diethyl)-aniline",676-677-7,106246-33-7,Aquatic Chronic 4,Notified C&L,103,H413:54;H411:32;Not classified:17
56768,Cu-HDO,608-595-4,312600-89-8,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,83,H400:83;H410:83;H302:83;H318:83
56773,Tetraisopropyl methylenebisphosphonate,216-765-0,1660-95-3,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2A;Aquatic Chronic 3,REACH registration C&L,69,H319:9;H302:14;H312:10;H412:6;H318:59;H411:14;H311:18;H331:14;H335:14;H301:14;H315:1
56777,"3,4-dichloro-N-[5-chloro-4-[2-[4-(hexadecyloxy)phenylsulfonyl]butyramido]-2-hydroxyphenyl]benzamide",431-110-0,,Aquatic Chronic 4,Harmonised C&L,0,H413:0
56784,TROYSOL LAC,452-570-9,,Skin Irrit. 2;Eye Dam. 1;STOT RE 2;Aquatic Chronic 2,Notified C&L,238,H315:238;H373:237;H318:238;H411:238;H319:52;H335:1
56785,"5,5'-dithiodi-1,3,4-thiadiazole-2(3H)-thione",276-763-0,72676-55-2,Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,49,H411:20;H317:20;Not classified:27;H315:2;H302:2;H318:2
56787,4-decylbenzoyl chloride,259-046-7,54256-43-8,,Notified C&L,4,H314:4
56788,"S,S',S'-tributyl phosphorotrithioite",205-761-4,150-50-5,Acute Tox. 4,Notified C&L,3,H302:2;Not classified:1
56790,"Oils, vegetable, Me esters, sulfurized",273-617-8,68990-64-7,Not Classified,Notified C&L,1,Not classified:1
56792,Trifluoro(piperidine)boron,209-752-6,592-39-2,Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,1,H315:1;H300:1;H335:1;H319:1
56796,Heptyltriphenylphosphonium bromide,236-539-5,13423-48-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:44;H319:44;H335:43;H302:1
56804,"Tall oil, reaction products with N-(2-aminoethyl)piperazine",295-532-5,92062-17-4,Not Classified,Notified C&L,9,Not classified:9
56805,"Poly(oxy-1,2-ethanediyl), #-(2-methyl-1-oxo-2-propen-1-yl)-#-(nonylphenoxy)-",610-593-3,50974-49-7,Acute Tox. 3;Aquatic Chronic 2,Notified C&L,20,H411:20;H301:20
56808,p-propylbenzaldehyde,249-221-6,28785-06-0,Acute Tox. 4,Notified C&L,39,H302:39;H315:1;H332:1;H319:1;H312:1;H335:1
56809,S-allyl O-pentyl dithiocarbonate,220-977-9,2956-12-9,Flam. Liq. 4;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,18,H315:18;H319:4;H302:18;H312:4;H227:4;H411:14;H311:14
56811,"4-chloro-α,α,α-trifluoro-m-toluidine",206-277-6,320-51-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,58,H315:58;H319:58;H335:52;H302:45;H332:6;H312:6;H311:2;H331:2;H301:2;H412:1
56816,"Nonylbenzoate, branched and linear",447-010-5,670241-72-2,Aquatic Chronic 2,Notified C&L,2,H411:2;H361:1
56822,Tributylhexadecylphosphonium bromide,239-014-9,14937-45-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:43;H319:43;H335:42
56823,6-methoxy-2-phenyl-4-benzopyrone,248-144-5,26964-24-9,,Notified C&L,4,H315:4;H319:4;H335:4
56824,Methyl benzilate,200-991-1,76-89-1,Acute Tox. 4,REACH registration C&L,41,H302:40;Not classified:1
56828,"Trisodium 4,5-dihydro-5-oxo-4-[[4-[[[3-[[2-(sulphonatooxy)ethyl]sulphonyl]phenyl]amino]carbonyl]phenyl]azo]-1-(4-sulphonatophenyl)-1H-pyrazole-3-carboxylate",276-449-3,72187-36-1,,Notified C&L,11,Not classified:11
56829,"Fatty acids, C18-unsatd., polymers with diethylenetriamine and maleic anhydride",617-659-0,850255-82-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
56830,"Phosphoric acid, C8-16-alkyl esters, reaction products with (Z)-N-9-octadecenyl-1,3-propanediamine",291-909-3,90506-47-1,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,26,H315:26;H319:26
56832,Tetrahydro-4-methyl-2-(2-methylprop-1-enyl)pyran,240-457-5,16409-43-1,Skin Irrit. 2;Eye Irrit. 2;Repr. 2,REACH registration C&L,1750,H315:1663;H319:1621;H361:1528;H412:111;Not classified:88;H360:1
56835,"4-(benzoylamino)-5-hydroxynaphthalene-2,7-disulphonic acid",204-192-9,117-46-4,Not Classified,Notified C&L,1,Not classified:1
56836,"Ethanol, 2,2'-iminobis-, N-[3-(branched decyloxy)propyl] derivs., N-oxides",270-830-8,68478-65-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,59,H315:37;H319:59;H226:1
56839,Cinnamonitrile,224-441-5,4360-47-8,Acute Tox. 3;Acute Tox. 4;Skin Sens. 1,Notified C&L,1620,H312:1596;H317:1596;H301:1594;H315:24;H319:24;H332:13;H335:4;H302:2
56844,"5-bromo-5-nitro-1,3-dioxane",250-001-7,30007-47-7,Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,200,H400:87;H373:86;H314:151;H302:199;H318:152;H410:151;H317:42;H315:44;H319:5;H312:3;H311:1;H335:1
56849,Sodium DL-methionate,255-568-4,41863-30-3,Eye Dam. 1,Notified C&L,5,H318:5
56850,Dimethyl[(3-stearoylamino)propyl]ammonium lactate,259-837-7,55819-53-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,20,H315:20;H319:19;H318:1
56854,Nicoboxil,237-684-7,13912-80-6,Acute Tox. 4,Notified C&L,5,H302:5;H315:1;H319:1;H335:1
56856,React Navy Blue 9913,442-890-7,,Skin Sens. 1;Resp. Sens. 1;Aquatic Chronic 3,Notified C&L,2,H412:1;H317:1;H334:1;Not classified:1
56859,"3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)aniline",401-790-3,104147-32-2,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H302:0
56860,1-Amidinopyrazole Hydrochloride,609-797-5,4023-02-3,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;STOT RE 2;Aquatic Chronic 3,Notified C&L,40,H373:39;H412:40;H302:40;H318:40;H317:40
56864,"(2,2-dimethyl-1,3-dioxolan-4-yl)methyl anthranilate",225-572-0,4934-23-0,Acute Tox. 4,Notified C&L,1,H302:1
56865,"2-hydroxy-4,6-dimethylnicotinonitrile",212-207-5,769-28-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,46,H315:46;H332:40;H319:46;H302:45;H312:41;H335:45
56867,"3-[(dimethylvinylsilyl)oxy]-1,1,5,5-tetramethyl-3-phenyl-1,5-divinyltrisiloxane",262-056-4,60111-47-9,Aquatic Chronic 4,Notified C&L,37,H413:36;H315:1;H319:1
56868,2-oxopropiononitrile,211-159-2,631-57-2,Flam. Liq. 2;Acute Tox. 3;Skin Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,40,H315:40;H225:40;H331:38;H335:40;H301:38;H330:2;H410:2;H411:2;H300:2
56870,Tributylmethylammonium bromide,253-313-1,37026-88-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H315:42;H319:42;H335:42
56873,2-furfuryl-α-methylamine,244-778-1,22095-34-7,,Notified C&L,1,H225:1;H314:1
56876,"(Z)-3-[2-hydroxy-3-(9-octadecenyloxy)propoxy]propane-1,2-diol",307-788-8,97752-26-6,Not Classified,Notified C&L,1,Not classified:1
56878,Benz[cd]indol-2(1H)-one,204-973-4,130-00-7,Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,45,H411:3;H319:4;H302:42;H315:1;H332:1;H335:1
56880,Sodium bis(2-hydroxyhexadecyl) phosphate,304-615-8,94277-32-4,Not Classified,Notified C&L,47,Not classified:47
56881,Labdanum,283-893-1,84775-64-4,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1475,H304:1457;H400:1447;H319:1388;H317:1465;H226:1394;H410:1455;H411:45;Not classified:9;H315:8;H316:2;H401:2;H412:1
56884,"Decanoic acid, mixed esters with heptanoic acid, octanoic acid and trimethylolpropane",268-596-7,68130-53-0,Not Classified,REACH registration C&L,35,Not classified:35
56891,"m-(4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzenesulphonamide",201-895-2,89-29-2,Not Classified,Notified C&L,278,Not classified:239;H315:39;H319:39;H335:38
56895,Hexyl dihydrogen phosphate,223-451-7,3900-04-7,Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,84,H412:83;H318:83;H314:83;Not classified:1
56897,Hexakis[μ-(acetato-O:O')]tripalladium,258-424-9,53189-26-7,Eye Dam. 1,Notified C&L,37,H318:36;H413:1;H317:1;H319:1
56903,Bis[4-[2-hydroxy-3-(isopropylamino)propoxy]-2-methyl-1H-indole] sulphate,260-153-6,56396-94-2,Acute Tox. 3,Notified C&L,24,H301:24
56906,Bromopride,223-842-2,4093-35-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,40,H332:39;H302:39;H312:39;Not classified:1
56909,Tetravinylstannane,214-193-6,1112-56-7,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,42,H301:42;H331:42;H311:42;H226:42
56916,"1,2,3,4-tetrahydrobenzo[h]quinolin-3-ol",226-556-6,5423-67-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:39
56920,(E)-non-2-ene,229-216-5,6434-78-2,Flam. Liq. 3,Notified C&L,43,H226:43
56927,Ethyl pyridine-2-carboxylate,219-758-0,2524-52-9,Not Classified,Notified C&L,133,Not classified:88;H315:40;H319:44;H335:39;H332:1;H302:1;H312:1
56930,Silicic acid,215-683-2,1343-98-2,Not Classified,Notified C&L,148,Not classified:148
56932,Strontium di(acetate),208-854-8,543-94-2,Not Classified,REACH registration C&L,90,Not classified:90
56933,"Protein hydrolyzates, vegetable",309-353-8,100209-45-8,Not Classified,REACH registration C&L,127,Not classified:126;H319:1
56934,"Phenol, 2,4-dinitro-, sulfurized, thiosulfonated",215-445-8,1326-83-6,Not Classified,REACH registration C&L,107,Not classified:107
56940,Hydrozincite,235-179-6,12122-17-7,Not Classified,Notified C&L,88,Not classified:62;H315:25;H319:25;H400:23;H410:22;H411:3
56943,C.I. Solvent Yellow 83:1,612-085-7,61116-27-6,Not Classified,Notified C&L,73,Not classified:73
56944,3-methyl-5-phenylpentan-1-al,611-227-5,55066-49-4,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,285,H315:285;H302:260;H411:260;H317:260
56945,trans-5-isopropyl-2-methylcyclohexan-1-one,207-887-5,499-70-7,Acute Tox. 4,Notified C&L,117,H302:93;Not classified:24
56952,"Amines, C12-14-tert-alkyl, ethoxylated",615-914-0,73138-27-9,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,96,H412:58;H318:96;H315:40;H335:38
56953,N-tert-butylcyclohexylamine,257-320-0,51609-06-4,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,38,H314:38;H226:38
56960,"Hexamethylene diisocyanate, oligomers, reaction products with 3-methoxypropylamine",500-740-9,162492-07-1,Not Classified,REACH registration C&L,156,Not classified:156
56963,4-Fluoro-3-methoxybenzaldehyde,603-276-6,128495-46-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,47,H315:47;H335:46;H302:40;H318:39;H319:8;H332:1;H312:1
56965,"Proteinase, Mucor aspartic",232-975-5,9073-79-4,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,46,H315:41;H319:41;H335:41;H334:46
56966,"6-methylheptane-2,4-dione",221-093-6,3002-23-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,47,H315:47;H319:47;H335:45;H226:44
56968,"(±)-2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-1-ol",413-570-4,,Aquatic Chronic 3,Harmonised C&L,0,H412:0
56970,(R)-1-hydroxy-1-phenylacetone,217-285-4,1798-60-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,85,H315:85;H302:85;H318:84;H319:1;H335:1
56972,"reaction mass of complexes of: titanium, 2,2'-oxydiethanol, ammonium lactate, nitrilotris(2-propanol) and ethylene glycol",405-250-8,,Aquatic Chronic 2,Harmonised C&L,0,H411:0
56973,Dibutyl adipate,203-350-4,105-99-7,Not Classified,REACH registration C&L,171,Not classified:149;H411:21;H361:1;H412:1
56975,Diisopropyl fumarate,230-707-1,7283-70-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
56983,7-Chloro-2-methylquinoline,610-466-2,4965-33-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H315:41;H319:41;H335:40;H332:1;H302:1;H312:1
56985,"2,6-dimethylpiperazine",203-588-9,108-49-6,Flam. Sol. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:43;H228:44;H335:42;H319:43;H318:1;H314:1
56987,Iron phosphide,247-751-2,26508-33-8,Not Classified,Notified C&L,6,Not classified:6
56990,Ethyl undec-10-enoate,211-734-8,692-86-4,Not Classified,REACH registration C&L,235,Not classified:235
56992,2-chloro-4-nitrobenzoic acid,202-771-0,99-60-5,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,52,H315:52;H335:51;H318:51;H319:1
56994,4-fluoro-3-nitrobenzoic acid,207-221-3,453-71-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H315:45;H319:45;H302:38;H335:44
56999,"reaction products of 3,10-bis((2-aminopropyl)amino)-6,13-dichloro-4,11-triphenodioxazinedisulfonic acid with 2-amino-1,4-benzenedisulfonic acid, 2-((4-aminophenyl)sulfonyl)ethyl hydrogen sulfate and 2,4,6-trifluoro-1,3,5-triazine, sodium salts",426-860-0,191877-09-5,Eye Dam. 1,Harmonised C&L,0,H318:0
57000,"Sodium 4-[4-[(3-chloro-2-hydroxy-5-nitrophenyl)azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonate",233-373-5,10132-99-7,Not Classified,REACH registration C&L,3,Not classified:3
57002,4-Methyl-2-(methylthio)pyrimidine,604-169-7,14001-63-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,43,H315:43;H335:39;H302:39;H318:39;H319:4
57004,3-Chloro-4-fluorotoluene,604-795-0,1513-25-3,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:39;H226:38
57006,"Cyclopent-4-ene-1,3-dione",213-219-3,930-60-9,Acute Tox. 4;Skin Sens. 1,Notified C&L,38,H302:38;H317:38
57008,"(±)-[(R*,R*) and (R*,S*)]-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran",419-600-2,99199-90-3,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H317:0
57012,Iodomethylmagnesium,213-031-1,917-64-6,Water-react. 1;Skin Corr. 1B,Notified C&L,42,H260:38;H314:42;H261:4;H226:4
57013,"Oils, almond, ethoxylated",602-972-7,124046-50-0,Not Classified,Notified C&L,36,Not classified:36
57014,1-chloro-3-methoxypropane,252-919-3,36215-07-3,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H315:2;H319:2;H226:2;H225:1
57015,"1,1,2-triphenylethanol",224-614-5,4428-13-1,Eye Dam. 1;Aquatic Chronic 4,Notified C&L,38,H318:38;H413:38
57017,Ethyl 4-hydroxycyclohexanecarboxylate,241-215-1,17159-80-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:40;H319:40;H335:40
57018,Piperidine-N-carbaldehyde,219-986-0,2591-86-8,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2,REACH registration C&L,49,H315:48;H302:49;H311:44;H319:47;H335:44;H312:5;H332:1;H412:1
57019,2-methoxyethylmercury chloride,204-659-7,123-88-6,Acute Tox. 3;Skin Corr. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H314:0;H372:0;H410:0;H301:0
57023,"1-(2,6-xylyl)piperazine",213-791-4,1012-91-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H315:2;H319:2;H335:2
57024,Piperonyl acetate,206-312-5,326-61-4,Acute Tox. 4;Skin Sens. 1B,REACH registration C&L,166,H302:1;H317:1;Not classified:164;H315:1;H319:1
57030,Methyl 3-chloro-3-oxopropionate,253-540-6,37517-81-0,Skin Corr. 1B;STOT SE 3,Notified C&L,51,H335:39;H314:51;H290:1;H318:2
57031,"Naphthenic acids, nickel salts",263-000-1,61788-71-4,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1;Muta. 2;Carc. 1A;Repr. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,63,H360:2;H350:2;H400:11;H341:2;H411:2;H302:4;H317:49;H334:2;H372:2;Not classified:12;H351:11;H410:9;H301:8;H226:2
57032,2-phenoxybutyric acid,237-449-9,13794-14-4,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
57033,"4-ethoxy-2,5-dimethylfuran-3(2H)-one",265-701-8,65330-49-6,Not Classified,Notified C&L,88,Not classified:88
57035,"2,6-dichlorobenzyl chloride",217-940-4,2014-83-7,Skin Corr. 1C;Eye Dam. 1;STOT SE 2;Aquatic Chronic 2,REACH registration C&L,68,H371:6;H318:7;H411:9;H314:65;Not classified:3;H315:3;H319:3;H335:3;H302:1
57039,"3,5-dichlorotoluene",246-722-1,25186-47-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H332:1;H319:1;H302:1;H312:1;H335:1
57041,"1,1,1,2,2-pentafluoro-4-iodobutane",255-055-5,40723-80-6,Acute Tox. 3;Eye Irrit. 2,Notified C&L,42,H319:41;H301:40;H331:1;H311:1;H315:1;H335:1;H225:1
57043,1-(3-chlorophenyl)piperazinium chloride,235-976-9,13078-15-4,,Notified C&L,4,H315:4;H319:4;H335:4;H301:4
57044,(+)-N-Ethyl-N-methyl-3-[1 (dimethylamino)ethyl]phenylcarbamate tartrate acid,603-318-3,129101-54-8,Acute Tox. 2,Notified C&L,9,H300:8;H411:4;H372:4;H335:1;H301:1
57045,Disodium [3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)][1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphtholato(2-)]chromate(2-),279-140-1,79371-81-6,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,12,H411:8;H319:9;Not classified:2;H410:1;H315:1
57046,1-(4-amino-3-fluorophenyl)ethan-1-one,277-610-0,73792-22-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H332:1;H319:1;H302:1;H312:1;H335:1
57047,Glycosyltransferase,232-890-3,9033-07-2,Resp. Sens. 1,Notified C&L,6,H334:6
57049,"Licorice, Glycyrrhiza echinata, ext.",290-006-1,90063-48-2,Not Classified,Notified C&L,1,Not classified:1
57050,"3,7-dimethylocta-2,6-dienoic acid",207-299-9,459-80-3,Acute Tox. 4,Notified C&L,308,H312:308;H315:44;H319:5;H335:5;H332:1;H302:1
57051,N-(4-amino-o-tolyl)-4-chlorophthalimide,261-173-8,58230-69-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
57058,"Iris germanica, ext.",285-368-2,85085-39-8,Not Classified,Notified C&L,89,Not classified:78;H226:11
57059,Maltose,200-716-5,69-79-4,Not Classified,REACH registration C&L,96,Not classified:96
57070,Sodium 2-amino-4-nitrophenoxide,262-914-8,61702-43-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1;H312:1
57075,p-isopropylphenyl isocyanate,250-439-9,31027-31-3,Skin Corr. 1C;Skin Sens. 1A;Eye Dam. 1;Acute Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,69,H330:30;H400:1;H410:1;H314:26;H318:26;H317:1;H335:69;H315:43;H332:39;H319:43;H302:39;H312:39;H334:29;H301:4
57078,4-(6-acryloyloxyhexyloxy)-benzoic acid (4-cyanophenyl ester),425-120-4,83847-14-7,Skin Sens. 1,REACH registration C&L,4,H317:4
57081,3-methoxybenzenethiol,239-617-7,15570-12-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,132,H315:132;H332:92;H319:132;H302:97;H312:93;H335:131;H300:33;H311:2;H331:3;H301:2
57082,"2-Pentenoic acid, 2,4-dimethyl-, ethyl ester, (2E)-",606-686-3,21016-46-6,Eye Irrit. 2,Notified C&L,79,H319:38;Not classified:37;H314:4
57085,p-benzyloxybenzyl chloride,212-649-9,836-43-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
57088,3-methylbutane-2-thiol,218-223-9,2084-18-6,Flam. Liq. 2,Notified C&L,1567,H225:1567;H315:6;H332:5;H319:6;H302:5;H335:5;H312:1
57089,Triethyloxonium tetrafluoroborate(1-),206-705-1,368-39-8,Skin Corr. 1B,Notified C&L,45,H314:45;H228:4;H318:1
57090,1-(2-Pyridinyl)ethylamine,640-812-8,42088-91-5,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,45,H315:40;H335:40;H318:40;H301:40;H314:5
57092,Diphenylethanedione dihydrazone,225-183-6,4702-78-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,38,H315:38;H400:38;H319:38;H302:38;H335:38
57095,disodium hexachloroplatinate,240-983-5,16923-58-3,Acute Tox. 3;Eye Dam. 1;Skin Sens. 1;Resp. Sens. 1,Harmonised C&L,0,H318:0;H317:0;H334:0;H301:0
57098,"2,9-diphenylanthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetrone",204-902-7,128-65-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
57108,Ternidazole,214-077-5,1077-93-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;STOT SE 3,Notified C&L,2,H315:1;H332:1;H319:1;H302:1;H312:1;H335:1;Not classified:1
57111,"Glycerol alpha,alpha'-Diallyl Ether",678-127-1,17018-07-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
57114,Yttrium chloride hexahydrate,233-801-0,10361-92-9,Skin Sens. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,49,H400:2;H410:2;H318:3;H317:3;H315:46;H319:46;H335:46;H332:5;H302:5;H312:5;H411:1;H290:1
57115,5-fluoro-o-toluidine,206-689-6,367-29-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47,H315:46;H332:46;H319:46;H302:46;H312:42;H335:39;H373:7;H311:5;H331:1;H301:1
57116,"D,L-asparagine monohydrate",221-521-1,3130-87-8,,Notified C&L,36,Not classified:36
57118,reaction mass of: pentaerythriol tetraesters with heptanoic acid and 2-ethylhexanoic acid,410-830-9,,Aquatic Chronic 4,Harmonised C&L,0,H413:0
57120,Linalyl formate,204-120-6,115-99-1,Flam. Liq. 4;Aquatic Chronic 3,REACH registration C&L,1626,H227:4;H412:1315;Not classified:311
57122,1-(3-chlorophenyl)-4-(3-chloropropyl)piperazine,254-529-9,39577-43-0,Acute Tox. 4,REACH registration C&L,4,H302:4;H332:1;H312:1;H360:1;H317:1;H341:1
57127,Butyl(ethyl)amine,236-415-0,13360-63-9,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1,REACH registration C&L,45,H302:45;H225:45;H314:45;H318:2;H335:1
57128,Toluene-4-sulphonohydrazide,216-407-3,1576-35-8,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Muta. 2;STOT RE 2;Aquatic Chronic 1,REACH registration C&L,172,H315:47;H319:48;H373:46;H341:47;H302:55;H317:46;H410:46;H301:117;H242:66;H411:15;H228:6
57130,Methyl anthranilate,205-132-4,134-20-3,Eye Irrit. 2,REACH registration C&L,2541,H319:2537;H315:197;H335:100;Not classified:7;H228:1
57131,Allyl isovalerate,220-609-7,2835-39-4,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1596,H301:1583;H311:1583;H226:1596;H315:38;H319:38;H335:38;H302:13;H312:13
57141,Tetraphenylphosphonium tetrakis(1-naphthoyloxy) borate (1-),429-410-1,182235-77-4,Aquatic Chronic 4,Notified C&L,3,H413:3
57142,Calcium disalicylate,212-525-4,824-35-1,Eye Irrit. 2,Notified C&L,67,H319:39;Not classified:28;H315:1;H318:1
57148,"5-(methylamino)-1,3,4-thiadiazole-2(3H)-thione",248-436-2,27386-01-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H302:39;H335:39
57150,"N,N'-methylenebisformamide",230-041-1,6921-98-8,Skin Sens. 1;Eye Irrit. 2,Notified C&L,43,H319:43;H317:38;H315:5;H335:4
57153,Cyclohex-1-ene-1-ethylamine,222-267-4,3399-73-3,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,45,H314:45;H226:45;H318:1
57155,Methyl (Z)-3-methylhex-2-enoate and Methyl (E)-3-methylhex-2-enoate,463-510-6,50652-80-7,Flam. Liq. 3,Notified C&L,24,H226:24
57157,Calcium phosphinate,232-190-8,7789-79-9,Flam. Sol. 2;Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,84,H228:83;H302:35;H319:9;Not classified:2;H318:1
57158,"Cardamon, Elettaria cardamomum robusta, ext.",296-818-2,93062-63-6,,Notified C&L,1,H410:1;H317:1;H226:1
57160,Asolectin,602-938-1,123465-35-0,Not Classified,Notified C&L,36,Not classified:36
57161,oxalic acid diethylester;diethyl oxalate,202-464-1,95-92-1,Acute Tox. 4;Eye Irrit. 2,Harmonised C&L,0,H319:0;H302:0
57169,(pentafluorophenoxy)acetyl chloride,259-676-2,55502-53-9,,Notified C&L,4,H314:4
57175,1-benzyl-N-phenylpiperidin-4-amine,214-583-6,1155-56-2,Acute Tox. 4;Skin Sens. 1B;Aquatic Chronic 1,REACH registration C&L,44,H410:1;H302:44;H317:1;H315:43;H319:43;H413:38;H335:43;H332:1;H312:1
57177,"Benzaldehyde, 4-[(2-fluorophenyl)methoxy]-",615-133-5,70627-20-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
57178,"1,3,5-tris-[(2S and 2R)-2,3-epoxypropyl]-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione",611-858-6,59653-74-6,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Acute Tox. 3;Muta. 1B;STOT RE 2,Notified C&L,1,H340:1;H373:1;H302:1;H318:1;H317:1;H331:1
57180,2-(chloromethyl)oxirane; Formaldehyde; Phenol,608-164-0,28064-14-4,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1556,H315:1474;H319:1470;H411:1520;H317:1525;Not classified:27;H335:6;H413:2;H400:1;H332:1;H302:1;H312:1
57181,2-bromo-N-[4-chloro-2-(2-chlorobenzoyl)phenyl]acetamide,226-844-1,5504-92-7,Not Classified,REACH registration C&L,3,Not classified:3
57182,Disodium dodecyl(sulphonatophenoxy)benzenesulphonate,249-063-8,28519-02-0,Not Classified,Notified C&L,961,Not classified:294;H411:518;H318:414;H319:252;H302:257;H413:126;H315:18;H317:1;H334:1
57183,2-(2-nitroethenyl)-1-benzoate benzeneethanol,604-110-5,139122-16-0,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H319:1;H410:1
57184,"4',5'-dibromo-3',6'-dihydroxyspiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one",209-876-0,596-03-2,Not Classified,REACH registration C&L,80,Not classified:37;H301:38;H315:5;H319:5;H335:5
57185,azoxybenzene,207-802-1,495-48-7,Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H302:0;H332:0
57188,N-[(tert-butoxy)carbonyl]-L-tryptophan,236-072-7,13139-14-5,Not Classified,Notified C&L,3,Not classified:2;H315:1;H319:1;H335:1
57189,"[2-[[4-[(2,6-dichloro-4-nitrophenyl)azo]phenyl]ethylamino]ethyl]trimethylammonium hydrogen sulphate",276-887-5,72828-75-2,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,2,H411:2;H319:2;H302:2
57190,Tris(pentafluorophenyl)phosphine,215-021-2,1259-35-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H315:46;H319:46;H335:45
57191,"3,4,3',4'-tetraphenyl-1,1'-ethandiylbispyrol-2,5-dione",431-500-0,226065-73-2,Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0,H413:0;H317:0
57193,"1'-(phenylmethyl)-[1,4'-bipiperidine]-4'-carbonitrile",282-544-0,84254-97-7,Acute Tox. 3;Skin Sens. 1B;Muta. 2;Aquatic Chronic 2,REACH registration C&L,2,H411:1;H317:1;H341:1;H301:1;H332:1;H302:1;H312:1
57195,"4,4'-Methylenediphenyl diisocyanate, oligomeric reaction products with 2,4'-diisocyanatodiphenylmethane, [(methylethylene)bis(oxy)]dipropanol and oxydipropanol",500-439-2,159168-82-8,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 2;STOT RE 2,Notified C&L,71,H315:69;H332:69;H319:71;H373:69;H351:69;H317:71;H334:71;H335:69
57198,Dodecylphenol,248-312-8,27193-86-8,Skin Irrit. 2;Eye Irrit. 2;Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,623,H315:525;H400:563;H319:500;H361:500;H410:563;H413:55;H314:41;Not classified:2
57201,Diphenyl azodicarboxylate,219-510-1,2449-14-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
57204,"1,3,5-TRIAZINE-2,4,6-TRIAMINE, POLYMER WITH FORMALDEHYDE",618-354-5,9003-08-1,Not Classified,Notified C&L,215,Not classified:129;H410:57;H412:26;H317:2;H315:1;H319:1;H334:1
57206,Disodium di-2-naphthylmethanedisulphonate,267-188-6,67801-68-7,Not Classified,Notified C&L,3,Not classified:3
57208,"(1R,2S,5R)-5-methyl-2-(propan-2-yl)-N-[2-(pyridin-2-yl)ethyl]cyclohexanecarboxamide",700-097-6,847565-09-7,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,1375,H412:1375;H302:1375
57209,"Dioxobis(pentane-2,4-dionato-O,O')molybdenum",241-522-0,17524-05-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,44,H315:44;H332:39;H319:44;H351:38;H302:43;H312:39;H335:43
57210,Oct-1-en-3-one,224-327-5,4312-99-6,Acute Tox. 4,Notified C&L,1592,H302:1548;H226:71;H315:6;H319:6;H301:1
57211,"1-(3,5-dihydroxyphenyl)ethan-1-one",257-480-1,51863-60-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,52,H315:52;H319:52;H335:51
57219,"3,3',4',7-tetrahydroxyflavone",208-434-4,528-48-3,,Notified C&L,8,H315:7;H319:7;H335:6;Not classified:1
57221,cerium oxide isostearate,419-760-3,,Aquatic Chronic 4,Harmonised C&L,0,H413:0
57222,Iron orthophosphate,233-149-7,10045-86-0,Not Classified,REACH registration C&L,148,Not classified:96;H315:49;H319:50;H335:50;H412:2
57223,Cyanomethyl(methyl)ammonium chloride,247-277-6,25808-30-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:39;H319:39;H335:38;H332:1;H302:1;H312:1
57226,Terephthalohydrazide,205-253-2,136-64-1,Acute Tox. 4,Notified C&L,44,H302:38;H315:6;H319:6;H335:5
57227,Vanadyl Oxalate n-Hydrate,604-991-6,15500-04-6,Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:2;H332:1;H335:1
57229,"Benzoic acid, 6-[7-[5-ethyl-5-(5-ethyltetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl)tetrahydro-3-methyl-2-furanyl]-4-hydroxy-3,5-dimethyl-6-oxononyl]-2-hydroxy-3-methyl-, monosodium salt, [2R-[2α[2S*(3R*,4S*,5S*,7R*),3S*,5S*],5α,6β]]-",247-400-3,25999-20-6,Acute Tox. 3,Notified C&L,195,H301:194;Not classified:1
57231,"Benzenesulfonic acid, hydroxy[(4-hydroxyphenyl)sulfonyl]-, reaction products with formaldehyde and urea",296-377-6,92623-48-8,Not Classified,Notified C&L,1,Not classified:1
57233,Agar,232-658-1,9002-18-0,Not Classified,Notified C&L,167,Not classified:167
57234,"dapsone;4,4'-diamino diphenyl sulfone",201-248-4,80-08-0,Acute Tox. 4,Harmonised C&L,0,H302:0
57239,4-[(5-carbamoyl-o-tolyl)azo]-3-hydroxynaphth-2-anilide,240-454-9,16403-84-2,Not Classified,REACH registration C&L,30,Not classified:29;H412:1;H312:1;H341:1
57241,nickel boride (NiB),234-493-0,12007-00-0,Skin Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0,H350:0;H400:0;H317:0;H372:0;H410:0
57242,Tetrahexylgermanium,225-407-2,4828-44-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H332:38;H302:38;H312:38
57247,"2',3',4'-trihydroxyacetophenone",208-430-2,528-21-2,,Notified C&L,5,H315:5;H319:5;H335:4
57253,Cytidine 5'-(disodium dihydrogen triphosphate),252-849-3,36051-68-0,Not Classified,Notified C&L,2,Not classified:2
57255,"Fennel, Foeniculum vulgare vulgare, ext.",296-407-8,92623-75-1,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Muta. 2;Carc. 2;STOT SE 2;STOT SE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,53,H315:53;H371:31;H304:52;H400:52;H341:52;H351:52;H317:52;H226:41;H410:52;H319:1
57256,"Rosin, reaction products with bisphenol A, formaldehyde, glycerol and 4-(1,1,3,3-tetramethylbutyl)phenol",293-658-5,91081-52-6,Not Classified,Notified C&L,13,Not classified:13
57260,Tris(2-chloropropyl) phosphate,228-150-4,6145-73-9,,Notified C&L,33,Not classified:33
57263,"Oils, animal, sulfated, sodium salts",304-835-4,94279-90-0,Not Classified,REACH registration C&L,52,Not classified:52
57265,2-tert-butylcyclohexyl ethyl carbonate,267-184-4,67801-64-3,Aquatic Chronic 2,REACH registration C&L,1586,H411:37;H412:1549
57274,"Disodium 5-amino-4-hydroxy-3-(phenylazo)naphthalene-2,7-disulphonate",222-656-9,3567-66-6,Not Classified,REACH registration C&L,386,Not classified:113;H319:273;H335:10
57275,3-hydroxy-N-1-naphthyl-2-naphthamide,205-075-5,132-68-3,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H400:38;H410:38
57281,"Thiophene, 3-(methylthio)-",606-615-6,20731-74-2,Not Classified,Notified C&L,1,Not classified:1
57286,"2,5-dinitrothiophen-2-amine",218-065-0,2045-70-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
57291,Hydrazine derivative,449-460-8,,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 1,Notified C&L,1,H302:1;H318:1;H317:1;H310:1;H410:1
57292,"Aspartic acid, N-(1,2-dicarboxyethyl)-, sodium salt (1:4)",604-420-0,144538-83-0,,Notified C&L,71,Not classified:71
57293,"2,4-dichloro-α,α,α-trifluorotoluene",206-278-1,320-60-5,Skin Corr. 1B,Notified C&L,45,H314:44;H411:1;H318:1
57295,Chlorosulphonyl fluoride,237-126-2,13637-84-8,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 3,Notified C&L,38,H314:38;H318:38;H311:38;H331:38;H301:38
57296,Aluminium(III) tris(monomethyl methylphosphonate),403-680-0,,Not Classified,Notified C&L,1,Not classified:1
57298,"Resin acids and Rosin acids, maleated, sodium salts",269-228-8,68201-60-5,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,46,H411:10;H318:12;H317:12;Not classified:34
57300,"Phenol, 4-[4-[4-(trifluoromethoxy)phenoxy]-1-piperidinyl]-, 4-methylbenzenesulfonate (1:1)",617-895-4,866109-93-5,,Notified C&L,33,Not classified:33
57306,Methyl tetracosanoate,219-475-2,2442-49-1,Not Classified,Notified C&L,6,Not classified:5;H318:1
57307,(S)-4-oxo-4-[(1-phenylethyl)amino]butyric acid,244-569-5,21752-34-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
57314,2-ethylbenzofuran,221-524-8,3131-63-3,Not Classified,Notified C&L,2,Not classified:2
57322,"Resin acids and Rosin acids, esters with diethylene glycol",268-884-2,68153-38-8,Not Classified,REACH registration C&L,22,Not classified:20;H315:1;H319:1;H413:1
57328,4-fluorophenylhydrazine hydrochloride,212-521-2,823-85-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,82,H315:82;H319:51;H335:50;H400:31;H351:33;H318:31;H311:31;H331:31;H410:31;H301:31;H302:8;H332:3;H312:3;H317:1
57332,"Benzoic acid, 4-hydroxy-, isodecyl ester, polymer with formaldehyde",468-870-8,872418-55-8,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,4,H319:4;H413:4;H317:4
57333,"3,7-DIMETHYLOCTA-1,6-DIEN-3-YL DIMETHYLCARBAMATE",466-280-5,,Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,1287,H315:1287;H411:1287;H400:1
57336,"Galactaric acid, compound with N,1,5-trimethylhex-4-en-1-ylamine (1:2)",231-315-3,7492-31-1,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H332:1;H319:1;H302:1;H312:1
57342,1-(dichloromethyl)-2-(trifluoromethyl)benzene,615-161-8,707-72-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H315:1;H319:1;H335:1;H332:1;H314:1;H302:1;H312:1;H318:1
57346,(2-hydroxyethyl)(2-hydroxyhexadecyl)dimethylammonium chloride,283-450-2,84643-53-8,Skin Corr. 1C;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,106,H400:83;H410:106;H318:105;H314:106
57350,Red RWa 4681 (notification presscake),461-090-9,,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,37,H412:37;H318:37;H317:37
57352,Dipotassium heptafluoroniobate,240-987-7,16924-03-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:39;H319:39;H335:39;H302:5;H332:5;H312:1
57355,"Benzoic acid, 2-hydroxy-, polymer with formaldehyde and 2-methylphenol",614-371-7,68189-17-3,Not Classified,Notified C&L,36,Not classified:36
57356,"2,2'-[methylenebis(thio)]bisacetic acid",218-189-5,2068-24-8,Acute Tox. 4;Eye Irrit. 2,Notified C&L,42,H319:42;H302:38;H315:4;H335:4
57357,"4,4'-[(3,3'-dimethoxy[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[2,4-dihydro-5-methyl-2-(p-tolyl)-3H-pyrazol-3-one]",229-986-2,6883-91-6,Not Classified,Notified C&L,1,Not classified:1
57358,Bis(nonylphenyl) phosphonate,247-811-8,26569-08-4,Not Classified,Notified C&L,2,Not classified:2
57359,Tetrakis(decyl)ammonium bromide,239-013-3,14937-42-9,,Notified C&L,2,Not classified:1;H315:1;H319:1
57361,"1-Methyl-4-[(trans,trans)-4'-propyl[1,1'-bicyclohexyl]-4-yl] -benzene",617-606-1,84656-75-7,Not Classified,REACH registration C&L,1,Not classified:1
57362,Polypropylene,618-352-4,9003-07-0,Not Classified,Notified C&L,313,Not classified:311;H228:2
57364,"1-Brom-3,5-difluorbenzol",610-286-4,461-96-1,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,45,H315:44;H400:43;H373:43;H302:44;H317:44;H226:45;H410:43;H319:1;H411:1;Not classified:1
57368,Diethyl [2-(cyclohexylamino)vinyl]phosphonate,243-492-4,20061-84-1,Skin Corr. 1B,Notified C&L,40,H314:38;Not classified:1;H315:1;H319:1;H335:1
57371,Periciazine,220-071-3,2622-26-6,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Acute Tox. 4,Notified C&L,2,H332:1;H302:2;H312:1;H317:2
57376,Methyl 4-(acetylamino)-5-bromo-o-anisate,223-841-7,4093-34-9,Aquatic Chronic 2,REACH registration C&L,6,H411:4;Not classified:1;H315:1;H319:1;H302:1;H335:1
57377,"3,4,7,8-tetramethyl-1,10-phenanthroline",216-762-4,1660-93-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H332:1;H319:1;H302:1;H312:1;H335:1
57384,"Adipic acid, compound with 1,4-bis(3-aminopropyl)piperazine (1:1)",226-555-0,5423-61-0,Not Classified,Notified C&L,1,Not classified:1
57387,"Trisodium dihydrogen -N,N-[bis[2-[bis(carboxylatomethyl)amino]ethyl]]glycinate",235-979-5,13078-36-9,Repr. 2,REACH registration C&L,42,H361:3;Not classified:37;H315:2;H319:2;H373:1;H332:1;H290:1
57393,"Barium 3,5,5-trimethylhexanoate",252-917-2,36211-43-5,Acute Tox. 4;Eye Dam. 1;Acute Tox. 4,REACH registration C&L,2,H302:2;H332:2;H318:2
57397,[No public or meaningful name is available],476-120-6,,Not Classified,Notified C&L,1,Not classified:1
57400,Dialuminium silicate,245-167-2,22708-90-3,,Notified C&L,3,Not classified:3
57405,"Reaction mass of 2-chloro-N-[9,10-dioxo-4-(phenylsulfanyl)-9,10-dihydroanthracen-1-yl]benzamide and 3-chloro-N-[9,10-dioxo-4-(phenylsulfanyl)-9,10-dihydroanthracen-1-yl]benzamide and 4-chloro-N-[9,10-dioxo-4-(phenylsulfanyl)-9,10-dihydroanthracen-1-yl]benzamide",439-570-4,,Aquatic Chronic 4,Notified C&L,1,H413:1
57406,"2-Hexanone, 3-hydroxy-5-methyl-",605-311-0,163038-04-8,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,87,H315:87;H319:87;H332:77;H335:87;H331:10
57414,"2,2'-dithiobis[5-chloroaniline]",249-453-8,29124-55-8,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H315:38;H400:38;H410:38;H318:38;H335:38
57415,"Smilax japecanga, ext.",309-354-3,100209-47-0,Not Classified,Notified C&L,1,Not classified:1
57417,(chloromethyl)triphenylphosphonium chloride,226-139-9,5293-84-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:38
57420,"Hexanedioic acid, mixed esters with decanoic acid, heptanoic acid, octanoic acid and pentaerythritol",268-597-2,68130-55-2,Skin Sens. 1,REACH registration C&L,12,H317:2;Not classified:10
57426,Dodecyl(2-hydroxyethyl)dimethylammonium bromide,230-289-0,7009-61-2,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
57433,"[(1,1-dimethyl-2-propynyl)oxy]trimethylsilane",241-823-7,17869-77-1,Flam. Liq. 2,Notified C&L,43,H225:43;H315:4;H319:4;H335:4
57436,"Ethyl 2-methylpenta-3,4-dienoate",262-278-1,60523-21-9,Flam. Liq. 3;Acute Tox. 4,REACH registration C&L,226,H302:226;H226:226
57438,Oxymesterone,205-646-9,145-12-0,Repr. 2,Notified C&L,1,H361:1
57441,"4,4,4-trifluoro-1-(2-thienyl)butane-1,3-dione",206-316-7,326-91-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,140,H315:139;H319:139;H335:136;Not classified:1;H332:1;H302:1;H312:1
57442,"2,7-naphthalenedisulfonic acid, 4-amino-5-hydroxy-, diazotized, coupled with diazotized 2-amino-4,6-dinitrophenol, diazotized 4-nitrobenzenamine and resorcinol, sodium salts",232-380-0,8011-86-7,Eye Irrit. 2,REACH registration C&L,108,H319:78;Not classified:29;H412:5;H317:1
57446,fentin hydroxide (ISO);triphenyltin hydroxide,200-990-6,76-87-9,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 2;STOT SE 3;Carc. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H315:0;H330:0;H400:0;H410:0;H351:0;H361:0;H318:0;H372:0;H311:0;H335:0;H301:0
57448,"4,5-dihydro-1-[3-(triethoxysilyl)propyl]-1H-imidazole",261-093-3,58068-97-6,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B,Notified C&L,71,H302:38;H312:38;H314:38;H315:33;H319:33;H335:33
57450,"(3R,4S,5R,6R)-3,4,5-tris[(trimethylsilanyl)oxy]-6-{[(trimethylsilanyl)oxy]methyl}tetrahydro-2H-pyran-2-one",608-732-8,32384-65-9,Not Classified,REACH registration C&L,4,Not classified:4
57453,(chloromethyl)pentafluorobenzene,211-501-0,653-35-0,,Notified C&L,6,H332:5;H302:5;H312:5;H314:5;H315:1;H319:1;H335:1
57454,Diphenyl phosphorochloridate,219-759-6,2524-64-3,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,56,H314:56;H411:6;H302:7;H317:6;H335:6;H290:2;H318:2
57455,Phenyltoloxamine dihydrogen citrate,214-644-7,1176-08-5,Acute Tox. 4,Notified C&L,43,H302:43;H332:1;H312:1
57457,"Reaction mass of Benzene sulfonic acid, hexadecyl(sulfophenoxy)-,disodium salt and Benzene sulfonic acid, - oxibis[hexadecyl]-, disodium salt",405-430-6,65143-89-7,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,59,H400:4;H410:3;H318:59;H411:55
57458,Neodymium citrate,221-096-2,3002-54-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
57459,p-(dimethylamino)benzohydrazide,242-985-1,19353-92-5,Acute Tox. 4;Skin Sens. 1;Carc. 2,Notified C&L,43,H351:38;H302:38;H317:38;H315:5;H319:5;H335:5
57462,12-wolframophosphoric acid,215-682-7,1343-93-7,Skin Corr. 1B,Notified C&L,10,H314:8;H318:2;H319:2;H290:2;Not classified:1
57465,Fettsäurepolyglykoletherester,600-721-6,106168-35-8,Aquatic Chronic 3,Notified C&L,34,H412:34
57468,4-hydroxy-1-methyl-3-[(3-nitrophenyl)azo]-2-quinolone,229-219-1,6439-53-8,Aquatic Chronic 2,Notified C&L,9,H411:9
57471,boron trichloride,233-658-4,10294-34-5,Press. Gas;Acute Tox. 2;Skin Corr. 1B;Acute Tox. 2,Harmonised C&L,0,H300:0;Not classified:0;H314:0;H330:0
57473,3-Mercaptohexyl Acetate,603-987-1,136954-20-6,Not Classified,Notified C&L,94,Not classified:89;H315:5;H319:5;H335:4;H224:1
57474,"D-Glucose, reaction products with alcohols C16-18 (excess)",928-176-2,,Not Classified,Notified C&L,83,Not classified:83
57476,"1-Piperidinyloxy, 4-(acetylamino)-2,2,6,6-tetramethyl-",604-549-2,14691-89-5,Acute Tox. 4;Eye Irrit. 2,Notified C&L,198,H319:160;H302:194;H315:4;H335:4
57478,Phenicarbazide,203-072-3,103-03-7,Acute Tox. 4,Notified C&L,44,H302:39;H315:6;H319:6;H335:5;H351:5
57479,"cis-1,2-Cyclohexanediamine",604-372-0,1436-59-5,Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,43,H318:3;H317:2;H314:43
57481,Octadecyl 5-oxo-L-prolinate,225-571-5,4931-72-0,Not Classified,Notified C&L,1,Not classified:1
57482,"Tar, coal, high-temp., distn. and storage residues;Coal Tar Solids Residue;[Coke- and ash-containing solid residues that separate on distillation and thermal treatment of bituminous coal high temperature tar in distillation installations and storage vessels. Consists predominantly of carbon and contains a small quantity of hetero compounds as well as ash components.]",295-535-1,92062-20-9,Carc. 1B,Harmonised C&L,0,H350:0
57483,"1,3-Butadiene, 2-methyl-, polymer with 2-methyl-1-propene, brominated",614-497-2,68441-14-5,,Notified C&L,55,Not classified:55
57485,"(1E,5E,9Z)-cyclododeca-1,5,9-triene",211-893-3,706-31-0,Acute Tox. 3;Aquatic Chronic 2,Notified C&L,43,H331:39;H411:42;H315:5;H332:4;H319:5;H317:4;H335:4;H311:1;H301:1
57490,"2-(Chloromethyl)-4-methoxy-3,5-dimethylpyridine",617-518-3,84006-10-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
57492,4-amino-N-methylaniline,210-770-1,623-09-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H332:1;H319:1;H302:1;H312:1;H335:1
57496,"Disodium 2,2'-(5,8-dihydroxy-9,10-dioxoanthracene-1,4-diyldiimino)bis(5-methylbenzenesulphonate",224-617-1,4430-16-4,Aquatic Chronic 3,Notified C&L,3,H412:3
57498,"α,α-diphenylpiperidine-4-methanol hydrochloride",217-284-9,1798-50-1,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,1,H319:1;H302:1
57500,tert-pentyl hydroperoxide,222-321-7,3425-61-4,Flam. Liq. 3;Org. Perox. E;Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Acute Tox. 3;Muta. 2;Aquatic Chronic 2,REACH registration C&L,25,H226:22;H341:4;H314:25;H411:9;H302:25;H318:9;H317:9;H311:9;H331:8;H242:25;H332:17;H312:16
57504,Calcium iodate,232-191-3,7789-80-2,Ox. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,196,H315:132;H272:146;H335:132;H319:132;H302:52;H314:43;H371:4;H370:5;H271:1
57506,"1,2-Ethanediyl bisacrylate",607-960-5,26570-48-9,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,553,H315:373;H318:415;H317:436;Not classified:68;H335:79;H319:69;H411:41;H302:2
57509,"Proteinase, Bacillus alkaline",232-972-9,9073-77-2,Not Classified,Notified C&L,2,Not classified:2
57511,SOLVENT BLUE 43,612-411-8,61813-75-0,Not Classified,REACH registration C&L,3,Not classified:3
